The table below lists the options of the executed module.
Option | Value |
---|---|
analyze.sites | yes |
region.types | tiling, genes, promoters, cpgislands |
differential.permutations | 0 |
differential.comparison.columns | cmp_ESC_vs_differentiated, cmp_colon_tumor_vs_normal, cmp_brain_AD_vs_normal, cmp_derGermLayer_meso_vs_ecto, cmp_derGermLayer_meso_vs_endo, cmp_derGermLayer_endo_vs_ecto |
differential.comparison.columns.all.pairwise | default |
columns.pairing | default |
differential.site.test.method | limma |
covariate.adjustment.columns | default |
differential.adjustment.sva | yes |
differential.adjustment.celltype | yes |
differential.enrichment | yes |
Differential methylation analysis was conducted on site and region level according to the sample groups specified in the analysis.
The following comparisons were made:
In the following anlyses, p-values on the site level were computed using the limma
method. I.e. hierarchical linear models from the limma package were employed and fitted using an empirical Bayes approach on derived M-values.
Differential methylation on the site level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each site: a) the difference in mean methylation levels of the two groups being compared, b) the quotient in mean methylation and c) a statistical test (t-test or limma depending on the settings) assessing whether the methylation values in the two groups originate from distinct distributions. Additionally each site was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) rank among the three ranks. The smaller the combined rank for a site, the more evidence for differential methylation it exhibits. This section includes scatterplots of the site group means as well as volcano plots of each pairwise comparison colored according to the combined ranks or p-values of a given site.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated sites:
Rank Cutoff | |
ESC vs. derived (based on cmp_ESC_vs_differentiated) | 4320614 |
normal vs. tumor (based on cmp_colon_tumor_vs_normal) | 0 |
AD vs. control (based on cmp_brain_AD_vs_normal) | 4105800 |
ectoderm vs. mesoderm (based on cmp_derGermLayer_meso_vs_ecto) | 3783408 |
endoderm vs. mesoderm (based on cmp_derGermLayer_meso_vs_endo) | 3882234 |
ectoderm vs. endoderm (based on cmp_derGermLayer_endo_vs_ecto) | 3636816 |
comparison | |
differential methylation measure |
Scatterplot for differential methylation (sites). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. If the number of points exceeds 2e+06 then the number of points for density estimation is reduced to that number by random sampling.The1% of the points in the sparsest populated plot regions are drawn explicitly (up to a maximum of 10000 points).Additionally, the colored points represent differentially methylated sites (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the site level for the individual comparisons are provided in this section. Below, a brief explanation of the different columns can be found:
Differential methylation on the region level was computed based on a variety of metrics. Of particular interest for the following plots and analyses are the following quantities for each region: the mean difference in means across all sites in a region of the two groups being compared and the mean of quotients in mean methylation as well as a combined p-value calculated from all site p-values in the region [1]. Additionally each region was assigned a rank based on each of these three criteria. A combined rank is computed as the maximum (i.e. worst) value among the three ranks. The smaller the combined rank for a region, the more evidence for differential methylation it exhibits. Regions were defined based on the region types specified in the analysis. This section includes scatterplots of the region group means as well as volcano plots of each pairwise comparison colored according to the combined rank of a given region.
The following rank cutfoffs have been automatically selected for the analysis of differentially methylated regions:
tiling | genes | promoters | cpgislands | |
ESC vs. derived (based on cmp_ESC_vs_differentiated) | 4931 | 2317 | 349 | 145 |
normal vs. tumor (based on cmp_colon_tumor_vs_normal) | 0 | 0 | 0 | 0 |
AD vs. control (based on cmp_brain_AD_vs_normal) | 165 | 1395 | 265 | 218 |
ectoderm vs. mesoderm (based on cmp_derGermLayer_meso_vs_ecto) | 669 | 1062 | 74 | 225 |
endoderm vs. mesoderm (based on cmp_derGermLayer_meso_vs_endo) | 1774 | 1399 | 162 | 328 |
ectoderm vs. endoderm (based on cmp_derGermLayer_endo_vs_ecto) | 439 | 1056 | 91 | 143 |
comparison | |
regions | |
differential methylation measure |
Scatterplot for differential methylation (regions). If the selected criterion is not rankGradient
:
The transparency corresponds to point density. The 1% of the points in the sparsest populated plot regions are drawn explicitly.
Additionally, the colored points represent differentially methylated regions (according to the selected criterion).
If the selected criterion is rankGradient
: median combined ranks accross hexagonal bins are shown
as a gradient according to the color legend.
comparison | |
regions | |
difference metric | |
significance metric |
Volcano plot for differential methylation quantified by various metrics. Color scale according to combined ranking.
A tabular overview of measures for differential methylation on the region level for the individual comparisons are provided in this section.
The tables for the individual comparisons can be found here:
tiling | genes | promoters | cpgislands | |
ESC vs. derived (based on cmp_ESC_vs_differentiated) | csv | csv | csv | csv |
normal vs. tumor (based on cmp_colon_tumor_vs_normal) | csv | csv | csv | csv |
AD vs. control (based on cmp_brain_AD_vs_normal) | csv | csv | csv | csv |
ectoderm vs. mesoderm (based on cmp_derGermLayer_meso_vs_ecto) | csv | csv | csv | csv |
endoderm vs. mesoderm (based on cmp_derGermLayer_meso_vs_endo) | csv | csv | csv | csv |
ectoderm vs. endoderm (based on cmp_derGermLayer_endo_vs_ecto) | csv | csv | csv | csv |
Enrichment Analysis was conducted. The wordclouds and tables below contains significant GO terms as determined by a hypergeometric test.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
Wordclouds for GO enrichment terms.
comparison | |
Hypermethylation/hypomethylation | |
ontology | |
regions | |
differential methylation measure |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 162.9451 | 0.1211 | 4 | 368 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 134.7397 | 0.1454 | 4 | 442 | detection of chemical stimulus |
GO:0050906 | 0 | 132.2511 | 0.1481 | 4 | 450 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 130.4425 | 0.15 | 4 | 456 | sensory perception of chemical stimulus |
GO:0007186 | 1e-04 | 50.5984 | 0.3675 | 4 | 1117 | G-protein coupled receptor signaling pathway |
GO:0050877 | 2e-04 | 48.0274 | 0.3856 | 4 | 1172 | neurological system process |
GO:0044707 | 0.0093 | Inf | 1.9639 | 5 | 5969 | single-multicellular organism process |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0006351 | 0 | 6.8612 | 6.5215 | 20 | 3197 | transcription, DNA-templated |
GO:0034654 | 0 | 6.7444 | 7.3884 | 21 | 3622 | nucleobase-containing compound biosynthetic process |
GO:0016070 | 0 | 5.2305 | 8.0208 | 20 | 3932 | RNA metabolic process |
GO:0021530 | 0 | 1045.8621 | 0.0061 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0045666 | 0 | 30.2142 | 0.1591 | 4 | 78 | positive regulation of neuron differentiation |
GO:0010629 | 0 | 6.8113 | 2.0419 | 10 | 1001 | negative regulation of gene expression |
GO:0045934 | 0 | 6.653 | 2.0868 | 10 | 1023 | negative regulation of nucleobase-containing compound metabolic process |
GO:0009059 | 0 | 4.5871 | 8.8225 | 20 | 4325 | macromolecule biosynthetic process |
GO:0021510 | 0 | 25.9776 | 0.1836 | 4 | 90 | spinal cord development |
GO:0048665 | 0 | 57.926 | 0.0632 | 3 | 31 | neuron fate specification |
GO:0021779 | 0 | 348.5747 | 0.0102 | 2 | 5 | oligodendrocyte cell fate commitment |
GO:0021780 | 0 | 348.5747 | 0.0102 | 2 | 5 | glial cell fate specification |
GO:0007423 | 0 | 9.0208 | 0.9832 | 7 | 482 | sensory organ development |
GO:0009890 | 0 | 6.1192 | 2.2541 | 10 | 1105 | negative regulation of biosynthetic process |
GO:1902679 | 1e-04 | 6.562 | 1.8338 | 9 | 899 | negative regulation of RNA biosynthetic process |
GO:0032502 | 1e-04 | 4.3878 | 10.0566 | 21 | 4930 | developmental process |
GO:1902680 | 1e-04 | 5.8367 | 2.354 | 10 | 1154 | positive regulation of RNA biosynthetic process |
GO:0046483 | 1e-04 | 4.5177 | 12.0781 | 23 | 5921 | heterocycle metabolic process |
GO:0006725 | 1e-04 | 4.5002 | 12.1067 | 23 | 5935 | cellular aromatic compound metabolic process |
GO:0010628 | 1e-04 | 5.5121 | 2.4805 | 10 | 1216 | positive regulation of gene expression |
GO:0044249 | 1e-04 | 4.146 | 10.4442 | 21 | 5120 | cellular biosynthetic process |
GO:2000113 | 1e-04 | 5.9025 | 2.0236 | 9 | 992 | negative regulation of cellular macromolecule biosynthetic process |
GO:0034641 | 1e-04 | 4.2635 | 12.5065 | 23 | 6131 | cellular nitrogen compound metabolic process |
GO:1901360 | 1e-04 | 4.2624 | 12.5085 | 23 | 6132 | organic cyclic compound metabolic process |
GO:0000122 | 1e-04 | 7.3879 | 1.1892 | 7 | 583 | negative regulation of transcription from RNA polymerase II promoter |
GO:0021892 | 1e-04 | 149.3498 | 0.0184 | 2 | 9 | cerebral cortex GABAergic interneuron differentiation |
GO:0055123 | 2e-04 | 16.8732 | 0.2774 | 4 | 136 | digestive system development |
GO:0007399 | 2e-04 | 4.5404 | 3.8023 | 12 | 1864 | nervous system development |
GO:0007420 | 2e-04 | 8.6992 | 0.8607 | 6 | 463 | brain development |
GO:0031018 | 2e-04 | 31.7542 | 0.1102 | 3 | 54 | endocrine pancreas development |
GO:0006335 | 2e-04 | 130.6724 | 0.0204 | 2 | 10 | DNA replication-dependent nucleosome assembly |
GO:0065007 | 2e-04 | 8.0245 | 19.9745 | 29 | 9792 | biological regulation |
GO:0045944 | 2e-04 | 6.0931 | 1.687 | 8 | 827 | positive regulation of transcription from RNA polymerase II promoter |
GO:0045935 | 2e-04 | 5.0033 | 2.709 | 10 | 1328 | positive regulation of nucleobase-containing compound metabolic process |
GO:0050794 | 3e-04 | 9.0274 | 8.4683 | 16 | 5630 | regulation of cellular process |
GO:0021954 | 3e-04 | 25.2824 | 0.1367 | 3 | 67 | central nervous system neuron development |
GO:2000112 | 3e-04 | 4.9542 | 3.7062 | 11 | 2393 | regulation of cellular macromolecule biosynthetic process |
GO:0009891 | 3e-04 | 4.6457 | 2.8966 | 10 | 1420 | positive regulation of biosynthetic process |
GO:0060581 | 4e-04 | 80.3873 | 0.0306 | 2 | 15 | cell fate commitment involved in pattern specification |
GO:0016577 | 5e-04 | 69.6598 | 0.0347 | 2 | 17 | histone demethylation |
GO:0021514 | 5e-04 | 69.6598 | 0.0347 | 2 | 17 | ventral spinal cord interneuron differentiation |
GO:0008214 | 7e-04 | 61.4564 | 0.0388 | 2 | 19 | protein dealkylation |
GO:0021513 | 0.0012 | 45.4063 | 0.051 | 2 | 25 | spinal cord dorsal/ventral patterning |
GO:0021871 | 0.0012 | 45.4063 | 0.051 | 2 | 25 | forebrain regionalization |
GO:0044707 | 0.0012 | 3.2545 | 12.176 | 21 | 5969 | single-multicellular organism process |
GO:2001141 | 0.0019 | 5.2603 | 1.9493 | 7 | 1465 | regulation of RNA biosynthetic process |
GO:0014003 | 0.0019 | 34.7954 | 0.0653 | 2 | 32 | oligodendrocyte development |
GO:0021543 | 0.0019 | 13.5477 | 0.2489 | 3 | 122 | pallium development |
GO:0003327 | 0.002 | Inf | 0.002 | 1 | 1 | type B pancreatic cell fate commitment |
GO:0003359 | 0.002 | Inf | 0.002 | 1 | 1 | noradrenergic neuron fate commitment |
GO:0007400 | 0.002 | Inf | 0.002 | 1 | 1 | neuroblast fate determination |
GO:0021858 | 0.002 | Inf | 0.002 | 1 | 1 | GABAergic neuron differentiation in basal ganglia |
GO:0060165 | 0.002 | Inf | 0.002 | 1 | 1 | regulation of timing of subpallium neuron differentiation |
GO:0060580 | 0.002 | Inf | 0.002 | 1 | 1 | ventral spinal cord interneuron fate determination |
GO:0061100 | 0.002 | Inf | 0.002 | 1 | 1 | lung neuroendocrine cell differentiation |
GO:0061103 | 0.002 | Inf | 0.002 | 1 | 1 | carotid body glomus cell differentiation |
GO:0071259 | 0.002 | Inf | 0.002 | 1 | 1 | cellular response to magnetism |
GO:0021522 | 0.0022 | 32.6164 | 0.0694 | 2 | 34 | spinal cord motor neuron differentiation |
GO:0048663 | 0.0022 | 32.2692 | 0.0702 | 2 | 38 | neuron fate commitment |
GO:0043010 | 0.0022 | 8.1427 | 0.561 | 4 | 275 | camera-type eye development |
GO:0001764 | 0.0023 | 12.7891 | 0.2631 | 3 | 129 | neuron migration |
GO:0030154 | 0.0023 | 3.5579 | 4.4548 | 11 | 2493 | cell differentiation |
GO:0009889 | 0.0025 | 5.0618 | 2.0717 | 7 | 1599 | regulation of biosynthetic process |
GO:0030902 | 0.0026 | 12.2029 | 0.2754 | 3 | 135 | hindbrain development |
GO:0008544 | 0.0028 | 7.6533 | 0.5956 | 4 | 292 | epidermis development |
GO:0001709 | 0.0035 | 25.4415 | 0.0877 | 2 | 43 | cell fate determination |
GO:0070988 | 0.0038 | 24.255 | 0.0918 | 2 | 45 | demethylation |
GO:0010001 | 0.0039 | 10.4443 | 0.3203 | 3 | 157 | glial cell differentiation |
GO:0060042 | 0.0039 | 23.7022 | 0.0938 | 2 | 46 | retina morphogenesis in camera-type eye |
GO:0003326 | 0.0041 | 505.5 | 0.0041 | 1 | 2 | pancreatic A cell fate commitment |
GO:0003329 | 0.0041 | 505.5 | 0.0041 | 1 | 2 | pancreatic PP cell fate commitment |
GO:0008355 | 0.0041 | 505.5 | 0.0041 | 1 | 2 | olfactory learning |
GO:0014016 | 0.0041 | 505.5 | 0.0041 | 1 | 2 | neuroblast differentiation |
GO:0021750 | 0.0041 | 505.5 | 0.0041 | 1 | 2 | vestibular nucleus development |
GO:0035574 | 0.0041 | 505.5 | 0.0041 | 1 | 2 | histone H4-K20 demethylation |
GO:0060163 | 0.0041 | 505.5 | 0.0041 | 1 | 2 | subpallium neuron fate commitment |
GO:0060465 | 0.0041 | 505.5 | 0.0041 | 1 | 2 | pharynx development |
GO:0061074 | 0.0041 | 505.5 | 0.0041 | 1 | 2 | regulation of neural retina development |
GO:0061102 | 0.0041 | 505.5 | 0.0041 | 1 | 2 | stomach neuroendocrine cell differentiation |
GO:0061104 | 0.0041 | 505.5 | 0.0041 | 1 | 2 | adrenal chromaffin cell differentiation |
GO:0030855 | 0.0042 | 5.3106 | 1.0913 | 5 | 535 | epithelial cell differentiation |
GO:0045665 | 0.0054 | 20.0451 | 0.1102 | 2 | 54 | negative regulation of neuron differentiation |
GO:0006357 | 0.006 | 9.2931 | 0.3793 | 3 | 280 | regulation of transcription from RNA polymerase II promoter |
GO:0003358 | 0.0061 | 252.7333 | 0.0061 | 1 | 3 | noradrenergic neuron development |
GO:0014707 | 0.0061 | 252.7333 | 0.0061 | 1 | 3 | branchiomeric skeletal muscle development |
GO:0021902 | 0.0061 | 252.7333 | 0.0061 | 1 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0050883 | 0.0061 | 252.7333 | 0.0061 | 1 | 3 | musculoskeletal movement, spinal reflex action |
GO:0060166 | 0.0061 | 252.7333 | 0.0061 | 1 | 3 | olfactory pit development |
GO:0048731 | 0.0061 | 4.1521 | 2.3984 | 7 | 1764 | system development |
GO:0021872 | 0.0068 | 17.6587 | 0.1244 | 2 | 61 | forebrain generation of neurons |
GO:0010468 | 0.007 | 4.1165 | 2.4764 | 7 | 1951 | regulation of gene expression |
GO:0009888 | 0.0071 | 3.6711 | 2.3585 | 7 | 1302 | tissue development |
GO:0048523 | 0.0075 | 2.6826 | 6.5888 | 13 | 3230 | negative regulation of cellular process |
GO:0007195 | 0.0081 | 168.4778 | 0.0082 | 1 | 4 | adenylate cyclase-inhibiting dopamine receptor signaling pathway |
GO:0032417 | 0.0081 | 168.4778 | 0.0082 | 1 | 4 | positive regulation of sodium:proton antiporter activity |
GO:0051582 | 0.0081 | 168.4778 | 0.0082 | 1 | 4 | positive regulation of neurotransmitter uptake |
GO:0051586 | 0.0081 | 168.4778 | 0.0082 | 1 | 4 | positive regulation of dopamine uptake involved in synaptic transmission |
GO:0097476 | 0.0081 | 168.4778 | 0.0082 | 1 | 4 | spinal cord motor neuron migration |
GO:0035270 | 0.0089 | 15.4256 | 0.1424 | 2 | 77 | endocrine system development |
GO:0019219 | 0.009 | 3.9007 | 2.5922 | 7 | 2023 | regulation of nucleobase-containing compound metabolic process |
GO:0051705 | 0.0092 | 15.0895 | 0.1448 | 2 | 71 | multi-organism behavior |
GO:0048699 | 0.0098 | 3.7801 | 1.8919 | 6 | 1015 | generation of neurons |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003167 | 3e-04 | Inf | 3e-04 | 1 | 1 | atrioventricular bundle cell differentiation |
GO:0019358 | 3e-04 | Inf | 3e-04 | 1 | 1 | nicotinate nucleotide salvage |
GO:0046497 | 3e-04 | Inf | 3e-04 | 1 | 1 | nicotinate nucleotide metabolic process |
GO:0006769 | 7e-04 | 3797.75 | 7e-04 | 1 | 2 | nicotinamide metabolic process |
GO:0010159 | 7e-04 | 3797.75 | 7e-04 | 1 | 2 | specification of organ position |
GO:0060931 | 0.001 | 1898.75 | 0.001 | 1 | 3 | sinoatrial node cell development |
GO:0003164 | 0.0013 | 1265.75 | 0.0013 | 1 | 4 | His-Purkinje system development |
GO:0021913 | 0.0013 | 1265.75 | 0.0013 | 1 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0060596 | 0.0013 | 1265.75 | 0.0013 | 1 | 4 | mammary placode formation |
GO:0003163 | 0.0016 | 949.25 | 0.0016 | 1 | 5 | sinoatrial node development |
GO:0060920 | 0.002 | 759.35 | 0.002 | 1 | 6 | cardiac pacemaker cell differentiation |
GO:0046884 | 0.0023 | 632.75 | 0.0023 | 1 | 7 | follicle-stimulating hormone secretion |
GO:0045165 | 0.0024 | 41.7099 | 0.0793 | 2 | 241 | cell fate commitment |
GO:0032275 | 0.0026 | 542.3214 | 0.0026 | 1 | 8 | luteinizing hormone secretion |
GO:0060923 | 0.0026 | 542.3214 | 0.0026 | 1 | 8 | cardiac muscle cell fate commitment |
GO:0060573 | 0.0036 | 379.55 | 0.0036 | 1 | 11 | cell fate specification involved in pattern specification |
GO:0043173 | 0.0039 | 345.0227 | 0.0039 | 1 | 12 | nucleotide salvage |
GO:0045662 | 0.0043 | 316.25 | 0.0043 | 1 | 13 | negative regulation of myoblast differentiation |
GO:0071697 | 0.0043 | 316.25 | 0.0043 | 1 | 13 | ectodermal placode morphogenesis |
GO:0007350 | 0.0046 | 291.9038 | 0.0046 | 1 | 14 | blastoderm segmentation |
GO:0008595 | 0.0046 | 291.9038 | 0.0046 | 1 | 14 | anterior/posterior axis specification, embryo |
GO:0009435 | 0.0049 | 271.0357 | 0.0049 | 1 | 15 | NAD biosynthetic process |
GO:0060579 | 0.0049 | 271.0357 | 0.0049 | 1 | 15 | ventral spinal cord interneuron fate commitment |
GO:0030540 | 0.0053 | 252.95 | 0.0053 | 1 | 16 | female genitalia development |
GO:0019363 | 0.0059 | 223.1618 | 0.0059 | 1 | 18 | pyridine nucleotide biosynthetic process |
GO:0030539 | 0.0072 | 180.6071 | 0.0072 | 1 | 22 | male genitalia development |
GO:0007389 | 0.0073 | 23.4476 | 0.1388 | 2 | 422 | pattern specification process |
GO:0060444 | 0.0085 | 151.67 | 0.0086 | 1 | 26 | branching involved in mammary gland duct morphogenesis |
GO:0021511 | 0.0089 | 145.8269 | 0.0089 | 1 | 27 | spinal cord patterning |
GO:0060412 | 0.0092 | 140.4167 | 0.0092 | 1 | 28 | ventricular septum morphogenesis |
GO:0030857 | 0.0095 | 135.3929 | 0.0095 | 1 | 29 | negative regulation of epithelial cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019358 | 3e-04 | Inf | 3e-04 | 1 | 1 | nicotinate nucleotide salvage |
GO:0046497 | 3e-04 | Inf | 3e-04 | 1 | 1 | nicotinate nucleotide metabolic process |
GO:0006769 | 5e-04 | 5064 | 5e-04 | 1 | 2 | nicotinamide metabolic process |
GO:2000381 | 5e-04 | 5064 | 5e-04 | 1 | 2 | negative regulation of mesoderm development |
GO:0035582 | 8e-04 | 2531.8333 | 8e-04 | 1 | 3 | sequestering of BMP in extracellular matrix |
GO:0003419 | 0.0011 | 1687.7778 | 0.0011 | 1 | 4 | growth plate cartilage chondrocyte proliferation |
GO:0071692 | 0.0013 | 1265.75 | 0.0013 | 1 | 5 | protein localization to extracellular region |
GO:0048263 | 0.0024 | 632.7083 | 0.0024 | 1 | 9 | determination of dorsal identity |
GO:0032926 | 0.0026 | 562.3704 | 0.0026 | 1 | 10 | negative regulation of activin receptor signaling pathway |
GO:0043173 | 0.0032 | 460.0606 | 0.0032 | 1 | 12 | nucleotide salvage |
GO:0042074 | 0.0034 | 421.6944 | 0.0034 | 1 | 13 | cell migration involved in gastrulation |
GO:1900116 | 0.0034 | 421.6944 | 0.0034 | 1 | 13 | extracellular negative regulation of signal transduction |
GO:0009435 | 0.0039 | 361.4048 | 0.0039 | 1 | 15 | NAD biosynthetic process |
GO:0019363 | 0.0047 | 297.5686 | 0.0047 | 1 | 18 | pyridine nucleotide biosynthetic process |
GO:0003416 | 0.005 | 281.0185 | 0.005 | 1 | 19 | endochondral bone growth |
GO:0071773 | 0.0055 | 252.8833 | 0.0055 | 1 | 21 | cellular response to BMP stimulus |
GO:0023019 | 0.0058 | 240.8254 | 0.0058 | 1 | 22 | signal transduction involved in regulation of gene expression |
GO:0060351 | 0.0058 | 240.8254 | 0.0058 | 1 | 22 | cartilage development involved in endochondral bone morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | Inf | 0.0995 | 4 | 368 | olfactory receptor activity |
GO:0004930 | 0 | Inf | 0.2092 | 4 | 774 | G-protein coupled receptor activity |
GO:0038023 | 0 | Inf | 0.3298 | 4 | 1220 | signaling receptor activity |
GO:0060089 | 1e-04 | Inf | 0.4074 | 4 | 1507 | molecular transducer activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032090 | 9e-04 | 2465 | 9e-04 | 1 | 2 | Pyrin domain binding |
GO:0001077 | 0.002 | 40.6861 | 0.0691 | 2 | 146 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GO:0008656 | 0.0075 | 164.1778 | 0.0076 | 1 | 16 | cysteine-type endopeptidase activator activity involved in apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0036122 | 0.0011 | 1643.4444 | 0.0011 | 1 | 4 | BMP binding |
GO:0016015 | 0.0016 | 985.9333 | 0.0016 | 1 | 6 | morphogen activity |
GO:0004984 | 0.0036 | 39.4208 | 0.0995 | 2 | 368 | olfactory receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0035755 | 0.0011 | Inf | 0.0011 | 1 | 1 | cardiolipin hydrolase activity |
GO:0031386 | 0.0022 | 985.4 | 0.0022 | 1 | 2 | protein tag |
GO:0001591 | 0.0032 | 492.6667 | 0.0032 | 1 | 3 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0016167 | 0.0032 | 492.6667 | 0.0032 | 1 | 3 | glial cell-derived neurotrophic factor receptor activity |
GO:0060089 | 0.0036 | 5.3089 | 1.6294 | 6 | 1507 | molecular transducer activity |
GO:0038036 | 0.0054 | 246.3 | 0.0054 | 1 | 5 | sphingosine-1-phosphate receptor activity |
GO:0038023 | 0.0076 | 5.0756 | 1.3191 | 5 | 1220 | signaling receptor activity |
GO:0004930 | 0.0082 | 6.0658 | 0.8369 | 4 | 774 | G-protein coupled receptor activity |
GO:0004652 | 0.0086 | 140.7143 | 0.0086 | 1 | 8 | polynucleotide adenylyltransferase activity |
GO:0035240 | 0.0086 | 140.7143 | 0.0086 | 1 | 8 | dopamine binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0 | 15.3915 | 1.4434 | 13 | 712 | sequence-specific DNA binding |
GO:0046983 | 0 | 8.1992 | 1.9969 | 11 | 985 | protein dimerization activity |
GO:0000989 | 0 | 10.3553 | 1.0319 | 8 | 509 | transcription factor binding transcription factor activity |
GO:0003700 | 0 | 9.2439 | 1.0334 | 7 | 621 | sequence-specific DNA binding transcription factor activity |
GO:0000981 | 1e-04 | 9.7284 | 0.7623 | 6 | 376 | sequence-specific DNA binding RNA polymerase II transcription factor activity |
GO:0097159 | 2e-04 | 4.0373 | 11.0082 | 21 | 5430 | organic cyclic compound binding |
GO:0000975 | 4e-04 | 7.3624 | 0.9954 | 6 | 491 | regulatory region DNA binding |
GO:1901363 | 7e-04 | 3.5269 | 10.8744 | 20 | 5364 | heterocyclic compound binding |
GO:0003677 | 8e-04 | 6.28 | 1.7113 | 7 | 1407 | DNA binding |
GO:0003682 | 0.001 | 7.4917 | 0.7886 | 5 | 389 | chromatin binding |
GO:0003690 | 0.0011 | 16.8053 | 0.2027 | 3 | 100 | double-stranded DNA binding |
GO:0070888 | 0.002 | 33.9562 | 0.0669 | 2 | 33 | E-box binding |
GO:0003713 | 0.0022 | 8.261 | 0.5555 | 4 | 274 | transcription coactivator activity |
GO:0035575 | 0.0041 | 509.2069 | 0.0041 | 1 | 2 | histone demethylase activity (H4-K20 specific) |
GO:0001159 | 0.0048 | 9.7146 | 0.3446 | 3 | 170 | core promoter proximal region DNA binding |
GO:0001591 | 0.0061 | 254.5862 | 0.0061 | 1 | 3 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0003714 | 0.0068 | 8.5251 | 0.3913 | 3 | 193 | transcription corepressor activity |
GO:0030594 | 0.0086 | 15.6727 | 0.1399 | 2 | 69 | neurotransmitter receptor activity |
GO:0001104 | 0.0098 | 14.5794 | 0.15 | 2 | 74 | RNA polymerase II transcription cofactor activity |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004516 | 3e-04 | Inf | 3e-04 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
GO:0004514 | 0.001 | 1848.875 | 0.001 | 1 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
GO:0033038 | 0.0061 | 217.2941 | 0.0061 | 1 | 18 | bitter taste receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004516 | 2e-04 | Inf | 2e-04 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
GO:0004514 | 6e-04 | 3698.25 | 6e-04 | 1 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
GO:0036122 | 8e-04 | 2465.3333 | 8e-04 | 1 | 4 | BMP binding |
GO:0016015 | 0.0012 | 1479 | 0.0012 | 1 | 6 | morphogen activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0052731 | 7e-04 | Inf | 7e-04 | 1 | 1 | phosphocholine phosphatase activity |
GO:0052732 | 7e-04 | Inf | 7e-04 | 1 | 1 | phosphoethanolamine phosphatase activity |
GO:0032090 | 0.0014 | 1643 | 0.0014 | 1 | 2 | Pyrin domain binding |
GO:0008190 | 0.0047 | 273.7407 | 0.0047 | 1 | 7 | eukaryotic initiation factor 4E binding |
GO:0002161 | 0.0061 | 205.2778 | 0.0061 | 1 | 9 | aminoacyl-tRNA editing activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015782 | 6e-04 | Inf | 6e-04 | 1 | 1 | CMP-N-acetylneuraminate transport |
GO:0046373 | 0.0012 | 1898.125 | 0.0012 | 1 | 2 | L-arabinose metabolic process |
GO:0045110 | 0.003 | 474.4375 | 0.003 | 1 | 5 | intermediate filament bundle assembly |
GO:0015780 | 0.0035 | 379.525 | 0.0036 | 1 | 6 | nucleotide-sugar transport |
GO:0035414 | 0.0047 | 271.0536 | 0.0047 | 1 | 8 | negative regulation of catenin import into nucleus |
GO:0072307 | 0.0047 | 271.0536 | 0.0047 | 1 | 8 | regulation of metanephric nephron tubule epithelial cell differentiation |
GO:1901679 | 0.0053 | 237.1562 | 0.0053 | 1 | 9 | nucleotide transmembrane transport |
GO:0031581 | 0.0071 | 172.4432 | 0.0071 | 1 | 12 | hemidesmosome assembly |
GO:0019321 | 0.0077 | 158.0625 | 0.0077 | 1 | 13 | pentose metabolic process |
GO:0060390 | 0.0083 | 145.8942 | 0.0083 | 1 | 14 | regulation of SMAD protein import into nucleus |
GO:2000696 | 0.0083 | 145.8942 | 0.0083 | 1 | 14 | regulation of epithelial cell differentiation involved in kidney development |
GO:0072160 | 0.0089 | 135.4643 | 0.0089 | 1 | 15 | nephron tubule epithelial cell differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045214 | 0 | 52.303 | 0.0694 | 3 | 31 | sarcomere organization |
GO:0097284 | 2e-04 | 135.3036 | 0.0201 | 2 | 9 | hepatocyte apoptotic process |
GO:0043588 | 8e-04 | 7.7728 | 0.7474 | 5 | 334 | skin development |
GO:0048598 | 0.0013 | 5.725 | 1.2374 | 6 | 553 | embryonic morphogenesis |
GO:0060007 | 0.0022 | Inf | 0.0022 | 1 | 1 | linear vestibuloocular reflex |
GO:0034612 | 0.0023 | 12.5514 | 0.2663 | 3 | 119 | response to tumor necrosis factor |
GO:0055002 | 0.0032 | 11.1893 | 0.2976 | 3 | 133 | striated muscle cell development |
GO:0032501 | 0.0039 | 2.6855 | 13.8126 | 22 | 6173 | multicellular organismal process |
GO:0009628 | 0.0039 | 4.0039 | 2.0787 | 7 | 929 | response to abiotic stimulus |
GO:0071230 | 0.0041 | 23.0488 | 0.0962 | 2 | 43 | cellular response to amino acid stimulus |
GO:0042692 | 0.0042 | 6.7659 | 0.6646 | 4 | 297 | muscle cell differentiation |
GO:0007308 | 0.0045 | 459.3939 | 0.0045 | 1 | 2 | oocyte construction |
GO:0007314 | 0.0045 | 459.3939 | 0.0045 | 1 | 2 | oocyte anterior/posterior axis specification |
GO:0030719 | 0.0045 | 459.3939 | 0.0045 | 1 | 2 | P granule organization |
GO:0046294 | 0.0045 | 459.3939 | 0.0045 | 1 | 2 | formaldehyde catabolic process |
GO:0060715 | 0.0045 | 459.3939 | 0.0045 | 1 | 2 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development |
GO:1903225 | 0.0045 | 459.3939 | 0.0045 | 1 | 2 | negative regulation of endodermal cell differentiation |
GO:0001654 | 0.005 | 6.4086 | 0.7004 | 4 | 313 | eye development |
GO:0007275 | 0.0054 | 2.5732 | 9.5321 | 17 | 4260 | multicellular organismal development |
GO:0009913 | 0.0062 | 8.7953 | 0.3759 | 3 | 168 | epidermal cell differentiation |
GO:0006177 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | GMP biosynthetic process |
GO:0006344 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | maintenance of chromatin silencing |
GO:0061198 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | fungiform papilla formation |
GO:0051289 | 0.0067 | 17.816 | 0.1231 | 2 | 55 | protein homotetramerization |
GO:0071260 | 0.0087 | 15.4713 | 0.141 | 2 | 63 | cellular response to mechanical stimulus |
GO:0035994 | 0.0089 | 153.1111 | 0.009 | 1 | 4 | response to muscle stretch |
GO:0036462 | 0.0089 | 153.1111 | 0.009 | 1 | 4 | TRAIL-activated apoptotic signaling pathway |
GO:0042699 | 0.0089 | 153.1111 | 0.009 | 1 | 4 | follicle-stimulating hormone signaling pathway |
GO:0061196 | 0.0089 | 153.1111 | 0.009 | 1 | 4 | fungiform papilla development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045214 | 8e-04 | 54.9728 | 0.0428 | 2 | 31 | sarcomere organization |
GO:0044726 | 0.0014 | Inf | 0.0014 | 1 | 1 | protection of DNA demethylation of female pronucleus |
GO:0050928 | 0.0014 | Inf | 0.0014 | 1 | 1 | negative regulation of positive chemotaxis |
GO:1901536 | 0.0014 | Inf | 0.0014 | 1 | 1 | negative regulation of DNA demethylation |
GO:0009948 | 0.0017 | 37.0404 | 0.0622 | 2 | 45 | anterior/posterior axis specification |
GO:2000381 | 0.0028 | 758.65 | 0.0028 | 1 | 2 | negative regulation of mesoderm development |
GO:0070555 | 0.004 | 23.7345 | 0.0954 | 2 | 69 | response to interleukin-1 |
GO:0035582 | 0.0041 | 379.3 | 0.0041 | 1 | 3 | sequestering of BMP in extracellular matrix |
GO:0048014 | 0.0041 | 379.3 | 0.0041 | 1 | 3 | Tie signaling pathway |
GO:2000653 | 0.0041 | 379.3 | 0.0041 | 1 | 3 | regulation of genetic imprinting |
GO:0030510 | 0.0043 | 23.0435 | 0.0981 | 2 | 71 | regulation of BMP signaling pathway |
GO:0003419 | 0.0055 | 252.85 | 0.0055 | 1 | 4 | growth plate cartilage chondrocyte proliferation |
GO:0035994 | 0.0055 | 252.85 | 0.0055 | 1 | 4 | response to muscle stretch |
GO:0042699 | 0.0055 | 252.85 | 0.0055 | 1 | 4 | follicle-stimulating hormone signaling pathway |
GO:0032259 | 0.0064 | 8.9633 | 0.387 | 3 | 280 | methylation |
GO:0048859 | 0.0069 | 189.625 | 0.0069 | 1 | 5 | formation of anatomical boundary |
GO:0071692 | 0.0069 | 189.625 | 0.0069 | 1 | 5 | protein localization to extracellular region |
GO:0009628 | 0.0076 | 4.8194 | 1.2839 | 5 | 929 | response to abiotic stimulus |
GO:0071356 | 0.0081 | 16.3614 | 0.1368 | 2 | 99 | cellular response to tumor necrosis factor |
GO:0043045 | 0.0083 | 151.69 | 0.0083 | 1 | 6 | DNA methylation involved in embryo development |
GO:2000279 | 0.0083 | 151.69 | 0.0083 | 1 | 6 | negative regulation of DNA biosynthetic process |
GO:0090101 | 0.0091 | 15.4021 | 0.1451 | 2 | 105 | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0040016 | 0.0096 | 126.4 | 0.0097 | 1 | 7 | embryonic cleavage |
GO:0051599 | 0.0096 | 126.4 | 0.0097 | 1 | 7 | response to hydrostatic pressure |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007286 | 3e-04 | 14.2857 | 0.3155 | 4 | 102 | spermatid development |
GO:0000003 | 0.0012 | 3.9397 | 2.6848 | 9 | 868 | reproduction |
GO:0007283 | 0.0016 | 5.3003 | 1.2775 | 6 | 413 | spermatogenesis |
GO:0007292 | 0.003 | 11.4076 | 0.2877 | 3 | 93 | female gamete generation |
GO:0021686 | 0.0031 | Inf | 0.0031 | 1 | 1 | cerebellar granular layer maturation |
GO:0051296 | 0.0031 | Inf | 0.0031 | 1 | 1 | establishment of meiotic spindle orientation |
GO:1902103 | 0.0031 | Inf | 0.0031 | 1 | 1 | negative regulation of metaphase/anaphase transition of meiotic cell cycle |
GO:0040020 | 0.0041 | 23.1709 | 0.0959 | 2 | 31 | regulation of meiosis |
GO:0021700 | 0.0048 | 6.4006 | 0.6836 | 4 | 221 | developmental maturation |
GO:0007198 | 0.0062 | 329.2826 | 0.0062 | 1 | 2 | adenylate cyclase-inhibiting serotonin receptor signaling pathway |
GO:0007308 | 0.0062 | 329.2826 | 0.0062 | 1 | 2 | oocyte construction |
GO:0007314 | 0.0062 | 329.2826 | 0.0062 | 1 | 2 | oocyte anterior/posterior axis specification |
GO:0021933 | 0.0062 | 329.2826 | 0.0062 | 1 | 2 | radial glia guided migration of cerebellar granule cell |
GO:0021941 | 0.0062 | 329.2826 | 0.0062 | 1 | 2 | negative regulation of cerebellar granule cell precursor proliferation |
GO:0030719 | 0.0062 | 329.2826 | 0.0062 | 1 | 2 | P granule organization |
GO:0030999 | 0.0062 | 329.2826 | 0.0062 | 1 | 2 | linear element assembly |
GO:0046294 | 0.0062 | 329.2826 | 0.0062 | 1 | 2 | formaldehyde catabolic process |
GO:0009994 | 0.0071 | 17.2182 | 0.1268 | 2 | 41 | oocyte differentiation |
GO:0007126 | 0.0078 | 7.9877 | 0.4066 | 3 | 137 | meiotic nuclear division |
GO:0006565 | 0.0093 | 164.6304 | 0.0093 | 1 | 3 | L-serine catabolic process |
GO:0021590 | 0.0093 | 164.6304 | 0.0093 | 1 | 3 | cerebellum maturation |
GO:0033590 | 0.0093 | 164.6304 | 0.0093 | 1 | 3 | response to cobalamin |
GO:1901993 | 0.0093 | 164.6304 | 0.0093 | 1 | 3 | regulation of meiotic cell cycle phase transition |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007616 | 2e-04 | 29.9702 | 0.1173 | 3 | 27 | long-term memory |
GO:0007596 | 4e-04 | 4.5724 | 2.2326 | 9 | 514 | blood coagulation |
GO:0048167 | 0.0015 | 8.8088 | 0.4952 | 4 | 114 | regulation of synaptic plasticity |
GO:2000310 | 0.0016 | 39.3672 | 0.0608 | 2 | 14 | regulation of N-methyl-D-aspartate selective glutamate receptor activity |
GO:0050878 | 0.0017 | 3.6459 | 2.7668 | 9 | 637 | regulation of body fluid levels |
GO:0009611 | 0.0019 | 3.1251 | 4.0004 | 11 | 921 | response to wounding |
GO:0060074 | 0.0027 | 29.5176 | 0.0782 | 2 | 18 | synapse maturation |
GO:0031344 | 0.0039 | 4.3367 | 1.5072 | 6 | 347 | regulation of cell projection organization |
GO:0030900 | 0.0041 | 4.2852 | 1.5246 | 6 | 351 | forebrain development |
GO:0048666 | 0.0042 | 2.9483 | 3.7962 | 10 | 874 | neuron development |
GO:0019056 | 0.0043 | Inf | 0.0043 | 1 | 1 | modulation by virus of host transcription |
GO:0035854 | 0.0043 | Inf | 0.0043 | 1 | 1 | eosinophil fate commitment |
GO:0045299 | 0.0043 | Inf | 0.0043 | 1 | 1 | otolith mineralization |
GO:0045660 | 0.0043 | Inf | 0.0043 | 1 | 1 | positive regulation of neutrophil differentiation |
GO:0048691 | 0.0043 | Inf | 0.0043 | 1 | 1 | positive regulation of axon extension involved in regeneration |
GO:0071279 | 0.0043 | Inf | 0.0043 | 1 | 1 | cellular response to cobalt ion |
GO:0090138 | 0.0043 | Inf | 0.0043 | 1 | 1 | regulation of actin cytoskeleton organization by cell-cell adhesion |
GO:1902078 | 0.0043 | Inf | 0.0043 | 1 | 1 | positive regulation of lateral motor column neuron migration |
GO:1903056 | 0.0043 | Inf | 0.0043 | 1 | 1 | regulation of melanosome organization |
GO:1990144 | 0.0043 | Inf | 0.0043 | 1 | 1 | intrinsic apoptotic signaling pathway in response to hypoxia |
GO:0050795 | 0.0046 | 6.3995 | 0.6732 | 4 | 155 | regulation of behavior |
GO:0030198 | 0.0046 | 4.1858 | 1.5593 | 6 | 359 | extracellular matrix organization |
GO:0048699 | 0.0048 | 2.6318 | 5.1688 | 12 | 1190 | generation of neurons |
GO:0050927 | 0.0048 | 21.4588 | 0.1042 | 2 | 24 | positive regulation of positive chemotaxis |
GO:0021533 | 0.0052 | 20.5245 | 0.1086 | 2 | 25 | cell differentiation in hindbrain |
GO:0021680 | 0.0052 | 20.5245 | 0.1086 | 2 | 25 | cerebellar Purkinje cell layer development |
GO:0007416 | 0.0054 | 9.0717 | 0.3562 | 3 | 82 | synapse assembly |
GO:0030851 | 0.0065 | 18.1526 | 0.1216 | 2 | 28 | granulocyte differentiation |
GO:0035020 | 0.0065 | 18.1526 | 0.1216 | 2 | 28 | regulation of Rac protein signal transduction |
GO:0006029 | 0.0066 | 8.428 | 0.3822 | 3 | 88 | proteoglycan metabolic process |
GO:0030031 | 0.0066 | 4.5452 | 1.1858 | 5 | 273 | cell projection assembly |
GO:0007417 | 0.007 | 2.8929 | 3.4401 | 9 | 792 | central nervous system development |
GO:0090130 | 0.0072 | 5.6103 | 0.7645 | 4 | 176 | tissue migration |
GO:0032856 | 0.008 | 16.2716 | 0.1346 | 2 | 31 | activation of Ras GTPase activity |
GO:0003366 | 0.0087 | 232.7385 | 0.0087 | 1 | 2 | cell-matrix adhesion involved in ameboidal cell migration |
GO:0048023 | 0.0087 | 232.7385 | 0.0087 | 1 | 2 | positive regulation of melanin biosynthetic process |
GO:0048686 | 0.0087 | 232.7385 | 0.0087 | 1 | 2 | regulation of sprouting of injured axon |
GO:0070345 | 0.0087 | 232.7385 | 0.0087 | 1 | 2 | negative regulation of fat cell proliferation |
GO:0097324 | 0.0087 | 232.7385 | 0.0087 | 1 | 2 | melanocyte migration |
GO:1900273 | 0.0087 | 232.7385 | 0.0087 | 1 | 2 | positive regulation of long-term synaptic potentiation |
GO:1901492 | 0.0087 | 232.7385 | 0.0087 | 1 | 2 | positive regulation of lymphangiogenesis |
GO:1990009 | 0.0087 | 232.7385 | 0.0087 | 1 | 2 | retinal cell apoptotic process |
GO:2000969 | 0.0087 | 232.7385 | 0.0087 | 1 | 2 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity |
GO:0007611 | 0.0087 | 5.2985 | 0.8079 | 4 | 186 | learning or memory |
GO:0098609 | 0.0087 | 5.2985 | 0.8079 | 4 | 186 | cell-cell adhesion |
GO:0050900 | 0.009 | 4.209 | 1.277 | 5 | 294 | leukocyte migration |
GO:0051057 | 0.0095 | 14.7432 | 0.1477 | 2 | 34 | positive regulation of small GTPase mediated signal transduction |
GO:0051489 | 0.0095 | 14.7432 | 0.1477 | 2 | 34 | regulation of filopodium assembly |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007186 | 4e-04 | 12.6679 | 0.7345 | 5 | 1116 | G-protein coupled receptor signaling pathway |
GO:0050877 | 5e-04 | 12.0232 | 0.7706 | 5 | 1171 | neurological system process |
GO:0030311 | 0.0013 | 1687.1111 | 0.0013 | 1 | 2 | poly-N-acetyllactosamine biosynthetic process |
GO:0050911 | 0.0015 | 17.4502 | 0.2415 | 3 | 367 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0.0025 | 14.4295 | 0.2902 | 3 | 441 | detection of chemical stimulus |
GO:0048681 | 0.0026 | 562.2963 | 0.0026 | 1 | 4 | negative regulation of axon regeneration |
GO:0050906 | 0.0026 | 14.163 | 0.2955 | 3 | 449 | detection of stimulus involved in sensory perception |
GO:0007606 | 0.0027 | 13.9693 | 0.2994 | 3 | 455 | sensory perception of chemical stimulus |
GO:0031642 | 0.0046 | 281.0926 | 0.0046 | 1 | 7 | negative regulation of myelination |
GO:0035791 | 0.0046 | 281.0926 | 0.0046 | 1 | 7 | platelet-derived growth factor receptor-beta signaling pathway |
GO:0070570 | 0.0066 | 187.358 | 0.0066 | 1 | 10 | regulation of neuron projection regeneration |
GO:0031284 | 0.0072 | 168.6111 | 0.0072 | 1 | 11 | positive regulation of guanylate cyclase activity |
GO:0048305 | 0.0098 | 120.4048 | 0.0099 | 1 | 15 | immunoglobulin secretion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0021570 | 0 | 947.5 | 0.0067 | 2 | 3 | rhombomere 4 development |
GO:0001501 | 0 | 9.1217 | 0.9532 | 7 | 426 | skeletal system development |
GO:0021612 | 1e-04 | 157.8646 | 0.0179 | 2 | 8 | facial nerve structural organization |
GO:0048704 | 2e-04 | 32.4849 | 0.1077 | 3 | 51 | embryonic skeletal system morphogenesis |
GO:0021561 | 2e-04 | 118.3828 | 0.0224 | 2 | 10 | facial nerve development |
GO:0048568 | 2e-04 | 8.0523 | 0.8928 | 6 | 399 | embryonic organ development |
GO:0048532 | 5e-04 | 72.8269 | 0.0336 | 2 | 15 | anatomical structure arrangement |
GO:0048486 | 7e-04 | 59.1602 | 0.0403 | 2 | 18 | parasympathetic nervous system development |
GO:0021602 | 0.001 | 49.8092 | 0.047 | 2 | 21 | cranial nerve morphogenesis |
GO:0016338 | 0.0012 | 45.0595 | 0.0515 | 2 | 23 | calcium-independent cell-cell adhesion |
GO:0048598 | 0.0013 | 5.725 | 1.2374 | 6 | 553 | embryonic morphogenesis |
GO:0007043 | 0.0014 | 41.9 | 0.055 | 2 | 26 | cell-cell junction assembly |
GO:0034330 | 0.0014 | 9.1822 | 0.4945 | 4 | 221 | cell junction organization |
GO:0043009 | 0.0017 | 5.3871 | 1.3112 | 6 | 586 | chordate embryonic development |
GO:0003230 | 0.002 | 33.779 | 0.0671 | 2 | 30 | cardiac atrium development |
GO:0048265 | 0.0022 | 32.6121 | 0.0694 | 2 | 31 | response to pain |
GO:0002590 | 0.0022 | Inf | 0.0022 | 1 | 1 | negative regulation of antigen processing and presentation of peptide antigen via MHC class I |
GO:0021763 | 0.0022 | Inf | 0.0022 | 1 | 1 | subthalamic nucleus development |
GO:0036371 | 0.0022 | Inf | 0.0022 | 1 | 1 | protein localization to T-tubule |
GO:0060127 | 0.0022 | Inf | 0.0022 | 1 | 1 | prolactin secreting cell differentiation |
GO:0060578 | 0.0022 | Inf | 0.0022 | 1 | 1 | superior vena cava morphogenesis |
GO:0072046 | 0.0022 | Inf | 0.0022 | 1 | 1 | establishment of planar polarity involved in nephron morphogenesis |
GO:0001738 | 0.0026 | 29.5488 | 0.0761 | 2 | 34 | morphogenesis of a polarized epithelium |
GO:0086065 | 0.0029 | 27.807 | 0.0806 | 2 | 36 | cell communication involved in cardiac conduction |
GO:0086004 | 0.0031 | 27.0107 | 0.0828 | 2 | 37 | regulation of cardiac muscle cell contraction |
GO:0048701 | 0.004 | 23.6266 | 0.094 | 2 | 42 | embryonic cranial skeleton morphogenesis |
GO:1901019 | 0.0043 | 22.4985 | 0.0985 | 2 | 44 | regulation of calcium ion transmembrane transporter activity |
GO:0033292 | 0.0045 | 459.3939 | 0.0045 | 1 | 2 | T-tubule organization |
GO:0036309 | 0.0045 | 459.3939 | 0.0045 | 1 | 2 | protein localization to M-band |
GO:0060460 | 0.0045 | 459.3939 | 0.0045 | 1 | 2 | left lung morphogenesis |
GO:0060577 | 0.0045 | 459.3939 | 0.0045 | 1 | 2 | pulmonary vein morphogenesis |
GO:0072174 | 0.0045 | 459.3939 | 0.0045 | 1 | 2 | metanephric tubule formation |
GO:0072181 | 0.0045 | 459.3939 | 0.0045 | 1 | 2 | mesonephric duct formation |
GO:0055082 | 0.0049 | 5.0765 | 1.1255 | 5 | 503 | cellular chemical homeostasis |
GO:0035637 | 0.005 | 9.4927 | 0.3491 | 3 | 156 | multicellular organismal signaling |
GO:0016055 | 0.0055 | 6.2435 | 0.7183 | 4 | 321 | Wnt signaling pathway |
GO:0003002 | 0.0061 | 6.0675 | 0.7384 | 4 | 330 | regionalization |
GO:0002074 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | extraocular skeletal muscle development |
GO:0003253 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0003350 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | pulmonary myocardium development |
GO:0009786 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | regulation of asymmetric cell division |
GO:0019064 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | fusion of virus membrane with host plasma membrane |
GO:0019087 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | transformation of host cell by virus |
GO:0021754 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | facial nucleus development |
GO:0031630 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | regulation of synaptic vesicle fusion to presynaptic membrane |
GO:0035993 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | deltoid tuberosity development |
GO:0044800 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | multi-organism membrane fusion |
GO:0072003 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | kidney rudiment formation |
GO:0086018 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | SA node cell to atrial cardiac muscle cell signalling |
GO:0086046 | 0.0067 | 229.6818 | 0.0067 | 1 | 3 | membrane depolarization during SA node cell action potential |
GO:0043297 | 0.0067 | 17.816 | 0.1231 | 2 | 55 | apical junction assembly |
GO:0070252 | 0.0069 | 17.485 | 0.1253 | 2 | 56 | actin-mediated cell contraction |
GO:2001257 | 0.0069 | 17.485 | 0.1253 | 2 | 56 | regulation of cation channel activity |
GO:0009887 | 0.0076 | 3.9312 | 1.7748 | 6 | 817 | organ morphogenesis |
GO:0021569 | 0.0089 | 153.1111 | 0.009 | 1 | 4 | rhombomere 3 development |
GO:0021571 | 0.0089 | 153.1111 | 0.009 | 1 | 4 | rhombomere 5 development |
GO:0061031 | 0.0089 | 153.1111 | 0.009 | 1 | 4 | endodermal digestive tract morphogenesis |
GO:0061038 | 0.0089 | 153.1111 | 0.009 | 1 | 4 | uterus morphogenesis |
GO:0061325 | 0.0089 | 153.1111 | 0.009 | 1 | 4 | cell proliferation involved in outflow tract morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 33.2021 | 0.2728 | 5 | 367 | olfactory receptor activity |
GO:0016805 | 0 | 273.5741 | 0.0104 | 2 | 14 | dipeptidase activity |
GO:0038023 | 1e-04 | 13.4265 | 0.9063 | 6 | 1219 | signaling receptor activity |
GO:0004930 | 1e-04 | 15.2094 | 0.5747 | 5 | 773 | G-protein coupled receptor activity |
GO:0060089 | 3e-04 | 10.628 | 1.1196 | 6 | 1506 | molecular transducer activity |
GO:0008449 | 0.0022 | 739.15 | 0.0022 | 1 | 3 | N-acetylglucosamine-6-sulfatase activity |
GO:0004065 | 0.0059 | 211.1143 | 0.0059 | 1 | 8 | arylsulfatase activity |
GO:0008237 | 0.0071 | 18.8798 | 0.1294 | 2 | 174 | metallopeptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042030 | 0.0023 | 923.625 | 0.0023 | 1 | 2 | ATPase inhibitor activity |
GO:0004111 | 0.0046 | 307.8333 | 0.0046 | 1 | 4 | creatine kinase activity |
GO:0004175 | 0.0076 | 8.6319 | 0.4148 | 3 | 361 | endopeptidase activity |
GO:0008499 | 0.008 | 153.8854 | 0.008 | 1 | 7 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity |
GO:0000981 | 0.0085 | 8.2761 | 0.432 | 3 | 376 | sequence-specific DNA binding RNA polymerase II transcription factor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005456 | 6e-04 | Inf | 6e-04 | 1 | 1 | CMP-N-acetylneuraminate transmembrane transporter activity |
GO:0046556 | 0.0012 | 1848.25 | 0.0012 | 1 | 2 | alpha-L-arabinofuranosidase activity |
GO:1990254 | 0.0018 | 924.0625 | 0.0018 | 1 | 3 | keratin filament binding |
GO:0005338 | 0.0043 | 307.9375 | 0.0043 | 1 | 7 | nucleotide-sugar transmembrane transporter activity |
GO:0005351 | 0.0043 | 307.9375 | 0.0043 | 1 | 7 | sugar:proton symporter activity |
GO:0015605 | 0.0085 | 142.0577 | 0.0085 | 1 | 14 | organophosphate ester transmembrane transporter activity |
GO:0005132 | 0.0097 | 123.1 | 0.0097 | 1 | 16 | type I interferon receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004963 | 0.002 | Inf | 0.002 | 1 | 1 | follicle-stimulating hormone receptor activity |
GO:0018738 | 0.002 | Inf | 0.002 | 1 | 1 | S-formylglutathione hydrolase activity |
GO:0046539 | 0.002 | Inf | 0.002 | 1 | 1 | histamine N-methyltransferase activity |
GO:0097110 | 0.0021 | 32.8884 | 0.0689 | 2 | 34 | scaffold protein binding |
GO:0003938 | 0.0041 | 509.1379 | 0.0041 | 1 | 2 | IMP dehydrogenase activity |
GO:0035851 | 0.0041 | 509.1379 | 0.0041 | 1 | 2 | Krueppel-associated box domain binding |
GO:0097199 | 0.0041 | 509.1379 | 0.0041 | 1 | 2 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
GO:0047374 | 0.0061 | 254.5517 | 0.0061 | 1 | 3 | methylumbelliferyl-acetate deacetylase activity |
GO:0046332 | 0.0074 | 16.9401 | 0.1298 | 2 | 64 | SMAD binding |
GO:0003960 | 0.0081 | 169.6897 | 0.0081 | 1 | 4 | NADPH:quinone reductase activity |
GO:0035877 | 0.0081 | 169.6897 | 0.0081 | 1 | 4 | death effector domain binding |
GO:0004197 | 0.0091 | 15.2143 | 0.144 | 2 | 71 | cysteine-type endopeptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048407 | 4e-04 | 88.5766 | 0.029 | 2 | 11 | platelet-derived growth factor binding |
GO:0001968 | 0.0021 | 33.1824 | 0.0685 | 2 | 26 | fibronectin binding |
GO:0043236 | 0.0026 | 29.4895 | 0.0764 | 2 | 29 | laminin binding |
GO:0005144 | 0.0026 | Inf | 0.0026 | 1 | 1 | interleukin-13 receptor binding |
GO:0015459 | 0.0043 | 22.7367 | 0.0975 | 2 | 37 | potassium channel regulator activity |
GO:0005019 | 0.0053 | 388.3158 | 0.0053 | 1 | 2 | platelet-derived growth factor beta-receptor activity |
GO:0004992 | 0.0079 | 194.1447 | 0.0079 | 1 | 3 | platelet activating factor receptor activity |
GO:0008384 | 0.0079 | 194.1447 | 0.0079 | 1 | 3 | IkappaB kinase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004963 | 0.0012 | Inf | 0.0012 | 1 | 1 | follicle-stimulating hormone receptor activity |
GO:0005124 | 0.0012 | Inf | 0.0012 | 1 | 1 | scavenger receptor binding |
GO:0046539 | 0.0012 | Inf | 0.0012 | 1 | 1 | histamine N-methyltransferase activity |
GO:0036122 | 0.0049 | 289.7059 | 0.0049 | 1 | 4 | BMP binding |
GO:0003828 | 0.0061 | 217.2647 | 0.0061 | 1 | 5 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity |
GO:0008142 | 0.0061 | 217.2647 | 0.0061 | 1 | 5 | oxysterol binding |
GO:0016015 | 0.0073 | 173.8 | 0.0073 | 1 | 6 | morphogen activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000224 | 0.0028 | Inf | 0.0028 | 1 | 1 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity |
GO:0018738 | 0.0028 | Inf | 0.0028 | 1 | 1 | S-formylglutathione hydrolase activity |
GO:0035755 | 0.0028 | Inf | 0.0028 | 1 | 1 | cardiolipin hydrolase activity |
GO:0004794 | 0.0055 | 368.85 | 0.0055 | 1 | 2 | L-threonine ammonia-lyase activity |
GO:0008502 | 0.0055 | 368.85 | 0.0055 | 1 | 2 | melatonin receptor activity |
GO:0003941 | 0.0083 | 184.4125 | 0.0083 | 1 | 3 | L-serine ammonia-lyase activity |
GO:0047374 | 0.0083 | 184.4125 | 0.0083 | 1 | 3 | methylumbelliferyl-acetate deacetylase activity |
GO:0000980 | 0.0091 | 15.0821 | 0.1441 | 2 | 52 | RNA polymerase II distal enhancer sequence-specific DNA binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005509 | 4e-04 | 4.1278 | 2.7847 | 10 | 654 | calcium ion binding |
GO:0001158 | 0.0027 | 11.8315 | 0.2768 | 3 | 65 | enhancer sequence-specific DNA binding |
GO:0043185 | 0.0043 | Inf | 0.0043 | 1 | 1 | vascular endothelial growth factor receptor 3 binding |
GO:0043795 | 0.0043 | Inf | 0.0043 | 1 | 1 | glyceraldehyde oxidoreductase activity |
GO:0004031 | 0.0085 | 237.6129 | 0.0085 | 1 | 2 | aldehyde oxidase activity |
GO:0004360 | 0.0085 | 237.6129 | 0.0085 | 1 | 2 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity |
GO:0004854 | 0.0085 | 237.6129 | 0.0085 | 1 | 2 | xanthine dehydrogenase activity |
GO:0030899 | 0.0085 | 237.6129 | 0.0085 | 1 | 2 | calcium-dependent ATPase activity |
GO:0050659 | 0.0085 | 237.6129 | 0.0085 | 1 | 2 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005019 | 0.0014 | 1642.7778 | 0.0014 | 1 | 2 | platelet-derived growth factor beta-receptor activity |
GO:0016262 | 0.0014 | 1642.7778 | 0.0014 | 1 | 2 | protein N-acetylglucosaminyltransferase activity |
GO:0004984 | 0.0016 | 16.9804 | 0.248 | 3 | 367 | olfactory receptor activity |
GO:0004992 | 0.002 | 821.3333 | 0.002 | 1 | 3 | platelet activating factor receptor activity |
GO:0008048 | 0.0034 | 410.6111 | 0.0034 | 1 | 5 | calcium sensitive guanylate cyclase activator activity |
GO:0010853 | 0.0047 | 273.7037 | 0.0047 | 1 | 7 | cyclase activator activity |
GO:0030249 | 0.0054 | 234.5873 | 0.0054 | 1 | 8 | guanylate cyclase regulator activity |
GO:0038023 | 0.0064 | 7.4464 | 0.8239 | 4 | 1219 | signaling receptor activity |
GO:0004930 | 0.0093 | 9.1375 | 0.4685 | 3 | 770 | G-protein coupled receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003908 | 0.001 | Inf | 0.001 | 1 | 1 | methylated-DNA-[protein]-cysteine S-methyltransferase activity |
GO:0004516 | 0.001 | Inf | 0.001 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
GO:0008112 | 0.001 | Inf | 0.001 | 1 | 1 | nicotinamide N-methyltransferase activity |
GO:0043914 | 0.001 | Inf | 0.001 | 1 | 1 | NADPH:sulfur oxidoreductase activity |
GO:0004514 | 0.003 | 527.8214 | 0.003 | 1 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
GO:0008401 | 0.003 | 527.8214 | 0.003 | 1 | 3 | retinoic acid 4-hydroxylase activity |
GO:0009008 | 0.0051 | 263.875 | 0.0051 | 1 | 5 | DNA-methyltransferase activity |
GO:0016874 | 0.0071 | 9.0345 | 0.4065 | 3 | 401 | ligase activity |
GO:0004252 | 0.009 | 15.9738 | 0.145 | 2 | 143 | serine-type endopeptidase activity |
GO:0071949 | 0.0091 | 131.9018 | 0.0091 | 1 | 9 | FAD binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004516 | 0.0011 | Inf | 0.0011 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
GO:0097573 | 0.0011 | Inf | 0.0011 | 1 | 1 | glutathione oxidoreductase activity |
GO:0004514 | 0.0034 | 461.7812 | 0.0034 | 1 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
GO:0036122 | 0.0046 | 307.8333 | 0.0046 | 1 | 4 | BMP binding |
GO:0015038 | 0.0057 | 230.8594 | 0.0057 | 1 | 5 | glutathione disulfide oxidoreductase activity |
GO:0016015 | 0.0069 | 184.675 | 0.0069 | 1 | 6 | morphogen activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016798 | 0.0019 | 13.5694 | 0.2476 | 3 | 111 | hydrolase activity, acting on glycosyl bonds |
GO:0001191 | 0.0022 | 32.7786 | 0.0691 | 2 | 31 | RNA polymerase II transcription factor binding transcription factor activity involved in negative regulation of transcription |
GO:0008112 | 0.0022 | Inf | 0.0022 | 1 | 1 | nicotinamide N-methyltransferase activity |
GO:0030294 | 0.0022 | Inf | 0.0022 | 1 | 1 | receptor signaling protein tyrosine kinase inhibitor activity |
GO:0033906 | 0.0045 | 461.3125 | 0.0045 | 1 | 2 | hyaluronoglucuronidase activity |
GO:0008184 | 0.0067 | 230.6406 | 0.0067 | 1 | 3 | glycogen phosphorylase activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 57.0837 | 0.4601 | 11 | 368 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 47.0467 | 0.5526 | 11 | 442 | detection of chemical stimulus |
GO:0050906 | 0 | 46.1643 | 0.5626 | 11 | 450 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 45.5233 | 0.5701 | 11 | 456 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 17.4946 | 1.3965 | 11 | 1117 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 16.6007 | 1.4653 | 11 | 1172 | neurological system process |
GO:0031424 | 0 | 63.0542 | 0.06 | 3 | 48 | keratinization |
GO:0044707 | 7e-04 | 6.7662 | 6.2536 | 13 | 5921 | single-multicellular organism process |
GO:0009913 | 0.0011 | 17.0602 | 0.21 | 3 | 168 | epidermal cell differentiation |
GO:0035574 | 0.0025 | 843.1667 | 0.0025 | 1 | 2 | histone H4-K20 demethylation |
GO:0007165 | 0.0054 | 3.6208 | 6.1125 | 12 | 4889 | signal transduction |
GO:0045653 | 0.0062 | 210.75 | 0.0063 | 1 | 5 | negative regulation of megakaryocyte differentiation |
GO:0043588 | 0.0079 | 8.4103 | 0.4176 | 3 | 334 | skin development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 1e-04 | 60.9329 | 0.1211 | 3 | 368 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 2e-04 | 50.4089 | 0.1454 | 3 | 442 | detection of chemical stimulus |
GO:0050906 | 2e-04 | 49.4799 | 0.1481 | 3 | 450 | detection of stimulus involved in sensory perception |
GO:0007606 | 3e-04 | 48.8046 | 0.15 | 3 | 456 | sensory perception of chemical stimulus |
GO:0007186 | 0.0035 | 18.956 | 0.3675 | 3 | 1117 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0.0041 | 17.9936 | 0.3856 | 3 | 1172 | neurological system process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007565 | 0 | 40.9571 | 0.1429 | 4 | 167 | female pregnancy |
GO:0035994 | 0.0034 | 421.6944 | 0.0034 | 1 | 4 | response to muscle stretch |
GO:0070886 | 0.0043 | 316.25 | 0.0043 | 1 | 5 | positive regulation of calcineurin-NFAT signaling cascade |
GO:0021937 | 0.0051 | 252.9833 | 0.0051 | 1 | 6 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
GO:0045656 | 0.0051 | 252.9833 | 0.0051 | 1 | 6 | negative regulation of monocyte differentiation |
GO:2000279 | 0.0051 | 252.9833 | 0.0051 | 1 | 6 | negative regulation of DNA biosynthetic process |
GO:0045617 | 0.006 | 210.8056 | 0.006 | 1 | 7 | negative regulation of keratinocyte differentiation |
GO:0032501 | 0.0089 | 4.8765 | 5.2823 | 10 | 6175 | multicellular organismal process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031326 | 0 | 6.5839 | 34.6542 | 97 | 3632 | regulation of cellular biosynthetic process |
GO:0006355 | 0 | 6.3635 | 29.5496 | 89 | 3097 | regulation of transcription, DNA-templated |
GO:0051252 | 0 | 6.2454 | 30.6755 | 90 | 3215 | regulation of RNA metabolic process |
GO:0010556 | 0 | 6.1385 | 33.2898 | 93 | 3489 | regulation of macromolecule biosynthetic process |
GO:0051171 | 0 | 5.5103 | 38.5852 | 96 | 4044 | regulation of nitrogen compound metabolic process |
GO:0010628 | 0 | 6.6712 | 11.6023 | 52 | 1216 | positive regulation of gene expression |
GO:0045944 | 0 | 7.7585 | 7.8273 | 43 | 826 | positive regulation of transcription from RNA polymerase II promoter |
GO:0045935 | 0 | 6.2249 | 12.6709 | 53 | 1328 | positive regulation of nucleobase-containing compound metabolic process |
GO:1902680 | 0 | 6.4423 | 11.0107 | 49 | 1154 | positive regulation of RNA biosynthetic process |
GO:0090304 | 0 | 4.6865 | 42.335 | 95 | 4437 | nucleic acid metabolic process |
GO:0009891 | 0 | 5.7672 | 13.5487 | 53 | 1420 | positive regulation of biosynthetic process |
GO:0080090 | 0 | 4.545 | 49.1571 | 101 | 5152 | regulation of primary metabolic process |
GO:0032501 | 0 | 4.5998 | 54.1241 | 102 | 5964 | multicellular organismal process |
GO:1901576 | 0 | 4.0496 | 49.7486 | 98 | 5214 | organic substance biosynthetic process |
GO:0065007 | 0 | 6.1883 | 93.429 | 133 | 9792 | biological regulation |
GO:0007399 | 0 | 4.4166 | 16.4443 | 51 | 1789 | nervous system development |
GO:0048562 | 0 | 13.7697 | 1.6388 | 18 | 182 | embryonic organ morphogenesis |
GO:0046483 | 0 | 3.6412 | 56.4944 | 101 | 5921 | heterocycle metabolic process |
GO:0034641 | 0 | 3.5501 | 58.4981 | 102 | 6131 | cellular nitrogen compound metabolic process |
GO:0006725 | 0 | 3.4971 | 54.1783 | 96 | 5847 | cellular aromatic compound metabolic process |
GO:0045934 | 0 | 4.8873 | 9.7608 | 37 | 1023 | negative regulation of nucleobase-containing compound metabolic process |
GO:0009890 | 0 | 4.6548 | 10.5432 | 38 | 1105 | negative regulation of biosynthetic process |
GO:0010629 | 0 | 4.8213 | 9.5509 | 36 | 1001 | negative regulation of gene expression |
GO:1902679 | 0 | 5.0238 | 8.5777 | 34 | 899 | negative regulation of RNA biosynthetic process |
GO:1901360 | 0 | 3.309 | 56.0037 | 96 | 6044 | organic cyclic compound metabolic process |
GO:0000122 | 0 | 5.9656 | 5.5626 | 27 | 583 | negative regulation of transcription from RNA polymerase II promoter |
GO:0034645 | 0 | 3.6691 | 25.0504 | 57 | 3206 | cellular macromolecule biosynthetic process |
GO:0009790 | 0 | 4.9423 | 7.8653 | 31 | 868 | embryo development |
GO:2000113 | 0 | 4.5063 | 9.465 | 34 | 992 | negative regulation of cellular macromolecule biosynthetic process |
GO:0007275 | 0 | 4.2003 | 16.2785 | 43 | 2415 | multicellular organismal development |
GO:0048468 | 0 | 4.2159 | 10.3229 | 34 | 1181 | cell development |
GO:0007420 | 0 | 6.3988 | 3.9323 | 21 | 438 | brain development |
GO:0045666 | 0 | 16.3224 | 0.7442 | 10 | 78 | positive regulation of neuron differentiation |
GO:0048523 | 0 | 2.8021 | 30.8186 | 62 | 3230 | negative regulation of cellular process |
GO:0043583 | 0 | 8.5883 | 1.8987 | 14 | 199 | ear development |
GO:0021517 | 0 | 23.0718 | 0.4389 | 8 | 46 | ventral spinal cord development |
GO:0032502 | 0 | 3.6318 | 15.8965 | 38 | 2469 | developmental process |
GO:0035270 | 0 | 15.2063 | 0.7068 | 9 | 77 | endocrine system development |
GO:0032774 | 0 | 3.8818 | 10.1632 | 29 | 1637 | RNA biosynthetic process |
GO:0032095 | 0 | 53.7214 | 0.1431 | 5 | 15 | regulation of response to food |
GO:0009952 | 0 | 9.9147 | 1.1602 | 10 | 130 | anterior/posterior pattern specification |
GO:0048704 | 0 | 11.792 | 0.8873 | 9 | 93 | embryonic skeletal system morphogenesis |
GO:0043010 | 0 | 6.0564 | 2.6239 | 14 | 275 | camera-type eye development |
GO:0042472 | 0 | 11.0015 | 0.9446 | 9 | 99 | inner ear morphogenesis |
GO:0045665 | 0 | 16.1941 | 0.5152 | 7 | 54 | negative regulation of neuron differentiation |
GO:0048663 | 0 | 22.8962 | 0.3252 | 6 | 36 | neuron fate commitment |
GO:0021530 | 0 | Inf | 0.0286 | 3 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0021515 | 0 | 20.0628 | 0.3648 | 6 | 39 | cell differentiation in spinal cord |
GO:0007423 | 0 | 6.0696 | 2.23 | 12 | 263 | sensory organ development |
GO:0051093 | 0 | 3.7671 | 6.0458 | 20 | 638 | negative regulation of developmental process |
GO:0060537 | 0 | 5.0655 | 3.1009 | 14 | 325 | muscle tissue development |
GO:0007517 | 0 | 5.0325 | 3.12 | 14 | 327 | muscle organ development |
GO:2000026 | 0 | 3.064 | 10.3144 | 27 | 1133 | regulation of multicellular organismal development |
GO:0003151 | 0 | 16.8456 | 0.4238 | 6 | 45 | outflow tract morphogenesis |
GO:0021520 | 0 | 47.4169 | 0.124 | 4 | 13 | spinal cord motor neuron cell fate specification |
GO:0048935 | 0 | 47.4169 | 0.124 | 4 | 13 | peripheral nervous system neuron development |
GO:0030855 | 0 | 4.7607 | 3.295 | 14 | 356 | epithelial cell differentiation |
GO:0003278 | 0 | 158.9789 | 0.0477 | 3 | 5 | apoptotic process involved in heart morphogenesis |
GO:0021779 | 0 | 158.9789 | 0.0477 | 3 | 5 | oligodendrocyte cell fate commitment |
GO:0021780 | 0 | 158.9789 | 0.0477 | 3 | 5 | glial cell fate specification |
GO:0009953 | 0 | 8.7311 | 1.0305 | 8 | 108 | dorsal/ventral pattern formation |
GO:0050885 | 0 | 14.0813 | 0.4962 | 6 | 52 | neuromuscular process controlling balance |
GO:0021542 | 0 | 38.7905 | 0.1431 | 4 | 15 | dentate gyrus development |
GO:0050794 | 0 | 3.2853 | 20.9301 | 37 | 3782 | regulation of cellular process |
GO:0031018 | 0 | 13.4928 | 0.5152 | 6 | 54 | endocrine pancreas development |
GO:0021953 | 0 | 10.2075 | 0.776 | 7 | 85 | central nervous system neuron differentiation |
GO:0001756 | 0 | 13.4024 | 0.5179 | 6 | 55 | somitogenesis |
GO:0001501 | 0 | 4.1103 | 4.0646 | 15 | 426 | skeletal system development |
GO:0048699 | 0 | 3.7378 | 5.1685 | 17 | 625 | generation of neurons |
GO:0048863 | 0 | 12.9065 | 0.5352 | 6 | 58 | stem cell differentiation |
GO:0048852 | 0 | 105.9789 | 0.0572 | 3 | 6 | diencephalon morphogenesis |
GO:0060022 | 0 | 105.9789 | 0.0572 | 3 | 6 | hard palate development |
GO:0048665 | 0 | 31.3431 | 0.1671 | 4 | 18 | neuron fate specification |
GO:0060173 | 0 | 6.487 | 1.5362 | 9 | 161 | limb development |
GO:0021871 | 0 | 28.8403 | 0.1789 | 4 | 19 | forebrain regionalization |
GO:0007368 | 0 | 8.9317 | 0.8778 | 7 | 92 | determination of left/right symmetry |
GO:0021796 | 0 | 79.4789 | 0.0668 | 3 | 7 | cerebral cortex regionalization |
GO:0033555 | 0 | 11.3555 | 0.6011 | 6 | 63 | multicellular organismal response to stress |
GO:0001709 | 0 | 16.0017 | 0.3671 | 5 | 39 | cell fate determination |
GO:0003231 | 0 | 8.6255 | 0.9064 | 7 | 95 | cardiac ventricle development |
GO:0043586 | 0 | 26.6596 | 0.1908 | 4 | 20 | tongue development |
GO:0050767 | 0 | 4.2494 | 3.3855 | 13 | 370 | regulation of neurogenesis |
GO:0044699 | 0 | 3.0298 | 116.2901 | 134 | 12188 | single-organism process |
GO:0001662 | 0 | 25.4473 | 0.1977 | 4 | 21 | behavioral fear response |
GO:0031960 | 0 | 6.9174 | 1.2785 | 8 | 134 | response to corticosteroid |
GO:0060562 | 0 | 4.4518 | 2.9674 | 12 | 311 | epithelial tube morphogenesis |
GO:0023019 | 1e-04 | 23.6942 | 0.2099 | 4 | 22 | signal transduction involved in regulation of gene expression |
GO:0009799 | 1e-04 | 7.9862 | 0.9732 | 7 | 102 | specification of symmetry |
GO:0035050 | 1e-04 | 9.9526 | 0.6774 | 6 | 71 | embryonic heart tube development |
GO:0048592 | 1e-04 | 6.6003 | 1.3358 | 8 | 140 | eye morphogenesis |
GO:0003206 | 1e-04 | 7.8205 | 0.9923 | 7 | 104 | cardiac chamber morphogenesis |
GO:0035107 | 1e-04 | 6.5502 | 1.3453 | 8 | 141 | appendage morphogenesis |
GO:0021892 | 1e-04 | 52.9789 | 0.0859 | 3 | 9 | cerebral cortex GABAergic interneuron differentiation |
GO:0035051 | 1e-04 | 7.5843 | 1.0209 | 7 | 107 | cardiocyte differentiation |
GO:0032104 | 1e-04 | 13.0758 | 0.4389 | 5 | 46 | regulation of response to extracellular stimulus |
GO:0007422 | 1e-04 | 9.3732 | 0.7156 | 6 | 75 | peripheral nervous system development |
GO:0030814 | 1e-04 | 7.4346 | 1.04 | 7 | 109 | regulation of cAMP metabolic process |
GO:0003326 | 1e-04 | Inf | 0.0191 | 2 | 2 | pancreatic A cell fate commitment |
GO:0003329 | 1e-04 | Inf | 0.0191 | 2 | 2 | pancreatic PP cell fate commitment |
GO:0043503 | 1e-04 | Inf | 0.0191 | 2 | 2 | skeletal muscle fiber adaptation |
GO:0048866 | 1e-04 | Inf | 0.0191 | 2 | 2 | stem cell fate specification |
GO:0008284 | 1e-04 | 3.168 | 5.9587 | 17 | 648 | positive regulation of cell proliferation |
GO:0009653 | 1e-04 | 2.5129 | 12.6115 | 27 | 1581 | anatomical structure morphogenesis |
GO:0003211 | 1e-04 | 45.4074 | 0.0954 | 3 | 10 | cardiac ventricle formation |
GO:0032099 | 1e-04 | 45.4074 | 0.0954 | 3 | 10 | negative regulation of appetite |
GO:0048703 | 1e-04 | 45.4074 | 0.0954 | 3 | 10 | embryonic viscerocranium morphogenesis |
GO:0090009 | 1e-04 | 45.4074 | 0.0954 | 3 | 10 | primitive streak formation |
GO:0044058 | 1e-04 | 19.381 | 0.2481 | 4 | 26 | regulation of digestive system process |
GO:0030802 | 1e-04 | 7.1522 | 1.0782 | 7 | 113 | regulation of cyclic nucleotide biosynthetic process |
GO:0048732 | 1e-04 | 4.0396 | 3.2559 | 12 | 350 | gland development |
GO:0007492 | 1e-04 | 8.8572 | 0.7538 | 6 | 79 | endoderm development |
GO:0030801 | 1e-04 | 8.8572 | 0.7538 | 6 | 79 | positive regulation of cyclic nucleotide metabolic process |
GO:0001704 | 1e-04 | 7.0849 | 1.0877 | 7 | 114 | formation of primary germ layer |
GO:0050877 | 1e-04 | 2.5256 | 11.1825 | 25 | 1172 | neurological system process |
GO:1900371 | 1e-04 | 6.9539 | 1.1068 | 7 | 116 | regulation of purine nucleotide biosynthetic process |
GO:0010001 | 1e-04 | 5.8406 | 1.498 | 8 | 157 | glial cell differentiation |
GO:0030178 | 1e-04 | 6.7663 | 1.1354 | 7 | 119 | negative regulation of Wnt signaling pathway |
GO:0060429 | 2e-04 | 3.8829 | 3.4063 | 12 | 408 | epithelium development |
GO:0001942 | 2e-04 | 8.1812 | 0.811 | 6 | 85 | hair follicle development |
GO:0022404 | 2e-04 | 8.1812 | 0.811 | 6 | 85 | molting cycle process |
GO:0023061 | 2e-04 | 3.8462 | 3.4063 | 12 | 357 | signal release |
GO:0043009 | 2e-04 | 3.4292 | 4.4938 | 14 | 507 | chordate embryonic development |
GO:0048565 | 2e-04 | 8.1356 | 0.8149 | 6 | 87 | digestive tract development |
GO:0030326 | 2e-04 | 6.5885 | 1.164 | 7 | 122 | embryonic limb morphogenesis |
GO:0001764 | 2e-04 | 6.5689 | 1.1672 | 7 | 124 | neuron migration |
GO:0019228 | 2e-04 | 8.0784 | 0.8206 | 6 | 86 | neuronal action potential |
GO:1902742 | 2e-04 | 16.395 | 0.2862 | 4 | 30 | apoptotic process involved in development |
GO:0048870 | 2e-04 | 2.5348 | 10.1615 | 23 | 1065 | cell motility |
GO:0071385 | 2e-04 | 15.7867 | 0.2958 | 4 | 31 | cellular response to glucocorticoid stimulus |
GO:0046887 | 2e-04 | 7.6917 | 0.8587 | 6 | 90 | positive regulation of hormone secretion |
GO:0014003 | 2e-04 | 15.2219 | 0.3053 | 4 | 32 | oligodendrocyte development |
GO:0045761 | 2e-04 | 9.9193 | 0.5629 | 5 | 59 | regulation of adenylate cyclase activity |
GO:0048513 | 2e-04 | 3.1248 | 5.9971 | 16 | 1023 | organ development |
GO:0022037 | 2e-04 | 7.5118 | 0.8778 | 6 | 92 | metencephalon development |
GO:0007586 | 2e-04 | 6.1567 | 1.2404 | 7 | 130 | digestion |
GO:0010841 | 3e-04 | 210.5035 | 0.0286 | 2 | 3 | positive regulation of circadian sleep/wake cycle, wakefulness |
GO:0032100 | 3e-04 | 210.5035 | 0.0286 | 2 | 3 | positive regulation of appetite |
GO:0035284 | 3e-04 | 210.5035 | 0.0286 | 2 | 3 | brain segmentation |
GO:0055014 | 3e-04 | 210.5035 | 0.0286 | 2 | 3 | atrial cardiac muscle cell development |
GO:0052652 | 3e-04 | 6.0573 | 1.2595 | 7 | 132 | cyclic purine nucleotide metabolic process |
GO:1900544 | 3e-04 | 7.2571 | 0.9064 | 6 | 95 | positive regulation of purine nucleotide metabolic process |
GO:0048536 | 3e-04 | 14.2052 | 0.3244 | 4 | 34 | spleen development |
GO:0030819 | 3e-04 | 9.3954 | 0.5916 | 5 | 62 | positive regulation of cAMP biosynthetic process |
GO:0051048 | 3e-04 | 5.817 | 1.3083 | 7 | 139 | negative regulation of secretion |
GO:0021527 | 4e-04 | 26.4789 | 0.1431 | 3 | 15 | spinal cord association neuron differentiation |
GO:0007519 | 4e-04 | 6.8991 | 0.95 | 6 | 102 | skeletal muscle tissue development |
GO:0032755 | 4e-04 | 12.9112 | 0.353 | 4 | 37 | positive regulation of interleukin-6 production |
GO:0035137 | 4e-04 | 12.9112 | 0.353 | 4 | 37 | hindlimb morphogenesis |
GO:0002793 | 4e-04 | 8.7769 | 0.6297 | 5 | 66 | positive regulation of peptide secretion |
GO:0090087 | 4e-04 | 4.8519 | 1.7842 | 8 | 187 | regulation of peptide transport |
GO:0003215 | 4e-04 | 24.4404 | 0.1527 | 3 | 16 | cardiac right ventricle morphogenesis |
GO:0060037 | 4e-04 | 24.4404 | 0.1527 | 3 | 16 | pharyngeal system development |
GO:0021954 | 4e-04 | 8.6348 | 0.6393 | 5 | 67 | central nervous system neuron development |
GO:0042633 | 5e-04 | 6.655 | 0.9828 | 6 | 103 | hair cycle |
GO:0060485 | 5e-04 | 4.8061 | 1.8005 | 8 | 190 | mesenchyme development |
GO:0043270 | 5e-04 | 5.5223 | 1.374 | 7 | 144 | positive regulation of ion transport |
GO:0048522 | 5e-04 | 2.1197 | 18.7078 | 33 | 2453 | positive regulation of cellular process |
GO:0010623 | 5e-04 | 12.1718 | 0.3721 | 4 | 39 | developmental programmed cell death |
GO:0045776 | 5e-04 | 12.1718 | 0.3721 | 4 | 39 | negative regulation of blood pressure |
GO:2000179 | 5e-04 | 12.1718 | 0.3721 | 4 | 39 | positive regulation of neural precursor cell proliferation |
GO:0007218 | 5e-04 | 6.4541 | 1.0114 | 6 | 106 | neuropeptide signaling pathway |
GO:0035814 | 5e-04 | 105.2448 | 0.0382 | 2 | 4 | negative regulation of renal sodium excretion |
GO:0051461 | 5e-04 | 105.2448 | 0.0382 | 2 | 4 | positive regulation of corticotropin secretion |
GO:0060214 | 5e-04 | 105.2448 | 0.0382 | 2 | 4 | endocardium formation |
GO:0060913 | 5e-04 | 105.2448 | 0.0382 | 2 | 4 | cardiac cell fate determination |
GO:0097476 | 5e-04 | 105.2448 | 0.0382 | 2 | 4 | spinal cord motor neuron migration |
GO:1903365 | 5e-04 | 105.2448 | 0.0382 | 2 | 4 | regulation of fear response |
GO:2000987 | 5e-04 | 105.2448 | 0.0382 | 2 | 4 | positive regulation of behavioral fear response |
GO:0048332 | 5e-04 | 8.2346 | 0.6679 | 5 | 70 | mesoderm morphogenesis |
GO:0048538 | 6e-04 | 11.8329 | 0.3817 | 4 | 40 | thymus development |
GO:0007267 | 6e-04 | 4.6473 | 1.8669 | 8 | 215 | cell-cell signaling |
GO:0001570 | 6e-04 | 8.1093 | 0.6774 | 5 | 71 | vasculogenesis |
GO:0032108 | 6e-04 | 21.1789 | 0.1717 | 3 | 18 | negative regulation of response to nutrient levels |
GO:0042693 | 6e-04 | 21.1789 | 0.1717 | 3 | 18 | muscle cell fate commitment |
GO:0030810 | 7e-04 | 7.8697 | 0.6965 | 5 | 73 | positive regulation of nucleotide biosynthetic process |
GO:0021854 | 7e-04 | 19.8539 | 0.1813 | 3 | 19 | hypothalamus development |
GO:0051924 | 7e-04 | 5.0735 | 1.4885 | 7 | 156 | regulation of calcium ion transport |
GO:0010467 | 8e-04 | 2.1941 | 17.1517 | 30 | 2802 | gene expression |
GO:0031175 | 9e-04 | 2.5797 | 7.1942 | 17 | 754 | neuron projection development |
GO:0048485 | 9e-04 | 18.6848 | 0.1908 | 3 | 20 | sympathetic nervous system development |
GO:0021853 | 9e-04 | 70.1585 | 0.0477 | 2 | 5 | cerebral cortex GABAergic interneuron migration |
GO:0035881 | 9e-04 | 70.1585 | 0.0477 | 2 | 5 | amacrine cell differentiation |
GO:0060023 | 9e-04 | 70.1585 | 0.0477 | 2 | 5 | soft palate development |
GO:0060040 | 9e-04 | 70.1585 | 0.0477 | 2 | 5 | retinal bipolar neuron differentiation |
GO:0031290 | 0.001 | 17.6455 | 0.2004 | 3 | 21 | retinal ganglion cell axon guidance |
GO:0051953 | 0.001 | 17.6455 | 0.2004 | 3 | 21 | negative regulation of amine transport |
GO:0009914 | 0.0011 | 3.7649 | 2.5666 | 9 | 269 | hormone transport |
GO:0045595 | 0.0013 | 2.7635 | 5.5319 | 14 | 652 | regulation of cell differentiation |
GO:0003357 | 0.0013 | 52.9859 | 0.0569 | 2 | 6 | noradrenergic neuron differentiation |
GO:0010656 | 0.0013 | 15.8789 | 0.2195 | 3 | 23 | negative regulation of muscle cell apoptotic process |
GO:0042474 | 0.0013 | 15.8789 | 0.2195 | 3 | 23 | middle ear morphogenesis |
GO:0050880 | 0.0013 | 5.3712 | 1.2022 | 6 | 126 | regulation of blood vessel size |
GO:0008344 | 0.0013 | 6.6839 | 0.811 | 5 | 85 | adult locomotory behavior |
GO:0021797 | 0.0013 | 52.6154 | 0.0572 | 2 | 6 | forebrain anterior/posterior pattern specification |
GO:0042320 | 0.0013 | 52.6154 | 0.0572 | 2 | 6 | regulation of circadian sleep/wake cycle, REM sleep |
GO:0060235 | 0.0013 | 52.6154 | 0.0572 | 2 | 6 | lens induction in camera-type eye |
GO:0060956 | 0.0013 | 52.6154 | 0.0572 | 2 | 6 | endocardial cell differentiation |
GO:0045165 | 0.0014 | 6.6182 | 0.817 | 5 | 100 | cell fate commitment |
GO:0043588 | 0.0014 | 3.3672 | 3.1868 | 10 | 334 | skin development |
GO:0014032 | 0.0014 | 9.0569 | 0.4866 | 4 | 51 | neural crest cell development |
GO:0001963 | 0.0017 | 14.4334 | 0.2385 | 3 | 25 | synaptic transmission, dopaminergic |
GO:0030324 | 0.0017 | 4.3626 | 1.7174 | 7 | 180 | lung development |
GO:0021761 | 0.0017 | 8.5166 | 0.5146 | 4 | 55 | limbic system development |
GO:0001947 | 0.0017 | 8.5118 | 0.5152 | 4 | 54 | heart looping |
GO:0021885 | 0.0017 | 8.5118 | 0.5152 | 4 | 54 | forebrain cell migration |
GO:0010579 | 0.0018 | 42.0895 | 0.0668 | 2 | 7 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
GO:0021843 | 0.0018 | 42.0895 | 0.0668 | 2 | 7 | substrate-independent telencephalic tangential interneuron migration |
GO:2000252 | 0.0018 | 42.0895 | 0.0668 | 2 | 7 | negative regulation of feeding behavior |
GO:0042755 | 0.0019 | 13.805 | 0.2481 | 3 | 26 | eating behavior |
GO:0071407 | 0.002 | 3.4412 | 2.7956 | 9 | 293 | cellular response to organic cyclic compound |
GO:0032844 | 0.0021 | 3.4166 | 2.8147 | 9 | 295 | regulation of homeostatic process |
GO:0021511 | 0.0021 | 13.2289 | 0.2576 | 3 | 27 | spinal cord patterning |
GO:1902692 | 0.0021 | 13.2289 | 0.2576 | 3 | 27 | regulation of neuroblast proliferation |
GO:0035914 | 0.0023 | 7.8792 | 0.5534 | 4 | 58 | skeletal muscle cell differentiation |
GO:0048512 | 0.0023 | 12.6989 | 0.2672 | 3 | 28 | circadian behavior |
GO:0060412 | 0.0023 | 12.6989 | 0.2672 | 3 | 28 | ventricular septum morphogenesis |
GO:0050768 | 0.0024 | 5.8075 | 0.9255 | 5 | 97 | negative regulation of neurogenesis |
GO:0060415 | 0.0024 | 7.7354 | 0.5629 | 4 | 59 | muscle tissue morphogenesis |
GO:0003263 | 0.0024 | 35.0723 | 0.0763 | 2 | 8 | cardioblast proliferation |
GO:0010667 | 0.0024 | 35.0723 | 0.0763 | 2 | 8 | negative regulation of cardiac muscle cell apoptotic process |
GO:0040019 | 0.0024 | 35.0723 | 0.0763 | 2 | 8 | positive regulation of embryonic development |
GO:0060253 | 0.0024 | 35.0723 | 0.0763 | 2 | 8 | negative regulation of glial cell proliferation |
GO:2000543 | 0.0024 | 35.0723 | 0.0763 | 2 | 8 | positive regulation of gastrulation |
GO:2000679 | 0.0024 | 35.0723 | 0.0763 | 2 | 8 | positive regulation of transcription regulatory region DNA binding |
GO:0007190 | 0.0026 | 12.2096 | 0.2767 | 3 | 29 | activation of adenylate cyclase activity |
GO:0048511 | 0.0027 | 3.5887 | 2.3758 | 8 | 249 | rhythmic process |
GO:0021872 | 0.0027 | 7.463 | 0.582 | 4 | 61 | forebrain generation of neurons |
GO:0042886 | 0.0028 | 3.5736 | 2.3853 | 8 | 250 | amide transport |
GO:0031016 | 0.0028 | 11.7983 | 0.2846 | 3 | 31 | pancreas development |
GO:0009954 | 0.0029 | 11.7567 | 0.2862 | 3 | 30 | proximal/distal pattern formation |
GO:0008306 | 0.0029 | 7.3338 | 0.5916 | 4 | 62 | associative learning |
GO:0009725 | 0.0029 | 2.3422 | 7.3755 | 16 | 773 | response to hormone |
GO:0048729 | 0.003 | 3.0162 | 3.5447 | 10 | 390 | tissue morphogenesis |
GO:0045471 | 0.0031 | 5.4497 | 0.9828 | 5 | 103 | response to ethanol |
GO:2000648 | 0.0031 | 7.209 | 0.6011 | 4 | 63 | positive regulation of stem cell proliferation |
GO:0010720 | 0.0031 | 3.9053 | 1.9083 | 7 | 200 | positive regulation of cell development |
GO:0003266 | 0.0031 | 30.0599 | 0.0859 | 2 | 9 | regulation of secondary heart field cardioblast proliferation |
GO:0008343 | 0.0031 | 30.0599 | 0.0859 | 2 | 9 | adult feeding behavior |
GO:0051584 | 0.0031 | 30.0599 | 0.0859 | 2 | 9 | regulation of dopamine uptake involved in synaptic transmission |
GO:0048333 | 0.0031 | 11.336 | 0.2958 | 3 | 31 | mesodermal cell differentiation |
GO:0051240 | 0.0032 | 2.5592 | 5.4493 | 13 | 579 | positive regulation of multicellular organismal process |
GO:0051091 | 0.0033 | 3.8647 | 1.9274 | 7 | 202 | positive regulation of sequence-specific DNA binding transcription factor activity |
GO:0021543 | 0.0033 | 11.0667 | 0.3014 | 3 | 33 | pallium development |
GO:0072001 | 0.0033 | 3.4574 | 2.4617 | 8 | 258 | renal system development |
GO:0034654 | 0.0034 | 4.5235 | 1.4706 | 6 | 318 | nucleobase-containing compound biosynthetic process |
GO:0048854 | 0.0034 | 10.9444 | 0.3053 | 3 | 32 | brain morphogenesis |
GO:0003013 | 0.0035 | 2.9393 | 3.6257 | 10 | 380 | circulatory system process |
GO:0035637 | 0.0038 | 4.2883 | 1.4885 | 6 | 156 | multicellular organismal signaling |
GO:0006335 | 0.0039 | 26.3007 | 0.0954 | 2 | 10 | DNA replication-dependent nucleosome assembly |
GO:0010544 | 0.0039 | 26.3007 | 0.0954 | 2 | 10 | negative regulation of platelet activation |
GO:0032525 | 0.0039 | 26.3007 | 0.0954 | 2 | 10 | somite rostral/caudal axis specification |
GO:0048869 | 0.0039 | 2.1786 | 9.9488 | 19 | 1532 | cellular developmental process |
GO:0048519 | 0.0039 | 3.7815 | 2.0085 | 7 | 289 | negative regulation of biological process |
GO:0040007 | 0.004 | 3.3548 | 2.5397 | 8 | 280 | growth |
GO:0003279 | 0.004 | 6.6436 | 0.6488 | 4 | 68 | cardiac septum development |
GO:0033993 | 0.0041 | 2.3949 | 6.2687 | 14 | 657 | response to lipid |
GO:0003156 | 0.0041 | 10.2369 | 0.3244 | 3 | 34 | regulation of organ formation |
GO:0014015 | 0.0041 | 10.2369 | 0.3244 | 3 | 34 | positive regulation of gliogenesis |
GO:0003002 | 0.0042 | 10.0392 | 0.3273 | 3 | 41 | regionalization |
GO:0022414 | 0.0043 | 2.0515 | 10.5814 | 20 | 1109 | reproductive process |
GO:2000027 | 0.0044 | 4.993 | 1.0676 | 5 | 114 | regulation of organ morphogenesis |
GO:0045168 | 0.0045 | 9.9164 | 0.3339 | 3 | 35 | cell-cell signaling involved in cell fate commitment |
GO:0043069 | 0.0045 | 2.3679 | 6.3355 | 14 | 664 | negative regulation of programmed cell death |
GO:0042391 | 0.0045 | 3.0273 | 3.1582 | 9 | 331 | regulation of membrane potential |
GO:0043249 | 0.0047 | 23.3768 | 0.105 | 2 | 11 | erythrocyte maturation |
GO:0048617 | 0.0047 | 23.3768 | 0.105 | 2 | 11 | embryonic foregut morphogenesis |
GO:0051934 | 0.0047 | 23.3768 | 0.105 | 2 | 11 | catecholamine uptake involved in synaptic transmission |
GO:0060379 | 0.0047 | 23.3768 | 0.105 | 2 | 11 | cardiac muscle cell myoblast differentiation |
GO:0090494 | 0.0047 | 23.3768 | 0.105 | 2 | 11 | dopamine uptake |
GO:0050796 | 0.0047 | 4.0952 | 1.5552 | 6 | 163 | regulation of insulin secretion |
GO:0009152 | 0.0048 | 3.585 | 2.0705 | 7 | 217 | purine ribonucleotide biosynthetic process |
GO:0032651 | 0.0048 | 9.6152 | 0.3435 | 3 | 36 | regulation of interleukin-1 beta production |
GO:0045668 | 0.0048 | 9.6152 | 0.3435 | 3 | 36 | negative regulation of osteoblast differentiation |
GO:0055123 | 0.005 | 22.2791 | 0.1083 | 2 | 12 | digestive system development |
GO:1903034 | 0.0052 | 2.9614 | 3.225 | 9 | 338 | regulation of response to wounding |
GO:0051101 | 0.0052 | 6.1601 | 0.6965 | 4 | 73 | regulation of DNA binding |
GO:0035136 | 0.0052 | 9.3318 | 0.353 | 3 | 37 | forelimb morphogenesis |
GO:0042312 | 0.0052 | 9.3318 | 0.353 | 3 | 37 | regulation of vasodilation |
GO:0048566 | 0.0052 | 9.3318 | 0.353 | 3 | 37 | embryonic digestive tract development |
GO:0007631 | 0.0052 | 9.3097 | 0.3528 | 3 | 39 | feeding behavior |
GO:0007565 | 0.0053 | 3.9924 | 1.5934 | 6 | 167 | female pregnancy |
GO:0009888 | 0.0054 | 3.5327 | 2.1223 | 7 | 298 | tissue development |
GO:0001946 | 0.0056 | 21.0378 | 0.1145 | 2 | 12 | lymphangiogenesis |
GO:0042789 | 0.0056 | 21.0378 | 0.1145 | 2 | 12 | mRNA transcription from RNA polymerase II promoter |
GO:0048148 | 0.0056 | 21.0378 | 0.1145 | 2 | 12 | behavioral response to cocaine |
GO:0048714 | 0.0056 | 21.0378 | 0.1145 | 2 | 12 | positive regulation of oligodendrocyte differentiation |
GO:0051580 | 0.0056 | 21.0378 | 0.1145 | 2 | 12 | regulation of neurotransmitter uptake |
GO:1901385 | 0.0056 | 21.0378 | 0.1145 | 2 | 12 | regulation of voltage-gated calcium channel activity |
GO:0055010 | 0.0056 | 9.0646 | 0.3626 | 3 | 38 | ventricular cardiac muscle tissue morphogenesis |
GO:0040008 | 0.0058 | 2.4722 | 5.1714 | 12 | 542 | regulation of growth |
GO:0007188 | 0.0058 | 4.6388 | 1.145 | 5 | 120 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0072091 | 0.0062 | 19.7299 | 0.1203 | 2 | 13 | regulation of stem cell proliferation |
GO:0007268 | 0.0063 | 2.2727 | 6.5835 | 14 | 690 | synaptic transmission |
GO:0032414 | 0.0065 | 8.5735 | 0.3817 | 3 | 40 | positive regulation of ion transmembrane transporter activity |
GO:0010454 | 0.0066 | 19.124 | 0.124 | 2 | 13 | negative regulation of cell fate commitment |
GO:0015812 | 0.0066 | 19.124 | 0.124 | 2 | 13 | gamma-aminobutyric acid transport |
GO:0042053 | 0.0066 | 19.124 | 0.124 | 2 | 13 | regulation of dopamine metabolic process |
GO:0043584 | 0.0066 | 19.124 | 0.124 | 2 | 13 | nose development |
GO:0055015 | 0.0066 | 19.124 | 0.124 | 2 | 13 | ventricular cardiac muscle cell development |
GO:0060413 | 0.0066 | 19.124 | 0.124 | 2 | 13 | atrial septum morphogenesis |
GO:0060042 | 0.0067 | 8.4648 | 0.3859 | 3 | 41 | retina morphogenesis in camera-type eye |
GO:0046390 | 0.0067 | 3.3578 | 2.2041 | 7 | 231 | ribose phosphate biosynthetic process |
GO:0007166 | 0.0069 | 1.6239 | 29.2252 | 42 | 3063 | cell surface receptor signaling pathway |
GO:0021545 | 0.007 | 8.3473 | 0.3912 | 3 | 41 | cranial nerve development |
GO:0030902 | 0.0072 | 8.2312 | 0.3957 | 3 | 43 | hindbrain development |
GO:0032102 | 0.0072 | 5.5755 | 0.765 | 4 | 82 | negative regulation of response to external stimulus |
GO:0021987 | 0.0073 | 5.563 | 0.7666 | 4 | 82 | cerebral cortex development |
GO:0045597 | 0.0073 | 3.0158 | 2.811 | 8 | 318 | positive regulation of cell differentiation |
GO:0002064 | 0.0074 | 3.7125 | 1.7079 | 6 | 179 | epithelial cell development |
GO:0071495 | 0.0075 | 2.0544 | 8.883 | 17 | 931 | cellular response to endogenous stimulus |
GO:0060579 | 0.0075 | 17.6526 | 0.1327 | 2 | 14 | ventral spinal cord interneuron fate commitment |
GO:0072522 | 0.0075 | 3.2834 | 2.2518 | 7 | 236 | purine-containing compound biosynthetic process |
GO:0003148 | 0.0076 | 17.5291 | 0.1336 | 2 | 14 | outflow tract septum morphogenesis |
GO:0090280 | 0.0076 | 17.5291 | 0.1336 | 2 | 14 | positive regulation of calcium ion import |
GO:0044706 | 0.0078 | 7.9896 | 0.4069 | 3 | 44 | multi-multicellular organism process |
GO:0002067 | 0.0079 | 7.9289 | 0.4103 | 3 | 43 | glandular epithelial cell differentiation |
GO:0007618 | 0.0079 | 7.9289 | 0.4103 | 3 | 43 | mating |
GO:0061351 | 0.008 | 5.4127 | 0.7868 | 4 | 84 | neural precursor cell proliferation |
GO:1901700 | 0.0081 | 1.9251 | 11.2111 | 20 | 1175 | response to oxygen-containing compound |
GO:0050728 | 0.0082 | 5.3768 | 0.7919 | 4 | 83 | negative regulation of inflammatory response |
GO:0021536 | 0.0084 | 5.3373 | 0.797 | 4 | 87 | diencephalon development |
GO:0031281 | 0.0085 | 7.735 | 0.4198 | 3 | 44 | positive regulation of cyclase activity |
GO:0061005 | 0.0085 | 7.735 | 0.4198 | 3 | 44 | cell differentiation involved in kidney development |
GO:0072089 | 0.0085 | 7.7168 | 0.42 | 3 | 46 | stem cell proliferation |
GO:0048864 | 0.0086 | 3.1982 | 2.309 | 7 | 242 | stem cell development |
GO:0015671 | 0.0088 | 16.1797 | 0.1431 | 2 | 15 | oxygen transport |
GO:0021984 | 0.0088 | 16.1797 | 0.1431 | 2 | 15 | adenohypophysis development |
GO:0030252 | 0.0088 | 16.1797 | 0.1431 | 2 | 15 | growth hormone secretion |
GO:0031649 | 0.0088 | 16.1797 | 0.1431 | 2 | 15 | heat generation |
GO:0032891 | 0.0088 | 16.1797 | 0.1431 | 2 | 15 | negative regulation of organic acid transport |
GO:0042749 | 0.0088 | 16.1797 | 0.1431 | 2 | 15 | regulation of circadian sleep/wake cycle |
GO:0060841 | 0.0088 | 16.1797 | 0.1431 | 2 | 15 | venous blood vessel development |
GO:0002520 | 0.0088 | 2.1748 | 6.8602 | 14 | 719 | immune system development |
GO:0048583 | 0.0089 | 1.6087 | 27.8798 | 40 | 2922 | regulation of response to stimulus |
GO:0009798 | 0.0089 | 5.2433 | 0.811 | 4 | 85 | axis specification |
GO:0006584 | 0.009 | 7.5503 | 0.4294 | 3 | 45 | catecholamine metabolic process |
GO:0007409 | 0.0092 | 2.4141 | 4.8279 | 11 | 506 | axonogenesis |
GO:0018958 | 0.0094 | 5.1528 | 0.8244 | 4 | 87 | phenol-containing compound metabolic process |
GO:0001828 | 0.0095 | Inf | 0.0095 | 1 | 1 | inner cell mass cellular morphogenesis |
GO:0002037 | 0.0095 | Inf | 0.0095 | 1 | 1 | negative regulation of L-glutamate transport |
GO:0002878 | 0.0095 | Inf | 0.0095 | 1 | 1 | negative regulation of acute inflammatory response to non-antigenic stimulus |
GO:0003142 | 0.0095 | Inf | 0.0095 | 1 | 1 | cardiogenic plate morphogenesis |
GO:0003168 | 0.0095 | Inf | 0.0095 | 1 | 1 | Purkinje myocyte differentiation |
GO:0003327 | 0.0095 | Inf | 0.0095 | 1 | 1 | type B pancreatic cell fate commitment |
GO:0003335 | 0.0095 | Inf | 0.0095 | 1 | 1 | corneocyte development |
GO:0003342 | 0.0095 | Inf | 0.0095 | 1 | 1 | proepicardium development |
GO:0003359 | 0.0095 | Inf | 0.0095 | 1 | 1 | noradrenergic neuron fate commitment |
GO:0007400 | 0.0095 | Inf | 0.0095 | 1 | 1 | neuroblast fate determination |
GO:0014036 | 0.0095 | Inf | 0.0095 | 1 | 1 | neural crest cell fate specification |
GO:0014822 | 0.0095 | Inf | 0.0095 | 1 | 1 | detection of wounding |
GO:0021572 | 0.0095 | Inf | 0.0095 | 1 | 1 | rhombomere 6 development |
GO:0021858 | 0.0095 | Inf | 0.0095 | 1 | 1 | GABAergic neuron differentiation in basal ganglia |
GO:0033494 | 0.0095 | Inf | 0.0095 | 1 | 1 | ferulate metabolic process |
GO:0035332 | 0.0095 | Inf | 0.0095 | 1 | 1 | positive regulation of hippo signaling |
GO:0035847 | 0.0095 | Inf | 0.0095 | 1 | 1 | uterine epithelium development |
GO:0035849 | 0.0095 | Inf | 0.0095 | 1 | 1 | nephric duct elongation |
GO:0035852 | 0.0095 | Inf | 0.0095 | 1 | 1 | horizontal cell localization |
GO:0045994 | 0.0095 | Inf | 0.0095 | 1 | 1 | positive regulation of translational initiation by iron |
GO:0048006 | 0.0095 | Inf | 0.0095 | 1 | 1 | antigen processing and presentation, endogenous lipid antigen via MHC class Ib |
GO:0048613 | 0.0095 | Inf | 0.0095 | 1 | 1 | embryonic ectodermal digestive tract morphogenesis |
GO:0050973 | 0.0095 | Inf | 0.0095 | 1 | 1 | detection of mechanical stimulus involved in equilibrioception |
GO:0051296 | 0.0095 | Inf | 0.0095 | 1 | 1 | establishment of meiotic spindle orientation |
GO:0060165 | 0.0095 | Inf | 0.0095 | 1 | 1 | regulation of timing of subpallium neuron differentiation |
GO:0060446 | 0.0095 | Inf | 0.0095 | 1 | 1 | branching involved in open tracheal system development |
GO:0060461 | 0.0095 | Inf | 0.0095 | 1 | 1 | right lung morphogenesis |
GO:0060580 | 0.0095 | Inf | 0.0095 | 1 | 1 | ventral spinal cord interneuron fate determination |
GO:0060807 | 0.0095 | Inf | 0.0095 | 1 | 1 | regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification |
GO:0060929 | 0.0095 | Inf | 0.0095 | 1 | 1 | atrioventricular node cell fate commitment |
GO:0061048 | 0.0095 | Inf | 0.0095 | 1 | 1 | negative regulation of branching involved in lung morphogenesis |
GO:0061100 | 0.0095 | Inf | 0.0095 | 1 | 1 | lung neuroendocrine cell differentiation |
GO:0061103 | 0.0095 | Inf | 0.0095 | 1 | 1 | carotid body glomus cell differentiation |
GO:0071259 | 0.0095 | Inf | 0.0095 | 1 | 1 | cellular response to magnetism |
GO:0072051 | 0.0095 | Inf | 0.0095 | 1 | 1 | juxtaglomerular apparatus development |
GO:0072227 | 0.0095 | Inf | 0.0095 | 1 | 1 | metanephric macula densa development |
GO:0090131 | 0.0095 | Inf | 0.0095 | 1 | 1 | mesenchyme migration |
GO:0090274 | 0.0095 | Inf | 0.0095 | 1 | 1 | positive regulation of somatostatin secretion |
GO:1902103 | 0.0095 | Inf | 0.0095 | 1 | 1 | negative regulation of metaphase/anaphase transition of meiotic cell cycle |
GO:2000763 | 0.0095 | Inf | 0.0095 | 1 | 1 | positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process |
GO:2000764 | 0.0095 | Inf | 0.0095 | 1 | 1 | positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis |
GO:2001111 | 0.0095 | Inf | 0.0095 | 1 | 1 | positive regulation of lens epithelial cell proliferation |
GO:2001260 | 0.0095 | Inf | 0.0095 | 1 | 1 | regulation of semaphorin-plexin signaling pathway |
GO:0001656 | 0.0096 | 5.1163 | 0.8301 | 4 | 87 | metanephros development |
GO:0014070 | 0.0098 | 2.6616 | 3.577 | 9 | 392 | response to organic cyclic compound |
GO:0001711 | 0.0099 | 15.023 | 0.1527 | 2 | 16 | endodermal cell fate commitment |
GO:0001967 | 0.0099 | 15.023 | 0.1527 | 2 | 16 | suckling behavior |
GO:0007379 | 0.0099 | 15.023 | 0.1527 | 2 | 16 | segment specification |
GO:0007512 | 0.0099 | 15.023 | 0.1527 | 2 | 16 | adult heart development |
GO:0010662 | 0.0099 | 15.023 | 0.1527 | 2 | 16 | regulation of striated muscle cell apoptotic process |
GO:0051968 | 0.0099 | 15.023 | 0.1527 | 2 | 16 | positive regulation of synaptic transmission, glutamatergic |
GO:0060039 | 0.0099 | 15.023 | 0.1527 | 2 | 16 | pericardium development |
GO:0070076 | 0.0099 | 15.023 | 0.1527 | 2 | 16 | histone lysine demethylation |
GO:2000136 | 0.0099 | 15.023 | 0.1527 | 2 | 16 | regulation of cell proliferation involved in heart morphogenesis |
GO:0007548 | 0.01 | 3.1043 | 2.3758 | 7 | 249 | sex differentiation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031424 | 0 | 76.4192 | 0.0695 | 4 | 48 | keratinization |
GO:0009913 | 1e-04 | 20.3401 | 0.2432 | 4 | 168 | epidermal cell differentiation |
GO:0043588 | 1e-04 | 13.2719 | 0.4835 | 5 | 334 | skin development |
GO:0051606 | 2e-04 | 8.8331 | 0.9033 | 6 | 624 | detection of stimulus |
GO:0060429 | 4e-04 | 6.7228 | 1.4361 | 7 | 992 | epithelium development |
GO:0032501 | 5e-04 | 4.9785 | 8.9393 | 17 | 6175 | multicellular organismal process |
GO:0007186 | 7e-04 | 5.9132 | 1.617 | 7 | 1117 | G-protein coupled receptor signaling pathway |
GO:0001580 | 9e-04 | 52.2276 | 0.0449 | 2 | 31 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0007600 | 0.001 | 6.4238 | 1.2204 | 6 | 843 | sensory perception |
GO:0050907 | 0.001 | 49.9122 | 0.0473 | 2 | 39 | detection of chemical stimulus involved in sensory perception |
GO:0019358 | 0.0014 | Inf | 0.0014 | 1 | 1 | nicotinate nucleotide salvage |
GO:0046497 | 0.0014 | Inf | 0.0014 | 1 | 1 | nicotinate nucleotide metabolic process |
GO:1901208 | 0.0014 | Inf | 0.0014 | 1 | 1 | negative regulation of heart looping |
GO:1901211 | 0.0014 | Inf | 0.0014 | 1 | 1 | negative regulation of cardiac chamber formation |
GO:0050911 | 0.0018 | 9.0421 | 0.5327 | 4 | 368 | detection of chemical stimulus involved in sensory perception of smell |
GO:0006769 | 0.0029 | 722.5714 | 0.0029 | 1 | 2 | nicotinamide metabolic process |
GO:0007521 | 0.0029 | 722.5714 | 0.0029 | 1 | 2 | muscle cell fate determination |
GO:0008615 | 0.0029 | 722.5714 | 0.0029 | 1 | 2 | pyridoxine biosynthetic process |
GO:0035483 | 0.0029 | 722.5714 | 0.0029 | 1 | 2 | gastric emptying |
GO:0042823 | 0.0029 | 722.5714 | 0.0029 | 1 | 2 | pyridoxal phosphate biosynthetic process |
GO:0060465 | 0.0029 | 722.5714 | 0.0029 | 1 | 2 | pharynx development |
GO:0097341 | 0.0029 | 722.5714 | 0.0029 | 1 | 2 | zymogen inhibition |
GO:1901219 | 0.0029 | 722.5714 | 0.0029 | 1 | 2 | regulation of cardiac chamber morphogenesis |
GO:1902530 | 0.0029 | 722.5714 | 0.0029 | 1 | 2 | positive regulation of protein linear polyubiquitination |
GO:1990001 | 0.0029 | 722.5714 | 0.0029 | 1 | 2 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process |
GO:2000381 | 0.0029 | 722.5714 | 0.0029 | 1 | 2 | negative regulation of mesoderm development |
GO:0050909 | 0.003 | 27.4909 | 0.0825 | 2 | 57 | sensory perception of taste |
GO:2000117 | 0.0042 | 23.2462 | 0.097 | 2 | 67 | negative regulation of cysteine-type endopeptidase activity |
GO:0010482 | 0.0043 | 361.2619 | 0.0043 | 1 | 3 | regulation of epidermal cell division |
GO:0031064 | 0.0043 | 361.2619 | 0.0043 | 1 | 3 | negative regulation of histone deacetylation |
GO:0035582 | 0.0043 | 361.2619 | 0.0043 | 1 | 3 | sequestering of BMP in extracellular matrix |
GO:0030510 | 0.0047 | 21.8928 | 0.1028 | 2 | 71 | regulation of BMP signaling pathway |
GO:0003419 | 0.0058 | 240.8254 | 0.0058 | 1 | 4 | growth plate cartilage chondrocyte proliferation |
GO:0042816 | 0.0058 | 240.8254 | 0.0058 | 1 | 4 | vitamin B6 metabolic process |
GO:0051461 | 0.0058 | 240.8254 | 0.0058 | 1 | 4 | positive regulation of corticotropin secretion |
GO:0060455 | 0.0058 | 240.8254 | 0.0058 | 1 | 4 | negative regulation of gastric acid secretion |
GO:0060596 | 0.0058 | 240.8254 | 0.0058 | 1 | 4 | mammary placode formation |
GO:0060743 | 0.0058 | 240.8254 | 0.0058 | 1 | 4 | epithelial cell maturation involved in prostate gland development |
GO:1903365 | 0.0058 | 240.8254 | 0.0058 | 1 | 4 | regulation of fear response |
GO:2000987 | 0.0058 | 240.8254 | 0.0058 | 1 | 4 | positive regulation of behavioral fear response |
GO:0040008 | 0.007 | 6.0458 | 0.7846 | 4 | 542 | regulation of growth |
GO:0060452 | 0.0072 | 180.6071 | 0.0072 | 1 | 5 | positive regulation of cardiac muscle contraction |
GO:0070424 | 0.0072 | 180.6071 | 0.0072 | 1 | 5 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
GO:0071692 | 0.0072 | 180.6071 | 0.0072 | 1 | 5 | protein localization to extracellular region |
GO:0030154 | 0.0078 | 3.2069 | 4.5456 | 10 | 3140 | cell differentiation |
GO:0036302 | 0.0087 | 144.4762 | 0.0087 | 1 | 6 | atrioventricular canal development |
GO:0003008 | 0.0087 | 3.6578 | 2.4958 | 7 | 1724 | system process |
GO:0030307 | 0.0089 | 15.5443 | 0.1433 | 2 | 99 | positive regulation of cell growth |
GO:0009855 | 0.0093 | 15.2283 | 0.1462 | 2 | 101 | determination of bilateral symmetry |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045935 | 1e-04 | 3.2324 | 7.0782 | 19 | 1328 | positive regulation of nucleobase-containing compound metabolic process |
GO:0007389 | 1e-04 | 5.0267 | 2.2493 | 10 | 422 | pattern specification process |
GO:0032502 | 1e-04 | 2.3685 | 26.2769 | 43 | 4930 | developmental process |
GO:0021517 | 1e-04 | 18.6444 | 0.2452 | 4 | 46 | ventral spinal cord development |
GO:0009891 | 1e-04 | 3 | 7.5686 | 19 | 1420 | positive regulation of biosynthetic process |
GO:0021515 | 2e-04 | 15.653 | 0.2878 | 4 | 54 | cell differentiation in spinal cord |
GO:0042036 | 3e-04 | 25.2391 | 0.1386 | 3 | 26 | negative regulation of cytokine biosynthetic process |
GO:0035502 | 4e-04 | 95.6456 | 0.032 | 2 | 6 | metanephric part of ureteric bud development |
GO:0009888 | 6e-04 | 2.6347 | 8.496 | 19 | 1594 | tissue development |
GO:0048665 | 6e-04 | 20.7253 | 0.1652 | 3 | 31 | neuron fate specification |
GO:2000543 | 8e-04 | 63.7553 | 0.0426 | 2 | 8 | positive regulation of gastrulation |
GO:0009953 | 8e-04 | 10.3993 | 0.4218 | 4 | 81 | dorsal/ventral pattern formation |
GO:0043009 | 0.0011 | 3.5554 | 3.1234 | 10 | 586 | chordate embryonic development |
GO:0032501 | 0.0011 | 2.0275 | 32.9127 | 47 | 6175 | multicellular organismal process |
GO:0007420 | 0.0013 | 3.4799 | 3.1873 | 10 | 598 | brain development |
GO:0022037 | 0.0015 | 8.8713 | 0.4904 | 4 | 92 | metencephalon development |
GO:0045995 | 0.0017 | 8.4833 | 0.5117 | 4 | 96 | regulation of embryonic development |
GO:0045165 | 0.0018 | 5.0659 | 1.2845 | 6 | 241 | cell fate commitment |
GO:0048520 | 0.0019 | 8.2138 | 0.5277 | 4 | 99 | positive regulation of behavior |
GO:0021953 | 0.0019 | 6.1111 | 0.8848 | 5 | 166 | central nervous system neuron differentiation |
GO:0030856 | 0.0023 | 7.8005 | 0.5543 | 4 | 104 | regulation of epithelial cell differentiation |
GO:0071542 | 0.0024 | 31.865 | 0.0746 | 2 | 14 | dopaminergic neuron differentiation |
GO:0008630 | 0.0025 | 7.6465 | 0.565 | 4 | 106 | intrinsic apoptotic signaling pathway in response to DNA damage |
GO:0052547 | 0.0025 | 4.111 | 1.8495 | 7 | 347 | regulation of peptidase activity |
GO:0045893 | 0.0027 | 4.6772 | 1.3981 | 6 | 287 | positive regulation of transcription, DNA-templated |
GO:0045187 | 0.0028 | 29.4119 | 0.0799 | 2 | 15 | regulation of circadian sleep/wake cycle, sleep |
GO:0070374 | 0.0029 | 7.2868 | 0.5916 | 4 | 111 | positive regulation of ERK1 and ERK2 cascade |
GO:0021783 | 0.0032 | 27.3092 | 0.0853 | 2 | 16 | preganglionic parasympathetic nervous system development |
GO:0030540 | 0.0032 | 27.3092 | 0.0853 | 2 | 16 | female genitalia development |
GO:0042832 | 0.0032 | 27.3092 | 0.0853 | 2 | 16 | defense response to protozoan |
GO:2000116 | 0.0034 | 5.339 | 1.0074 | 5 | 189 | regulation of cysteine-type endopeptidase activity |
GO:0048869 | 0.0034 | 2.0456 | 15.5005 | 26 | 3091 | cellular developmental process |
GO:0046330 | 0.0036 | 10.5322 | 0.3091 | 3 | 58 | positive regulation of JNK cascade |
GO:0009893 | 0.0038 | 6.782 | 0.6409 | 4 | 139 | positive regulation of metabolic process |
GO:0007399 | 0.0039 | 2.2395 | 9.2596 | 18 | 1796 | nervous system development |
GO:0045944 | 0.0043 | 2.7539 | 4.4079 | 11 | 827 | positive regulation of transcription from RNA polymerase II promoter |
GO:0022410 | 0.0045 | 22.4855 | 0.1013 | 2 | 19 | circadian sleep/wake cycle process |
GO:0050866 | 0.0046 | 6.3845 | 0.6716 | 4 | 126 | negative regulation of cell activation |
GO:0051239 | 0.0046 | 2.116 | 10.9158 | 20 | 2048 | regulation of multicellular organismal process |
GO:0010951 | 0.0047 | 4.9316 | 1.0873 | 5 | 204 | negative regulation of endopeptidase activity |
GO:0048705 | 0.0047 | 4.9316 | 1.0873 | 5 | 204 | skeletal system morphogenesis |
GO:0050776 | 0.005 | 2.841 | 3.8589 | 10 | 724 | regulation of immune response |
GO:0043154 | 0.005 | 9.3387 | 0.3464 | 3 | 65 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:0072089 | 0.0051 | 6.1802 | 0.6929 | 4 | 130 | stem cell proliferation |
GO:0008284 | 0.0052 | 2.8202 | 3.8856 | 10 | 729 | positive regulation of cell proliferation |
GO:0035270 | 0.0053 | 6.1311 | 0.6982 | 4 | 131 | endocrine system development |
GO:0002646 | 0.0053 | Inf | 0.0053 | 1 | 1 | regulation of central tolerance induction |
GO:0002897 | 0.0053 | Inf | 0.0053 | 1 | 1 | positive regulation of central B cell tolerance induction |
GO:0003167 | 0.0053 | Inf | 0.0053 | 1 | 1 | atrioventricular bundle cell differentiation |
GO:0003335 | 0.0053 | Inf | 0.0053 | 1 | 1 | corneocyte development |
GO:0021642 | 0.0053 | Inf | 0.0053 | 1 | 1 | trochlear nerve formation |
GO:0021703 | 0.0053 | Inf | 0.0053 | 1 | 1 | locus ceruleus development |
GO:0030844 | 0.0053 | Inf | 0.0053 | 1 | 1 | positive regulation of intermediate filament depolymerization |
GO:0032788 | 0.0053 | Inf | 0.0053 | 1 | 1 | saturated monocarboxylic acid metabolic process |
GO:0032789 | 0.0053 | Inf | 0.0053 | 1 | 1 | unsaturated monocarboxylic acid metabolic process |
GO:0035847 | 0.0053 | Inf | 0.0053 | 1 | 1 | uterine epithelium development |
GO:0035849 | 0.0053 | Inf | 0.0053 | 1 | 1 | nephric duct elongation |
GO:0035852 | 0.0053 | Inf | 0.0053 | 1 | 1 | horizontal cell localization |
GO:0036363 | 0.0053 | Inf | 0.0053 | 1 | 1 | transforming growth factor beta activation |
GO:0042502 | 0.0053 | Inf | 0.0053 | 1 | 1 | tyrosine phosphorylation of Stat2 protein |
GO:0045108 | 0.0053 | Inf | 0.0053 | 1 | 1 | regulation of intermediate filament polymerization or depolymerization |
GO:0072016 | 0.0053 | Inf | 0.0053 | 1 | 1 | glomerular parietal epithelial cell development |
GO:0097499 | 0.0053 | Inf | 0.0053 | 1 | 1 | protein localization to nonmotile primary cilium |
GO:1901003 | 0.0053 | Inf | 0.0053 | 1 | 1 | negative regulation of fermentation |
GO:1901248 | 0.0053 | Inf | 0.0053 | 1 | 1 | positive regulation of lung ciliated cell differentiation |
GO:1902462 | 0.0053 | Inf | 0.0053 | 1 | 1 | positive regulation of mesenchymal stem cell proliferation |
GO:0021602 | 0.0055 | 20.1159 | 0.1119 | 2 | 21 | cranial nerve morphogenesis |
GO:0021675 | 0.0057 | 8.9059 | 0.3624 | 3 | 68 | nerve development |
GO:0010604 | 0.0061 | 2.0571 | 11.1823 | 20 | 2098 | positive regulation of macromolecule metabolic process |
GO:0042752 | 0.0062 | 8.6389 | 0.3731 | 3 | 70 | regulation of circadian rhythm |
GO:0070304 | 0.0062 | 8.6389 | 0.3731 | 3 | 70 | positive regulation of stress-activated protein kinase signaling cascade |
GO:0006959 | 0.0063 | 5.8081 | 0.7355 | 4 | 138 | humoral immune response |
GO:0007267 | 0.0066 | 2.3913 | 6.0336 | 13 | 1132 | cell-cell signaling |
GO:0009790 | 0.0072 | 2.6934 | 4.0734 | 10 | 796 | embryo development |
GO:0000038 | 0.0072 | 17.3694 | 0.1279 | 2 | 24 | very long-chain fatty acid metabolic process |
GO:0001773 | 0.0072 | 17.3694 | 0.1279 | 2 | 24 | myeloid dendritic cell activation |
GO:0002687 | 0.0075 | 8.0363 | 0.3997 | 3 | 75 | positive regulation of leukocyte migration |
GO:0008045 | 0.0078 | 16.6131 | 0.1332 | 2 | 25 | motor neuron axon guidance |
GO:0032965 | 0.0078 | 16.6131 | 0.1332 | 2 | 25 | regulation of collagen biosynthetic process |
GO:0061053 | 0.008 | 7.8181 | 0.4104 | 3 | 77 | somite development |
GO:0032675 | 0.0083 | 7.7133 | 0.4157 | 3 | 78 | regulation of interleukin-6 production |
GO:0007187 | 0.0084 | 5.3265 | 0.7995 | 4 | 150 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0021904 | 0.009 | 15.282 | 0.1439 | 2 | 27 | dorsal/ventral neural tube patterning |
GO:0048522 | 0.0092 | 1.9262 | 14.1872 | 23 | 2891 | positive regulation of cellular process |
GO:0001676 | 0.0095 | 7.3208 | 0.4371 | 3 | 82 | long-chain fatty acid metabolic process |
GO:0001958 | 0.0097 | 14.6933 | 0.1492 | 2 | 28 | endochondral ossification |
GO:0030279 | 0.0097 | 14.6933 | 0.1492 | 2 | 28 | negative regulation of ossification |
GO:0030431 | 0.0097 | 14.6933 | 0.1492 | 2 | 28 | sleep |
GO:0060412 | 0.0097 | 14.6933 | 0.1492 | 2 | 28 | ventricular septum morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 111.1246 | 0.373 | 11 | 368 | olfactory receptor activity |
GO:0004930 | 0 | 50.5308 | 0.7846 | 11 | 774 | G-protein coupled receptor activity |
GO:0038023 | 0 | 30.8755 | 1.2367 | 11 | 1220 | signaling receptor activity |
GO:0060089 | 0 | 24.4246 | 1.5276 | 11 | 1507 | molecular transducer activity |
GO:0035575 | 0.002 | 1055.8571 | 0.002 | 1 | 2 | histone demethylase activity (H4-K20 specific) |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031851 | 7e-04 | Inf | 7e-04 | 1 | 1 | kappa-type opioid receptor binding |
GO:0016262 | 0.0014 | 1643 | 0.0014 | 1 | 2 | protein N-acetylglucosaminyltransferase activity |
GO:0004945 | 0.0027 | 547.5926 | 0.0027 | 1 | 4 | angiotensin type II receptor activity |
GO:0008194 | 0.003 | 29.8069 | 0.0845 | 2 | 125 | UDP-glycosyltransferase activity |
GO:0005134 | 0.0034 | 410.6667 | 0.0034 | 1 | 5 | interleukin-2 receptor binding |
GO:0008508 | 0.0034 | 410.6667 | 0.0034 | 1 | 5 | bile acid:sodium symporter activity |
GO:0043208 | 0.0054 | 234.619 | 0.0054 | 1 | 8 | glycosphingolipid binding |
GO:0016758 | 0.0065 | 20.0632 | 0.1243 | 2 | 184 | transferase activity, transferring hexosyl groups |
GO:0005125 | 0.0081 | 17.8725 | 0.1392 | 2 | 206 | cytokine activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 1e-04 | 118.5945 | 0.0995 | 3 | 368 | olfactory receptor activity |
GO:0004930 | 5e-04 | 54.5642 | 0.2092 | 3 | 774 | G-protein coupled receptor activity |
GO:0038023 | 0.0021 | 33.4684 | 0.3298 | 3 | 1220 | signaling receptor activity |
GO:0060089 | 0.0039 | 26.5093 | 0.4074 | 3 | 1507 | molecular transducer activity |
GO:0015020 | 0.0081 | 169.7126 | 0.0081 | 1 | 30 | glucuronosyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031432 | 0.0081 | 149.2626 | 0.0081 | 1 | 12 | titin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0 | 9.2703 | 1.8284 | 12 | 712 | sequence-specific DNA binding |
GO:0003700 | 2e-04 | 4.9837 | 2.5602 | 10 | 997 | sequence-specific DNA binding transcription factor activity |
GO:0005144 | 0.0026 | Inf | 0.0026 | 1 | 1 | interleukin-13 receptor binding |
GO:0032090 | 0.0051 | 398.8919 | 0.0051 | 1 | 2 | Pyrin domain binding |
GO:0005080 | 0.0057 | 19.4683 | 0.113 | 2 | 44 | protein kinase C binding |
GO:0001077 | 0.0062 | 8.7614 | 0.3749 | 3 | 146 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 45.7873 | 0.373 | 8 | 368 | olfactory receptor activity |
GO:0004930 | 0 | 20.9131 | 0.7846 | 8 | 774 | G-protein coupled receptor activity |
GO:0038023 | 0 | 12.7968 | 1.2367 | 8 | 1220 | signaling receptor activity |
GO:0060089 | 0 | 10.1279 | 1.5276 | 8 | 1507 | molecular transducer activity |
GO:0004733 | 0.001 | Inf | 0.001 | 1 | 1 | pyridoxamine-phosphate oxidase activity |
GO:0004556 | 0.003 | 527.8929 | 0.003 | 1 | 3 | alpha-amylase activity |
GO:0036122 | 0.004 | 351.9048 | 0.0041 | 1 | 4 | BMP binding |
GO:0016015 | 0.0061 | 211.1143 | 0.0061 | 1 | 6 | morphogen activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001205 | 0.005 | 21.2026 | 0.1064 | 2 | 21 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GO:0004733 | 0.0051 | Inf | 0.0051 | 1 | 1 | pyridoxamine-phosphate oxidase activity |
GO:0004778 | 0.0051 | Inf | 0.0051 | 1 | 1 | succinyl-CoA hydrolase activity |
GO:0031855 | 0.0051 | Inf | 0.0051 | 1 | 1 | oxytocin receptor binding |
GO:0035755 | 0.0051 | Inf | 0.0051 | 1 | 1 | cardiolipin hydrolase activity |
GO:0047277 | 0.0051 | Inf | 0.0051 | 1 | 1 | globoside alpha-N-acetylgalactosaminyltransferase activity |
GO:0052731 | 0.0051 | Inf | 0.0051 | 1 | 1 | phosphocholine phosphatase activity |
GO:0052732 | 0.0051 | Inf | 0.0051 | 1 | 1 | phosphoethanolamine phosphatase activity |
GO:0005184 | 0.006 | 19.1807 | 0.1166 | 2 | 23 | neuropeptide hormone activity |
GO:0035326 | 0.0072 | 8.1378 | 0.3953 | 3 | 78 | enhancer binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 99.3664 | 0.1741 | 5 | 368 | olfactory receptor activity |
GO:0004930 | 0 | 45.5852 | 0.3661 | 5 | 774 | G-protein coupled receptor activity |
GO:0038023 | 1e-04 | 27.9342 | 0.5771 | 5 | 1220 | signaling receptor activity |
GO:0060089 | 2e-04 | 22.1188 | 0.7129 | 5 | 1507 | molecular transducer activity |
GO:0031851 | 5e-04 | Inf | 5e-04 | 1 | 1 | kappa-type opioid receptor binding |
GO:0005134 | 0.0024 | 616.125 | 0.0024 | 1 | 5 | interleukin-2 receptor binding |
GO:0043208 | 0.0038 | 352 | 0.0038 | 1 | 8 | glycosphingolipid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0033038 | 0.0011 | 48.4934 | 0.0487 | 2 | 18 | bitter taste receptor activity |
GO:0043027 | 0.0012 | 45.6378 | 0.0514 | 2 | 19 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process |
GO:0004857 | 0.0013 | 6.8761 | 0.8277 | 5 | 314 | enzyme inhibitor activity |
GO:0004516 | 0.0027 | Inf | 0.0027 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
GO:0004778 | 0.0027 | Inf | 0.0027 | 1 | 1 | succinyl-CoA hydrolase activity |
GO:0031770 | 0.0027 | Inf | 0.0027 | 1 | 1 | growth hormone-releasing hormone receptor binding |
GO:0052731 | 0.0027 | Inf | 0.0027 | 1 | 1 | phosphocholine phosphatase activity |
GO:0052732 | 0.0027 | Inf | 0.0027 | 1 | 1 | phosphoethanolamine phosphatase activity |
GO:0070888 | 0.0036 | 25.0034 | 0.0892 | 2 | 33 | E-box binding |
GO:0001785 | 0.0054 | 378.3846 | 0.0054 | 1 | 2 | prostaglandin J receptor activity |
GO:0004956 | 0.0054 | 378.3846 | 0.0054 | 1 | 2 | prostaglandin D receptor activity |
GO:0016608 | 0.0054 | 378.3846 | 0.0054 | 1 | 2 | growth hormone-releasing hormone activity |
GO:0045519 | 0.0054 | 378.3846 | 0.0054 | 1 | 2 | interleukin-23 receptor binding |
GO:0046811 | 0.0054 | 378.3846 | 0.0054 | 1 | 2 | histone deacetylase inhibitor activity |
GO:0004866 | 0.0078 | 8.004 | 0.4082 | 3 | 151 | endopeptidase inhibitor activity |
GO:0001591 | 0.0081 | 189.1795 | 0.0081 | 1 | 3 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0004514 | 0.0081 | 189.1795 | 0.0081 | 1 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
GO:0008426 | 0.0081 | 189.1795 | 0.0081 | 1 | 3 | protein kinase C inhibitor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0033038 | 3e-04 | 102.5139 | 0.0243 | 2 | 18 | bitter taste receptor activity |
GO:0004930 | 4e-04 | 7.8181 | 1.0461 | 6 | 774 | G-protein coupled receptor activity |
GO:0004984 | 0.0013 | 9.8997 | 0.4974 | 4 | 368 | olfactory receptor activity |
GO:0004516 | 0.0014 | Inf | 0.0014 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
GO:0004733 | 0.0014 | Inf | 0.0014 | 1 | 1 | pyridoxamine-phosphate oxidase activity |
GO:0060089 | 0.0026 | 4.7665 | 2.0368 | 7 | 1507 | molecular transducer activity |
GO:0046811 | 0.0027 | 777.7368 | 0.0027 | 1 | 2 | histone deacetylase inhibitor activity |
GO:0004514 | 0.004 | 388.8421 | 0.0041 | 1 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
GO:0008426 | 0.004 | 388.8421 | 0.0041 | 1 | 3 | protein kinase C inhibitor activity |
GO:0038023 | 0.0044 | 4.7884 | 1.6489 | 6 | 1220 | signaling receptor activity |
GO:0036122 | 0.0054 | 259.2105 | 0.0054 | 1 | 4 | BMP binding |
GO:0051430 | 0.0054 | 259.2105 | 0.0054 | 1 | 4 | corticotropin-releasing hormone receptor 1 binding |
GO:0051431 | 0.0054 | 259.2105 | 0.0054 | 1 | 4 | corticotropin-releasing hormone receptor 2 binding |
GO:0016015 | 0.0081 | 155.5053 | 0.0081 | 1 | 6 | morphogen activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0 | 4.5368 | 3.6567 | 14 | 712 | sequence-specific DNA binding |
GO:0016290 | 0.0014 | 44.1832 | 0.0565 | 2 | 11 | palmitoyl-CoA hydrolase activity |
GO:0008191 | 0.0017 | 39.7622 | 0.0616 | 2 | 12 | metalloendopeptidase inhibitor activity |
GO:0010576 | 0.002 | 36.145 | 0.0668 | 2 | 13 | metalloenzyme regulator activity |
GO:0005104 | 0.0051 | 20.9147 | 0.1079 | 2 | 21 | fibroblast growth factor receptor binding |
GO:0004778 | 0.0051 | Inf | 0.0051 | 1 | 1 | succinyl-CoA hydrolase activity |
GO:0031770 | 0.0051 | Inf | 0.0051 | 1 | 1 | growth hormone-releasing hormone receptor binding |
GO:0047021 | 0.0051 | Inf | 0.0051 | 1 | 1 | 15-hydroxyprostaglandin dehydrogenase (NADP+) activity |
GO:0050221 | 0.0051 | Inf | 0.0051 | 1 | 1 | prostaglandin-E2 9-reductase activity |
GO:0052731 | 0.0051 | Inf | 0.0051 | 1 | 1 | phosphocholine phosphatase activity |
GO:0052732 | 0.0051 | Inf | 0.0051 | 1 | 1 | phosphoethanolamine phosphatase activity |
GO:0008083 | 0.0079 | 5.4336 | 0.7858 | 4 | 153 | growth factor activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 25.4917 | 1.425 | 22 | 367 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 20.8846 | 1.7123 | 22 | 441 | detection of chemical stimulus |
GO:0050906 | 0 | 20.4822 | 1.7434 | 22 | 449 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 20.1901 | 1.7667 | 22 | 455 | sensory perception of chemical stimulus |
GO:0050877 | 0 | 8.3631 | 4.5468 | 24 | 1171 | neurological system process |
GO:0007186 | 0 | 8.2085 | 4.3333 | 23 | 1116 | G-protein coupled receptor signaling pathway |
GO:0007165 | 0.0022 | 2.1886 | 18.9794 | 30 | 4888 | signal transduction |
GO:0045671 | 0.0024 | 31.2054 | 0.0738 | 2 | 19 | negative regulation of osteoclast differentiation |
GO:0044707 | 0.0032 | 2.1096 | 23.169 | 34 | 5967 | single-multicellular organism process |
GO:0023052 | 0.0051 | 2.0257 | 20.8898 | 31 | 5380 | signaling |
GO:0014846 | 0.0078 | 260.9483 | 0.0078 | 1 | 2 | esophagus smooth muscle contraction |
GO:0042361 | 0.0078 | 260.9483 | 0.0078 | 1 | 2 | menaquinone catabolic process |
GO:0042377 | 0.0078 | 260.9483 | 0.0078 | 1 | 2 | vitamin K catabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0033135 | 6e-04 | 11.5901 | 0.3814 | 4 | 92 | regulation of peptidyl-serine phosphorylation |
GO:0002664 | 6e-04 | 70.8431 | 0.0373 | 2 | 9 | regulation of T cell tolerance induction |
GO:0030183 | 7e-04 | 10.846 | 0.4063 | 4 | 98 | B cell differentiation |
GO:0045109 | 0.0015 | 41.3115 | 0.058 | 2 | 14 | intermediate filament organization |
GO:0002507 | 0.0022 | 33.0426 | 0.0705 | 2 | 17 | tolerance induction |
GO:0033141 | 0.0022 | 33.0426 | 0.0705 | 2 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0002250 | 0.0023 | 5.8703 | 0.9287 | 5 | 224 | adaptive immune response |
GO:0045343 | 0.0034 | 26.0794 | 0.0871 | 2 | 21 | regulation of MHC class I biosynthetic process |
GO:0010625 | 0.0041 | Inf | 0.0041 | 1 | 1 | positive regulation of Schwann cell proliferation |
GO:0015782 | 0.0041 | Inf | 0.0041 | 1 | 1 | CMP-N-acetylneuraminate transport |
GO:0042466 | 0.0041 | Inf | 0.0041 | 1 | 1 | chemokinesis |
GO:0050783 | 0.0041 | Inf | 0.0041 | 1 | 1 | cocaine metabolic process |
GO:0071329 | 0.0041 | Inf | 0.0041 | 1 | 1 | cellular response to sucrose stimulus |
GO:0050896 | 0.0042 | 2.0412 | 30.1131 | 41 | 7263 | response to stimulus |
GO:0002366 | 0.0051 | 6.2261 | 0.6924 | 4 | 167 | leukocyte activation involved in immune response |
GO:0002323 | 0.0052 | 20.6393 | 0.1078 | 2 | 26 | natural killer cell activation involved in immune response |
GO:0018209 | 0.0057 | 6.0026 | 0.7173 | 4 | 173 | peptidyl-serine modification |
GO:0014016 | 0.0083 | 244.0484 | 0.0083 | 1 | 2 | neuroblast differentiation |
GO:0046373 | 0.0083 | 244.0484 | 0.0083 | 1 | 2 | L-arabinose metabolic process |
GO:0010043 | 0.0097 | 14.5593 | 0.1493 | 2 | 36 | response to zinc ion |
GO:0045103 | 0.0097 | 14.5593 | 0.1493 | 2 | 36 | intermediate filament-based process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0045214 | 0 | 24.8132 | 0.1918 | 4 | 31 | sarcomere organization |
GO:0007155 | 1e-04 | 3.1199 | 6.279 | 17 | 1015 | cell adhesion |
GO:0007156 | 2e-04 | 7.8519 | 0.8413 | 6 | 136 | homophilic cell adhesion |
GO:0007507 | 3e-04 | 4.1921 | 2.6415 | 10 | 427 | heart development |
GO:0060706 | 4e-04 | 24.8588 | 0.1423 | 3 | 23 | cell differentiation involved in embryonic placenta development |
GO:0071260 | 6e-04 | 11.3311 | 0.3897 | 4 | 63 | cellular response to mechanical stimulus |
GO:0044253 | 7e-04 | 19.1145 | 0.1794 | 3 | 29 | positive regulation of multicellular organismal metabolic process |
GO:0010712 | 8e-04 | 18.4054 | 0.1856 | 3 | 30 | regulation of collagen metabolic process |
GO:0030510 | 0.001 | 9.9728 | 0.4392 | 4 | 71 | regulation of BMP signaling pathway |
GO:0097284 | 0.0013 | 46.8758 | 0.0557 | 2 | 9 | hepatocyte apoptotic process |
GO:0055002 | 0.0014 | 6.5717 | 0.8228 | 5 | 133 | striated muscle cell development |
GO:0032501 | 0.0014 | 1.897 | 38.1877 | 53 | 6173 | multicellular organismal process |
GO:0021924 | 0.0016 | 41.0136 | 0.0619 | 2 | 10 | cell proliferation in external granule layer |
GO:0098657 | 0.0016 | 41.0136 | 0.0619 | 2 | 10 | import into cell |
GO:0009628 | 0.0017 | 2.7132 | 5.747 | 14 | 929 | response to abiotic stimulus |
GO:0045605 | 0.002 | 36.4541 | 0.068 | 2 | 11 | negative regulation of epidermal cell differentiation |
GO:0010811 | 0.0022 | 7.8515 | 0.5506 | 4 | 89 | positive regulation of cell-substrate adhesion |
GO:0021936 | 0.0024 | 32.8065 | 0.0742 | 2 | 12 | regulation of cerebellar granule cell precursor proliferation |
GO:0050708 | 0.0026 | 5.6761 | 0.9465 | 5 | 153 | regulation of protein secretion |
GO:0055024 | 0.0027 | 11.8203 | 0.2784 | 3 | 45 | regulation of cardiac muscle tissue development |
GO:0048568 | 0.0033 | 3.4997 | 2.4683 | 8 | 399 | embryonic organ development |
GO:0003008 | 0.0039 | 2.1263 | 10.6589 | 20 | 1723 | system process |
GO:0007369 | 0.0041 | 5.0855 | 1.0517 | 5 | 170 | gastrulation |
GO:0070201 | 0.0045 | 3.3083 | 2.6044 | 8 | 421 | regulation of establishment of protein localization |
GO:0072359 | 0.0048 | 2.5752 | 5.0975 | 12 | 824 | circulatory system development |
GO:0002021 | 0.0048 | 21.8638 | 0.1052 | 2 | 17 | response to dietary excess |
GO:0007160 | 0.0049 | 4.8477 | 1.1012 | 5 | 178 | cell-matrix adhesion |
GO:0001701 | 0.0055 | 3.5249 | 2.1281 | 7 | 344 | in utero embryonic development |
GO:0044259 | 0.0058 | 5.948 | 0.7176 | 4 | 116 | multicellular organismal macromolecule metabolic process |
GO:0007601 | 0.0061 | 4.6052 | 1.1568 | 5 | 187 | visual perception |
GO:0060007 | 0.0062 | Inf | 0.0062 | 1 | 1 | linear vestibuloocular reflex |
GO:0060464 | 0.0062 | Inf | 0.0062 | 1 | 1 | lung lobe formation |
GO:1902961 | 0.0062 | Inf | 0.0062 | 1 | 1 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process |
GO:0070723 | 0.0067 | 18.2162 | 0.1237 | 2 | 20 | response to cholesterol |
GO:2000352 | 0.0067 | 18.2162 | 0.1237 | 2 | 20 | negative regulation of endothelial cell apoptotic process |
GO:0033993 | 0.0073 | 2.6595 | 4.0644 | 10 | 657 | response to lipid |
GO:0032967 | 0.0074 | 17.2563 | 0.1299 | 2 | 21 | positive regulation of collagen biosynthetic process |
GO:0034446 | 0.0076 | 7.9966 | 0.4021 | 3 | 65 | substrate adhesion-dependent cell spreading |
GO:0001525 | 0.0086 | 3.2212 | 2.3198 | 7 | 375 | angiogenesis |
GO:0010927 | 0.0087 | 4.207 | 1.262 | 5 | 204 | cellular component assembly involved in morphogenesis |
GO:0070555 | 0.0089 | 7.51 | 0.4269 | 3 | 69 | response to interleukin-1 |
GO:0008015 | 0.009 | 3.1945 | 2.3384 | 7 | 378 | blood circulation |
GO:0007178 | 0.0096 | 3.5193 | 1.8126 | 6 | 293 | transmembrane receptor protein serine/threonine kinase signaling pathway |
GO:0014070 | 0.0097 | 2.5443 | 4.2376 | 10 | 685 | response to organic cyclic compound |
GO:0048856 | 0.0099 | 1.6858 | 27.0463 | 38 | 4372 | anatomical structure development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001568 | 1e-04 | 2.9614 | 7.3743 | 20 | 514 | blood vessel development |
GO:0001300 | 2e-04 | Inf | 0.0287 | 2 | 2 | chronological cell aging |
GO:0010810 | 2e-04 | 4.8061 | 2.0372 | 9 | 142 | regulation of cell-substrate adhesion |
GO:0044259 | 3e-04 | 5.2448 | 1.6642 | 8 | 116 | multicellular organismal macromolecule metabolic process |
GO:0051674 | 3e-04 | 2.1496 | 15.2794 | 30 | 1065 | localization of cell |
GO:0001508 | 4e-04 | 4.3443 | 2.2381 | 9 | 156 | action potential |
GO:0007275 | 5e-04 | 1.6214 | 61.1175 | 84 | 4260 | multicellular organismal development |
GO:0032501 | 5e-04 | 1.5836 | 88.5629 | 113 | 6173 | multicellular organismal process |
GO:2000145 | 5e-04 | 2.5898 | 7.4747 | 18 | 521 | regulation of cell motility |
GO:0008366 | 6e-04 | 5.3095 | 1.4347 | 7 | 100 | axon ensheathment |
GO:0072358 | 8e-04 | 2.1923 | 11.8218 | 24 | 824 | cardiovascular system development |
GO:0010712 | 8e-04 | 10.7484 | 0.4304 | 4 | 30 | regulation of collagen metabolic process |
GO:0065008 | 9e-04 | 1.6597 | 41.6345 | 61 | 2902 | regulation of biological quality |
GO:0072278 | 0.0012 | 69.3287 | 0.0574 | 2 | 4 | metanephric comma-shaped body morphogenesis |
GO:0003283 | 0.0017 | 14.9133 | 0.2439 | 3 | 17 | atrial septum development |
GO:0043542 | 0.0018 | 4.3253 | 1.736 | 7 | 121 | endothelial cell migration |
GO:0022617 | 0.0019 | 4.2874 | 1.7503 | 7 | 122 | extracellular matrix disassembly |
GO:0036119 | 0.002 | 46.216 | 0.0717 | 2 | 5 | response to platelet-derived growth factor |
GO:2000609 | 0.002 | 46.216 | 0.0717 | 2 | 5 | regulation of thyroid hormone generation |
GO:0009605 | 0.002 | 1.7144 | 26.8573 | 42 | 1872 | response to external stimulus |
GO:0048562 | 0.0021 | 2.9616 | 3.9454 | 11 | 275 | embryonic organ morphogenesis |
GO:0043062 | 0.0021 | 2.6736 | 5.1649 | 13 | 360 | extracellular structure organization |
GO:0048705 | 0.0028 | 3.2643 | 2.9268 | 9 | 204 | skeletal system morphogenesis |
GO:0007605 | 0.0029 | 3.9418 | 1.8938 | 7 | 132 | sensory perception of sound |
GO:0072284 | 0.003 | 34.6597 | 0.0861 | 2 | 6 | metanephric S-shaped body morphogenesis |
GO:2000049 | 0.003 | 34.6597 | 0.0861 | 2 | 6 | positive regulation of cell-cell adhesion mediated by cadherin |
GO:0045766 | 0.003 | 4.5295 | 1.4203 | 6 | 99 | positive regulation of angiogenesis |
GO:0032967 | 0.0032 | 11.5961 | 0.3013 | 3 | 21 | positive regulation of collagen biosynthetic process |
GO:0042403 | 0.0032 | 11.5961 | 0.3013 | 3 | 21 | thyroid hormone metabolic process |
GO:0007267 | 0.0033 | 1.8518 | 16.2406 | 28 | 1132 | cell-cell signaling |
GO:0009653 | 0.0035 | 1.7517 | 21.1244 | 34 | 1539 | anatomical structure morphogenesis |
GO:0050900 | 0.0035 | 2.7592 | 4.218 | 11 | 294 | leukocyte migration |
GO:0051239 | 0.0036 | 1.637 | 29.3823 | 44 | 2048 | regulation of multicellular organismal process |
GO:0061448 | 0.0037 | 3.1184 | 3.0559 | 9 | 213 | connective tissue development |
GO:0060586 | 0.0041 | 27.7259 | 0.1004 | 2 | 7 | multicellular organismal iron ion homeostasis |
GO:0061042 | 0.0041 | 27.7259 | 0.1004 | 2 | 7 | vascular wound healing |
GO:0044089 | 0.0042 | 10.4351 | 0.33 | 3 | 23 | positive regulation of cellular component biogenesis |
GO:0071560 | 0.0043 | 3.0428 | 3.1276 | 9 | 218 | cellular response to transforming growth factor beta stimulus |
GO:0045597 | 0.0044 | 2.1574 | 8.3499 | 17 | 582 | positive regulation of cell differentiation |
GO:0032526 | 0.0044 | 4.1685 | 1.5351 | 6 | 107 | response to retinoic acid |
GO:0030574 | 0.0044 | 4.999 | 1.076 | 5 | 75 | collagen catabolic process |
GO:0007612 | 0.0046 | 4.1274 | 1.5495 | 6 | 108 | learning |
GO:0032649 | 0.0047 | 4.9283 | 1.0904 | 5 | 76 | regulation of interferon-gamma production |
GO:0051093 | 0.005 | 2.0806 | 9.1676 | 18 | 639 | negative regulation of developmental process |
GO:0009792 | 0.0052 | 2.1184 | 8.4933 | 17 | 592 | embryo development ending in birth or egg hatching |
GO:0044708 | 0.0053 | 2.4853 | 5.0931 | 12 | 355 | single-organism behavior |
GO:0086014 | 0.0054 | 23.1034 | 0.1148 | 2 | 8 | atrial cardiac muscle cell action potential |
GO:0086066 | 0.0054 | 23.1034 | 0.1148 | 2 | 8 | atrial cardiac muscle cell to AV node cell communication |
GO:0032677 | 0.0057 | 6.067 | 0.7173 | 4 | 50 | regulation of interleukin-8 production |
GO:0048844 | 0.0057 | 6.067 | 0.7173 | 4 | 50 | artery morphogenesis |
GO:0001525 | 0.0057 | 2.7205 | 3.876 | 10 | 276 | angiogenesis |
GO:0007155 | 0.0057 | 1.8301 | 14.562 | 25 | 1015 | cell adhesion |
GO:0022603 | 0.0058 | 2.0074 | 10.0284 | 19 | 699 | regulation of anatomical structure morphogenesis |
GO:0040011 | 0.0058 | 1.772 | 16.9332 | 28 | 1210 | locomotion |
GO:1901342 | 0.0058 | 3.1316 | 2.6972 | 8 | 188 | regulation of vasculature development |
GO:0042060 | 0.0059 | 2.0428 | 9.3254 | 18 | 650 | wound healing |
GO:0010761 | 0.0059 | 9.0722 | 0.373 | 3 | 26 | fibroblast migration |
GO:0036151 | 0.0059 | 9.0722 | 0.373 | 3 | 26 | phosphatidylcholine acyl-chain remodeling |
GO:0040013 | 0.006 | 3.1141 | 2.7115 | 8 | 189 | negative regulation of locomotion |
GO:0030335 | 0.0061 | 2.6897 | 3.9167 | 10 | 273 | positive regulation of cell migration |
GO:0030509 | 0.0063 | 3.8605 | 1.6499 | 6 | 115 | BMP signaling pathway |
GO:0034698 | 0.0066 | 8.6936 | 0.3874 | 3 | 27 | response to gonadotropin |
GO:0001936 | 0.0068 | 4.4839 | 1.1908 | 5 | 83 | regulation of endothelial cell proliferation |
GO:0060973 | 0.0069 | 19.8016 | 0.1291 | 2 | 9 | cell migration involved in heart development |
GO:0061035 | 0.007 | 5.6944 | 0.7604 | 4 | 53 | regulation of cartilage development |
GO:0007584 | 0.0073 | 3.3015 | 2.2381 | 7 | 156 | response to nutrient |
GO:0001958 | 0.0073 | 8.3453 | 0.4017 | 3 | 28 | endochondral ossification |
GO:0002042 | 0.0073 | 8.3453 | 0.4017 | 3 | 28 | cell migration involved in sprouting angiogenesis |
GO:0045665 | 0.0074 | 5.5802 | 0.7747 | 4 | 54 | negative regulation of neuron differentiation |
GO:0002237 | 0.0075 | 2.7733 | 3.4145 | 9 | 238 | response to molecule of bacterial origin |
GO:0006935 | 0.0078 | 2.0266 | 8.852 | 17 | 617 | chemotaxis |
GO:0003008 | 0.0079 | 1.6115 | 24.7196 | 37 | 1723 | system process |
GO:0043001 | 0.0081 | 8.0238 | 0.4161 | 3 | 29 | Golgi to plasma membrane protein transport |
GO:0044253 | 0.0081 | 8.0238 | 0.4161 | 3 | 29 | positive regulation of multicellular organismal metabolic process |
GO:0045165 | 0.0081 | 2.7369 | 3.4576 | 9 | 241 | cell fate commitment |
GO:0009952 | 0.0083 | 2.9335 | 2.8694 | 8 | 200 | anterior/posterior pattern specification |
GO:0051272 | 0.0084 | 2.5608 | 4.1032 | 10 | 286 | positive regulation of cellular component movement |
GO:0001775 | 0.0084 | 1.8644 | 11.9222 | 21 | 831 | cell activation |
GO:0043032 | 0.0085 | 17.3252 | 0.1435 | 2 | 10 | positive regulation of macrophage activation |
GO:0090009 | 0.0085 | 17.3252 | 0.1435 | 2 | 10 | primitive streak formation |
GO:2000484 | 0.0085 | 17.3252 | 0.1435 | 2 | 10 | positive regulation of interleukin-8 secretion |
GO:2000351 | 0.0089 | 7.7261 | 0.4304 | 3 | 30 | regulation of endothelial cell apoptotic process |
GO:0048706 | 0.009 | 3.5639 | 1.779 | 6 | 124 | embryonic skeletal system development |
GO:0006928 | 0.0093 | 1.7021 | 17.5647 | 28 | 1259 | cellular component movement |
GO:0048265 | 0.0097 | 7.4497 | 0.4448 | 3 | 31 | response to pain |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009593 | 0 | 7.5651 | 2.0896 | 13 | 441 | detection of chemical stimulus |
GO:0050911 | 0 | 8.32 | 1.739 | 12 | 367 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050906 | 0 | 7.4223 | 2.1275 | 13 | 449 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 7.3185 | 2.156 | 13 | 455 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 3.9442 | 5.2881 | 17 | 1116 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 3.7415 | 5.5487 | 17 | 1171 | neurological system process |
GO:0035994 | 1e-04 | 216.0143 | 0.019 | 2 | 4 | response to muscle stretch |
GO:0050896 | 4e-04 | 2.3357 | 34.415 | 49 | 7263 | response to stimulus |
GO:0045214 | 4e-04 | 23.4394 | 0.1469 | 3 | 31 | sarcomere organization |
GO:0043092 | 0.0012 | 47.981 | 0.0521 | 2 | 11 | L-amino acid import |
GO:0009948 | 0.0013 | 15.6118 | 0.2132 | 3 | 45 | anterior/posterior axis specification |
GO:0044707 | 0.0018 | 2.0526 | 28.274 | 41 | 5967 | single-multicellular organism process |
GO:0007165 | 0.0026 | 2.0018 | 23.1613 | 35 | 4888 | signal transduction |
GO:0023052 | 0.0038 | 1.935 | 25.4926 | 37 | 5380 | signaling |
GO:0055001 | 0.0047 | 6.3411 | 0.6776 | 4 | 143 | muscle cell development |
GO:0010900 | 0.0047 | Inf | 0.0047 | 1 | 1 | negative regulation of phosphatidylcholine catabolic process |
GO:0010963 | 0.0047 | Inf | 0.0047 | 1 | 1 | regulation of L-arginine import |
GO:0038195 | 0.0047 | Inf | 0.0047 | 1 | 1 | urokinase plasminogen activator signaling pathway |
GO:0043056 | 0.0047 | Inf | 0.0047 | 1 | 1 | forward locomotion |
GO:0044726 | 0.0047 | Inf | 0.0047 | 1 | 1 | protection of DNA demethylation of female pronucleus |
GO:0050928 | 0.0047 | Inf | 0.0047 | 1 | 1 | negative regulation of positive chemotaxis |
GO:0070489 | 0.0047 | Inf | 0.0047 | 1 | 1 | T cell aggregation |
GO:0090158 | 0.0047 | Inf | 0.0047 | 1 | 1 | endoplasmic reticulum membrane organization |
GO:0090521 | 0.0047 | Inf | 0.0047 | 1 | 1 | glomerular visceral epithelial cell migration |
GO:1901536 | 0.0047 | Inf | 0.0047 | 1 | 1 | negative regulation of DNA demethylation |
GO:1901846 | 0.0047 | Inf | 0.0047 | 1 | 1 | positive regulation of cell communication by electrical coupling involved in cardiac conduction |
GO:1902225 | 0.0047 | Inf | 0.0047 | 1 | 1 | negative regulation of acrosome reaction |
GO:0006805 | 0.006 | 5.9116 | 0.725 | 4 | 153 | xenobiotic metabolic process |
GO:0009410 | 0.0068 | 5.6805 | 0.7534 | 4 | 159 | response to xenobiotic stimulus |
GO:0009913 | 0.0083 | 5.3655 | 0.7961 | 4 | 168 | epidermal cell differentiation |
GO:0035282 | 0.0087 | 7.6021 | 0.4217 | 3 | 89 | segmentation |
GO:0007356 | 0.0095 | 212.9859 | 0.0095 | 1 | 2 | thorax and anterior abdomen determination |
GO:0008615 | 0.0095 | 212.9859 | 0.0095 | 1 | 2 | pyridoxine biosynthetic process |
GO:0016476 | 0.0095 | 212.9859 | 0.0095 | 1 | 2 | regulation of embryonic cell shape |
GO:0032185 | 0.0095 | 212.9859 | 0.0095 | 1 | 2 | septin cytoskeleton organization |
GO:0042823 | 0.0095 | 212.9859 | 0.0095 | 1 | 2 | pyridoxal phosphate biosynthetic process |
GO:0043366 | 0.0095 | 212.9859 | 0.0095 | 1 | 2 | beta selection |
GO:0090467 | 0.0095 | 212.9859 | 0.0095 | 1 | 2 | arginine import |
GO:1902023 | 0.0095 | 212.9859 | 0.0095 | 1 | 2 | L-arginine transport |
GO:2000381 | 0.0095 | 212.9859 | 0.0095 | 1 | 2 | negative regulation of mesoderm development |
GO:2001076 | 0.0095 | 212.9859 | 0.0095 | 1 | 2 | positive regulation of metanephric ureteric bud development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051321 | 1e-04 | 5.0227 | 2.1776 | 10 | 176 | meiotic cell cycle |
GO:0045324 | 5e-04 | 161.3548 | 0.0371 | 2 | 3 | late endosome to vacuole transport |
GO:2000300 | 6e-04 | 22.1071 | 0.1732 | 3 | 14 | regulation of synaptic vesicle exocytosis |
GO:0045577 | 0.0013 | 16.2076 | 0.2227 | 3 | 18 | regulation of B cell differentiation |
GO:0050851 | 0.0014 | 4.5313 | 1.6579 | 7 | 134 | antigen receptor-mediated signaling pathway |
GO:0051177 | 0.0015 | 53.7778 | 0.0619 | 2 | 5 | meiotic sister chromatid cohesion |
GO:0007135 | 0.0022 | 40.3306 | 0.0742 | 2 | 6 | meiosis II |
GO:0071493 | 0.0022 | 40.3306 | 0.0742 | 2 | 6 | cellular response to UV-B |
GO:0050856 | 0.0031 | 11.5722 | 0.2969 | 3 | 24 | regulation of T cell receptor signaling pathway |
GO:0050863 | 0.0032 | 3.1881 | 2.9941 | 9 | 242 | regulation of T cell activation |
GO:0001662 | 0.0035 | 11.0455 | 0.3093 | 3 | 25 | behavioral fear response |
GO:0032693 | 0.0041 | 26.8835 | 0.099 | 2 | 8 | negative regulation of interleukin-10 production |
GO:0000186 | 0.0054 | 6.1337 | 0.7052 | 4 | 57 | activation of MAPKK activity |
GO:0030098 | 0.0064 | 2.8518 | 3.3282 | 9 | 269 | lymphocyte differentiation |
GO:0031115 | 0.0064 | 20.1599 | 0.1237 | 2 | 10 | negative regulation of microtubule polymerization |
GO:0060119 | 0.0065 | 8.6751 | 0.3835 | 3 | 31 | inner ear receptor cell development |
GO:0070232 | 0.0065 | 8.6751 | 0.3835 | 3 | 31 | regulation of T cell apoptotic process |
GO:0045835 | 0.0078 | 17.9188 | 0.1361 | 2 | 11 | negative regulation of meiosis |
GO:0043029 | 0.0084 | 7.834 | 0.4207 | 3 | 34 | T cell homeostasis |
GO:0002757 | 0.009 | 2.5379 | 4.1448 | 10 | 335 | immune response-activating signal transduction |
GO:0031295 | 0.009 | 5.2402 | 0.8166 | 4 | 66 | T cell costimulation |
GO:0090102 | 0.0091 | 7.5887 | 0.433 | 3 | 35 | cochlea development |
GO:0050855 | 0.0093 | 16.1258 | 0.1485 | 2 | 12 | regulation of B cell receptor signaling pathway |
GO:1902358 | 0.0093 | 16.1258 | 0.1485 | 2 | 12 | sulfate transmembrane transport |
GO:1990090 | 0.0093 | 16.1258 | 0.1485 | 2 | 12 | cellular response to nerve growth factor stimulus |
GO:0045321 | 0.0093 | 2.0892 | 7.5843 | 15 | 613 | leukocyte activation |
GO:0007140 | 0.0099 | 7.3582 | 0.4454 | 3 | 36 | male meiosis |
GO:2000106 | 0.01 | 5.0757 | 0.8413 | 4 | 68 | regulation of leukocyte apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0000904 | 0 | 3.1445 | 15.2849 | 42 | 759 | cell morphogenesis involved in differentiation |
GO:0032989 | 0 | 2.5995 | 22.9374 | 52 | 1139 | cellular component morphogenesis |
GO:0007420 | 0 | 3.0646 | 12.0426 | 33 | 598 | brain development |
GO:0048858 | 0 | 2.6627 | 15.0231 | 36 | 746 | cell projection morphogenesis |
GO:0032501 | 0 | 1.7298 | 124.3131 | 165 | 6173 | multicellular organismal process |
GO:0040011 | 0 | 2.1078 | 28.1733 | 53 | 1399 | locomotion |
GO:0007275 | 0 | 1.9858 | 40.486 | 68 | 2276 | multicellular organismal development |
GO:0022008 | 0 | 2.5284 | 14.881 | 34 | 779 | neurogenesis |
GO:0043583 | 0 | 4.1195 | 4.0075 | 15 | 199 | ear development |
GO:0044700 | 0 | 1.6387 | 108.3435 | 144 | 5380 | single organism signaling |
GO:0050767 | 0 | 2.7907 | 9.767 | 25 | 485 | regulation of neurogenesis |
GO:0001654 | 0 | 3.2865 | 6.3033 | 19 | 313 | eye development |
GO:0007154 | 0 | 1.6233 | 109.9143 | 145 | 5458 | cell communication |
GO:0051674 | 0 | 2.1564 | 21.4472 | 42 | 1065 | localization of cell |
GO:0048562 | 0 | 3.3358 | 5.538 | 17 | 275 | embryonic organ morphogenesis |
GO:0060041 | 0 | 4.7904 | 2.5374 | 11 | 126 | retina development in camera-type eye |
GO:0006935 | 1e-04 | 2.4453 | 12.4253 | 28 | 617 | chemotaxis |
GO:0060078 | 1e-04 | 7.8987 | 1.027 | 7 | 51 | regulation of postsynaptic membrane potential |
GO:0051252 | 1e-04 | 1.6456 | 64.7443 | 93 | 3215 | regulation of RNA metabolic process |
GO:0007411 | 1e-04 | 2.8674 | 7.1491 | 19 | 355 | axon guidance |
GO:0031175 | 1e-04 | 2.563 | 9.6915 | 23 | 494 | neuron projection development |
GO:0048538 | 1e-04 | 8.7382 | 0.8055 | 6 | 40 | thymus development |
GO:0007268 | 1e-04 | 2.6537 | 8.5352 | 21 | 443 | synaptic transmission |
GO:0045666 | 2e-04 | 5.6832 | 1.5708 | 8 | 78 | positive regulation of neuron differentiation |
GO:0035113 | 2e-04 | 4.4573 | 2.4569 | 10 | 122 | embryonic appendage morphogenesis |
GO:2000463 | 2e-04 | 17.9145 | 0.3021 | 4 | 15 | positive regulation of excitatory postsynaptic membrane potential |
GO:0007399 | 2e-04 | 2.4716 | 10.087 | 23 | 570 | nervous system development |
GO:0048513 | 2e-04 | 1.7413 | 39.1585 | 61 | 2103 | organ development |
GO:0051093 | 2e-04 | 2.2576 | 12.8683 | 27 | 639 | negative regulation of developmental process |
GO:0090036 | 2e-04 | 16.4205 | 0.3222 | 4 | 16 | regulation of protein kinase C signaling |
GO:0035116 | 3e-04 | 10.2886 | 0.584 | 5 | 29 | embryonic hindlimb morphogenesis |
GO:0030182 | 3e-04 | 2.1231 | 15.7867 | 31 | 824 | neuron differentiation |
GO:0006355 | 3e-04 | 1.5938 | 62.368 | 88 | 3097 | regulation of transcription, DNA-templated |
GO:0006928 | 3e-04 | 1.7932 | 31.1135 | 51 | 1545 | cellular component movement |
GO:0031326 | 3e-04 | 1.5609 | 73.142 | 100 | 3632 | regulation of cellular biosynthetic process |
GO:0007218 | 3e-04 | 4.6211 | 2.1346 | 9 | 106 | neuropeptide signaling pathway |
GO:0051171 | 3e-04 | 1.5402 | 81.4389 | 109 | 4044 | regulation of nitrogen compound metabolic process |
GO:0072089 | 3e-04 | 4.1579 | 2.618 | 10 | 130 | stem cell proliferation |
GO:0045944 | 3e-04 | 2.0705 | 16.6543 | 32 | 827 | positive regulation of transcription from RNA polymerase II promoter |
GO:0010001 | 3e-04 | 3.7653 | 3.1617 | 11 | 157 | glial cell differentiation |
GO:0048665 | 4e-04 | 9.4959 | 0.6243 | 5 | 31 | neuron fate specification |
GO:0022610 | 4e-04 | 1.9479 | 20.5208 | 37 | 1019 | biological adhesion |
GO:0016477 | 4e-04 | 2.0384 | 16.914 | 32 | 858 | cell migration |
GO:0003326 | 4e-04 | Inf | 0.0403 | 2 | 2 | pancreatic A cell fate commitment |
GO:0003329 | 4e-04 | Inf | 0.0403 | 2 | 2 | pancreatic PP cell fate commitment |
GO:0071657 | 4e-04 | Inf | 0.0403 | 2 | 2 | positive regulation of granulocyte colony-stimulating factor production |
GO:1901256 | 4e-04 | Inf | 0.0403 | 2 | 2 | regulation of macrophage colony-stimulating factor production |
GO:0048864 | 4e-04 | 3.083 | 4.8734 | 14 | 242 | stem cell development |
GO:2000679 | 4e-04 | 29.4733 | 0.1611 | 3 | 8 | positive regulation of transcription regulatory region DNA binding |
GO:0048736 | 4e-04 | 3.6639 | 3.2423 | 11 | 161 | appendage development |
GO:0048167 | 5e-04 | 4.2667 | 2.2958 | 9 | 114 | regulation of synaptic plasticity |
GO:0044259 | 6e-04 | 4.1863 | 2.336 | 9 | 116 | multicellular organismal macromolecule metabolic process |
GO:0035108 | 6e-04 | 3.806 | 2.8395 | 10 | 141 | limb morphogenesis |
GO:0009790 | 6e-04 | 2.6316 | 6.9089 | 17 | 354 | embryo development |
GO:0036342 | 6e-04 | 12.3121 | 0.4028 | 4 | 20 | post-anal tail morphogenesis |
GO:0072358 | 6e-04 | 2.0038 | 16.5939 | 31 | 824 | cardiovascular system development |
GO:0010556 | 6e-04 | 1.5249 | 70.2622 | 95 | 3489 | regulation of macromolecule biosynthetic process |
GO:0007409 | 7e-04 | 3.69 | 2.9203 | 10 | 151 | axonogenesis |
GO:0045665 | 7e-04 | 6.1837 | 1.0875 | 6 | 54 | negative regulation of neuron differentiation |
GO:0030574 | 8e-04 | 5.1026 | 1.5104 | 7 | 75 | collagen catabolic process |
GO:0021953 | 8e-04 | 3.6182 | 2.9745 | 10 | 149 | central nervous system neuron differentiation |
GO:2000026 | 8e-04 | 1.8546 | 21.4856 | 37 | 1093 | regulation of multicellular organismal development |
GO:0042472 | 9e-04 | 4.3655 | 1.9937 | 8 | 99 | inner ear morphogenesis |
GO:0030199 | 0.0011 | 7.2577 | 0.7854 | 5 | 39 | collagen fibril organization |
GO:0014033 | 0.0012 | 5.5985 | 1.1882 | 6 | 59 | neural crest cell differentiation |
GO:0007171 | 0.0012 | 18.4171 | 0.2215 | 3 | 11 | activation of transmembrane receptor protein tyrosine kinase activity |
GO:0060379 | 0.0012 | 18.4171 | 0.2215 | 3 | 11 | cardiac muscle cell myoblast differentiation |
GO:0050794 | 0.0012 | 1.4908 | 137.5931 | 162 | 7301 | regulation of cellular process |
GO:0001766 | 0.0012 | 97.9474 | 0.0604 | 2 | 3 | membrane raft polarization |
GO:0002572 | 0.0012 | 97.9474 | 0.0604 | 2 | 3 | pro-T cell differentiation |
GO:0021530 | 0.0012 | 97.9474 | 0.0604 | 2 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0021902 | 0.0012 | 97.9474 | 0.0604 | 2 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0090074 | 0.0012 | 97.9474 | 0.0604 | 2 | 3 | negative regulation of protein homodimerization activity |
GO:0001764 | 0.0012 | 3.7295 | 2.5978 | 9 | 129 | neuron migration |
GO:0042733 | 0.0013 | 5.4944 | 1.2083 | 6 | 60 | embryonic digit morphogenesis |
GO:0035148 | 0.0014 | 3.6378 | 2.6582 | 9 | 132 | tube formation |
GO:0007269 | 0.0014 | 4.0106 | 2.1548 | 8 | 107 | neurotransmitter secretion |
GO:0048646 | 0.0015 | 1.9826 | 14.5218 | 27 | 748 | anatomical structure formation involved in morphogenesis |
GO:0021533 | 0.0015 | 9.3775 | 0.5035 | 4 | 25 | cell differentiation in hindbrain |
GO:1901342 | 0.0015 | 3.0993 | 3.786 | 11 | 188 | regulation of vasculature development |
GO:0010664 | 0.0016 | 16.3696 | 0.2417 | 3 | 12 | negative regulation of striated muscle cell apoptotic process |
GO:0009888 | 0.0016 | 1.6888 | 28.7385 | 45 | 1468 | tissue development |
GO:0060021 | 0.0016 | 4.4455 | 1.7117 | 7 | 85 | palate development |
GO:0001709 | 0.0016 | 6.492 | 0.8659 | 5 | 43 | cell fate determination |
GO:0045165 | 0.0018 | 3.246 | 3.2885 | 10 | 168 | cell fate commitment |
GO:0065007 | 0.0018 | 1.4685 | 185.2853 | 209 | 9562 | biological regulation |
GO:0030198 | 0.0019 | 2.502 | 6.3552 | 15 | 320 | extracellular matrix organization |
GO:0030855 | 0.0019 | 2.4168 | 7.0176 | 16 | 356 | epithelial cell differentiation |
GO:0001756 | 0.0019 | 5.0271 | 1.309 | 6 | 65 | somitogenesis |
GO:0007616 | 0.002 | 8.5609 | 0.5437 | 4 | 27 | long-term memory |
GO:0021511 | 0.002 | 8.5609 | 0.5437 | 4 | 27 | spinal cord patterning |
GO:0021846 | 0.002 | 8.5609 | 0.5437 | 4 | 27 | cell proliferation in forebrain |
GO:0010665 | 0.002 | 14.7317 | 0.2618 | 3 | 13 | regulation of cardiac muscle cell apoptotic process |
GO:0009712 | 0.002 | 6.1665 | 0.9062 | 5 | 45 | catechol-containing compound metabolic process |
GO:0034654 | 0.0022 | 1.4504 | 72.9406 | 95 | 3622 | nucleobase-containing compound biosynthetic process |
GO:0051099 | 0.0022 | 4.1763 | 1.8124 | 7 | 90 | positive regulation of binding |
GO:0051665 | 0.0024 | 48.9704 | 0.0806 | 2 | 4 | membrane raft localization |
GO:0061056 | 0.0024 | 48.9704 | 0.0806 | 2 | 4 | sclerotome development |
GO:0061183 | 0.0024 | 48.9704 | 0.0806 | 2 | 4 | regulation of dermatome development |
GO:0072107 | 0.0024 | 48.9704 | 0.0806 | 2 | 4 | positive regulation of ureteric bud formation |
GO:0097476 | 0.0024 | 48.9704 | 0.0806 | 2 | 4 | spinal cord motor neuron migration |
GO:0010975 | 0.0024 | 2.6301 | 5.2359 | 13 | 260 | regulation of neuron projection development |
GO:0021681 | 0.0025 | 13.3915 | 0.2819 | 3 | 14 | cerebellar granular layer development |
GO:0010628 | 0.0025 | 1.7017 | 24.4881 | 39 | 1216 | positive regulation of gene expression |
GO:0042391 | 0.0027 | 2.8651 | 4.0735 | 11 | 206 | regulation of membrane potential |
GO:0035019 | 0.0027 | 5.7351 | 0.9666 | 5 | 48 | somatic stem cell maintenance |
GO:0072006 | 0.0027 | 4.0298 | 1.8729 | 7 | 93 | nephron development |
GO:0001838 | 0.0028 | 3.5741 | 2.3964 | 8 | 119 | embryonic epithelial tube formation |
GO:0051899 | 0.0028 | 3.5741 | 2.3964 | 8 | 119 | membrane depolarization |
GO:0007610 | 0.003 | 2.2384 | 8.0245 | 17 | 407 | behavior |
GO:0097094 | 0.0031 | 12.2748 | 0.3021 | 3 | 15 | craniofacial suture morphogenesis |
GO:0003002 | 0.0031 | 2.4519 | 6.0328 | 14 | 303 | regionalization |
GO:0035115 | 0.0033 | 7.2907 | 0.6243 | 4 | 31 | embryonic forelimb morphogenesis |
GO:0048518 | 0.0033 | 1.4129 | 81.2979 | 103 | 4037 | positive regulation of biological process |
GO:0002064 | 0.0034 | 2.9426 | 3.6047 | 10 | 179 | epithelial cell development |
GO:0048814 | 0.0035 | 5.36 | 1.027 | 5 | 51 | regulation of dendrite morphogenesis |
GO:0048565 | 0.0036 | 3.4189 | 2.4971 | 8 | 124 | digestive tract development |
GO:0048856 | 0.0036 | 1.7913 | 18.7861 | 31 | 1122 | anatomical structure development |
GO:0021537 | 0.0037 | 2.9095 | 3.6426 | 10 | 182 | telencephalon development |
GO:0042136 | 0.0037 | 11.3298 | 0.3222 | 3 | 16 | neurotransmitter biosynthetic process |
GO:0021766 | 0.0038 | 5.2456 | 1.0472 | 5 | 52 | hippocampus development |
GO:0045766 | 0.0038 | 3.7654 | 1.9937 | 7 | 99 | positive regulation of angiogenesis |
GO:0007626 | 0.0039 | 2.8907 | 3.6652 | 10 | 182 | locomotory behavior |
GO:0042127 | 0.0039 | 1.6451 | 25.9179 | 40 | 1287 | regulation of cell proliferation |
GO:0003180 | 0.0039 | 32.6447 | 0.1007 | 2 | 5 | aortic valve morphogenesis |
GO:0021779 | 0.0039 | 32.6447 | 0.1007 | 2 | 5 | oligodendrocyte cell fate commitment |
GO:0021780 | 0.0039 | 32.6447 | 0.1007 | 2 | 5 | glial cell fate specification |
GO:0035881 | 0.0039 | 32.6447 | 0.1007 | 2 | 5 | amacrine cell differentiation |
GO:0060164 | 0.0039 | 32.6447 | 0.1007 | 2 | 5 | regulation of timing of neuron differentiation |
GO:0061304 | 0.0039 | 32.6447 | 0.1007 | 2 | 5 | retinal blood vessel morphogenesis |
GO:1901723 | 0.0039 | 32.6447 | 0.1007 | 2 | 5 | negative regulation of cell proliferation involved in kidney development |
GO:0001568 | 0.0039 | 2.0377 | 10.351 | 20 | 514 | blood vessel development |
GO:0080090 | 0.0044 | 1.3737 | 103.752 | 126 | 5152 | regulation of primary metabolic process |
GO:0021514 | 0.0045 | 10.5198 | 0.3423 | 3 | 17 | ventral spinal cord interneuron differentiation |
GO:0007611 | 0.0045 | 2.8242 | 3.7457 | 10 | 186 | learning or memory |
GO:0071363 | 0.0045 | 1.909 | 12.7072 | 23 | 631 | cellular response to growth factor stimulus |
GO:0001755 | 0.0046 | 6.5603 | 0.6847 | 4 | 34 | neural crest cell migration |
GO:0046189 | 0.0046 | 6.5603 | 0.6847 | 4 | 34 | phenol-containing compound biosynthetic process |
GO:0051057 | 0.0046 | 6.5603 | 0.6847 | 4 | 34 | positive regulation of small GTPase mediated signal transduction |
GO:0045471 | 0.0048 | 3.6075 | 2.0742 | 7 | 103 | response to ethanol |
GO:0021549 | 0.0052 | 4.0592 | 1.5909 | 6 | 79 | cerebellum development |
GO:0010660 | 0.0052 | 6.3482 | 0.7048 | 4 | 35 | regulation of muscle cell apoptotic process |
GO:0045168 | 0.0052 | 6.3482 | 0.7048 | 4 | 35 | cell-cell signaling involved in cell fate commitment |
GO:0090102 | 0.0052 | 6.3482 | 0.7048 | 4 | 35 | cochlea development |
GO:0042423 | 0.0053 | 9.8178 | 0.3625 | 3 | 18 | catecholamine biosynthetic process |
GO:0060231 | 0.0053 | 9.8178 | 0.3625 | 3 | 18 | mesenchymal to epithelial transition |
GO:0045597 | 0.0054 | 2.0127 | 9.9353 | 19 | 504 | positive regulation of cell differentiation |
GO:0007167 | 0.0054 | 1.7156 | 19.1112 | 31 | 949 | enzyme linked receptor protein signaling pathway |
GO:0048863 | 0.0054 | 4.8018 | 1.1326 | 5 | 58 | stem cell differentiation |
GO:0002520 | 0.0057 | 1.8197 | 14.4794 | 25 | 719 | immune system development |
GO:0007193 | 0.0057 | 4.7396 | 1.1479 | 5 | 57 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0002318 | 0.0057 | 24.4819 | 0.1208 | 2 | 6 | myeloid progenitor cell differentiation |
GO:0015870 | 0.0057 | 24.4819 | 0.1208 | 2 | 6 | acetylcholine transport |
GO:0021960 | 0.0057 | 24.4819 | 0.1208 | 2 | 6 | anterior commissure morphogenesis |
GO:0035860 | 0.0057 | 24.4819 | 0.1208 | 2 | 6 | glial cell-derived neurotrophic factor receptor signaling pathway |
GO:0035989 | 0.0057 | 24.4819 | 0.1208 | 2 | 6 | tendon development |
GO:0060017 | 0.0057 | 24.4819 | 0.1208 | 2 | 6 | parathyroid gland development |
GO:0030010 | 0.0058 | 3.9504 | 1.6312 | 6 | 81 | establishment of cell polarity |
GO:0055085 | 0.0058 | 1.6408 | 23.2596 | 36 | 1155 | transmembrane transport |
GO:0010721 | 0.006 | 3.1204 | 2.7187 | 8 | 135 | negative regulation of cell development |
GO:0035270 | 0.0061 | 3.9147 | 1.6439 | 6 | 83 | endocrine system development |
GO:2000178 | 0.0062 | 9.2036 | 0.3826 | 3 | 19 | negative regulation of neural precursor cell proliferation |
GO:0007416 | 0.0062 | 3.8982 | 1.6513 | 6 | 82 | synapse assembly |
GO:0072001 | 0.0062 | 2.4296 | 5.1957 | 12 | 258 | renal system development |
GO:0009611 | 0.0064 | 1.7077 | 18.5473 | 30 | 921 | response to wounding |
GO:0010629 | 0.0065 | 1.6777 | 20.1583 | 32 | 1001 | negative regulation of gene expression |
GO:0045785 | 0.0065 | 2.8435 | 3.3429 | 9 | 166 | positive regulation of cell adhesion |
GO:0001843 | 0.0066 | 3.8473 | 1.6715 | 6 | 83 | neural tube closure |
GO:0046903 | 0.0069 | 1.7142 | 17.8424 | 29 | 886 | secretion |
GO:0007595 | 0.0069 | 5.7869 | 0.7653 | 4 | 38 | lactation |
GO:0071377 | 0.0069 | 5.7869 | 0.7653 | 4 | 38 | cellular response to glucagon stimulus |
GO:0034765 | 0.007 | 2.2982 | 5.9408 | 13 | 295 | regulation of ion transmembrane transport |
GO:0035295 | 0.007 | 2.0424 | 8.7397 | 17 | 442 | tube development |
GO:0038084 | 0.0072 | 8.6616 | 0.4028 | 3 | 20 | vascular endothelial growth factor signaling pathway |
GO:0048485 | 0.0072 | 8.6616 | 0.4028 | 3 | 20 | sympathetic nervous system development |
GO:0097503 | 0.0072 | 8.6616 | 0.4028 | 3 | 20 | sialylation |
GO:0022604 | 0.0073 | 2.1412 | 7.3504 | 15 | 365 | regulation of cell morphogenesis |
GO:0071805 | 0.0075 | 3.0012 | 2.8193 | 8 | 140 | potassium ion transmembrane transport |
GO:0021872 | 0.0076 | 4.3999 | 1.2284 | 5 | 61 | forebrain generation of neurons |
GO:0050804 | 0.0077 | 3.2801 | 2.2648 | 7 | 115 | regulation of synaptic transmission |
GO:0015816 | 0.0079 | 19.5842 | 0.141 | 2 | 7 | glycine transport |
GO:0042661 | 0.0079 | 19.5842 | 0.141 | 2 | 7 | regulation of mesodermal cell fate specification |
GO:0042761 | 0.0079 | 19.5842 | 0.141 | 2 | 7 | very long-chain fatty acid biosynthetic process |
GO:0060073 | 0.0079 | 19.5842 | 0.141 | 2 | 7 | micturition |
GO:0061003 | 0.0079 | 19.5842 | 0.141 | 2 | 7 | positive regulation of dendritic spine morphogenesis |
GO:0071481 | 0.0079 | 19.5842 | 0.141 | 2 | 7 | cellular response to X-ray |
GO:0008306 | 0.0081 | 4.3224 | 1.2486 | 5 | 62 | associative learning |
GO:0001656 | 0.0082 | 3.6563 | 1.752 | 6 | 87 | metanephros development |
GO:0001759 | 0.0082 | 8.1799 | 0.4229 | 3 | 21 | organ induction |
GO:0051954 | 0.0082 | 8.1799 | 0.4229 | 3 | 21 | positive regulation of amine transport |
GO:0072132 | 0.0082 | 8.1799 | 0.4229 | 3 | 21 | mesenchyme morphogenesis |
GO:0007596 | 0.0082 | 1.9251 | 10.351 | 19 | 514 | blood coagulation |
GO:0021510 | 0.0083 | 4.2982 | 1.2544 | 5 | 63 | spinal cord development |
GO:0002009 | 0.0083 | 2.0511 | 8.1761 | 16 | 406 | morphogenesis of an epithelium |
GO:0048705 | 0.0085 | 2.559 | 4.1082 | 10 | 204 | skeletal system morphogenesis |
GO:0031589 | 0.0085 | 2.3238 | 5.4172 | 12 | 269 | cell-substrate adhesion |
GO:0006029 | 0.0087 | 3.6115 | 1.7722 | 6 | 88 | proteoglycan metabolic process |
GO:0009792 | 0.0088 | 1.8477 | 11.9218 | 21 | 592 | embryo development ending in birth or egg hatching |
GO:0051260 | 0.009 | 2.4085 | 4.7929 | 11 | 238 | protein homooligomerization |
GO:0021987 | 0.0091 | 3.5677 | 1.7923 | 6 | 89 | cerebral cortex development |
GO:0098655 | 0.0094 | 1.8654 | 11.2371 | 20 | 558 | cation transmembrane transport |
GO:0021697 | 0.0094 | 7.7488 | 0.443 | 3 | 22 | cerebellar cortex formation |
GO:0023019 | 0.0094 | 7.7488 | 0.443 | 3 | 22 | signal transduction involved in regulation of gene expression |
GO:1902680 | 0.0098 | 1.5893 | 23.2395 | 35 | 1154 | positive regulation of RNA biosynthetic process |
GO:0007215 | 0.0099 | 4.1055 | 1.309 | 5 | 65 | glutamate receptor signaling pathway |
GO:0021983 | 0.0099 | 5.1764 | 0.8458 | 4 | 42 | pituitary gland development |
GO:0050878 | 0.0099 | 1.7979 | 12.828 | 22 | 637 | regulation of body fluid levels |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002827 | 0 | 70.309 | 0.0625 | 3 | 10 | positive regulation of T-helper 1 type immune response |
GO:0050792 | 1e-04 | 8.0362 | 0.9691 | 7 | 155 | regulation of viral process |
GO:0045071 | 1e-04 | 18.3932 | 0.2501 | 4 | 40 | negative regulation of viral genome replication |
GO:0071073 | 4e-04 | 108.2222 | 0.0313 | 2 | 5 | positive regulation of phospholipid biosynthetic process |
GO:0051606 | 5e-04 | 3.4285 | 3.895 | 12 | 623 | detection of stimulus |
GO:0043901 | 5e-04 | 8.2503 | 0.6627 | 5 | 106 | negative regulation of multi-organism process |
GO:2000318 | 6e-04 | 81.1613 | 0.0375 | 2 | 6 | positive regulation of T-helper 17 type immune response |
GO:0010529 | 8e-04 | 64.9247 | 0.0438 | 2 | 7 | negative regulation of transposition |
GO:0010985 | 8e-04 | 64.9247 | 0.0438 | 2 | 7 | negative regulation of lipoprotein particle clearance |
GO:0044539 | 8e-04 | 64.9247 | 0.0438 | 2 | 7 | long-chain fatty acid import |
GO:0051607 | 0.0016 | 5.1799 | 1.2504 | 6 | 200 | defense response to virus |
GO:0050965 | 0.0017 | 40.5699 | 0.0625 | 2 | 10 | detection of temperature stimulus involved in sensory perception of pain |
GO:0046068 | 0.0017 | 14.0357 | 0.2376 | 3 | 38 | cGMP metabolic process |
GO:0032729 | 0.0018 | 13.6449 | 0.2438 | 3 | 39 | positive regulation of interferon-gamma production |
GO:0006952 | 0.002 | 2.3579 | 8.6278 | 18 | 1380 | defense response |
GO:0006955 | 0.0023 | 2.3857 | 8.0089 | 17 | 1281 | immune response |
GO:0009605 | 0.0023 | 2.1585 | 11.7038 | 22 | 1872 | response to external stimulus |
GO:0051707 | 0.0026 | 2.9348 | 4.1013 | 11 | 656 | response to other organism |
GO:0016048 | 0.0034 | 27.0394 | 0.0875 | 2 | 14 | detection of temperature stimulus |
GO:0007602 | 0.0037 | 6.7987 | 0.6315 | 4 | 101 | phototransduction |
GO:0009607 | 0.0037 | 2.7898 | 4.3014 | 11 | 688 | response to biotic stimulus |
GO:0050951 | 0.0044 | 23.1736 | 0.1 | 2 | 16 | sensory perception of temperature stimulus |
GO:0002821 | 0.0052 | 9.2578 | 0.3501 | 3 | 56 | positive regulation of adaptive immune response |
GO:0034341 | 0.0058 | 5.9356 | 0.719 | 4 | 115 | response to interferon-gamma |
GO:0050877 | 0.0059 | 2.2617 | 7.3212 | 15 | 1171 | neurological system process |
GO:0006876 | 0.0063 | Inf | 0.0063 | 1 | 1 | cellular cadmium ion homeostasis |
GO:0015707 | 0.0063 | Inf | 0.0063 | 1 | 1 | nitrite transport |
GO:0030421 | 0.0063 | Inf | 0.0063 | 1 | 1 | defecation |
GO:0034120 | 0.0063 | Inf | 0.0063 | 1 | 1 | positive regulation of erythrocyte aggregation |
GO:0035397 | 0.0063 | Inf | 0.0063 | 1 | 1 | helper T cell enhancement of adaptive immune response |
GO:0038114 | 0.0063 | Inf | 0.0063 | 1 | 1 | interleukin-21-mediated signaling pathway |
GO:0070839 | 0.0063 | Inf | 0.0063 | 1 | 1 | divalent metal ion export |
GO:0042632 | 0.0078 | 7.9092 | 0.4064 | 3 | 65 | cholesterol homeostasis |
GO:0033198 | 0.009 | 15.4419 | 0.1438 | 2 | 23 | response to ATP |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0072358 | 1e-04 | 2.5362 | 10.4118 | 24 | 824 | cardiovascular system development |
GO:0001501 | 3e-04 | 3.0088 | 5.3828 | 15 | 426 | skeletal system development |
GO:0003350 | 5e-04 | 157.9158 | 0.0379 | 2 | 3 | pulmonary myocardium development |
GO:0021570 | 5e-04 | 157.9158 | 0.0379 | 2 | 3 | rhombomere 4 development |
GO:0035993 | 5e-04 | 157.9158 | 0.0379 | 2 | 3 | deltoid tuberosity development |
GO:0072003 | 5e-04 | 157.9158 | 0.0379 | 2 | 3 | kidney rudiment formation |
GO:0043062 | 7e-04 | 3.0674 | 4.5489 | 13 | 360 | extracellular structure organization |
GO:0048646 | 8e-04 | 2.1952 | 11.8938 | 24 | 951 | anatomical structure formation involved in morphogenesis |
GO:0022617 | 9e-04 | 4.8985 | 1.5416 | 7 | 122 | extracellular matrix disassembly |
GO:0045197 | 0.001 | 18.3028 | 0.2022 | 3 | 16 | establishment or maintenance of epithelial cell apical/basal polarity |
GO:0055003 | 0.001 | 18.3028 | 0.2022 | 3 | 16 | cardiac myofibril assembly |
GO:0048486 | 0.0014 | 15.8603 | 0.2274 | 3 | 18 | parasympathetic nervous system development |
GO:0030199 | 0.0014 | 9.0991 | 0.4928 | 4 | 39 | collagen fibril organization |
GO:2000609 | 0.0015 | 52.6316 | 0.0632 | 2 | 5 | regulation of thyroid hormone generation |
GO:0021602 | 0.0022 | 13.2143 | 0.2654 | 3 | 21 | cranial nerve morphogenesis |
GO:0042403 | 0.0022 | 13.2143 | 0.2654 | 3 | 21 | thyroid hormone metabolic process |
GO:0072038 | 0.0023 | 39.4711 | 0.0758 | 2 | 6 | mesenchymal stem cell maintenance involved in nephron morphogenesis |
GO:0030574 | 0.0026 | 5.704 | 0.9477 | 5 | 75 | collagen catabolic process |
GO:0016338 | 0.0029 | 11.8913 | 0.2906 | 3 | 23 | calcium-independent cell-cell adhesion |
GO:0003339 | 0.0032 | 31.5747 | 0.0885 | 2 | 7 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis |
GO:0030948 | 0.0032 | 31.5747 | 0.0885 | 2 | 7 | negative regulation of vascular endothelial growth factor receptor signaling pathway |
GO:0060586 | 0.0032 | 31.5747 | 0.0885 | 2 | 7 | multicellular organismal iron ion homeostasis |
GO:0061245 | 0.0033 | 11.3243 | 0.3033 | 3 | 24 | establishment or maintenance of bipolar cell polarity |
GO:0044259 | 0.0035 | 4.3674 | 1.4657 | 6 | 116 | multicellular organismal macromolecule metabolic process |
GO:0010761 | 0.0042 | 10.3382 | 0.3285 | 3 | 26 | fibroblast migration |
GO:0007275 | 0.0042 | 1.5148 | 53.8282 | 71 | 4260 | multicellular organismal development |
GO:0021612 | 0.0042 | 26.3105 | 0.1011 | 2 | 8 | facial nerve structural organization |
GO:0055007 | 0.0044 | 4.9876 | 1.074 | 5 | 85 | cardiac muscle cell differentiation |
GO:0048598 | 0.0045 | 2.2785 | 6.9876 | 15 | 553 | embryonic morphogenesis |
GO:0010770 | 0.0048 | 6.363 | 0.6823 | 4 | 54 | positive regulation of cell morphogenesis involved in differentiation |
GO:0055006 | 0.0048 | 6.363 | 0.6823 | 4 | 54 | cardiac cell development |
GO:0048568 | 0.0048 | 2.5178 | 5.0417 | 12 | 399 | embryonic organ development |
GO:0001568 | 0.0058 | 2.2814 | 6.4948 | 14 | 514 | blood vessel development |
GO:0003230 | 0.0063 | 8.8042 | 0.3791 | 3 | 30 | cardiac atrium development |
GO:0048704 | 0.0065 | 4.5318 | 1.1751 | 5 | 93 | embryonic skeletal system morphogenesis |
GO:0048857 | 0.0065 | 5.7826 | 0.7455 | 4 | 59 | neural nucleus development |
GO:0021561 | 0.0067 | 19.7303 | 0.1264 | 2 | 10 | facial nerve development |
GO:0072173 | 0.0067 | 19.7303 | 0.1264 | 2 | 10 | metanephric tubule morphogenesis |
GO:0022603 | 0.0075 | 2.0399 | 8.8324 | 17 | 699 | regulation of anatomical structure morphogenesis |
GO:0043009 | 0.0076 | 2.1419 | 7.4045 | 15 | 586 | chordate embryonic development |
GO:0031032 | 0.0078 | 5.4824 | 0.7834 | 4 | 62 | actomyosin structure organization |
GO:0070208 | 0.0081 | 17.5368 | 0.139 | 2 | 11 | protein heterotrimerization |
GO:0048536 | 0.0089 | 7.6662 | 0.4296 | 3 | 34 | spleen development |
GO:0003002 | 0.0093 | 2.5211 | 4.1698 | 10 | 330 | regionalization |
GO:0060707 | 0.0096 | 15.7821 | 0.1516 | 2 | 12 | trophoblast giant cell differentiation |
GO:0086003 | 0.0096 | 15.7821 | 0.1516 | 2 | 12 | cardiac muscle cell contraction |
GO:0055001 | 0.0097 | 3.5004 | 1.8069 | 6 | 143 | muscle cell development |
GO:0006941 | 0.0099 | 4.0666 | 1.3015 | 5 | 103 | striated muscle contraction |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 26.9983 | 1.389 | 22 | 367 | olfactory receptor activity |
GO:0004930 | 0 | 13.0008 | 2.9257 | 23 | 773 | G-protein coupled receptor activity |
GO:0038023 | 0 | 9.1492 | 4.6137 | 25 | 1219 | signaling receptor activity |
GO:0060089 | 0 | 7.2199 | 5.6999 | 25 | 1506 | molecular transducer activity |
GO:0016805 | 0.0012 | 45.4568 | 0.053 | 2 | 14 | dipeptidase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001965 | 0.0038 | 25.4965 | 0.0927 | 2 | 14 | G-protein alpha-subunit binding |
GO:0005149 | 0.0049 | 21.8512 | 0.106 | 2 | 16 | interleukin-1 receptor binding |
GO:0004979 | 0.0066 | Inf | 0.0066 | 1 | 1 | beta-endorphin receptor activity |
GO:0018585 | 0.0066 | Inf | 0.0066 | 1 | 1 | fluorene oxygenase activity |
GO:0035727 | 0.0066 | Inf | 0.0066 | 1 | 1 | lysophosphatidic acid binding |
GO:0038047 | 0.0066 | Inf | 0.0066 | 1 | 1 | morphine receptor activity |
GO:0050479 | 0.0066 | Inf | 0.0066 | 1 | 1 | glyceryl-ether monooxygenase activity |
GO:0070330 | 0.0084 | 16.0954 | 0.1391 | 2 | 21 | aromatase activity |
GO:0003779 | 0.0094 | 3.1627 | 2.3579 | 7 | 356 | actin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0046332 | 6e-04 | 11.6254 | 0.3806 | 4 | 64 | SMAD binding |
GO:0044548 | 0.0019 | 37.9819 | 0.0654 | 2 | 11 | S100 protein binding |
GO:0016811 | 0.0038 | 10.3468 | 0.3152 | 3 | 53 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides |
GO:0004963 | 0.0059 | Inf | 0.0059 | 1 | 1 | follicle-stimulating hormone receptor activity |
GO:0008123 | 0.0059 | Inf | 0.0059 | 1 | 1 | cholesterol 7-alpha-monooxygenase activity |
GO:0008725 | 0.0059 | Inf | 0.0059 | 1 | 1 | DNA-3-methyladenine glycosylase activity |
GO:0018738 | 0.0059 | Inf | 0.0059 | 1 | 1 | S-formylglutathione hydrolase activity |
GO:0043916 | 0.0059 | Inf | 0.0059 | 1 | 1 | DNA-7-methylguanine glycosylase activity |
GO:0046539 | 0.0059 | Inf | 0.0059 | 1 | 1 | histamine N-methyltransferase activity |
GO:0052821 | 0.0059 | Inf | 0.0059 | 1 | 1 | DNA-7-methyladenine glycosylase activity |
GO:0052822 | 0.0059 | Inf | 0.0059 | 1 | 1 | DNA-3-methylguanine glycosylase activity |
GO:0004888 | 0.0063 | 2.3199 | 6.6791 | 14 | 1123 | transmembrane signaling receptor activity |
GO:0004872 | 0.0092 | 2.0991 | 8.4693 | 16 | 1424 | receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030020 | 0 | 74.0761 | 0.0811 | 3 | 6 | extracellular matrix structural constituent conferring tensile strength |
GO:0043236 | 6e-04 | 11.8947 | 0.392 | 4 | 29 | laminin binding |
GO:0022803 | 0.0026 | 2.6078 | 5.2987 | 13 | 392 | passive transmembrane transporter activity |
GO:0001968 | 0.005 | 9.6489 | 0.3514 | 3 | 26 | fibronectin binding |
GO:0005125 | 0.007 | 3.0299 | 2.7845 | 8 | 206 | cytokine activity |
GO:0022836 | 0.0076 | 2.6055 | 4.0416 | 10 | 299 | gated channel activity |
GO:0005515 | 0.0079 | 1.4413 | 105.8666 | 123 | 7967 | protein binding |
GO:0048407 | 0.0092 | 16.3715 | 0.1487 | 2 | 11 | platelet-derived growth factor binding |
GO:0005518 | 0.0098 | 5.1154 | 0.8381 | 4 | 62 | collagen binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 9.1689 | 1.6123 | 12 | 367 | olfactory receptor activity |
GO:0004930 | 0 | 6.0277 | 3.3959 | 16 | 773 | G-protein coupled receptor activity |
GO:0038023 | 0 | 4.0748 | 5.2688 | 17 | 1218 | signaling receptor activity |
GO:0060089 | 0 | 3.6788 | 6.616 | 19 | 1506 | molecular transducer activity |
GO:0047760 | 5e-04 | 77.9101 | 0.0351 | 2 | 8 | butyrate-CoA ligase activity |
GO:0004733 | 0.0044 | Inf | 0.0044 | 1 | 1 | pyridoxamine-phosphate oxidase activity |
GO:0004963 | 0.0044 | Inf | 0.0044 | 1 | 1 | follicle-stimulating hormone receptor activity |
GO:0005124 | 0.0044 | Inf | 0.0044 | 1 | 1 | scavenger receptor binding |
GO:0005519 | 0.0044 | Inf | 0.0044 | 1 | 1 | cytoskeletal regulatory protein binding |
GO:0030377 | 0.0044 | Inf | 0.0044 | 1 | 1 | urokinase plasminogen activator receptor activity |
GO:0046539 | 0.0044 | Inf | 0.0044 | 1 | 1 | histamine N-methyltransferase activity |
GO:0043178 | 0.0054 | 9.09 | 0.3558 | 3 | 81 | alcohol binding |
GO:0016877 | 0.0081 | 16.0941 | 0.1362 | 2 | 31 | ligase activity, forming carbon-sulfur bonds |
GO:0004053 | 0.0088 | 230.1562 | 0.0088 | 1 | 2 | arginase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015277 | 0.0014 | 56.0038 | 0.0595 | 2 | 5 | kainate selective glutamate receptor activity |
GO:0008066 | 0.0035 | 11.0055 | 0.3093 | 3 | 26 | glutamate receptor activity |
GO:0008376 | 0.0076 | 8.1609 | 0.4044 | 3 | 34 | acetylgalactosaminyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0 | 2.4203 | 14.0032 | 31 | 712 | sequence-specific DNA binding |
GO:0030545 | 1e-04 | 8.9604 | 0.7867 | 6 | 40 | receptor regulator activity |
GO:0071837 | 2e-04 | 16.8328 | 0.3147 | 4 | 16 | HMG box domain binding |
GO:0070888 | 4e-04 | 9.0391 | 0.649 | 5 | 33 | E-box binding |
GO:0003700 | 9e-04 | 2.1611 | 11.886 | 24 | 621 | sequence-specific DNA binding transcription factor activity |
GO:0004965 | 0.0011 | 100.3737 | 0.059 | 2 | 3 | G-protein coupled GABA receptor activity |
GO:0046982 | 0.0013 | 2.4378 | 7.4146 | 17 | 377 | protein heterodimerization activity |
GO:0022803 | 0.002 | 2.3378 | 7.7097 | 17 | 392 | passive transmembrane transporter activity |
GO:0046872 | 0.0022 | 1.4517 | 74.9921 | 97 | 3813 | metal ion binding |
GO:0022836 | 0.0025 | 2.5218 | 5.8806 | 14 | 299 | gated channel activity |
GO:0048018 | 0.0029 | 12.5807 | 0.295 | 3 | 15 | receptor agonist activity |
GO:0046873 | 0.003 | 2.3058 | 7.336 | 16 | 373 | metal ion transmembrane transporter activity |
GO:0008083 | 0.0033 | 3.1828 | 3.0091 | 9 | 153 | growth factor activity |
GO:0030297 | 0.0037 | 33.4533 | 0.0983 | 2 | 5 | transmembrane receptor protein tyrosine kinase activator activity |
GO:0005267 | 0.0066 | 3.3803 | 2.2028 | 7 | 112 | potassium channel activity |
GO:0008373 | 0.0067 | 8.8775 | 0.3933 | 3 | 20 | sialyltransferase activity |
GO:0022838 | 0.007 | 2.1538 | 7.3163 | 15 | 372 | substrate-specific channel activity |
GO:0005201 | 0.0074 | 4.4314 | 1.2194 | 5 | 62 | extracellular matrix structural constituent |
GO:0016782 | 0.0074 | 4.4314 | 1.2194 | 5 | 62 | transferase activity, transferring sulfur-containing groups |
GO:0005021 | 0.0076 | 20.0692 | 0.1377 | 2 | 7 | vascular endothelial growth factor-activated receptor activity |
GO:0008020 | 0.0076 | 20.0692 | 0.1377 | 2 | 7 | G-protein coupled photoreceptor activity |
GO:0000981 | 0.0077 | 2.1294 | 7.395 | 15 | 376 | sequence-specific DNA binding RNA polymerase II transcription factor activity |
GO:0005104 | 0.0077 | 8.3837 | 0.413 | 3 | 21 | fibroblast growth factor receptor binding |
GO:0005326 | 0.0077 | 8.3837 | 0.413 | 3 | 21 | neurotransmitter transporter activity |
GO:0004888 | 0.0078 | 1.6298 | 22.0866 | 34 | 1123 | transmembrane signaling receptor activity |
GO:0008324 | 0.0079 | 1.9013 | 11.0531 | 20 | 562 | cation transmembrane transporter activity |
GO:0005244 | 0.0081 | 2.7401 | 3.4615 | 9 | 176 | voltage-gated ion channel activity |
GO:0001158 | 0.009 | 4.2089 | 1.2784 | 5 | 65 | enhancer sequence-specific DNA binding |
GO:0005184 | 0.01 | 7.5443 | 0.4524 | 3 | 23 | neuropeptide hormone activity |
GO:0035240 | 0.01 | 16.7232 | 0.1573 | 2 | 8 | dopamine binding |
GO:0045294 | 0.01 | 16.7232 | 0.1573 | 2 | 8 | alpha-catenin binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001532 | 0.0064 | Inf | 0.0064 | 1 | 1 | interleukin-21 receptor activity |
GO:0001791 | 0.0064 | Inf | 0.0064 | 1 | 1 | IgM binding |
GO:0001872 | 0.0064 | Inf | 0.0064 | 1 | 1 | (1->3)-beta-D-glucan binding |
GO:0004304 | 0.0064 | Inf | 0.0064 | 1 | 1 | estrone sulfotransferase activity |
GO:0004458 | 0.0064 | Inf | 0.0064 | 1 | 1 | D-lactate dehydrogenase (cytochrome) activity |
GO:0016517 | 0.0064 | Inf | 0.0064 | 1 | 1 | interleukin-12 receptor activity |
GO:0047173 | 0.0064 | Inf | 0.0064 | 1 | 1 | phosphatidylcholine-retinol O-acyltransferase activity |
GO:0051139 | 0.0064 | Inf | 0.0064 | 1 | 1 | metal ion:proton antiporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004930 | 0.0039 | 2.6484 | 4.9632 | 12 | 773 | G-protein coupled receptor activity |
GO:0033038 | 0.0058 | 19.7379 | 0.1156 | 2 | 18 | bitter taste receptor activity |
GO:0003908 | 0.0064 | Inf | 0.0064 | 1 | 1 | methylated-DNA-[protein]-cysteine S-methyltransferase activity |
GO:0004516 | 0.0064 | Inf | 0.0064 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
GO:0004733 | 0.0064 | Inf | 0.0064 | 1 | 1 | pyridoxamine-phosphate oxidase activity |
GO:0005124 | 0.0064 | Inf | 0.0064 | 1 | 1 | scavenger receptor binding |
GO:0005183 | 0.0064 | Inf | 0.0064 | 1 | 1 | gonadotropin hormone-releasing hormone activity |
GO:0008887 | 0.0064 | Inf | 0.0064 | 1 | 1 | glycerate kinase activity |
GO:0047127 | 0.0064 | Inf | 0.0064 | 1 | 1 | thiomorpholine-carboxylate dehydrogenase activity |
GO:0097573 | 0.0064 | Inf | 0.0064 | 1 | 1 | glutathione oxidoreductase activity |
GO:0004984 | 0.0093 | 3.1688 | 2.3564 | 7 | 367 | olfactory receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0016641 | 5e-04 | 24.7559 | 0.1582 | 3 | 13 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor |
GO:0016901 | 0.0014 | 54.7303 | 0.0608 | 2 | 5 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor |
GO:0005089 | 0.0018 | 6.2043 | 0.8759 | 5 | 72 | Rho guanyl-nucleotide exchange factor activity |
GO:0031994 | 0.003 | 32.8337 | 0.0852 | 2 | 7 | insulin-like growth factor I binding |
GO:0001968 | 0.0037 | 10.7539 | 0.3163 | 3 | 26 | fibronectin binding |
GO:0004553 | 0.0038 | 5.1914 | 1.0341 | 5 | 85 | hydrolase activity, hydrolyzing O-glycosyl compounds |
GO:0038024 | 0.0068 | 5.7045 | 0.7543 | 4 | 62 | cargo receptor activity |
GO:0048407 | 0.0075 | 18.236 | 0.1338 | 2 | 11 | platelet-derived growth factor binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 55.8324 | 1.1623 | 27 | 368 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 45.6475 | 1.3961 | 27 | 442 | detection of chemical stimulus |
GO:0050906 | 0 | 44.7599 | 1.4213 | 27 | 450 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 44.1159 | 1.4403 | 27 | 456 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 16.5834 | 3.5281 | 27 | 1117 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 15.725 | 3.7018 | 27 | 1172 | neurological system process |
GO:0007165 | 0 | 3.8629 | 15.442 | 31 | 4889 | signal transduction |
GO:0023052 | 0 | 3.34 | 16.996 | 31 | 5381 | signaling |
GO:0044707 | 2e-04 | 3.1278 | 17.5883 | 30 | 5921 | single-multicellular organism process |
GO:0031424 | 5e-04 | 22.3763 | 0.1516 | 3 | 48 | keratinization |
GO:0050896 | 0.0027 | 2.409 | 22.9435 | 33 | 7264 | response to stimulus |
GO:0048387 | 0.0033 | 26.3026 | 0.0853 | 2 | 27 | negative regulation of retinoic acid receptor signaling pathway |
GO:0035574 | 0.0063 | 322.2979 | 0.0063 | 1 | 2 | histone H4-K20 demethylation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0030307 | 1e-04 | 22.6617 | 0.2085 | 4 | 99 | positive regulation of cell growth |
GO:0050911 | 1e-04 | 9.4367 | 0.7749 | 6 | 368 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 3e-04 | 7.7959 | 0.9307 | 6 | 442 | detection of chemical stimulus |
GO:0050906 | 3e-04 | 7.6512 | 0.9476 | 6 | 450 | detection of stimulus involved in sensory perception |
GO:0007606 | 3e-04 | 7.5462 | 0.9602 | 6 | 456 | sensory perception of chemical stimulus |
GO:0007186 | 4e-04 | 4.9644 | 2.352 | 9 | 1117 | G-protein coupled receptor signaling pathway |
GO:0050777 | 4e-04 | 23.3114 | 0.1474 | 3 | 70 | negative regulation of immune response |
GO:0002544 | 8e-04 | 56.1 | 0.0421 | 2 | 20 | chronic inflammatory response |
GO:1903035 | 9e-04 | 17.5234 | 0.1937 | 3 | 92 | negative regulation of response to wounding |
GO:0050727 | 0.0015 | 9.1154 | 0.5012 | 4 | 238 | regulation of inflammatory response |
GO:0031348 | 0.0015 | 14.6965 | 0.2295 | 3 | 109 | negative regulation of defense response |
GO:0045429 | 0.0019 | 34.7954 | 0.0653 | 2 | 31 | positive regulation of nitric oxide biosynthetic process |
GO:0097193 | 0.002 | 8.3529 | 0.5454 | 4 | 259 | intrinsic apoptotic signaling pathway |
GO:0002526 | 0.0021 | 13.1914 | 0.2548 | 3 | 121 | acute inflammatory response |
GO:0042466 | 0.0021 | Inf | 0.0021 | 1 | 1 | chemokinesis |
GO:0051707 | 0.0022 | 5.1533 | 1.3813 | 6 | 656 | response to other organism |
GO:0009607 | 0.0028 | 4.9006 | 1.4487 | 6 | 688 | response to biotic stimulus |
GO:0006950 | 0.0031 | 2.9325 | 6.7234 | 14 | 3193 | response to stress |
GO:0050900 | 0.0032 | 7.3276 | 0.6191 | 4 | 294 | leukocyte migration |
GO:0050709 | 0.0037 | 24.5919 | 0.0905 | 2 | 43 | negative regulation of protein secretion |
GO:0007165 | 0.0042 | 2.7171 | 10.2947 | 18 | 4889 | signal transduction |
GO:0042531 | 0.0042 | 22.9106 | 0.0969 | 2 | 46 | positive regulation of tyrosine phosphorylation of STAT protein |
GO:0009609 | 0.0042 | 489.1613 | 0.0042 | 1 | 2 | response to symbiotic bacterium |
GO:0030311 | 0.0042 | 489.1613 | 0.0042 | 1 | 2 | poly-N-acetyllactosamine biosynthetic process |
GO:0033861 | 0.0042 | 489.1613 | 0.0042 | 1 | 2 | negative regulation of NAD(P)H oxidase activity |
GO:0043000 | 0.0042 | 489.1613 | 0.0042 | 1 | 2 | Golgi to plasma membrane CFTR protein transport |
GO:0045818 | 0.0042 | 489.1613 | 0.0042 | 1 | 2 | negative regulation of glycogen catabolic process |
GO:0046013 | 0.0042 | 489.1613 | 0.0042 | 1 | 2 | regulation of T cell homeostatic proliferation |
GO:0070488 | 0.0042 | 489.1613 | 0.0042 | 1 | 2 | neutrophil aggregation |
GO:2000552 | 0.0042 | 489.1613 | 0.0042 | 1 | 2 | negative regulation of T-helper 2 cell cytokine production |
GO:2000663 | 0.0042 | 489.1613 | 0.0042 | 1 | 2 | negative regulation of interleukin-5 secretion |
GO:2000666 | 0.0042 | 489.1613 | 0.0042 | 1 | 2 | negative regulation of interleukin-13 secretion |
GO:0031424 | 0.0046 | 21.9116 | 0.1011 | 2 | 48 | keratinization |
GO:0032102 | 0.0049 | 9.5805 | 0.3474 | 3 | 165 | negative regulation of response to external stimulus |
GO:0042742 | 0.0057 | 9.0708 | 0.3664 | 3 | 174 | defense response to bacterium |
GO:0016266 | 0.0057 | 19.3756 | 0.1137 | 2 | 54 | O-glycan processing |
GO:0060443 | 0.0057 | 19.3756 | 0.1137 | 2 | 54 | mammary gland morphogenesis |
GO:0010482 | 0.0063 | 244.5645 | 0.0063 | 1 | 3 | regulation of epidermal cell division |
GO:0030185 | 0.0063 | 244.5645 | 0.0063 | 1 | 3 | nitric oxide transport |
GO:0060266 | 0.0063 | 244.5645 | 0.0063 | 1 | 3 | negative regulation of respiratory burst involved in inflammatory response |
GO:0040007 | 0.0063 | 4.1004 | 1.714 | 6 | 814 | growth |
GO:0051223 | 0.0067 | 5.9256 | 0.7602 | 4 | 361 | regulation of protein transport |
GO:0050730 | 0.0067 | 8.5639 | 0.3874 | 3 | 184 | regulation of peptidyl-tyrosine phosphorylation |
GO:0003008 | 0.0075 | 3.0688 | 3.6302 | 9 | 1724 | system process |
GO:0060326 | 0.0078 | 8.0673 | 0.4106 | 3 | 195 | cell chemotaxis |
GO:0046209 | 0.0082 | 15.981 | 0.1369 | 2 | 65 | nitric oxide metabolic process |
GO:0045908 | 0.0084 | 163.0323 | 0.0084 | 1 | 4 | negative regulation of vasodilation |
GO:0090336 | 0.0084 | 163.0323 | 0.0084 | 1 | 4 | positive regulation of brown fat cell differentiation |
GO:0010955 | 0.0092 | 15.0229 | 0.1453 | 2 | 69 | negative regulation of protein processing |
GO:0002700 | 0.0095 | 14.801 | 0.1474 | 2 | 70 | regulation of production of molecular mediator of immune response |
GO:0006954 | 0.0096 | 7.5704 | 0.4448 | 3 | 255 | inflammatory response |
GO:0034109 | 0.0098 | 14.5855 | 0.1495 | 2 | 71 | homotypic cell-cell adhesion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 21.6991 | 0.8475 | 12 | 368 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 17.875 | 1.018 | 12 | 442 | detection of chemical stimulus |
GO:0050906 | 0 | 17.539 | 1.0364 | 12 | 450 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 17.2949 | 1.0502 | 12 | 456 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 7.5245 | 2.5725 | 13 | 1117 | G-protein coupled receptor signaling pathway |
GO:0031424 | 0 | 44.3343 | 0.1105 | 4 | 48 | keratinization |
GO:0050877 | 0 | 6.2978 | 2.6992 | 12 | 1172 | neurological system process |
GO:1901687 | 0 | 59.1328 | 0.0622 | 3 | 27 | glutathione derivative biosynthetic process |
GO:0009913 | 0 | 15.3364 | 0.3869 | 5 | 168 | epidermal cell differentiation |
GO:0006749 | 1e-04 | 33.75 | 0.1036 | 3 | 45 | glutathione metabolic process |
GO:0006805 | 4e-04 | 13.0011 | 0.3524 | 4 | 153 | xenobiotic metabolic process |
GO:0009410 | 5e-04 | 12.4928 | 0.3662 | 4 | 159 | response to xenobiotic stimulus |
GO:0043588 | 9e-04 | 7.5142 | 0.7692 | 5 | 334 | skin development |
GO:0060429 | 0.0015 | 4.2692 | 2.2847 | 8 | 992 | epithelium development |
GO:0016269 | 0.0023 | Inf | 0.0023 | 1 | 1 | O-glycan processing, core 3 |
GO:0010043 | 0.0031 | 26.9661 | 0.0829 | 2 | 36 | response to zinc ion |
GO:0046686 | 0.0031 | 26.9661 | 0.0829 | 2 | 36 | response to cadmium ion |
GO:0032792 | 0.0046 | 445.9118 | 0.0046 | 1 | 2 | negative regulation of CREB transcription factor activity |
GO:0043603 | 0.0059 | 8.96 | 0.3685 | 3 | 160 | cellular amide metabolic process |
GO:0060350 | 0.0064 | 18.3176 | 0.1198 | 2 | 52 | endochondral bone morphogenesis |
GO:0035880 | 0.0069 | 222.9412 | 0.0069 | 1 | 3 | embryonic nail plate morphogenesis |
GO:0035993 | 0.0069 | 222.9412 | 0.0069 | 1 | 3 | deltoid tuberosity development |
GO:0043420 | 0.0069 | 222.9412 | 0.0069 | 1 | 3 | anthranilate metabolic process |
GO:0051795 | 0.0069 | 222.9412 | 0.0069 | 1 | 3 | positive regulation of catagen |
GO:2001055 | 0.0069 | 222.9412 | 0.0069 | 1 | 3 | positive regulation of mesenchymal cell apoptotic process |
GO:0051716 | 0.0087 | 2.3771 | 13.5583 | 21 | 5887 | cellular response to stimulus |
GO:0019805 | 0.0092 | 148.6176 | 0.0092 | 1 | 4 | quinolinate biosynthetic process |
GO:0034354 | 0.0092 | 148.6176 | 0.0092 | 1 | 4 | 'de novo' NAD biosynthetic process from tryptophan |
GO:0035990 | 0.0092 | 148.6176 | 0.0092 | 1 | 4 | tendon cell differentiation |
GO:0036018 | 0.0092 | 148.6176 | 0.0092 | 1 | 4 | cellular response to erythropoietin |
GO:0060364 | 0.0092 | 148.6176 | 0.0092 | 1 | 4 | frontal suture morphogenesis |
GO:0061056 | 0.0092 | 148.6176 | 0.0092 | 1 | 4 | sclerotome development |
GO:0070050 | 0.0092 | 148.6176 | 0.0092 | 1 | 4 | neuron cellular homeostasis |
GO:0090427 | 0.0092 | 148.6176 | 0.0092 | 1 | 4 | activation of meiosis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 18.4794 | 0.9444 | 12 | 368 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 15.2227 | 1.1343 | 12 | 442 | detection of chemical stimulus |
GO:0050906 | 0 | 14.9366 | 1.1548 | 12 | 450 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 14.7287 | 1.1702 | 12 | 456 | sensory perception of chemical stimulus |
GO:0007565 | 0 | 24.3441 | 0.4286 | 8 | 167 | female pregnancy |
GO:0007186 | 0 | 7.9719 | 2.8666 | 15 | 1117 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 6.0393 | 3.0077 | 13 | 1172 | neurological system process |
GO:0032501 | 0 | 4.8891 | 15.8469 | 30 | 6175 | multicellular organismal process |
GO:0045617 | 1e-04 | 163.8162 | 0.018 | 2 | 7 | negative regulation of keratinocyte differentiation |
GO:0045683 | 6e-04 | 68.2252 | 0.0359 | 2 | 14 | negative regulation of epidermis development |
GO:0023052 | 0.0022 | 2.6292 | 13.8092 | 23 | 5381 | signaling |
GO:0030857 | 0.0025 | 30.2923 | 0.0744 | 2 | 29 | negative regulation of epithelial cell differentiation |
GO:0051704 | 0.003 | 2.9875 | 5.0684 | 12 | 1975 | multi-organism process |
GO:0045604 | 0.004 | 23.356 | 0.095 | 2 | 37 | regulation of epidermal cell differentiation |
GO:0007165 | 0.0041 | 2.4661 | 12.5466 | 21 | 4889 | signal transduction |
GO:0046294 | 0.0051 | 398.8684 | 0.0051 | 1 | 2 | formaldehyde catabolic process |
GO:0002455 | 0.0057 | 19.4543 | 0.1129 | 2 | 44 | humoral immune response mediated by circulating immunoglobulin |
GO:0006953 | 0.0059 | 19.0006 | 0.1155 | 2 | 45 | acute-phase response |
GO:0022414 | 0.0063 | 3.2948 | 2.846 | 8 | 1109 | reproductive process |
GO:0010841 | 0.0077 | 199.4211 | 0.0077 | 1 | 3 | positive regulation of circadian sleep/wake cycle, wakefulness |
GO:0046005 | 0.0077 | 199.4211 | 0.0077 | 1 | 3 | positive regulation of circadian sleep/wake cycle, REM sleep |
GO:0050830 | 0.0078 | 16.333 | 0.1334 | 2 | 52 | defense response to Gram-positive bacterium |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015844 | 5e-04 | 8.5638 | 0.6475 | 5 | 60 | monoamine transport |
GO:0038170 | 0.0011 | 61.8519 | 0.054 | 2 | 5 | somatostatin signaling pathway |
GO:1900029 | 0.0011 | 61.8519 | 0.054 | 2 | 5 | positive regulation of ruffle assembly |
GO:0007187 | 0.0012 | 4.6426 | 1.6187 | 7 | 150 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0060406 | 0.0017 | 46.3858 | 0.0647 | 2 | 6 | positive regulation of penile erection |
GO:0001714 | 0.004 | 26.5009 | 0.0971 | 2 | 9 | endodermal cell fate specification |
GO:0002118 | 0.004 | 26.5009 | 0.0971 | 2 | 9 | aggressive behavior |
GO:0001820 | 0.0049 | 23.1867 | 0.1079 | 2 | 10 | serotonin secretion |
GO:0007283 | 0.0052 | 2.6167 | 4.4569 | 11 | 413 | spermatogenesis |
GO:0042220 | 0.0058 | 9.0174 | 0.3669 | 3 | 34 | response to cocaine |
GO:0042053 | 0.0084 | 16.8597 | 0.1403 | 2 | 13 | regulation of dopamine metabolic process |
GO:1901213 | 0.0084 | 16.8597 | 0.1403 | 2 | 13 | regulation of transcription from RNA polymerase II promoter involved in heart development |
GO:0019827 | 0.0085 | 4.2274 | 1.2518 | 5 | 116 | stem cell maintenance |
GO:0032729 | 0.0085 | 7.7624 | 0.4209 | 3 | 39 | positive regulation of interferon-gamma production |
GO:0032504 | 0.0087 | 2.1119 | 7.5433 | 15 | 699 | multicellular organism reproduction |
GO:0045071 | 0.0091 | 7.5521 | 0.4317 | 3 | 40 | negative regulation of viral genome replication |
GO:0015850 | 0.0093 | 3.53 | 1.7914 | 6 | 166 | organic hydroxy compound transport |
GO:0007320 | 0.0097 | 15.4537 | 0.1511 | 2 | 14 | insemination |
GO:0034123 | 0.0097 | 15.4537 | 0.1511 | 2 | 14 | positive regulation of toll-like receptor signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0018130 | 0 | 4.0059 | 59.4404 | 136 | 3687 | heterocycle biosynthetic process |
GO:0019438 | 0 | 4 | 59.5048 | 136 | 3691 | aromatic compound biosynthetic process |
GO:0044271 | 0 | 3.9942 | 60.3109 | 137 | 3741 | cellular nitrogen compound biosynthetic process |
GO:0045944 | 0 | 6.4283 | 13.3326 | 63 | 827 | positive regulation of transcription from RNA polymerase II promoter |
GO:1901362 | 0 | 3.8425 | 61.2782 | 136 | 3801 | organic cyclic compound biosynthetic process |
GO:0010628 | 0 | 5.0233 | 19.6039 | 72 | 1216 | positive regulation of gene expression |
GO:1902680 | 0 | 5.0106 | 18.6043 | 69 | 1154 | positive regulation of RNA biosynthetic process |
GO:0080090 | 0 | 3.493 | 83.0585 | 156 | 5152 | regulation of primary metabolic process |
GO:0045935 | 0 | 4.6321 | 21.4095 | 73 | 1328 | positive regulation of nucleobase-containing compound metabolic process |
GO:0009891 | 0 | 4.4633 | 22.8927 | 75 | 1420 | positive regulation of biosynthetic process |
GO:0034645 | 0 | 3.2903 | 67.6624 | 135 | 4197 | cellular macromolecule biosynthetic process |
GO:0006355 | 0 | 3.9698 | 30.6488 | 82 | 2216 | regulation of transcription, DNA-templated |
GO:0031326 | 0 | 3.9053 | 34.4171 | 87 | 2542 | regulation of cellular biosynthetic process |
GO:0090304 | 0 | 3.0898 | 71.5316 | 136 | 4437 | nucleic acid metabolic process |
GO:0051252 | 0 | 3.841 | 31.5515 | 82 | 2285 | regulation of RNA metabolic process |
GO:0010556 | 0 | 3.6941 | 33.4206 | 83 | 2452 | regulation of macromolecule biosynthetic process |
GO:0051171 | 0 | 3.4276 | 41.122 | 92 | 3000 | regulation of nitrogen compound metabolic process |
GO:0032502 | 0 | 3.1668 | 55.1948 | 109 | 3834 | developmental process |
GO:0065007 | 0 | 3.3626 | 157.8627 | 210 | 9792 | biological regulation |
GO:0048562 | 0 | 9.5407 | 2.8197 | 22 | 182 | embryonic organ morphogenesis |
GO:0043583 | 0 | 8.698 | 3.2082 | 23 | 199 | ear development |
GO:0051253 | 0 | 3.8869 | 14.9931 | 48 | 930 | negative regulation of RNA metabolic process |
GO:0051172 | 0 | 3.6955 | 16.831 | 51 | 1044 | negative regulation of nitrogen compound metabolic process |
GO:0031327 | 0 | 3.6681 | 16.9724 | 51 | 1064 | negative regulation of cellular biosynthetic process |
GO:0010558 | 0 | 3.6861 | 16.127 | 49 | 1011 | negative regulation of macromolecule biosynthetic process |
GO:0009790 | 0 | 4.0367 | 11.5072 | 39 | 754 | embryo development |
GO:0000122 | 0 | 4.3808 | 9.3989 | 35 | 583 | negative regulation of transcription from RNA polymerase II promoter |
GO:0007399 | 0 | 3.3305 | 18.0634 | 49 | 1268 | nervous system development |
GO:0021517 | 0 | 20.035 | 0.7416 | 11 | 46 | ventral spinal cord development |
GO:0032774 | 0 | 2.9892 | 26.9564 | 61 | 2151 | RNA biosynthetic process |
GO:0042472 | 0 | 10.6004 | 1.596 | 14 | 99 | inner ear morphogenesis |
GO:0030900 | 0 | 6.3941 | 3.629 | 20 | 238 | forebrain development |
GO:0048468 | 0 | 3.4656 | 12.1918 | 36 | 834 | cell development |
GO:0003151 | 0 | 12.9422 | 0.9512 | 10 | 59 | outflow tract morphogenesis |
GO:0048665 | 0 | 48.0676 | 0.2204 | 6 | 14 | neuron fate specification |
GO:0051093 | 0 | 3.4175 | 10.3017 | 31 | 639 | negative regulation of developmental process |
GO:0045666 | 0 | 10.4436 | 1.2575 | 11 | 78 | positive regulation of neuron differentiation |
GO:0060173 | 0 | 6.6138 | 2.5956 | 15 | 161 | limb development |
GO:0032095 | 0 | 41.682 | 0.2418 | 6 | 15 | regulation of response to food |
GO:0007423 | 0 | 5.2199 | 3.9029 | 18 | 267 | sensory organ development |
GO:0001501 | 0 | 3.9306 | 6.8678 | 24 | 426 | skeletal system development |
GO:0051239 | 0 | 2.4404 | 26.1258 | 54 | 1685 | regulation of multicellular organismal process |
GO:0021515 | 0 | 16.5862 | 0.6165 | 8 | 39 | cell differentiation in spinal cord |
GO:0030855 | 0 | 3.5215 | 8.6251 | 27 | 535 | epithelial cell differentiation |
GO:0045665 | 0 | 12.6331 | 0.8706 | 9 | 54 | negative regulation of neuron differentiation |
GO:0048523 | 0 | 2.0937 | 49.0181 | 83 | 3104 | negative regulation of cellular process |
GO:0050767 | 0 | 3.8796 | 6.646 | 23 | 419 | regulation of neurogenesis |
GO:0048663 | 0 | 20.25 | 0.4572 | 7 | 30 | neuron fate commitment |
GO:0048704 | 0 | 8.5246 | 1.4993 | 11 | 93 | embryonic skeletal system morphogenesis |
GO:0060537 | 0 | 4.2687 | 5.2395 | 20 | 325 | muscle tissue development |
GO:0008284 | 0 | 3.1011 | 10.8794 | 30 | 690 | positive regulation of cell proliferation |
GO:0048699 | 0 | 3.2875 | 9.2747 | 27 | 644 | generation of neurons |
GO:0048731 | 0 | 4.3643 | 5.0865 | 19 | 495 | system development |
GO:0001764 | 0 | 6.8817 | 1.9834 | 12 | 124 | neuron migration |
GO:0009952 | 0 | 6.8307 | 1.9938 | 12 | 130 | anterior/posterior pattern specification |
GO:0021520 | 0 | 38.9167 | 0.2096 | 5 | 13 | spinal cord motor neuron cell fate specification |
GO:0048935 | 0 | 38.9167 | 0.2096 | 5 | 13 | peripheral nervous system neuron development |
GO:0009953 | 0 | 7.1991 | 1.7411 | 11 | 108 | dorsal/ventral pattern formation |
GO:0048645 | 0 | 11.4369 | 0.8383 | 8 | 52 | organ formation |
GO:0050794 | 0 | 2.5011 | 40.739 | 65 | 3782 | regulation of cellular process |
GO:0045595 | 0 | 3.1508 | 9.2401 | 26 | 621 | regulation of cell differentiation |
GO:0007498 | 0 | 6.9121 | 1.8056 | 11 | 112 | mesoderm development |
GO:0007156 | 0 | 6.1587 | 2.1925 | 12 | 136 | homophilic cell adhesion |
GO:0001756 | 0 | 10.8369 | 0.8764 | 8 | 55 | somitogenesis |
GO:0021527 | 0 | 31.1292 | 0.2418 | 5 | 15 | spinal cord association neuron differentiation |
GO:0035107 | 0 | 5.918 | 2.2731 | 12 | 141 | appendage morphogenesis |
GO:0007379 | 0 | 28.2973 | 0.2579 | 5 | 16 | segment specification |
GO:0021530 | 0 | Inf | 0.0484 | 3 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:2000543 | 0 | 62.0249 | 0.129 | 4 | 8 | positive regulation of gastrulation |
GO:2000027 | 0 | 5.6107 | 2.386 | 12 | 148 | regulation of organ morphogenesis |
GO:0072080 | 0 | 11.8561 | 0.7094 | 7 | 44 | nephron tubule development |
GO:0007610 | 0 | 3.4434 | 6.3971 | 20 | 407 | behavior |
GO:0009954 | 0 | 15.6151 | 0.4836 | 6 | 30 | proximal/distal pattern formation |
GO:0048593 | 0 | 6.6549 | 1.6928 | 10 | 105 | camera-type eye morphogenesis |
GO:0007218 | 0 | 6.5851 | 1.7089 | 10 | 106 | neuropeptide signaling pathway |
GO:0072091 | 0 | 7.5646 | 1.3542 | 9 | 84 | regulation of stem cell proliferation |
GO:0001656 | 0 | 7.2722 | 1.4026 | 9 | 87 | metanephros development |
GO:0021879 | 0 | 21.2422 | 0.3152 | 5 | 20 | forebrain neuron differentiation |
GO:0007389 | 0 | 8.4247 | 1.0796 | 8 | 79 | pattern specification process |
GO:0032099 | 0 | 41.3444 | 0.1612 | 4 | 10 | negative regulation of appetite |
GO:0009887 | 0 | 3.89 | 4.5316 | 16 | 335 | organ morphogenesis |
GO:0036342 | 0 | 20.7458 | 0.3224 | 5 | 20 | post-anal tail morphogenesis |
GO:0048880 | 0 | 185.343 | 0.0645 | 3 | 4 | sensory system development |
GO:0061056 | 0 | 185.343 | 0.0645 | 3 | 4 | sclerotome development |
GO:0001662 | 0 | 19.6087 | 0.3359 | 5 | 21 | behavioral fear response |
GO:0030509 | 0 | 6.017 | 1.854 | 10 | 115 | BMP signaling pathway |
GO:0044707 | 0 | 1.9698 | 53.2871 | 79 | 4608 | single-multicellular organism process |
GO:0048729 | 0 | 3.1597 | 6.9246 | 20 | 440 | tissue morphogenesis |
GO:0003231 | 0 | 6.5921 | 1.5316 | 9 | 95 | cardiac ventricle development |
GO:0035137 | 0 | 12.0834 | 0.5965 | 6 | 37 | hindlimb morphogenesis |
GO:0042474 | 0 | 17.2847 | 0.3708 | 5 | 23 | middle ear morphogenesis |
GO:0051952 | 0 | 8.7659 | 0.9189 | 7 | 57 | regulation of amine transport |
GO:0048538 | 0 | 11.015 | 0.6449 | 6 | 40 | thymus development |
GO:0003278 | 0 | 92.6653 | 0.0806 | 3 | 5 | apoptotic process involved in heart morphogenesis |
GO:0021779 | 0 | 92.6653 | 0.0806 | 3 | 5 | oligodendrocyte cell fate commitment |
GO:0021780 | 0 | 92.6653 | 0.0806 | 3 | 5 | glial cell fate specification |
GO:0042755 | 1e-04 | 14.8125 | 0.4192 | 5 | 26 | eating behavior |
GO:0021983 | 1e-04 | 10.4017 | 0.6771 | 6 | 42 | pituitary gland development |
GO:0021953 | 1e-04 | 8.0878 | 0.9817 | 7 | 65 | central nervous system neuron differentiation |
GO:0021511 | 1e-04 | 14.1383 | 0.4353 | 5 | 27 | spinal cord patterning |
GO:0021884 | 1e-04 | 14.1383 | 0.4353 | 5 | 27 | forebrain neuron development |
GO:0033555 | 1e-04 | 7.8235 | 1.0157 | 7 | 63 | multicellular organismal response to stress |
GO:0048565 | 1e-04 | 6.4497 | 1.383 | 8 | 87 | digestive tract development |
GO:0015671 | 1e-04 | 22.5439 | 0.2418 | 4 | 15 | oxygen transport |
GO:0021542 | 1e-04 | 22.5439 | 0.2418 | 4 | 15 | dentate gyrus development |
GO:0048852 | 1e-04 | 61.7727 | 0.0967 | 3 | 6 | diencephalon morphogenesis |
GO:0060022 | 1e-04 | 61.7727 | 0.0967 | 3 | 6 | hard palate development |
GO:0008406 | 1e-04 | 4.1336 | 3.1598 | 12 | 196 | gonad development |
GO:0061458 | 1e-04 | 3.0244 | 6.4486 | 18 | 400 | reproductive system development |
GO:0032104 | 1e-04 | 9.359 | 0.7416 | 6 | 46 | regulation of response to extracellular stimulus |
GO:0035295 | 1e-04 | 3.1382 | 5.879 | 17 | 389 | tube development |
GO:0001709 | 1e-04 | 12.697 | 0.4742 | 5 | 30 | cell fate determination |
GO:0043009 | 1e-04 | 2.8163 | 7.7133 | 20 | 507 | chordate embryonic development |
GO:0001707 | 1e-04 | 7.3 | 1.0801 | 7 | 67 | mesoderm formation |
GO:0046887 | 1e-04 | 6.1212 | 1.4509 | 8 | 90 | positive regulation of hormone secretion |
GO:0060037 | 1e-04 | 20.6639 | 0.2579 | 4 | 16 | pharyngeal system development |
GO:0072088 | 1e-04 | 11.9599 | 0.4998 | 5 | 31 | nephron epithelium morphogenesis |
GO:0072006 | 1e-04 | 5.904 | 1.4993 | 8 | 93 | nephron development |
GO:0050877 | 1e-04 | 2.0949 | 18.8945 | 36 | 1172 | neurological system process |
GO:0021796 | 1e-04 | 46.3264 | 0.1129 | 3 | 7 | cerebral cortex regionalization |
GO:0021543 | 1e-04 | 11.475 | 0.5155 | 5 | 33 | pallium development |
GO:0009058 | 2e-04 | 1.8074 | 47.7377 | 70 | 3869 | biosynthetic process |
GO:0014032 | 2e-04 | 8.3163 | 0.8222 | 6 | 51 | neural crest cell development |
GO:0032108 | 2e-04 | 17.7095 | 0.2902 | 4 | 18 | negative regulation of response to nutrient levels |
GO:0048536 | 2e-04 | 10.7205 | 0.5481 | 5 | 34 | spleen development |
GO:0060429 | 2e-04 | 3.1719 | 5.1163 | 15 | 353 | epithelium development |
GO:0007422 | 2e-04 | 6.4377 | 1.2091 | 7 | 75 | peripheral nervous system development |
GO:0060041 | 2e-04 | 4.8354 | 2.0313 | 9 | 126 | retina development in camera-type eye |
GO:0021871 | 2e-04 | 16.6616 | 0.3039 | 4 | 19 | forebrain regionalization |
GO:0010467 | 2e-04 | 1.8059 | 41.9199 | 63 | 3388 | gene expression |
GO:0021854 | 2e-04 | 16.5278 | 0.3063 | 4 | 19 | hypothalamus development |
GO:0031175 | 2e-04 | 2.3196 | 12.1557 | 26 | 754 | neuron projection development |
GO:0003263 | 2e-04 | 37.0587 | 0.129 | 3 | 8 | cardioblast proliferation |
GO:0010667 | 2e-04 | 37.0587 | 0.129 | 3 | 8 | negative regulation of cardiac muscle cell apoptotic process |
GO:0031018 | 2e-04 | 7.795 | 0.8706 | 6 | 54 | endocrine pancreas development |
GO:0048870 | 2e-04 | 2.0996 | 17.1695 | 33 | 1065 | cell motility |
GO:0009855 | 2e-04 | 5.3932 | 1.6283 | 8 | 101 | determination of bilateral symmetry |
GO:0021761 | 2e-04 | 7.7575 | 0.8733 | 6 | 55 | limbic system development |
GO:0045168 | 2e-04 | 10.3625 | 0.5643 | 5 | 35 | cell-cell signaling involved in cell fate commitment |
GO:0023061 | 2e-04 | 2.9937 | 5.7554 | 16 | 357 | signal release |
GO:0000904 | 2e-04 | 2.303 | 12.2363 | 26 | 759 | cell morphogenesis involved in differentiation |
GO:0097154 | 3e-04 | Inf | 0.0319 | 2 | 2 | GABAergic neuron differentiation |
GO:0003002 | 3e-04 | 9.983 | 0.5748 | 5 | 41 | regionalization |
GO:0003326 | 3e-04 | Inf | 0.0322 | 2 | 2 | pancreatic A cell fate commitment |
GO:0003329 | 3e-04 | Inf | 0.0322 | 2 | 2 | pancreatic PP cell fate commitment |
GO:0043503 | 3e-04 | Inf | 0.0322 | 2 | 2 | skeletal muscle fiber adaptation |
GO:0048866 | 3e-04 | Inf | 0.0322 | 2 | 2 | stem cell fate specification |
GO:0072272 | 3e-04 | Inf | 0.0322 | 2 | 2 | proximal/distal pattern formation involved in metanephric nephron development |
GO:0043586 | 3e-04 | 15.4938 | 0.3224 | 4 | 20 | tongue development |
GO:0007517 | 3e-04 | 3.3982 | 4.1208 | 13 | 262 | muscle organ development |
GO:0007492 | 3e-04 | 6.0784 | 1.2736 | 7 | 79 | endoderm development |
GO:0035136 | 3e-04 | 9.7135 | 0.5965 | 5 | 37 | forelimb morphogenesis |
GO:0031960 | 3e-04 | 4.5235 | 2.1603 | 9 | 134 | response to corticosteroid |
GO:0003266 | 3e-04 | 30.8802 | 0.1451 | 3 | 9 | regulation of secondary heart field cardioblast proliferation |
GO:0008343 | 3e-04 | 30.8802 | 0.1451 | 3 | 9 | adult feeding behavior |
GO:0021892 | 3e-04 | 30.8802 | 0.1451 | 3 | 9 | cerebral cortex GABAergic interneuron differentiation |
GO:0048664 | 3e-04 | 30.8802 | 0.1451 | 3 | 9 | neuron fate determination |
GO:0061004 | 3e-04 | 30.8802 | 0.1451 | 3 | 9 | pattern specification involved in kidney development |
GO:0035914 | 3e-04 | 7.1934 | 0.9351 | 6 | 58 | skeletal muscle cell differentiation |
GO:0023019 | 4e-04 | 13.7704 | 0.3547 | 4 | 22 | signal transduction involved in regulation of gene expression |
GO:0021954 | 4e-04 | 9.0547 | 0.6328 | 5 | 40 | central nervous system neuron development |
GO:0051048 | 4e-04 | 4.3846 | 2.2232 | 9 | 139 | negative regulation of secretion |
GO:0001942 | 4e-04 | 5.6086 | 1.3703 | 7 | 85 | hair follicle development |
GO:0022404 | 4e-04 | 5.6086 | 1.3703 | 7 | 85 | molting cycle process |
GO:0060349 | 4e-04 | 5.6086 | 1.3703 | 7 | 85 | bone morphogenesis |
GO:0003211 | 5e-04 | 26.4669 | 0.1612 | 3 | 10 | cardiac ventricle formation |
GO:0032525 | 5e-04 | 26.4669 | 0.1612 | 3 | 10 | somite rostral/caudal axis specification |
GO:0048703 | 5e-04 | 26.4669 | 0.1612 | 3 | 10 | embryonic viscerocranium morphogenesis |
GO:0090009 | 5e-04 | 26.4669 | 0.1612 | 3 | 10 | primitive streak formation |
GO:0010656 | 5e-04 | 13.0448 | 0.3708 | 4 | 23 | negative regulation of muscle cell apoptotic process |
GO:0030111 | 5e-04 | 3.6138 | 3.2727 | 11 | 203 | regulation of Wnt signaling pathway |
GO:0045165 | 5e-04 | 5.3894 | 1.4147 | 7 | 100 | cell fate commitment |
GO:0061333 | 5e-04 | 12.3917 | 0.3869 | 4 | 24 | renal tubule morphogenesis |
GO:0007409 | 6e-04 | 2.4971 | 8.1575 | 19 | 506 | axonogenesis |
GO:0048864 | 6e-04 | 3.2966 | 3.9014 | 12 | 242 | stem cell development |
GO:0002520 | 6e-04 | 2.2277 | 11.5914 | 24 | 719 | immune system development |
GO:0048869 | 6e-04 | 2.0755 | 16.1515 | 30 | 1305 | cellular developmental process |
GO:0021521 | 6e-04 | 23.157 | 0.1773 | 3 | 11 | ventral spinal cord interneuron specification |
GO:0016331 | 6e-04 | 4.0938 | 2.3699 | 9 | 147 | morphogenesis of embryonic epithelium |
GO:0003016 | 6e-04 | 11.8008 | 0.403 | 4 | 25 | respiratory system process |
GO:0021533 | 6e-04 | 11.8008 | 0.403 | 4 | 25 | cell differentiation in hindbrain |
GO:0050885 | 7e-04 | 8.0301 | 0.7039 | 5 | 44 | neuromuscular process controlling balance |
GO:0048762 | 7e-04 | 4.0347 | 2.4021 | 9 | 149 | mesenchymal cell differentiation |
GO:0022037 | 7e-04 | 5.1443 | 1.4832 | 7 | 92 | metencephalon development |
GO:0072175 | 7e-04 | 4.4726 | 1.9346 | 8 | 120 | epithelial tube formation |
GO:0044058 | 7e-04 | 11.2637 | 0.4192 | 4 | 26 | regulation of digestive system process |
GO:0003358 | 8e-04 | 123.0535 | 0.0484 | 2 | 3 | noradrenergic neuron development |
GO:0010841 | 8e-04 | 123.0535 | 0.0484 | 2 | 3 | positive regulation of circadian sleep/wake cycle, wakefulness |
GO:0021550 | 8e-04 | 123.0535 | 0.0484 | 2 | 3 | medulla oblongata development |
GO:0021902 | 8e-04 | 123.0535 | 0.0484 | 2 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0032100 | 8e-04 | 123.0535 | 0.0484 | 2 | 3 | positive regulation of appetite |
GO:0035284 | 8e-04 | 123.0535 | 0.0484 | 2 | 3 | brain segmentation |
GO:0055014 | 8e-04 | 123.0535 | 0.0484 | 2 | 3 | atrial cardiac muscle cell development |
GO:0060166 | 8e-04 | 123.0535 | 0.0484 | 2 | 3 | olfactory pit development |
GO:0070093 | 8e-04 | 123.0535 | 0.0484 | 2 | 3 | negative regulation of glucagon secretion |
GO:0070253 | 8e-04 | 123.0535 | 0.0484 | 2 | 3 | somatostatin secretion |
GO:2000035 | 8e-04 | 123.0535 | 0.0484 | 2 | 3 | regulation of stem cell division |
GO:0090087 | 9e-04 | 3.5521 | 3.0147 | 10 | 187 | regulation of peptide transport |
GO:0035050 | 0.001 | 5.7497 | 1.1446 | 6 | 71 | embryonic heart tube development |
GO:0048485 | 0.001 | 18.6713 | 0.208 | 3 | 13 | sympathetic nervous system development |
GO:0032844 | 0.001 | 2.915 | 4.7559 | 13 | 295 | regulation of homeostatic process |
GO:0035150 | 0.001 | 4.2075 | 2.0474 | 8 | 127 | regulation of tube size |
GO:0010454 | 0.0011 | 18.5231 | 0.2096 | 3 | 13 | negative regulation of cell fate commitment |
GO:0042053 | 0.0011 | 18.5231 | 0.2096 | 3 | 13 | regulation of dopamine metabolic process |
GO:0010463 | 0.0011 | 7.0587 | 0.79 | 5 | 49 | mesenchymal cell proliferation |
GO:0060993 | 0.0011 | 7.0587 | 0.79 | 5 | 49 | kidney morphogenesis |
GO:0007267 | 0.0011 | 3.4487 | 3.1041 | 10 | 209 | cell-cell signaling |
GO:0007519 | 0.0012 | 4.7021 | 1.6103 | 7 | 102 | skeletal muscle tissue development |
GO:0007586 | 0.0012 | 4.1032 | 2.0958 | 8 | 130 | digestion |
GO:0048522 | 0.0012 | 1.7122 | 33.0447 | 50 | 2453 | positive regulation of cellular process |
GO:0045892 | 0.0013 | 2.9917 | 4.2822 | 12 | 298 | negative regulation of transcription, DNA-templated |
GO:1902742 | 0.0013 | 9.5282 | 0.4836 | 4 | 30 | apoptotic process involved in development |
GO:0072189 | 0.0013 | 16.8381 | 0.2257 | 3 | 14 | ureter development |
GO:0044237 | 0.0013 | 1.5275 | 150.1566 | 173 | 9314 | cellular metabolic process |
GO:0042633 | 0.0014 | 4.5515 | 1.6605 | 7 | 103 | hair cycle |
GO:0072073 | 0.0014 | 4.0039 | 2.1442 | 8 | 133 | kidney epithelium development |
GO:0032102 | 0.0014 | 3.617 | 2.6601 | 9 | 165 | negative regulation of response to external stimulus |
GO:0071385 | 0.0015 | 9.1747 | 0.4998 | 4 | 31 | cellular response to glucocorticoid stimulus |
GO:0060579 | 0.0015 | 62.2583 | 0.0637 | 2 | 4 | ventral spinal cord interneuron fate commitment |
GO:0003357 | 0.0015 | 62.029 | 0.064 | 2 | 4 | noradrenergic neuron differentiation |
GO:0035814 | 0.0015 | 61.5226 | 0.0645 | 2 | 4 | negative regulation of renal sodium excretion |
GO:0042662 | 0.0015 | 61.5226 | 0.0645 | 2 | 4 | negative regulation of mesodermal cell fate specification |
GO:0051461 | 0.0015 | 61.5226 | 0.0645 | 2 | 4 | positive regulation of corticotropin secretion |
GO:0060214 | 0.0015 | 61.5226 | 0.0645 | 2 | 4 | endocardium formation |
GO:0060913 | 0.0015 | 61.5226 | 0.0645 | 2 | 4 | cardiac cell fate determination |
GO:0072086 | 0.0015 | 61.5226 | 0.0645 | 2 | 4 | specification of loop of Henle identity |
GO:0097476 | 0.0015 | 61.5226 | 0.0645 | 2 | 4 | spinal cord motor neuron migration |
GO:1903365 | 0.0015 | 61.5226 | 0.0645 | 2 | 4 | regulation of fear response |
GO:2000987 | 0.0015 | 61.5226 | 0.0645 | 2 | 4 | positive regulation of behavioral fear response |
GO:0014003 | 0.0017 | 8.8465 | 0.5159 | 4 | 32 | oligodendrocyte development |
GO:0030801 | 0.0017 | 5.1169 | 1.2736 | 6 | 79 | positive regulation of cyclic nucleotide metabolic process |
GO:0003206 | 0.0018 | 6.2953 | 0.875 | 5 | 55 | cardiac chamber morphogenesis |
GO:0021545 | 0.0018 | 8.6089 | 0.5279 | 4 | 33 | cranial nerve development |
GO:0030814 | 0.0019 | 4.282 | 1.7573 | 7 | 109 | regulation of cAMP metabolic process |
GO:0021987 | 0.002 | 4.975 | 1.3064 | 6 | 82 | cerebral cortex development |
GO:0001967 | 0.002 | 14.2457 | 0.2579 | 3 | 16 | suckling behavior |
GO:0003215 | 0.002 | 14.2457 | 0.2579 | 3 | 16 | cardiac right ventricle morphogenesis |
GO:0010662 | 0.002 | 14.2457 | 0.2579 | 3 | 16 | regulation of striated muscle cell apoptotic process |
GO:0033630 | 0.002 | 14.2457 | 0.2579 | 3 | 16 | positive regulation of cell adhesion mediated by integrin |
GO:2000136 | 0.002 | 14.2457 | 0.2579 | 3 | 16 | regulation of cell proliferation involved in heart morphogenesis |
GO:0060485 | 0.002 | 8.3262 | 0.5422 | 4 | 35 | mesenchyme development |
GO:0051960 | 0.002 | 6.0811 | 0.8997 | 5 | 61 | regulation of nervous system development |
GO:0001738 | 0.0021 | 8.2556 | 0.5481 | 4 | 34 | morphogenesis of a polarized epithelium |
GO:0051050 | 0.0021 | 2.1638 | 9.8342 | 20 | 610 | positive regulation of transport |
GO:0060840 | 0.0022 | 5.9696 | 0.9189 | 5 | 57 | artery development |
GO:0061371 | 0.0022 | 5.9696 | 0.9189 | 5 | 57 | determination of heart left/right asymmetry |
GO:0048858 | 0.0022 | 2.039 | 12.0267 | 23 | 746 | cell projection morphogenesis |
GO:0003018 | 0.0022 | 3.7048 | 2.3054 | 8 | 143 | vascular process in circulatory system |
GO:0007420 | 0.0024 | 3.1082 | 3.4193 | 10 | 244 | brain development |
GO:0030802 | 0.0024 | 4.1193 | 1.8217 | 7 | 113 | regulation of cyclic nucleotide biosynthetic process |
GO:0010842 | 0.0024 | 13.2273 | 0.2741 | 3 | 17 | retina layer formation |
GO:0009880 | 0.0024 | 5.8565 | 0.9351 | 5 | 58 | embryonic pattern specification |
GO:0014062 | 0.0025 | 41.0123 | 0.0806 | 2 | 5 | regulation of serotonin secretion |
GO:0021853 | 0.0025 | 41.0123 | 0.0806 | 2 | 5 | cerebral cortex GABAergic interneuron migration |
GO:0035881 | 0.0025 | 41.0123 | 0.0806 | 2 | 5 | amacrine cell differentiation |
GO:0045198 | 0.0025 | 41.0123 | 0.0806 | 2 | 5 | establishment of epithelial cell apical/basal polarity |
GO:0060023 | 0.0025 | 41.0123 | 0.0806 | 2 | 5 | soft palate development |
GO:0060040 | 0.0025 | 41.0123 | 0.0806 | 2 | 5 | retinal bipolar neuron differentiation |
GO:0072143 | 0.0025 | 41.0123 | 0.0806 | 2 | 5 | mesangial cell development |
GO:0072172 | 0.0025 | 41.0123 | 0.0806 | 2 | 5 | mesonephric tubule formation |
GO:0097070 | 0.0025 | 41.0123 | 0.0806 | 2 | 5 | ductus arteriosus closure |
GO:0043069 | 0.0025 | 2.0863 | 10.7047 | 21 | 664 | negative regulation of programmed cell death |
GO:0045761 | 0.0026 | 5.7477 | 0.9512 | 5 | 59 | regulation of adenylate cyclase activity |
GO:0060415 | 0.0026 | 5.7477 | 0.9512 | 5 | 59 | muscle tissue morphogenesis |
GO:0045777 | 0.0026 | 7.7386 | 0.5804 | 4 | 36 | positive regulation of blood pressure |
GO:0030324 | 0.0026 | 3.2964 | 2.9019 | 9 | 180 | lung development |
GO:0043010 | 0.0026 | 5.7041 | 0.9558 | 5 | 62 | camera-type eye development |
GO:0019228 | 0.0027 | 4.6669 | 1.3865 | 6 | 86 | neuronal action potential |
GO:0048863 | 0.0027 | 7.6372 | 0.5852 | 4 | 38 | stem cell differentiation |
GO:1900371 | 0.0027 | 4.0051 | 1.8701 | 7 | 116 | regulation of purine nucleotide biosynthetic process |
GO:0015844 | 0.0028 | 5.6428 | 0.9673 | 5 | 60 | monoamine transport |
GO:0042733 | 0.0028 | 5.6428 | 0.9673 | 5 | 60 | embryonic digit morphogenesis |
GO:0007626 | 0.0028 | 3.2578 | 2.9341 | 9 | 182 | locomotory behavior |
GO:0030878 | 0.0028 | 12.3446 | 0.2902 | 3 | 18 | thyroid gland development |
GO:0042693 | 0.0028 | 12.3446 | 0.2902 | 3 | 18 | muscle cell fate commitment |
GO:0032989 | 0.0028 | 1.81 | 18.3625 | 31 | 1139 | cellular component morphogenesis |
GO:0045995 | 0.0029 | 4.5891 | 1.4079 | 6 | 88 | regulation of embryonic development |
GO:0032755 | 0.0029 | 7.5036 | 0.5965 | 4 | 37 | positive regulation of interleukin-6 production |
GO:0048566 | 0.0029 | 7.5036 | 0.5965 | 4 | 37 | embryonic digestive tract development |
GO:0018958 | 0.003 | 4.5525 | 1.4187 | 6 | 88 | phenol-containing compound metabolic process |
GO:0030326 | 0.003 | 5.5394 | 0.983 | 5 | 62 | embryonic limb morphogenesis |
GO:0042311 | 0.003 | 5.5417 | 0.9834 | 5 | 61 | vasodilation |
GO:0043588 | 0.0031 | 2.554 | 5.3846 | 13 | 334 | skin development |
GO:0090090 | 0.0031 | 4.4974 | 1.4348 | 6 | 89 | negative regulation of canonical Wnt signaling pathway |
GO:0055010 | 0.0032 | 7.2824 | 0.6126 | 4 | 38 | ventricular cardiac muscle tissue morphogenesis |
GO:0009914 | 0.0032 | 2.7984 | 4.1599 | 11 | 260 | hormone transport |
GO:0030819 | 0.0032 | 5.4441 | 0.9995 | 5 | 62 | positive regulation of cAMP biosynthetic process |
GO:0007188 | 0.0033 | 3.8623 | 1.9346 | 7 | 120 | adenylate cyclase-modulating G-protein coupled receptor signaling pathway |
GO:0001710 | 0.0033 | 11.5723 | 0.3063 | 3 | 19 | mesodermal cell fate commitment |
GO:0002052 | 0.0033 | 11.5723 | 0.3063 | 3 | 19 | positive regulation of neuroblast proliferation |
GO:0051412 | 0.0033 | 11.5723 | 0.3063 | 3 | 19 | response to corticosterone |
GO:0010623 | 0.0035 | 7.0739 | 0.6287 | 4 | 39 | developmental programmed cell death |
GO:0045776 | 0.0035 | 7.0739 | 0.6287 | 4 | 39 | negative regulation of blood pressure |
GO:0048644 | 0.0036 | 31.2899 | 0.0951 | 2 | 6 | muscle organ morphogenesis |
GO:0002088 | 0.0037 | 5.2588 | 1.0318 | 5 | 64 | lens development in camera-type eye |
GO:0072359 | 0.0037 | 1.9211 | 13.2842 | 24 | 824 | circulatory system development |
GO:0021797 | 0.0037 | 30.7572 | 0.0967 | 2 | 6 | forebrain anterior/posterior pattern specification |
GO:0021937 | 0.0037 | 30.7572 | 0.0967 | 2 | 6 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation |
GO:0042320 | 0.0037 | 30.7572 | 0.0967 | 2 | 6 | regulation of circadian sleep/wake cycle, REM sleep |
GO:0043416 | 0.0037 | 30.7572 | 0.0967 | 2 | 6 | regulation of skeletal muscle tissue regeneration |
GO:0060235 | 0.0037 | 30.7572 | 0.0967 | 2 | 6 | lens induction in camera-type eye |
GO:0060956 | 0.0037 | 30.7572 | 0.0967 | 2 | 6 | endocardial cell differentiation |
GO:0072141 | 0.0037 | 30.7572 | 0.0967 | 2 | 6 | renal interstitial fibroblast development |
GO:2000179 | 0.0037 | 11.0158 | 0.3189 | 3 | 20 | positive regulation of neural precursor cell proliferation |
GO:0035637 | 0.0038 | 3.3764 | 2.515 | 8 | 156 | multicellular organismal signaling |
GO:0051924 | 0.0038 | 3.3764 | 2.515 | 8 | 156 | regulation of calcium ion transport |
GO:0055078 | 0.0038 | 6.8769 | 0.6449 | 4 | 40 | sodium ion homeostasis |
GO:0033057 | 0.0039 | 10.8909 | 0.3224 | 3 | 20 | multicellular organismal reproductive behavior |
GO:0007166 | 0.0039 | 1.5021 | 49.3805 | 67 | 3063 | cell surface receptor signaling pathway |
GO:0002793 | 0.0042 | 5.0857 | 1.064 | 5 | 66 | positive regulation of peptide secretion |
GO:0014013 | 0.0042 | 5.0857 | 1.064 | 5 | 66 | regulation of gliogenesis |
GO:0050866 | 0.0043 | 3.6661 | 2.0313 | 7 | 126 | negative regulation of cell activation |
GO:1900544 | 0.0043 | 4.1925 | 1.5316 | 6 | 95 | positive regulation of purine nucleotide metabolic process |
GO:0007369 | 0.0044 | 3.2984 | 2.5704 | 8 | 162 | gastrulation |
GO:0001759 | 0.0044 | 10.2851 | 0.3386 | 3 | 21 | organ induction |
GO:0007617 | 0.0044 | 10.2851 | 0.3386 | 3 | 21 | mating behavior |
GO:0031290 | 0.0044 | 10.2851 | 0.3386 | 3 | 21 | retinal ganglion cell axon guidance |
GO:0044062 | 0.0044 | 10.2851 | 0.3386 | 3 | 21 | regulation of excretion |
GO:0071773 | 0.0044 | 10.2851 | 0.3386 | 3 | 21 | cellular response to BMP stimulus |
GO:0072132 | 0.0044 | 10.2851 | 0.3386 | 3 | 21 | mesenchyme morphogenesis |
GO:0045638 | 0.0045 | 5.0034 | 1.0801 | 5 | 67 | negative regulation of myeloid cell differentiation |
GO:0060562 | 0.0047 | 6.4577 | 0.6808 | 4 | 44 | epithelial tube morphogenesis |
GO:0050796 | 0.005 | 3.2224 | 2.6278 | 8 | 163 | regulation of insulin secretion |
GO:0021510 | 0.005 | 9.7454 | 0.3527 | 3 | 23 | spinal cord development |
GO:0010002 | 0.0051 | 9.7431 | 0.3547 | 3 | 22 | cardioblast differentiation |
GO:0010579 | 0.0052 | 24.6041 | 0.1129 | 2 | 7 | positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway |
GO:0014060 | 0.0052 | 24.6041 | 0.1129 | 2 | 7 | regulation of epinephrine secretion |
GO:0021843 | 0.0052 | 24.6041 | 0.1129 | 2 | 7 | substrate-independent telencephalic tangential interneuron migration |
GO:0032277 | 0.0052 | 24.6041 | 0.1129 | 2 | 7 | negative regulation of gonadotropin secretion |
GO:0034259 | 0.0052 | 24.6041 | 0.1129 | 2 | 7 | negative regulation of Rho GTPase activity |
GO:0051957 | 0.0052 | 24.6041 | 0.1129 | 2 | 7 | positive regulation of amino acid transport |
GO:0061549 | 0.0052 | 24.6041 | 0.1129 | 2 | 7 | sympathetic ganglion development |
GO:2000252 | 0.0052 | 24.6041 | 0.1129 | 2 | 7 | negative regulation of feeding behavior |
GO:0048754 | 0.0052 | 3.2016 | 2.6439 | 8 | 164 | branching morphogenesis of an epithelial tube |
GO:0003006 | 0.0052 | 2.0686 | 9.1893 | 18 | 570 | developmental process involved in reproduction |
GO:0051241 | 0.0053 | 2.3857 | 5.7419 | 13 | 359 | negative regulation of multicellular organismal process |
GO:0045597 | 0.0053 | 2.1653 | 7.8005 | 16 | 504 | positive regulation of cell differentiation |
GO:0061005 | 0.0054 | 6.1876 | 0.7094 | 4 | 44 | cell differentiation involved in kidney development |
GO:0052652 | 0.0056 | 3.4887 | 2.1281 | 7 | 132 | cyclic purine nucleotide metabolic process |
GO:0009719 | 0.0057 | 1.69 | 20.8614 | 33 | 1294 | response to endogenous stimulus |
GO:0001570 | 0.0057 | 4.6989 | 1.1446 | 5 | 71 | vasculogenesis |
GO:0006584 | 0.0059 | 6.0362 | 0.7255 | 4 | 45 | catecholamine metabolic process |
GO:0072001 | 0.0059 | 2.7091 | 3.8891 | 10 | 244 | renal system development |
GO:0045667 | 0.0061 | 3.8849 | 1.6444 | 6 | 102 | regulation of osteoblast differentiation |
GO:0001763 | 0.0063 | 2.8563 | 3.3211 | 9 | 206 | morphogenesis of a branching structure |
GO:0030810 | 0.0064 | 4.56 | 1.1769 | 5 | 73 | positive regulation of nucleotide biosynthetic process |
GO:0051101 | 0.0064 | 4.56 | 1.1769 | 5 | 73 | regulation of DNA binding |
GO:0046661 | 0.0068 | 3.3534 | 2.2087 | 7 | 137 | male sex differentiation |
GO:0021546 | 0.0068 | 20.5021 | 0.129 | 2 | 8 | rhombomere development |
GO:0021559 | 0.0068 | 20.5021 | 0.129 | 2 | 8 | trigeminal nerve development |
GO:0040019 | 0.0068 | 20.5021 | 0.129 | 2 | 8 | positive regulation of embryonic development |
GO:0045650 | 0.0068 | 20.5021 | 0.129 | 2 | 8 | negative regulation of macrophage differentiation |
GO:0048793 | 0.0068 | 20.5021 | 0.129 | 2 | 8 | pronephros development |
GO:0050957 | 0.0068 | 20.5021 | 0.129 | 2 | 8 | equilibrioception |
GO:0051969 | 0.0068 | 20.5021 | 0.129 | 2 | 8 | regulation of transmission of nerve impulse |
GO:0060253 | 0.0068 | 20.5021 | 0.129 | 2 | 8 | negative regulation of glial cell proliferation |
GO:0072177 | 0.0068 | 20.5021 | 0.129 | 2 | 8 | mesonephric duct development |
GO:0072178 | 0.0068 | 20.5021 | 0.129 | 2 | 8 | nephric duct morphogenesis |
GO:2000679 | 0.0068 | 20.5021 | 0.129 | 2 | 8 | positive regulation of transcription regulatory region DNA binding |
GO:0040008 | 0.0069 | 2.0489 | 8.7379 | 17 | 542 | regulation of growth |
GO:0035270 | 0.007 | 8.5265 | 0.3962 | 3 | 26 | endocrine system development |
GO:0001944 | 0.0071 | 2.0449 | 8.754 | 17 | 543 | vasculature development |
GO:0007155 | 0.0071 | 1.7505 | 16.3634 | 27 | 1015 | cell adhesion |
GO:0048511 | 0.0073 | 2.6196 | 4.0143 | 10 | 249 | rhythmic process |
GO:0060021 | 0.0073 | 4.42 | 1.211 | 5 | 76 | palate development |
GO:0048583 | 0.0073 | 1.4642 | 47.1073 | 63 | 2922 | regulation of response to stimulus |
GO:0001963 | 0.0073 | 8.4128 | 0.403 | 3 | 25 | synaptic transmission, dopaminergic |
GO:0008045 | 0.0073 | 8.4128 | 0.403 | 3 | 25 | motor neuron axon guidance |
GO:0010226 | 0.0073 | 8.4128 | 0.403 | 3 | 25 | response to lithium ion |
GO:0046660 | 0.0074 | 3.7285 | 1.7089 | 6 | 106 | female sex differentiation |
GO:0042886 | 0.0075 | 2.6085 | 4.0304 | 10 | 250 | amide transport |
GO:0060541 | 0.0076 | 8.2616 | 0.4086 | 3 | 26 | respiratory system development |
GO:0014070 | 0.0077 | 1.9097 | 11.0433 | 20 | 685 | response to organic cyclic compound |
GO:0060411 | 0.0079 | 5.4982 | 0.79 | 4 | 49 | cardiac septum morphogenesis |
GO:1901700 | 0.0082 | 1.6826 | 18.9429 | 30 | 1175 | response to oxygen-containing compound |
GO:0042036 | 0.0082 | 8.0465 | 0.4192 | 3 | 26 | negative regulation of cytokine biosynthetic process |
GO:0045687 | 0.0082 | 8.0465 | 0.4192 | 3 | 26 | positive regulation of glial cell differentiation |
GO:0007268 | 0.0083 | 1.8948 | 11.1239 | 20 | 690 | synaptic transmission |
GO:0008015 | 0.0085 | 2.2394 | 6.094 | 13 | 378 | blood circulation |
GO:0060560 | 0.0085 | 3.2042 | 2.3054 | 7 | 143 | developmental growth involved in morphogenesis |
GO:0072079 | 0.0085 | 17.7143 | 0.144 | 2 | 9 | nephron tubule formation |
GO:0001714 | 0.0086 | 17.572 | 0.1451 | 2 | 9 | endodermal cell fate specification |
GO:0003334 | 0.0086 | 17.572 | 0.1451 | 2 | 9 | keratinocyte development |
GO:0048241 | 0.0086 | 17.572 | 0.1451 | 2 | 9 | epinephrine transport |
GO:0051584 | 0.0086 | 17.572 | 0.1451 | 2 | 9 | regulation of dopamine uptake involved in synaptic transmission |
GO:0051956 | 0.0086 | 17.572 | 0.1451 | 2 | 9 | negative regulation of amino acid transport |
GO:0061162 | 0.0086 | 17.572 | 0.1451 | 2 | 9 | establishment of monopolar cell polarity |
GO:0097285 | 0.0087 | 2.2331 | 6.1101 | 13 | 379 | cell-type specific apoptotic process |
GO:0001503 | 0.0091 | 2.3034 | 5.4652 | 12 | 339 | ossification |
GO:0021846 | 0.0091 | 7.7107 | 0.4353 | 3 | 27 | cell proliferation in forebrain |
GO:0001541 | 0.0091 | 5.2635 | 0.8222 | 4 | 51 | ovarian follicle development |
GO:0022029 | 0.0091 | 5.2635 | 0.8222 | 4 | 51 | telencephalon cell migration |
GO:2000177 | 0.0095 | 7.5732 | 0.4415 | 3 | 28 | regulation of neural precursor cell proliferation |
GO:0042476 | 0.0096 | 3.5161 | 1.8056 | 6 | 112 | odontogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0001709 | 0 | 18.3309 | 0.3197 | 5 | 43 | cell fate determination |
GO:0048729 | 0 | 4.1248 | 3.8219 | 14 | 514 | tissue morphogenesis |
GO:0045995 | 1e-04 | 9.3421 | 0.7138 | 6 | 96 | regulation of embryonic development |
GO:0023056 | 1e-04 | 2.8626 | 7.9859 | 20 | 1074 | positive regulation of signaling |
GO:0010647 | 1e-04 | 2.8481 | 8.0231 | 20 | 1079 | positive regulation of cell communication |
GO:0032760 | 1e-04 | 17.8195 | 0.2602 | 4 | 35 | positive regulation of tumor necrosis factor production |
GO:0090177 | 2e-04 | 34.2545 | 0.1115 | 3 | 15 | establishment of planar polarity involved in neural tube closure |
GO:0045599 | 2e-04 | 16.2439 | 0.2826 | 4 | 38 | negative regulation of fat cell differentiation |
GO:0003215 | 2e-04 | 31.6175 | 0.119 | 3 | 16 | cardiac right ventricle morphogenesis |
GO:0030178 | 3e-04 | 7.4292 | 0.8848 | 6 | 119 | negative regulation of Wnt signaling pathway |
GO:0048589 | 3e-04 | 4.643 | 2.1192 | 9 | 285 | developmental growth |
GO:0060596 | 3e-04 | 135.8739 | 0.0297 | 2 | 4 | mammary placode formation |
GO:0023061 | 3e-04 | 4.1233 | 2.6545 | 10 | 357 | signal release |
GO:0003205 | 3e-04 | 7.0518 | 0.9295 | 6 | 125 | cardiac chamber development |
GO:0080134 | 4e-04 | 2.781 | 6.8408 | 17 | 920 | regulation of response to stress |
GO:0048864 | 4e-04 | 4.8352 | 1.7994 | 8 | 242 | stem cell development |
GO:0042127 | 5e-04 | 3.4573 | 3.8484 | 12 | 551 | regulation of cell proliferation |
GO:0071773 | 5e-04 | 22.8273 | 0.1561 | 3 | 21 | cellular response to BMP stimulus |
GO:0003402 | 5e-04 | 90.5766 | 0.0372 | 2 | 5 | planar cell polarity pathway involved in axis elongation |
GO:0014032 | 6e-04 | 11.7408 | 0.3792 | 4 | 51 | neural crest cell development |
GO:0042886 | 6e-04 | 4.6728 | 1.8589 | 8 | 250 | amide transport |
GO:0061138 | 6e-04 | 5.2324 | 1.45 | 7 | 195 | morphogenesis of a branching epithelium |
GO:0051960 | 7e-04 | 3.2373 | 4.0599 | 12 | 546 | regulation of nervous system development |
GO:1901214 | 8e-04 | 5.0686 | 1.4946 | 7 | 201 | regulation of neuron death |
GO:0032415 | 8e-04 | 67.9279 | 0.0446 | 2 | 6 | regulation of sodium:proton antiporter activity |
GO:0032725 | 8e-04 | 67.9279 | 0.0446 | 2 | 6 | positive regulation of granulocyte macrophage colony-stimulating factor production |
GO:0003179 | 8e-04 | 18.6719 | 0.1859 | 3 | 25 | heart valve morphogenesis |
GO:0007164 | 8e-04 | 18.6719 | 0.1859 | 3 | 25 | establishment of tissue polarity |
GO:0032965 | 8e-04 | 18.6719 | 0.1859 | 3 | 25 | regulation of collagen biosynthetic process |
GO:0009914 | 9e-04 | 4.3271 | 2.0002 | 8 | 269 | hormone transport |
GO:0043370 | 9e-04 | 17.8589 | 0.1933 | 3 | 26 | regulation of CD4-positive, alpha-beta T cell differentiation |
GO:0051051 | 9e-04 | 3.8932 | 2.5058 | 9 | 337 | negative regulation of transport |
GO:0042517 | 0.001 | 17.1136 | 0.2008 | 3 | 27 | positive regulation of tyrosine phosphorylation of Stat3 protein |
GO:0007166 | 0.0011 | 1.94 | 22.7755 | 37 | 3063 | cell surface receptor signaling pathway |
GO:0060527 | 0.0011 | 54.3387 | 0.052 | 2 | 7 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis |
GO:0071481 | 0.0011 | 54.3387 | 0.052 | 2 | 7 | cellular response to X-ray |
GO:0072540 | 0.0011 | 54.3387 | 0.052 | 2 | 7 | T-helper 17 cell lineage commitment |
GO:0090175 | 0.0011 | 16.428 | 0.2082 | 3 | 28 | regulation of establishment of planar polarity |
GO:0048584 | 0.0012 | 2.3603 | 9.5514 | 20 | 1323 | positive regulation of response to stimulus |
GO:0007389 | 0.0012 | 3.4574 | 3.1379 | 10 | 422 | pattern specification process |
GO:0090277 | 0.0012 | 9.3454 | 0.4684 | 4 | 63 | positive regulation of peptide hormone secretion |
GO:0009611 | 0.0013 | 2.5843 | 6.8483 | 16 | 921 | response to wounding |
GO:0051240 | 0.0013 | 3.0253 | 4.3276 | 12 | 582 | positive regulation of multicellular organismal process |
GO:0043154 | 0.0014 | 9.0378 | 0.4833 | 4 | 65 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
GO:2000543 | 0.0015 | 45.2793 | 0.0595 | 2 | 8 | positive regulation of gastrulation |
GO:1902533 | 0.0016 | 2.9445 | 4.4471 | 12 | 612 | positive regulation of intracellular signal transduction |
GO:0051172 | 0.0018 | 2.4238 | 7.7628 | 17 | 1044 | negative regulation of nitrogen compound metabolic process |
GO:0051094 | 0.0018 | 2.6673 | 5.7586 | 14 | 788 | positive regulation of developmental process |
GO:0060457 | 0.0019 | 38.8082 | 0.0669 | 2 | 9 | negative regulation of digestive system process |
GO:0060341 | 0.002 | 2.5441 | 6.4765 | 15 | 871 | regulation of cellular localization |
GO:0050727 | 0.002 | 4.2461 | 1.7697 | 7 | 238 | regulation of inflammatory response |
GO:0001738 | 0.002 | 13.2431 | 0.2528 | 3 | 34 | morphogenesis of a polarized epithelium |
GO:0060411 | 0.0021 | 13.0556 | 0.2559 | 3 | 35 | cardiac septum morphogenesis |
GO:0044092 | 0.0021 | 2.5222 | 6.5285 | 15 | 878 | negative regulation of molecular function |
GO:0002294 | 0.0022 | 12.8284 | 0.2602 | 3 | 35 | CD4-positive, alpha-beta T cell differentiation involved in immune response |
GO:0043549 | 0.0022 | 2.7037 | 5.2422 | 13 | 705 | regulation of kinase activity |
GO:0040008 | 0.0023 | 2.9556 | 4.0301 | 11 | 542 | regulation of growth |
GO:0043373 | 0.0024 | 33.955 | 0.0744 | 2 | 10 | CD4-positive, alpha-beta T cell lineage commitment |
GO:0045721 | 0.0024 | 33.955 | 0.0744 | 2 | 10 | negative regulation of gluconeogenesis |
GO:0035567 | 0.0024 | 12.4388 | 0.2677 | 3 | 36 | non-canonical Wnt signaling pathway |
GO:0009605 | 0.0024 | 2.036 | 13.9196 | 25 | 1872 | response to external stimulus |
GO:0002011 | 0.0026 | 12.0722 | 0.2751 | 3 | 37 | morphogenesis of an epithelial sheet |
GO:0002287 | 0.0026 | 12.0722 | 0.2751 | 3 | 37 | alpha-beta T cell activation involved in immune response |
GO:0032755 | 0.0026 | 12.0722 | 0.2751 | 3 | 37 | positive regulation of interleukin-6 production |
GO:0071706 | 0.0027 | 7.4436 | 0.58 | 4 | 78 | tumor necrosis factor superfamily cytokine production |
GO:0032501 | 0.0027 | 1.7211 | 45.9153 | 61 | 6175 | multicellular organismal process |
GO:0044246 | 0.0028 | 11.7265 | 0.2826 | 3 | 38 | regulation of multicellular organismal metabolic process |
GO:0045058 | 0.0028 | 11.7265 | 0.2826 | 3 | 38 | T cell selection |
GO:0060379 | 0.0029 | 30.1802 | 0.0818 | 2 | 11 | cardiac muscle cell myoblast differentiation |
GO:0072176 | 0.0029 | 30.1802 | 0.0818 | 2 | 11 | nephric duct development |
GO:0002292 | 0.003 | 11.4 | 0.29 | 3 | 39 | T cell differentiation involved in immune response |
GO:0048771 | 0.003 | 5.4524 | 0.9815 | 5 | 132 | tissue remodeling |
GO:0007517 | 0.0031 | 3.5265 | 2.4315 | 8 | 327 | muscle organ development |
GO:0035239 | 0.0031 | 3.5265 | 2.4315 | 8 | 327 | tube morphogenesis |
GO:0072001 | 0.0031 | 3.9025 | 1.9184 | 7 | 258 | renal system development |
GO:0072358 | 0.0032 | 2.492 | 6.127 | 14 | 824 | cardiovascular system development |
GO:0031667 | 0.0032 | 3.4929 | 2.4538 | 8 | 330 | response to nutrient levels |
GO:0043392 | 0.0032 | 11.0912 | 0.2974 | 3 | 40 | negative regulation of DNA binding |
GO:0051047 | 0.0034 | 3.8403 | 1.9481 | 7 | 262 | positive regulation of secretion |
GO:0060525 | 0.0034 | 27.1604 | 0.0892 | 2 | 12 | prostate glandular acinus development |
GO:0072538 | 0.0034 | 27.1604 | 0.0892 | 2 | 12 | T-helper 17 type immune response |
GO:0043066 | 0.0034 | 2.6684 | 4.8704 | 12 | 655 | negative regulation of apoptotic process |
GO:0046824 | 0.0035 | 6.8826 | 0.6246 | 4 | 84 | positive regulation of nucleocytoplasmic transport |
GO:0051253 | 0.0037 | 2.3702 | 6.9152 | 15 | 930 | negative regulation of RNA metabolic process |
GO:0060021 | 0.0037 | 6.7971 | 0.632 | 4 | 85 | palate development |
GO:0043583 | 0.0037 | 4.3265 | 1.4797 | 6 | 199 | ear development |
GO:0021983 | 0.0037 | 10.521 | 0.3123 | 3 | 42 | pituitary gland development |
GO:0009952 | 0.0038 | 4.3039 | 1.4871 | 6 | 200 | anterior/posterior pattern specification |
GO:0048585 | 0.0039 | 2.2864 | 7.6662 | 16 | 1031 | negative regulation of response to stimulus |
GO:0045064 | 0.0041 | 24.6896 | 0.0967 | 2 | 13 | T-helper 2 cell differentiation |
GO:0071697 | 0.0041 | 24.6896 | 0.0967 | 2 | 13 | ectodermal placode morphogenesis |
GO:0072182 | 0.0041 | 24.6896 | 0.0967 | 2 | 13 | regulation of nephron tubule epithelial cell differentiation |
GO:0010558 | 0.0042 | 2.272 | 7.7108 | 16 | 1037 | negative regulation of macromolecule biosynthetic process |
GO:0010951 | 0.0042 | 4.2158 | 1.5169 | 6 | 204 | negative regulation of endopeptidase activity |
GO:0048705 | 0.0042 | 4.2158 | 1.5169 | 6 | 204 | skeletal system morphogenesis |
GO:0072080 | 0.0042 | 10.0064 | 0.3272 | 3 | 44 | nephron tubule development |
GO:0003281 | 0.0045 | 9.7675 | 0.3346 | 3 | 45 | ventricular septum development |
GO:0021510 | 0.0045 | 6.3998 | 0.6692 | 4 | 90 | spinal cord development |
GO:0048545 | 0.0046 | 3.2842 | 2.6025 | 8 | 350 | response to steroid hormone |
GO:0048646 | 0.0047 | 2.3057 | 7.0936 | 15 | 954 | anatomical structure formation involved in morphogenesis |
GO:0060828 | 0.0047 | 4.9064 | 1.0856 | 5 | 146 | regulation of canonical Wnt signaling pathway |
GO:0003148 | 0.0047 | 22.6306 | 0.1041 | 2 | 14 | outflow tract septum morphogenesis |
GO:0001568 | 0.005 | 2.8086 | 3.8219 | 10 | 514 | blood vessel development |
GO:0051098 | 0.005 | 4.0499 | 1.5764 | 6 | 212 | regulation of binding |
GO:0072006 | 0.0051 | 6.1829 | 0.6915 | 4 | 93 | nephron development |
GO:0048762 | 0.0051 | 4.8032 | 1.1079 | 5 | 149 | mesenchymal cell differentiation |
GO:0031327 | 0.0052 | 2.218 | 7.8936 | 16 | 1080 | negative regulation of cellular biosynthetic process |
GO:0048731 | 0.0053 | 1.8736 | 17.3704 | 28 | 2535 | system development |
GO:0002360 | 0.0054 | 20.8884 | 0.1115 | 2 | 15 | T cell lineage commitment |
GO:0045187 | 0.0054 | 20.8884 | 0.1115 | 2 | 15 | regulation of circadian sleep/wake cycle, sleep |
GO:0060911 | 0.0054 | 20.8884 | 0.1115 | 2 | 15 | cardiac cell fate commitment |
GO:0090179 | 0.0054 | 20.8884 | 0.1115 | 2 | 15 | planar cell polarity pathway involved in neural tube closure |
GO:0035019 | 0.0054 | 9.1145 | 0.3569 | 3 | 48 | somatic stem cell maintenance |
GO:0045892 | 0.0057 | 2.3189 | 6.5508 | 14 | 881 | negative regulation of transcription, DNA-templated |
GO:0032091 | 0.0058 | 8.9158 | 0.3643 | 3 | 49 | negative regulation of protein binding |
GO:0060993 | 0.0058 | 8.9158 | 0.3643 | 3 | 49 | kidney morphogenesis |
GO:0065008 | 0.0061 | 1.7563 | 21.5783 | 33 | 2902 | regulation of biological quality |
GO:0035710 | 0.0061 | 8.7255 | 0.3718 | 3 | 50 | CD4-positive, alpha-beta T cell activation |
GO:0010939 | 0.0061 | 19.3951 | 0.119 | 2 | 16 | regulation of necrotic cell death |
GO:0030540 | 0.0061 | 19.3951 | 0.119 | 2 | 16 | female genitalia development |
GO:0060037 | 0.0061 | 19.3951 | 0.119 | 2 | 16 | pharyngeal system development |
GO:0051222 | 0.0061 | 3.878 | 1.6433 | 6 | 221 | positive regulation of protein transport |
GO:0060548 | 0.0062 | 2.4635 | 5.2496 | 12 | 706 | negative regulation of cell death |
GO:0030154 | 0.0063 | 1.7311 | 23.348 | 35 | 3140 | cell differentiation |
GO:0030307 | 0.0063 | 5.7901 | 0.7361 | 4 | 99 | positive regulation of cell growth |
GO:0042472 | 0.0063 | 5.7901 | 0.7361 | 4 | 99 | inner ear morphogenesis |
GO:0048520 | 0.0063 | 5.7901 | 0.7361 | 4 | 99 | positive regulation of behavior |
GO:0002250 | 0.0066 | 3.8239 | 1.6656 | 6 | 224 | adaptive immune response |
GO:0002790 | 0.0067 | 3.8062 | 1.673 | 6 | 225 | peptide secretion |
GO:0060113 | 0.0068 | 8.3683 | 0.3867 | 3 | 52 | inner ear receptor cell differentiation |
GO:0007519 | 0.0069 | 4.4591 | 1.1897 | 5 | 160 | skeletal muscle tissue development |
GO:0003203 | 0.0069 | 18.1009 | 0.1264 | 2 | 17 | endocardial cushion morphogenesis |
GO:0021514 | 0.0069 | 18.1009 | 0.1264 | 2 | 17 | ventral spinal cord interneuron differentiation |
GO:0060026 | 0.0069 | 18.1009 | 0.1264 | 2 | 17 | convergent extension |
GO:0060122 | 0.0069 | 18.1009 | 0.1264 | 2 | 17 | inner ear receptor stereocilium organization |
GO:0072337 | 0.0069 | 18.1009 | 0.1264 | 2 | 17 | modified amino acid transport |
GO:0023057 | 0.0071 | 2.2553 | 6.7219 | 14 | 904 | negative regulation of signaling |
GO:0010830 | 0.0072 | 8.2004 | 0.3941 | 3 | 53 | regulation of myotube differentiation |
GO:0042509 | 0.0072 | 8.2004 | 0.3941 | 3 | 53 | regulation of tyrosine phosphorylation of STAT protein |
GO:0010648 | 0.0072 | 2.2499 | 6.7367 | 14 | 906 | negative regulation of cell communication |
GO:0002443 | 0.0073 | 3.7369 | 1.7028 | 6 | 229 | leukocyte mediated immunity |
GO:0045471 | 0.0073 | 5.5546 | 0.7659 | 4 | 103 | response to ethanol |
GO:0060284 | 0.0074 | 2.5117 | 4.6993 | 11 | 632 | regulation of cell development |
GO:0002121 | 0.0074 | Inf | 0.0074 | 1 | 1 | inter-male aggressive behavior |
GO:0003167 | 0.0074 | Inf | 0.0074 | 1 | 1 | atrioventricular bundle cell differentiation |
GO:0019358 | 0.0074 | Inf | 0.0074 | 1 | 1 | nicotinate nucleotide salvage |
GO:0032788 | 0.0074 | Inf | 0.0074 | 1 | 1 | saturated monocarboxylic acid metabolic process |
GO:0032789 | 0.0074 | Inf | 0.0074 | 1 | 1 | unsaturated monocarboxylic acid metabolic process |
GO:0035847 | 0.0074 | Inf | 0.0074 | 1 | 1 | uterine epithelium development |
GO:0035849 | 0.0074 | Inf | 0.0074 | 1 | 1 | nephric duct elongation |
GO:0035852 | 0.0074 | Inf | 0.0074 | 1 | 1 | horizontal cell localization |
GO:0035854 | 0.0074 | Inf | 0.0074 | 1 | 1 | eosinophil fate commitment |
GO:0035898 | 0.0074 | Inf | 0.0074 | 1 | 1 | parathyroid hormone secretion |
GO:0044345 | 0.0074 | Inf | 0.0074 | 1 | 1 | stromal-epithelial cell signaling involved in prostate gland development |
GO:0046497 | 0.0074 | Inf | 0.0074 | 1 | 1 | nicotinate nucleotide metabolic process |
GO:0061444 | 0.0074 | Inf | 0.0074 | 1 | 1 | endocardial cushion cell development |
GO:0061518 | 0.0074 | Inf | 0.0074 | 1 | 1 | microglial cell proliferation |
GO:0071228 | 0.0074 | Inf | 0.0074 | 1 | 1 | cellular response to tumor cell |
GO:0090246 | 0.0074 | Inf | 0.0074 | 1 | 1 | convergent extension involved in somitogenesis |
GO:0097291 | 0.0074 | Inf | 0.0074 | 1 | 1 | renal phosphate ion absorption |
GO:1901208 | 0.0074 | Inf | 0.0074 | 1 | 1 | negative regulation of heart looping |
GO:1901211 | 0.0074 | Inf | 0.0074 | 1 | 1 | negative regulation of cardiac chamber formation |
GO:1901740 | 0.0074 | Inf | 0.0074 | 1 | 1 | negative regulation of myoblast fusion |
GO:1902847 | 0.0074 | Inf | 0.0074 | 1 | 1 | regulation of neuronal signal transduction |
GO:1902949 | 0.0074 | Inf | 0.0074 | 1 | 1 | positive regulation of tau-protein kinase activity |
GO:1902957 | 0.0074 | Inf | 0.0074 | 1 | 1 | negative regulation of mitochondrial electron transport, NADH to ubiquinone |
GO:2000080 | 0.0074 | Inf | 0.0074 | 1 | 1 | negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation |
GO:2000607 | 0.0074 | Inf | 0.0074 | 1 | 1 | negative regulation of cell proliferation involved in mesonephros development |
GO:2000703 | 0.0074 | Inf | 0.0074 | 1 | 1 | negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation |
GO:2000734 | 0.0074 | Inf | 0.0074 | 1 | 1 | negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation |
GO:0030856 | 0.0075 | 5.4987 | 0.7733 | 4 | 104 | regulation of epithelial cell differentiation |
GO:0048546 | 0.0075 | 8.039 | 0.4015 | 3 | 54 | digestive tract morphogenesis |
GO:0060443 | 0.0075 | 8.039 | 0.4015 | 3 | 54 | mammary gland morphogenesis |
GO:0009950 | 0.0078 | 16.9685 | 0.1338 | 2 | 18 | dorsal/ventral axis specification |
GO:0042693 | 0.0078 | 16.9685 | 0.1338 | 2 | 18 | muscle cell fate commitment |
GO:0045577 | 0.0078 | 16.9685 | 0.1338 | 2 | 18 | regulation of B cell differentiation |
GO:0030278 | 0.0078 | 4.3183 | 1.2269 | 5 | 165 | regulation of ossification |
GO:0046888 | 0.0079 | 7.8839 | 0.409 | 3 | 55 | negative regulation of hormone secretion |
GO:0071695 | 0.0079 | 7.8839 | 0.409 | 3 | 55 | anatomical structure maturation |
GO:0008284 | 0.008 | 2.3807 | 5.4206 | 12 | 729 | positive regulation of cell proliferation |
GO:0045664 | 0.008 | 2.9722 | 2.8627 | 8 | 385 | regulation of neuron differentiation |
GO:0001932 | 0.0085 | 2.2052 | 6.8631 | 14 | 923 | regulation of protein phosphorylation |
GO:0022410 | 0.0086 | 15.9693 | 0.1413 | 2 | 19 | circadian sleep/wake cycle process |
GO:0033688 | 0.0086 | 15.9693 | 0.1413 | 2 | 19 | regulation of osteoblast proliferation |
GO:0060216 | 0.0086 | 15.9693 | 0.1413 | 2 | 19 | definitive hemopoiesis |
GO:0045669 | 0.0088 | 7.5909 | 0.4238 | 3 | 57 | positive regulation of osteoblast differentiation |
GO:0061371 | 0.0088 | 7.5909 | 0.4238 | 3 | 57 | determination of heart left/right asymmetry |
GO:0051896 | 0.0089 | 5.2351 | 0.8105 | 4 | 109 | regulation of protein kinase B signaling |
GO:1902107 | 0.0089 | 5.2351 | 0.8105 | 4 | 109 | positive regulation of leukocyte differentiation |
GO:0043009 | 0.0089 | 2.5654 | 4.1677 | 10 | 570 | chordate embryonic development |
GO:0046634 | 0.0092 | 7.4524 | 0.4313 | 3 | 58 | regulation of alpha-beta T cell activation |
GO:0045765 | 0.0092 | 4.1353 | 1.2789 | 5 | 172 | regulation of angiogenesis |
GO:0071900 | 0.0094 | 2.8858 | 2.9445 | 8 | 396 | regulation of protein serine/threonine kinase activity |
GO:0003143 | 0.0096 | 7.3188 | 0.4387 | 3 | 59 | embryonic heart tube morphogenesis |
GO:0045582 | 0.0096 | 7.3188 | 0.4387 | 3 | 59 | positive regulation of T cell differentiation |
GO:0046427 | 0.0096 | 7.3188 | 0.4387 | 3 | 59 | positive regulation of JAK-STAT cascade |
GO:0048568 | 0.0098 | 2.8631 | 2.9668 | 8 | 399 | embryonic organ development |
GO:0043067 | 0.0099 | 2.0106 | 9.2054 | 17 | 1238 | regulation of programmed cell death |
GO:0022612 | 0.0099 | 7.239 | 0.4431 | 3 | 61 | gland morphogenesis |
GO:0061458 | 0.01 | 2.8556 | 2.9743 | 8 | 400 | reproductive system development |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0051606 | 0 | 13.7808 | 1.6835 | 15 | 624 | detection of stimulus |
GO:0050911 | 0 | 17.2026 | 0.9928 | 12 | 368 | detection of chemical stimulus involved in sensory perception of smell |
GO:0007600 | 0 | 9.9833 | 2.2743 | 15 | 843 | sensory perception |
GO:0007186 | 0 | 8.17 | 3.0136 | 16 | 1117 | G-protein coupled receptor signaling pathway |
GO:0031424 | 0 | 48.8146 | 0.1295 | 5 | 48 | keratinization |
GO:0003008 | 0 | 5.5808 | 4.6512 | 17 | 1724 | system process |
GO:0032501 | 0 | 3.9993 | 16.6595 | 30 | 6175 | multicellular organismal process |
GO:0050907 | 1e-04 | 47.3205 | 0.0763 | 3 | 39 | detection of chemical stimulus involved in sensory perception |
GO:0001580 | 1e-04 | 42.6541 | 0.0836 | 3 | 31 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0009913 | 1e-04 | 12.7752 | 0.4532 | 5 | 168 | epidermal cell differentiation |
GO:0043588 | 3e-04 | 7.7498 | 0.9011 | 6 | 334 | skin development |
GO:0050909 | 5e-04 | 22.0789 | 0.1538 | 3 | 57 | sensory perception of taste |
GO:0010939 | 8e-04 | 55.4652 | 0.0432 | 2 | 16 | regulation of necrotic cell death |
GO:0042221 | 9e-04 | 2.8901 | 9.4588 | 19 | 3506 | response to chemical |
GO:0043403 | 0.0017 | 36.9597 | 0.0621 | 2 | 23 | skeletal muscle tissue regeneration |
GO:0002121 | 0.0027 | Inf | 0.0027 | 1 | 1 | inter-male aggressive behavior |
GO:0019358 | 0.0027 | Inf | 0.0027 | 1 | 1 | nicotinate nucleotide salvage |
GO:0046497 | 0.0027 | Inf | 0.0027 | 1 | 1 | nicotinate nucleotide metabolic process |
GO:1901208 | 0.0027 | Inf | 0.0027 | 1 | 1 | negative regulation of heart looping |
GO:1901211 | 0.0027 | Inf | 0.0027 | 1 | 1 | negative regulation of cardiac chamber formation |
GO:1901740 | 0.0027 | Inf | 0.0027 | 1 | 1 | negative regulation of myoblast fusion |
GO:1902957 | 0.0027 | Inf | 0.0027 | 1 | 1 | negative regulation of mitochondrial electron transport, NADH to ubiquinone |
GO:0018149 | 0.0028 | 28.735 | 0.0782 | 2 | 29 | peptide cross-linking |
GO:0060429 | 0.0044 | 3.4915 | 2.6763 | 8 | 992 | epithelium development |
GO:0006769 | 0.0054 | 378.875 | 0.0054 | 1 | 2 | nicotinamide metabolic process |
GO:0007521 | 0.0054 | 378.875 | 0.0054 | 1 | 2 | muscle cell fate determination |
GO:0008615 | 0.0054 | 378.875 | 0.0054 | 1 | 2 | pyridoxine biosynthetic process |
GO:0035483 | 0.0054 | 378.875 | 0.0054 | 1 | 2 | gastric emptying |
GO:0042823 | 0.0054 | 378.875 | 0.0054 | 1 | 2 | pyridoxal phosphate biosynthetic process |
GO:0060465 | 0.0054 | 378.875 | 0.0054 | 1 | 2 | pharynx development |
GO:0097341 | 0.0054 | 378.875 | 0.0054 | 1 | 2 | zymogen inhibition |
GO:1901219 | 0.0054 | 378.875 | 0.0054 | 1 | 2 | regulation of cardiac chamber morphogenesis |
GO:1902530 | 0.0054 | 378.875 | 0.0054 | 1 | 2 | positive regulation of protein linear polyubiquitination |
GO:1990001 | 0.0054 | 378.875 | 0.0054 | 1 | 2 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process |
GO:2000381 | 0.0054 | 378.875 | 0.0054 | 1 | 2 | negative regulation of mesoderm development |
GO:0014855 | 0.0063 | 18.4542 | 0.1187 | 2 | 44 | striated muscle cell proliferation |
GO:0048589 | 0.0071 | 5.7228 | 0.7689 | 4 | 285 | developmental growth |
GO:0010482 | 0.0081 | 189.425 | 0.0081 | 1 | 3 | regulation of epidermal cell division |
GO:0014717 | 0.0081 | 189.425 | 0.0081 | 1 | 3 | regulation of satellite cell activation involved in skeletal muscle regeneration |
GO:0031064 | 0.0081 | 189.425 | 0.0081 | 1 | 3 | negative regulation of histone deacetylation |
GO:0035582 | 0.0081 | 189.425 | 0.0081 | 1 | 3 | sequestering of BMP in extracellular matrix |
GO:0007165 | 0.0087 | 2.2191 | 13.19 | 21 | 4889 | signal transduction |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0007389 | 0 | 5.1641 | 5.637 | 25 | 422 | pattern specification process |
GO:0009790 | 0 | 3.2206 | 12.6366 | 35 | 946 | embryo development |
GO:0009891 | 0 | 2.5776 | 18.9682 | 42 | 1420 | positive regulation of biosynthetic process |
GO:0045935 | 0 | 2.6114 | 17.7393 | 40 | 1328 | positive regulation of nucleobase-containing compound metabolic process |
GO:0032502 | 0 | 2.0026 | 65.8544 | 99 | 4930 | developmental process |
GO:0043009 | 0 | 3.2752 | 7.8277 | 23 | 586 | chordate embryonic development |
GO:0045165 | 0 | 4.8187 | 3.2193 | 14 | 241 | cell fate commitment |
GO:0001501 | 0 | 3.7009 | 5.6905 | 19 | 426 | skeletal system development |
GO:0032501 | 0 | 1.8879 | 82.485 | 114 | 6175 | multicellular organismal process |
GO:0045944 | 0 | 2.8426 | 11.047 | 28 | 827 | positive regulation of transcription from RNA polymerase II promoter |
GO:0009952 | 0 | 4.948 | 2.6716 | 12 | 200 | anterior/posterior pattern specification |
GO:0010604 | 1e-04 | 1.9553 | 28.0249 | 48 | 2098 | positive regulation of macromolecule metabolic process |
GO:0060349 | 1e-04 | 6.8297 | 1.1354 | 7 | 85 | bone morphogenesis |
GO:0060932 | 2e-04 | Inf | 0.0267 | 2 | 2 | His-Purkinje system cell differentiation |
GO:0097168 | 2e-04 | Inf | 0.0267 | 2 | 2 | mesenchymal stem cell proliferation |
GO:0035282 | 2e-04 | 6.4948 | 1.1889 | 7 | 89 | segmentation |
GO:0021517 | 4e-04 | 9.2098 | 0.6145 | 5 | 46 | ventral spinal cord development |
GO:0007517 | 5e-04 | 3.1988 | 4.368 | 13 | 327 | muscle organ development |
GO:0001958 | 5e-04 | 12.5377 | 0.374 | 4 | 28 | endochondral ossification |
GO:0009967 | 5e-04 | 2.1654 | 13.6117 | 27 | 1019 | positive regulation of signal transduction |
GO:0003285 | 5e-04 | 149.1841 | 0.0401 | 2 | 3 | septum secundum development |
GO:0061146 | 5e-04 | 149.1841 | 0.0401 | 2 | 3 | Peyer's patch morphogenesis |
GO:0001836 | 6e-04 | 8.0308 | 0.6946 | 5 | 52 | release of cytochrome c from mitochondria |
GO:2000026 | 7e-04 | 2.037 | 16.1366 | 30 | 1228 | regulation of multicellular organismal development |
GO:0048518 | 7e-04 | 1.6945 | 43.4978 | 63 | 3455 | positive regulation of biological process |
GO:0048665 | 7e-04 | 11.1424 | 0.4141 | 4 | 31 | neuron fate specification |
GO:0021515 | 8e-04 | 7.702 | 0.7213 | 5 | 54 | cell differentiation in spinal cord |
GO:0030509 | 9e-04 | 4.9226 | 1.5362 | 7 | 115 | BMP signaling pathway |
GO:2001141 | 9e-04 | 1.6664 | 41.8637 | 61 | 3134 | regulation of RNA biosynthetic process |
GO:0048562 | 0.001 | 4.2593 | 2.0175 | 8 | 156 | embryonic organ morphogenesis |
GO:0002125 | 0.001 | 74.5871 | 0.0534 | 2 | 4 | maternal aggressive behavior |
GO:0003166 | 0.001 | 74.5871 | 0.0534 | 2 | 4 | bundle of His development |
GO:0021913 | 0.001 | 74.5871 | 0.0534 | 2 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0061056 | 0.001 | 74.5871 | 0.0534 | 2 | 4 | sclerotome development |
GO:0007267 | 0.0011 | 2.013 | 15.1211 | 28 | 1132 | cell-cell signaling |
GO:0035295 | 0.0013 | 2.4582 | 7.4097 | 17 | 560 | tube development |
GO:2000112 | 0.0014 | 1.6184 | 45.2165 | 64 | 3385 | regulation of cellular macromolecule biosynthetic process |
GO:0051091 | 0.0016 | 3.5577 | 2.6983 | 9 | 202 | positive regulation of sequence-specific DNA binding transcription factor activity |
GO:0009950 | 0.0017 | 14.979 | 0.2404 | 3 | 18 | dorsal/ventral axis specification |
GO:0051240 | 0.0017 | 2.3852 | 7.6214 | 17 | 576 | positive regulation of multicellular organismal process |
GO:0051891 | 0.0017 | 49.7214 | 0.0668 | 2 | 5 | positive regulation of cardioblast differentiation |
GO:0060926 | 0.0017 | 49.7214 | 0.0668 | 2 | 5 | cardiac pacemaker cell development |
GO:2000179 | 0.0018 | 8.591 | 0.521 | 4 | 39 | positive regulation of neural precursor cell proliferation |
GO:0060541 | 0.0018 | 3.4846 | 2.7517 | 9 | 206 | respiratory system development |
GO:0035270 | 0.0019 | 4.2828 | 1.7499 | 7 | 131 | endocrine system development |
GO:0031076 | 0.0019 | 8.3518 | 0.5343 | 4 | 40 | embryonic camera-type eye development |
GO:0048513 | 0.0019 | 1.7977 | 22.9116 | 37 | 1901 | organ development |
GO:0007423 | 0.0021 | 2.4819 | 6.4385 | 15 | 482 | sensory organ development |
GO:0007417 | 0.0021 | 2.1286 | 10.5795 | 21 | 792 | central nervous system development |
GO:0030858 | 0.0023 | 7.9111 | 0.561 | 4 | 42 | positive regulation of epithelial cell differentiation |
GO:0048332 | 0.0024 | 5.7999 | 0.9351 | 5 | 70 | mesoderm morphogenesis |
GO:0002067 | 0.0025 | 7.7078 | 0.5744 | 4 | 43 | glandular epithelial cell differentiation |
GO:0021523 | 0.0026 | 37.2886 | 0.0801 | 2 | 6 | somatic motor neuron differentiation |
GO:0032808 | 0.0026 | 37.2886 | 0.0801 | 2 | 6 | lacrimal gland development |
GO:0035502 | 0.0026 | 37.2886 | 0.0801 | 2 | 6 | metanephric part of ureteric bud development |
GO:0060406 | 0.0026 | 37.2886 | 0.0801 | 2 | 6 | positive regulation of penile erection |
GO:0007617 | 0.0026 | 12.48 | 0.2805 | 3 | 21 | mating behavior |
GO:0051954 | 0.0026 | 12.48 | 0.2805 | 3 | 21 | positive regulation of amine transport |
GO:0072378 | 0.0026 | 12.48 | 0.2805 | 3 | 21 | blood coagulation, fibrin clot formation |
GO:0031324 | 0.003 | 1.7691 | 20.9051 | 34 | 1565 | negative regulation of cellular metabolic process |
GO:0023019 | 0.003 | 11.8224 | 0.2939 | 3 | 22 | signal transduction involved in regulation of gene expression |
GO:0009890 | 0.0034 | 1.8944 | 14.7605 | 26 | 1105 | negative regulation of biosynthetic process |
GO:0060485 | 0.0035 | 3.4302 | 2.474 | 8 | 187 | mesenchyme development |
GO:0007620 | 0.0039 | 10.695 | 0.3206 | 3 | 24 | copulation |
GO:0045666 | 0.0039 | 5.1615 | 1.0419 | 5 | 78 | positive regulation of neuron differentiation |
GO:0060993 | 0.0041 | 6.6774 | 0.6545 | 4 | 49 | kidney morphogenesis |
GO:0045596 | 0.0041 | 2.2986 | 6.9194 | 15 | 518 | negative regulation of cell differentiation |
GO:0001704 | 0.0043 | 4.198 | 1.5228 | 6 | 114 | formation of primary germ layer |
GO:0034654 | 0.0047 | 1.5145 | 48.3823 | 65 | 3622 | nucleobase-containing compound biosynthetic process |
GO:0042538 | 0.0047 | 24.8557 | 0.1069 | 2 | 8 | hyperosmotic salinity response |
GO:0045924 | 0.0047 | 24.8557 | 0.1069 | 2 | 8 | regulation of female receptivity |
GO:0051969 | 0.0047 | 24.8557 | 0.1069 | 2 | 8 | regulation of transmission of nerve impulse |
GO:0060923 | 0.0047 | 24.8557 | 0.1069 | 2 | 8 | cardiac muscle cell fate commitment |
GO:2000543 | 0.0047 | 24.8557 | 0.1069 | 2 | 8 | positive regulation of gastrulation |
GO:0008284 | 0.0049 | 2.1385 | 8.4451 | 17 | 648 | positive regulation of cell proliferation |
GO:0042036 | 0.0049 | 9.7637 | 0.3473 | 3 | 26 | negative regulation of cytokine biosynthetic process |
GO:0060070 | 0.005 | 3.2137 | 2.6315 | 8 | 197 | canonical Wnt signaling pathway |
GO:0002062 | 0.0053 | 4.7676 | 1.1221 | 5 | 84 | chondrocyte differentiation |
GO:1902692 | 0.0054 | 9.3562 | 0.3607 | 3 | 27 | regulation of neuroblast proliferation |
GO:0061035 | 0.0054 | 6.1307 | 0.708 | 4 | 53 | regulation of cartilage development |
GO:0042129 | 0.0055 | 3.9754 | 1.6029 | 6 | 120 | regulation of T cell proliferation |
GO:0060021 | 0.0056 | 4.7077 | 1.1354 | 5 | 85 | palate development |
GO:0044699 | 0.0057 | 1.6907 | 162.8061 | 177 | 12188 | single-organism process |
GO:0007519 | 0.0057 | 3.4643 | 2.1373 | 7 | 160 | skeletal muscle tissue development |
GO:0048729 | 0.0057 | 2.3638 | 5.8116 | 13 | 444 | tissue morphogenesis |
GO:0001947 | 0.0058 | 6.0076 | 0.7213 | 4 | 54 | heart looping |
GO:0048546 | 0.0058 | 6.0076 | 0.7213 | 4 | 54 | digestive tract morphogenesis |
GO:0055006 | 0.0058 | 6.0076 | 0.7213 | 4 | 54 | cardiac cell development |
GO:0060173 | 0.0059 | 3.4416 | 2.1506 | 7 | 161 | limb development |
GO:0002634 | 0.006 | 21.3035 | 0.1202 | 2 | 9 | regulation of germinal center formation |
GO:0003334 | 0.006 | 21.3035 | 0.1202 | 2 | 9 | keratinocyte development |
GO:0030431 | 0.006 | 8.9814 | 0.374 | 3 | 28 | sleep |
GO:0060412 | 0.006 | 8.9814 | 0.374 | 3 | 28 | ventricular septum morphogenesis |
GO:0048511 | 0.0064 | 2.8519 | 3.3261 | 9 | 249 | rhythmic process |
GO:0043410 | 0.0066 | 2.5224 | 4.5951 | 11 | 344 | positive regulation of MAPK cascade |
GO:0019098 | 0.0066 | 8.6354 | 0.3874 | 3 | 29 | reproductive behavior |
GO:0035116 | 0.0066 | 8.6354 | 0.3874 | 3 | 29 | embryonic hindlimb morphogenesis |
GO:0046326 | 0.0066 | 8.6354 | 0.3874 | 3 | 29 | positive regulation of glucose import |
GO:0060487 | 0.0066 | 8.6354 | 0.3874 | 3 | 29 | lung epithelial cell differentiation |
GO:0009953 | 0.0067 | 4.4929 | 1.1858 | 5 | 90 | dorsal/ventral pattern formation |
GO:0009888 | 0.0069 | 1.8828 | 12.5101 | 22 | 1010 | tissue development |
GO:0060322 | 0.007 | 5.6664 | 0.7614 | 4 | 57 | head development |
GO:0050865 | 0.0071 | 2.3904 | 5.2897 | 12 | 396 | regulation of cell activation |
GO:0045597 | 0.0074 | 2.2885 | 5.9946 | 13 | 466 | positive regulation of cell differentiation |
GO:0006335 | 0.0074 | 18.6393 | 0.1336 | 2 | 10 | DNA replication-dependent nucleosome assembly |
GO:0032525 | 0.0074 | 18.6393 | 0.1336 | 2 | 10 | somite rostral/caudal axis specification |
GO:0045721 | 0.0074 | 18.6393 | 0.1336 | 2 | 10 | negative regulation of gluconeogenesis |
GO:0070472 | 0.0074 | 18.6393 | 0.1336 | 2 | 10 | regulation of uterine smooth muscle contraction |
GO:0046330 | 0.0075 | 5.5611 | 0.7748 | 4 | 58 | positive regulation of JNK cascade |
GO:0048545 | 0.0075 | 2.4767 | 4.6753 | 11 | 350 | response to steroid hormone |
GO:0007368 | 0.0078 | 4.3269 | 1.2289 | 5 | 92 | determination of left/right symmetry |
GO:0022037 | 0.0078 | 4.3269 | 1.2289 | 5 | 92 | metencephalon development |
GO:2000736 | 0.0078 | 4.3269 | 1.2289 | 5 | 92 | regulation of stem cell differentiation |
GO:0003151 | 0.0079 | 5.4597 | 0.7881 | 4 | 59 | outflow tract morphogenesis |
GO:0072088 | 0.008 | 8.0175 | 0.4141 | 3 | 31 | nephron epithelium morphogenesis |
GO:0048704 | 0.0081 | 4.2774 | 1.2423 | 5 | 93 | embryonic skeletal system morphogenesis |
GO:0030855 | 0.0084 | 2.2481 | 6.0936 | 13 | 468 | epithelial cell differentiation |
GO:0045893 | 0.0086 | 2.7142 | 3.4951 | 9 | 287 | positive regulation of transcription, DNA-templated |
GO:0048048 | 0.0088 | 7.7405 | 0.4275 | 3 | 32 | embryonic eye morphogenesis |
GO:0042711 | 0.009 | 16.5672 | 0.1469 | 2 | 11 | maternal behavior |
GO:0048617 | 0.009 | 16.5672 | 0.1469 | 2 | 11 | embryonic foregut morphogenesis |
GO:0060573 | 0.009 | 16.5672 | 0.1469 | 2 | 11 | cell fate specification involved in pattern specification |
GO:0060562 | 0.0091 | 2.5292 | 4.1543 | 10 | 311 | epithelial tube morphogenesis |
GO:0009605 | 0.0091 | 1.5984 | 25.006 | 37 | 1872 | response to external stimulus |
GO:0065007 | 0.0093 | 1.4558 | 130.8006 | 147 | 9792 | biological regulation |
GO:0002682 | 0.0094 | 1.7733 | 14.3998 | 24 | 1078 | regulation of immune system process |
GO:0055123 | 0.0099 | 3.4824 | 1.8167 | 6 | 136 | digestive system development |
GO:2000648 | 0.01 | 5.0882 | 0.8415 | 4 | 63 | positive regulation of stem cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 63.3959 | 1.1191 | 27 | 368 | olfactory receptor activity |
GO:0004930 | 0 | 28.1245 | 2.3537 | 27 | 774 | G-protein coupled receptor activity |
GO:0038023 | 0 | 17.0495 | 3.71 | 27 | 1220 | signaling receptor activity |
GO:0060089 | 0 | 13.4524 | 4.5827 | 27 | 1507 | molecular transducer activity |
GO:0016805 | 8e-04 | 57.1357 | 0.0426 | 2 | 14 | dipeptidase activity |
GO:0042974 | 0.0059 | 19.0142 | 0.1156 | 2 | 38 | retinoic acid receptor binding |
GO:0035575 | 0.0061 | 335.2727 | 0.0061 | 1 | 2 | histone demethylase activity (H4-K20 specific) |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 11.3725 | 0.6714 | 6 | 368 | olfactory receptor activity |
GO:0004930 | 4e-04 | 6.3904 | 1.4122 | 7 | 774 | G-protein coupled receptor activity |
GO:0031851 | 0.0018 | Inf | 0.0018 | 1 | 1 | kappa-type opioid receptor binding |
GO:0004601 | 0.0022 | 32.7444 | 0.0693 | 2 | 38 | peroxidase activity |
GO:0008009 | 0.0032 | 26.7764 | 0.0839 | 2 | 46 | chemokine activity |
GO:0016262 | 0.0036 | 568.0769 | 0.0036 | 1 | 2 | protein N-acetylglucosaminyltransferase activity |
GO:0031720 | 0.0036 | 568.0769 | 0.0036 | 1 | 2 | haptoglobin binding |
GO:0038023 | 0.0052 | 3.912 | 2.226 | 7 | 1220 | signaling receptor activity |
GO:0008426 | 0.0055 | 284.0192 | 0.0055 | 1 | 3 | protein kinase C inhibitor activity |
GO:0035662 | 0.0055 | 284.0192 | 0.0055 | 1 | 3 | Toll-like receptor 4 binding |
GO:0005126 | 0.0061 | 8.9981 | 0.3761 | 3 | 214 | cytokine receptor binding |
GO:0001664 | 0.0072 | 8.423 | 0.3996 | 3 | 219 | G-protein coupled receptor binding |
GO:0004945 | 0.0073 | 189.3333 | 0.0073 | 1 | 4 | angiotensin type II receptor activity |
GO:0005134 | 0.0091 | 141.9904 | 0.0091 | 1 | 5 | interleukin-2 receptor binding |
GO:0008508 | 0.0091 | 141.9904 | 0.0091 | 1 | 5 | bile acid:sodium symporter activity |
GO:0030492 | 0.0091 | 141.9904 | 0.0091 | 1 | 5 | hemoglobin binding |
GO:0050544 | 0.0091 | 141.9904 | 0.0091 | 1 | 5 | arachidonic acid binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 26.9888 | 0.746 | 12 | 368 | olfactory receptor activity |
GO:0004930 | 0 | 12.2537 | 1.5691 | 12 | 774 | G-protein coupled receptor activity |
GO:0038023 | 0 | 8.5917 | 2.4733 | 13 | 1220 | signaling receptor activity |
GO:0060089 | 0 | 6.7943 | 3.0551 | 13 | 1507 | molecular transducer activity |
GO:0004364 | 0 | 81.9333 | 0.0466 | 3 | 23 | glutathione transferase activity |
GO:0000334 | 0.002 | Inf | 0.002 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
GO:0043532 | 0.002 | Inf | 0.002 | 1 | 1 | angiostatin binding |
GO:0019825 | 0.0024 | 30.9538 | 0.073 | 2 | 36 | oxygen binding |
GO:0042030 | 0.0041 | 509.2069 | 0.0041 | 1 | 2 | ATPase inhibitor activity |
GO:0047223 | 0.0061 | 254.5862 | 0.0061 | 1 | 3 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 23.1284 | 0.8207 | 12 | 368 | olfactory receptor activity |
GO:0004930 | 0 | 13.5783 | 1.726 | 14 | 774 | G-protein coupled receptor activity |
GO:0038023 | 0 | 9.3776 | 2.7206 | 15 | 1220 | signaling receptor activity |
GO:0060089 | 0 | 7.4134 | 3.3607 | 15 | 1507 | molecular transducer activity |
GO:0001604 | 0.0022 | Inf | 0.0022 | 1 | 1 | urotensin II receptor activity |
GO:0018738 | 0.0022 | Inf | 0.0022 | 1 | 1 | S-formylglutathione hydrolase activity |
GO:0047374 | 0.0067 | 230.6719 | 0.0067 | 1 | 3 | methylumbelliferyl-acetate deacetylase activity |
GO:0003960 | 0.0089 | 153.7708 | 0.0089 | 1 | 4 | NADPH:quinone reductase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0 | 5.9633 | 3.8011 | 18 | 712 | sequence-specific DNA binding |
GO:0003700 | 7e-04 | 3.0097 | 5.3225 | 14 | 997 | sequence-specific DNA binding transcription factor activity |
GO:0044212 | 0.0042 | 3.3715 | 2.5839 | 8 | 484 | transcription regulatory region DNA binding |
GO:0001067 | 0.0046 | 3.321 | 2.6212 | 8 | 491 | regulatory region nucleic acid binding |
GO:0005144 | 0.0053 | Inf | 0.0053 | 1 | 1 | interleukin-13 receptor binding |
GO:0015052 | 0.0053 | Inf | 0.0053 | 1 | 1 | beta3-adrenergic receptor activity |
GO:0033682 | 0.0053 | Inf | 0.0053 | 1 | 1 | ATP-dependent 5'-3' DNA/RNA helicase activity |
GO:0005104 | 0.0055 | 20.0957 | 0.1121 | 2 | 21 | fibroblast growth factor receptor binding |
GO:0001077 | 0.0077 | 5.4749 | 0.7794 | 4 | 146 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GO:0042605 | 0.0091 | 15.2665 | 0.1441 | 2 | 27 | peptide antigen binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 41.408 | 0.9947 | 20 | 368 | olfactory receptor activity |
GO:0004930 | 0 | 18.5729 | 2.0922 | 20 | 774 | G-protein coupled receptor activity |
GO:0038023 | 0 | 11.2983 | 3.2977 | 20 | 1220 | signaling receptor activity |
GO:0060089 | 0 | 8.9247 | 4.0735 | 20 | 1507 | molecular transducer activity |
GO:0016015 | 1e-04 | 194.1316 | 0.0162 | 2 | 6 | morphogen activity |
GO:0004733 | 0.0027 | Inf | 0.0027 | 1 | 1 | pyridoxamine-phosphate oxidase activity |
GO:0030354 | 0.0054 | 378.3846 | 0.0054 | 1 | 2 | melanin-concentrating hormone activity |
GO:0070698 | 0.0054 | 378.3846 | 0.0054 | 1 | 2 | type I activin receptor binding |
GO:0004556 | 0.0081 | 189.1795 | 0.0081 | 1 | 3 | alpha-amylase activity |
GO:0035662 | 0.0081 | 189.1795 | 0.0081 | 1 | 3 | Toll-like receptor 4 binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0015293 | 3e-04 | 6.0051 | 1.2717 | 7 | 123 | symporter activity |
GO:0004994 | 0.001 | 64.6446 | 0.0517 | 2 | 5 | somatostatin receptor activity |
GO:0030676 | 0.0077 | 17.6207 | 0.1344 | 2 | 13 | Rac guanyl-nucleotide exchange factor activity |
GO:0022804 | 0.0091 | 2.8937 | 2.9157 | 8 | 282 | active transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 38.2808 | 0.7709 | 15 | 368 | olfactory receptor activity |
GO:0004930 | 0 | 17.3024 | 1.6214 | 15 | 774 | G-protein coupled receptor activity |
GO:0038023 | 0 | 13.6912 | 2.5558 | 17 | 1220 | signaling receptor activity |
GO:0060089 | 0 | 10.8202 | 3.157 | 17 | 1507 | molecular transducer activity |
GO:0031851 | 0.0021 | Inf | 0.0021 | 1 | 1 | kappa-type opioid receptor binding |
GO:0031727 | 0.0063 | 246.0833 | 0.0063 | 1 | 3 | CCR2 chemokine receptor binding |
GO:0005125 | 0.009 | 7.6868 | 0.4315 | 3 | 206 | cytokine activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 18.3609 | 2.8017 | 34 | 367 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 14.9472 | 3.3666 | 34 | 441 | detection of chemical stimulus |
GO:0050906 | 0 | 14.6511 | 3.4277 | 34 | 449 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 14.4364 | 3.4735 | 34 | 455 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 6.5849 | 8.5196 | 39 | 1116 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 5.9967 | 8.9395 | 38 | 1171 | neurological system process |
GO:0048387 | 0 | 30.8292 | 0.2061 | 5 | 27 | negative regulation of retinoic acid receptor signaling pathway |
GO:0007165 | 4e-04 | 1.9115 | 37.3154 | 55 | 4888 | signal transduction |
GO:0023052 | 0.0016 | 1.7707 | 41.0714 | 57 | 5380 | signaling |
GO:0050896 | 0.0043 | 1.6683 | 55.4464 | 70 | 7263 | response to stimulus |
GO:0031424 | 0.0058 | 8.8696 | 0.3664 | 3 | 48 | keratinization |
GO:0090158 | 0.0076 | Inf | 0.0076 | 1 | 1 | endoplasmic reticulum membrane organization |
GO:0097254 | 0.0076 | Inf | 0.0076 | 1 | 1 | renal tubular secretion |
GO:1901625 | 0.0076 | Inf | 0.0076 | 1 | 1 | cellular response to ergosterol |
GO:1901846 | 0.0076 | Inf | 0.0076 | 1 | 1 | positive regulation of cell communication by electrical coupling involved in cardiac conduction |
GO:0045671 | 0.0091 | 15.5439 | 0.145 | 2 | 19 | negative regulation of osteoclast differentiation |
GO:0032501 | 0.0099 | 1.5715 | 47.1252 | 60 | 6173 | multicellular organismal process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0048704 | 1e-04 | 6.7394 | 1.322 | 8 | 93 | embryonic skeletal system morphogenesis |
GO:0002426 | 6e-04 | 139.9813 | 0.0426 | 2 | 3 | immunoglobulin production in mucosal tissue |
GO:0060279 | 6e-04 | 139.9813 | 0.0426 | 2 | 3 | positive regulation of ovulation |
GO:0042993 | 0.0012 | 9.7267 | 0.4691 | 4 | 33 | positive regulation of transcription factor import into nucleus |
GO:1900180 | 0.0014 | 4.0187 | 2.1323 | 8 | 150 | regulation of protein localization to nucleus |
GO:0051223 | 0.002 | 2.6924 | 5.1317 | 13 | 361 | regulation of protein transport |
GO:0032387 | 0.0023 | 4.7801 | 1.3504 | 6 | 95 | negative regulation of intracellular transport |
GO:0030029 | 0.0029 | 2.3166 | 7.335 | 16 | 516 | actin filament-based process |
GO:0007015 | 0.0033 | 2.9562 | 3.5822 | 10 | 252 | actin filament organization |
GO:0051098 | 0.0034 | 3.1647 | 3.0136 | 9 | 212 | regulation of binding |
GO:0023019 | 0.0036 | 11.0897 | 0.3127 | 3 | 22 | signal transduction involved in regulation of gene expression |
GO:0036314 | 0.0041 | 10.5345 | 0.3269 | 3 | 23 | response to sterol |
GO:0044744 | 0.0043 | 3.0431 | 3.1273 | 9 | 220 | protein targeting to nucleus |
GO:1902593 | 0.0043 | 3.0431 | 3.1273 | 9 | 220 | single-organism nuclear import |
GO:1902743 | 0.0058 | 9.1586 | 0.3696 | 3 | 26 | regulation of lamellipodium organization |
GO:0043242 | 0.0059 | 5.9944 | 0.725 | 4 | 51 | negative regulation of protein complex disassembly |
GO:0042308 | 0.0067 | 5.7489 | 0.7534 | 4 | 53 | negative regulation of protein import into nucleus |
GO:0046824 | 0.0069 | 4.4694 | 1.1941 | 5 | 84 | positive regulation of nucleocytoplasmic transport |
GO:0007045 | 0.0072 | 5.6336 | 0.7676 | 4 | 54 | cell-substrate adherens junction assembly |
GO:0045444 | 0.0082 | 3.2242 | 2.2886 | 7 | 161 | fat cell differentiation |
GO:0051895 | 0.0084 | 17.4895 | 0.1422 | 2 | 10 | negative regulation of focal adhesion assembly |
GO:0002251 | 0.0087 | 7.7997 | 0.4265 | 3 | 30 | organ or tissue specific immune response |
GO:0007600 | 0.0088 | 1.8571 | 11.9692 | 21 | 842 | sensory perception |
GO:0042127 | 0.0089 | 1.6915 | 18.295 | 29 | 1287 | regulation of cell proliferation |
GO:0090316 | 0.0089 | 3.5678 | 1.7769 | 6 | 125 | positive regulation of intracellular protein transport |
GO:0060491 | 0.0096 | 4.1037 | 1.2936 | 5 | 91 | regulation of cell projection assembly |
GO:2001237 | 0.0096 | 4.1037 | 1.2936 | 5 | 91 | negative regulation of extrinsic apoptotic signaling pathway |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0009593 | 0 | 4.2967 | 4.9919 | 19 | 441 | detection of chemical stimulus |
GO:0097284 | 0 | 71.5143 | 0.1019 | 4 | 9 | hepatocyte apoptotic process |
GO:0044707 | 0 | 1.8776 | 67.5435 | 94 | 5967 | single-multicellular organism process |
GO:0050906 | 1e-04 | 3.4559 | 5.0825 | 16 | 449 | detection of stimulus involved in sensory perception |
GO:0007606 | 1e-04 | 3.4073 | 5.1504 | 16 | 455 | sensory perception of chemical stimulus |
GO:0050911 | 1e-04 | 3.6824 | 4.1543 | 14 | 367 | detection of chemical stimulus involved in sensory perception of smell |
GO:0050877 | 1e-04 | 2.3612 | 13.2551 | 28 | 1171 | neurological system process |
GO:0007186 | 1e-04 | 2.3826 | 12.6326 | 27 | 1116 | G-protein coupled receptor signaling pathway |
GO:0044253 | 3e-04 | 14.2838 | 0.3283 | 4 | 29 | positive regulation of multicellular organismal metabolic process |
GO:0010712 | 3e-04 | 13.7335 | 0.3396 | 4 | 30 | regulation of collagen metabolic process |
GO:0045214 | 4e-04 | 13.224 | 0.3509 | 4 | 31 | sarcomere organization |
GO:0010927 | 5e-04 | 4.1986 | 2.3092 | 9 | 204 | cellular component assembly involved in morphogenesis |
GO:0070482 | 6e-04 | 3.7545 | 2.8638 | 10 | 253 | response to oxygen levels |
GO:0042494 | 8e-04 | 88.3588 | 0.0453 | 2 | 4 | detection of bacterial lipoprotein |
GO:0001666 | 0.0015 | 3.5989 | 2.6714 | 9 | 236 | response to hypoxia |
GO:0032967 | 0.0016 | 14.7978 | 0.2377 | 3 | 21 | positive regulation of collagen biosynthetic process |
GO:0023052 | 0.0017 | 1.5952 | 60.899 | 80 | 5380 | signaling |
GO:0060706 | 0.0021 | 13.3163 | 0.2603 | 3 | 23 | cell differentiation involved in embryonic placenta development |
GO:0048545 | 0.0022 | 2.9595 | 3.9618 | 11 | 350 | response to steroid hormone |
GO:0007165 | 0.0028 | 1.5633 | 55.3298 | 73 | 4888 | signal transduction |
GO:0010811 | 0.0034 | 5.3247 | 1.0074 | 5 | 89 | positive regulation of cell-substrate adhesion |
GO:0009605 | 0.0034 | 1.7674 | 21.1901 | 34 | 1872 | response to external stimulus |
GO:0031223 | 0.0034 | 29.4451 | 0.0906 | 2 | 8 | auditory behavior |
GO:0051938 | 0.0034 | 29.4451 | 0.0906 | 2 | 8 | L-glutamate import |
GO:0030155 | 0.0038 | 2.901 | 3.6562 | 10 | 323 | regulation of cell adhesion |
GO:0055002 | 0.004 | 4.2394 | 1.5055 | 6 | 133 | striated muscle cell development |
GO:0007262 | 0.0044 | 25.237 | 0.1019 | 2 | 9 | STAT protein import into nucleus |
GO:0060973 | 0.0044 | 25.237 | 0.1019 | 2 | 9 | cell migration involved in heart development |
GO:0007156 | 0.0045 | 4.1408 | 1.5395 | 6 | 136 | homophilic cell adhesion |
GO:0032355 | 0.0047 | 4.9128 | 1.0867 | 5 | 96 | response to estradiol |
GO:0022607 | 0.0052 | 1.737 | 20.1374 | 32 | 1779 | cellular component assembly |
GO:0021924 | 0.0054 | 22.0809 | 0.1132 | 2 | 10 | cell proliferation in external granule layer |
GO:0098657 | 0.0054 | 22.0809 | 0.1132 | 2 | 10 | import into cell |
GO:0071260 | 0.0056 | 6.0387 | 0.7131 | 4 | 63 | cellular response to mechanical stimulus |
GO:0050707 | 0.0058 | 4.6554 | 1.1433 | 5 | 101 | regulation of cytokine secretion |
GO:0034097 | 0.0064 | 2.2591 | 6.5766 | 14 | 581 | response to cytokine |
GO:0045605 | 0.0066 | 19.6261 | 0.1245 | 2 | 11 | negative regulation of epidermal cell differentiation |
GO:0042221 | 0.0069 | 1.5985 | 31.7739 | 45 | 3064 | response to chemical |
GO:0042345 | 0.0077 | 8.0635 | 0.4075 | 3 | 36 | regulation of NF-kappaB import into nucleus |
GO:0002093 | 0.0078 | 17.6624 | 0.1358 | 2 | 12 | auditory receptor cell morphogenesis |
GO:0021936 | 0.0078 | 17.6624 | 0.1358 | 2 | 12 | regulation of cerebellar granule cell precursor proliferation |
GO:0048714 | 0.0078 | 17.6624 | 0.1358 | 2 | 12 | positive regulation of oligodendrocyte differentiation |
GO:0051896 | 0.008 | 4.295 | 1.2338 | 5 | 109 | regulation of protein kinase B signaling |
GO:0009306 | 0.0084 | 3.2093 | 2.2979 | 7 | 203 | protein secretion |
GO:0070201 | 0.0085 | 2.4351 | 4.7655 | 11 | 421 | regulation of establishment of protein localization |
GO:0030510 | 0.0086 | 5.3149 | 0.8037 | 4 | 71 | regulation of BMP signaling pathway |
GO:0007155 | 0.0086 | 2.1151 | 7.5379 | 15 | 692 | cell adhesion |
GO:0048738 | 0.0087 | 3.5839 | 1.7658 | 6 | 156 | cardiac muscle tissue development |
GO:0010883 | 0.009 | 7.6017 | 0.4301 | 3 | 38 | regulation of lipid storage |
GO:0009312 | 0.0092 | 16.0556 | 0.1472 | 2 | 13 | oligosaccharide biosynthetic process |
GO:0010745 | 0.0092 | 16.0556 | 0.1472 | 2 | 13 | negative regulation of macrophage derived foam cell differentiation |
GO:0043090 | 0.0092 | 16.0556 | 0.1472 | 2 | 13 | amino acid import |
GO:0001654 | 0.0094 | 2.6734 | 3.543 | 9 | 313 | eye development |
GO:0001952 | 0.0094 | 5.1601 | 0.8263 | 4 | 73 | regulation of cell-matrix adhesion |
GO:0048878 | 0.0094 | 1.992 | 9.0669 | 17 | 801 | chemical homeostasis |
GO:0006955 | 0.0098 | 1.7759 | 14.5003 | 24 | 1281 | immune response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0044259 | 0 | 5.8075 | 2.9849 | 15 | 116 | multicellular organismal macromolecule metabolic process |
GO:0022617 | 0 | 5.0531 | 3.1393 | 14 | 122 | extracellular matrix disassembly |
GO:0030574 | 0 | 6.2733 | 1.8436 | 10 | 72 | collagen catabolic process |
GO:0007267 | 0 | 1.9946 | 29.1288 | 53 | 1132 | cell-cell signaling |
GO:0072359 | 1e-04 | 2.0379 | 21.2033 | 40 | 824 | circulatory system development |
GO:0043062 | 2e-04 | 2.5517 | 9.2636 | 22 | 360 | extracellular structure organization |
GO:0051093 | 3e-04 | 2.0848 | 16.4428 | 32 | 639 | negative regulation of developmental process |
GO:0048856 | 3e-04 | 1.5105 | 84.6341 | 113 | 3426 | anatomical structure development |
GO:0048514 | 3e-04 | 2.2833 | 11.7081 | 25 | 455 | blood vessel morphogenesis |
GO:2000049 | 3e-04 | 38.1469 | 0.1544 | 3 | 6 | positive regulation of cell-cell adhesion mediated by cadherin |
GO:0048646 | 4e-04 | 1.9141 | 21.2771 | 38 | 840 | anatomical structure formation involved in morphogenesis |
GO:0061072 | 5e-04 | 28.6082 | 0.1801 | 3 | 7 | iris morphogenesis |
GO:0022603 | 6e-04 | 1.9568 | 17.9868 | 33 | 699 | regulation of anatomical structure morphogenesis |
GO:0050900 | 6e-04 | 2.5402 | 7.5653 | 18 | 294 | leukocyte migration |
GO:0001300 | 7e-04 | Inf | 0.0515 | 2 | 2 | chronological cell aging |
GO:1901246 | 7e-04 | Inf | 0.0515 | 2 | 2 | regulation of lung ciliated cell differentiation |
GO:0071230 | 8e-04 | 6.2199 | 1.1065 | 6 | 43 | cellular response to amino acid stimulus |
GO:0008015 | 8e-04 | 2.2968 | 9.7268 | 21 | 378 | blood circulation |
GO:0003008 | 0.001 | 1.5809 | 44.3365 | 65 | 1723 | system process |
GO:0044707 | 0.001 | 1.4602 | 92.407 | 118 | 3901 | single-multicellular organism process |
GO:0050896 | 0.001 | 1.4407 | 120.1304 | 147 | 5072 | response to stimulus |
GO:0045766 | 0.001 | 3.8518 | 2.5475 | 9 | 99 | positive regulation of angiogenesis |
GO:0043542 | 0.0011 | 3.4743 | 3.1136 | 10 | 121 | endothelial cell migration |
GO:0050665 | 0.0013 | 19.0696 | 0.2316 | 3 | 9 | hydrogen peroxide biosynthetic process |
GO:0060973 | 0.0013 | 19.0696 | 0.2316 | 3 | 9 | cell migration involved in heart development |
GO:0007389 | 0.0014 | 2.1469 | 10.859 | 22 | 422 | pattern specification process |
GO:2000026 | 0.0014 | 1.7002 | 27.6036 | 44 | 1093 | regulation of multicellular organismal development |
GO:0055007 | 0.0015 | 3.995 | 2.1872 | 8 | 85 | cardiac muscle cell differentiation |
GO:0001667 | 0.0015 | 2.5618 | 6.2272 | 15 | 242 | ameboidal cell migration |
GO:0042403 | 0.0018 | 8.9904 | 0.5404 | 4 | 21 | thyroid hormone metabolic process |
GO:0072659 | 0.0018 | 3.2389 | 3.3194 | 10 | 129 | protein localization to plasma membrane |
GO:0010710 | 0.0019 | 76.108 | 0.0772 | 2 | 3 | regulation of collagen catabolic process |
GO:0051896 | 0.002 | 3.4643 | 2.8048 | 9 | 109 | regulation of protein kinase B signaling |
GO:0023052 | 0.0021 | 1.357 | 138.439 | 166 | 5380 | signaling |
GO:0048562 | 0.0021 | 2.3961 | 7.0763 | 16 | 275 | embryonic organ morphogenesis |
GO:0048870 | 0.0022 | 1.6663 | 27.4047 | 43 | 1065 | cell motility |
GO:0008284 | 0.0023 | 1.8041 | 18.7587 | 32 | 729 | positive regulation of cell proliferation |
GO:0002064 | 0.0023 | 2.7751 | 4.6061 | 12 | 179 | epithelial cell development |
GO:0009790 | 0.0024 | 1.6976 | 24.3426 | 39 | 946 | embryo development |
GO:0048705 | 0.0024 | 2.6312 | 5.2494 | 13 | 204 | skeletal system morphogenesis |
GO:0051270 | 0.0025 | 1.8937 | 15.0533 | 27 | 585 | regulation of cellular component movement |
GO:0002040 | 0.0025 | 4.7909 | 1.3895 | 6 | 54 | sprouting angiogenesis |
GO:0045665 | 0.0025 | 4.7909 | 1.3895 | 6 | 54 | negative regulation of neuron differentiation |
GO:0055006 | 0.0025 | 4.7909 | 1.3895 | 6 | 54 | cardiac cell development |
GO:0001704 | 0.0027 | 3.2982 | 2.9335 | 9 | 114 | formation of primary germ layer |
GO:0044246 | 0.0027 | 5.798 | 0.9778 | 5 | 38 | regulation of multicellular organismal metabolic process |
GO:0007610 | 0.0028 | 1.8797 | 15.1562 | 27 | 589 | behavior |
GO:0009605 | 0.003 | 1.4892 | 48.1706 | 67 | 1872 | response to external stimulus |
GO:0007186 | 0.003 | 1.6243 | 28.7171 | 44 | 1116 | G-protein coupled receptor signaling pathway |
GO:0030199 | 0.0031 | 5.6271 | 1.0036 | 5 | 39 | collagen fibril organization |
GO:0065008 | 0.0032 | 1.4113 | 72.2734 | 94 | 2841 | regulation of biological quality |
GO:0048869 | 0.0034 | 1.3984 | 77.9261 | 100 | 3091 | cellular developmental process |
GO:1901342 | 0.0035 | 2.6316 | 4.8376 | 12 | 188 | regulation of vasculature development |
GO:0002520 | 0.0035 | 1.7668 | 18.5014 | 31 | 719 | immune system development |
GO:0097305 | 0.0037 | 2.3224 | 6.819 | 15 | 265 | response to alcohol |
GO:0010810 | 0.0037 | 2.9174 | 3.654 | 10 | 142 | regulation of cell-substrate adhesion |
GO:0072278 | 0.0038 | 38.0514 | 0.1029 | 2 | 4 | metanephric comma-shaped body morphogenesis |
GO:0045165 | 0.0039 | 2.3847 | 6.2014 | 14 | 241 | cell fate commitment |
GO:0001944 | 0.0041 | 2.1145 | 8.9655 | 18 | 355 | vasculature development |
GO:0001101 | 0.0041 | 2.2944 | 6.8962 | 15 | 268 | response to acid chemical |
GO:0007492 | 0.0042 | 3.7299 | 2.0328 | 7 | 79 | endoderm development |
GO:0051216 | 0.0044 | 2.6833 | 4.3487 | 11 | 169 | cartilage development |
GO:0042692 | 0.0045 | 2.2052 | 7.6424 | 16 | 297 | muscle cell differentiation |
GO:0042542 | 0.0045 | 3.3041 | 2.5989 | 8 | 101 | response to hydrogen peroxide |
GO:0050803 | 0.0047 | 4.1792 | 1.5697 | 6 | 61 | regulation of synapse structure and activity |
GO:0030334 | 0.0047 | 1.8978 | 12.7374 | 23 | 495 | regulation of cell migration |
GO:0002067 | 0.0047 | 5.0334 | 1.1065 | 5 | 43 | glandular epithelial cell differentiation |
GO:0090132 | 0.0048 | 2.6494 | 4.4002 | 11 | 171 | epithelium migration |
GO:0043009 | 0.005 | 1.8119 | 15.079 | 26 | 586 | chordate embryonic development |
GO:0001958 | 0.0054 | 6.3652 | 0.7205 | 4 | 28 | endochondral ossification |
GO:0032496 | 0.0056 | 2.3672 | 5.7897 | 13 | 225 | response to lipopolysaccharide |
GO:0009952 | 0.0057 | 2.4616 | 5.1464 | 12 | 200 | anterior/posterior pattern specification |
GO:2000482 | 0.0061 | 9.5309 | 0.386 | 3 | 15 | regulation of interleukin-8 secretion |
GO:0060487 | 0.0062 | 6.1102 | 0.7462 | 4 | 29 | lung epithelial cell differentiation |
GO:0002639 | 0.0063 | 25.3659 | 0.1287 | 2 | 5 | positive regulation of immunoglobulin production |
GO:0003032 | 0.0063 | 25.3659 | 0.1287 | 2 | 5 | detection of oxygen |
GO:0030240 | 0.0063 | 25.3659 | 0.1287 | 2 | 5 | skeletal muscle thin filament assembly |
GO:0036119 | 0.0063 | 25.3659 | 0.1287 | 2 | 5 | response to platelet-derived growth factor |
GO:2000609 | 0.0063 | 25.3659 | 0.1287 | 2 | 5 | regulation of thyroid hormone generation |
GO:0033993 | 0.0069 | 1.9228 | 10.9082 | 20 | 432 | response to lipid |
GO:0071310 | 0.0071 | 1.452 | 43.8218 | 60 | 1703 | cellular response to organic substance |
GO:0001508 | 0.0072 | 2.6351 | 4.0142 | 10 | 156 | action potential |
GO:0055003 | 0.0074 | 8.7972 | 0.4117 | 3 | 16 | cardiac myofibril assembly |
GO:0032964 | 0.0078 | 5.6568 | 0.7977 | 4 | 31 | collagen biosynthetic process |
GO:0048265 | 0.0078 | 5.6568 | 0.7977 | 4 | 31 | response to pain |
GO:0042476 | 0.0083 | 2.9524 | 2.882 | 8 | 112 | odontogenesis |
GO:0045597 | 0.0087 | 1.7471 | 14.9761 | 25 | 582 | positive regulation of cell differentiation |
GO:0003283 | 0.0088 | 8.1683 | 0.4374 | 3 | 17 | atrial septum development |
GO:0060572 | 0.0088 | 8.1683 | 0.4374 | 3 | 17 | morphogenesis of an epithelial bud |
GO:0001775 | 0.0089 | 1.6179 | 21.3834 | 33 | 831 | cell activation |
GO:0044767 | 0.009 | 1.5789 | 25.704 | 38 | 1117 | single-organism developmental process |
GO:0060048 | 0.0092 | 3.5893 | 1.8013 | 6 | 70 | cardiac muscle contraction |
GO:0010269 | 0.0093 | 19.0231 | 0.1544 | 2 | 6 | response to selenium ion |
GO:0032808 | 0.0093 | 19.0231 | 0.1544 | 2 | 6 | lacrimal gland development |
GO:0072284 | 0.0093 | 19.0231 | 0.1544 | 2 | 6 | metanephric S-shaped body morphogenesis |
GO:0030097 | 0.0094 | 1.697 | 16.6487 | 27 | 647 | hemopoiesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0031110 | 7e-04 | 6.2605 | 1.0888 | 6 | 47 | regulation of microtubule polymerization or depolymerization |
GO:0003350 | 0.0016 | 84.8114 | 0.0695 | 2 | 3 | pulmonary myocardium development |
GO:0021590 | 0.0016 | 84.8114 | 0.0695 | 2 | 3 | cerebellum maturation |
GO:0035993 | 0.0016 | 84.8114 | 0.0695 | 2 | 3 | deltoid tuberosity development |
GO:0045324 | 0.0016 | 84.8114 | 0.0695 | 2 | 3 | late endosome to vacuole transport |
GO:0051588 | 0.0016 | 5.2356 | 1.2741 | 6 | 55 | regulation of neurotransmitter transport |
GO:0001662 | 0.0024 | 8.1128 | 0.5791 | 4 | 25 | behavioral fear response |
GO:0046677 | 0.0027 | 5.766 | 0.973 | 5 | 42 | response to antibiotic |
GO:0042053 | 0.003 | 12.7504 | 0.3012 | 3 | 13 | regulation of dopamine metabolic process |
GO:0031117 | 0.0031 | 42.4029 | 0.0927 | 2 | 4 | positive regulation of microtubule depolymerization |
GO:0046952 | 0.0031 | 42.4029 | 0.0927 | 2 | 4 | ketone body catabolic process |
GO:0033555 | 0.0033 | 4.4983 | 1.4594 | 6 | 63 | multicellular organismal response to stress |
GO:0060079 | 0.0034 | 5.4696 | 1.0193 | 5 | 44 | regulation of excitatory postsynaptic membrane potential |
GO:2000300 | 0.0037 | 11.5905 | 0.3243 | 3 | 14 | regulation of synaptic vesicle exocytosis |
GO:0018958 | 0.0043 | 3.6978 | 2.0386 | 7 | 88 | phenol-containing compound metabolic process |
GO:0007126 | 0.0044 | 2.8419 | 3.733 | 10 | 162 | meiotic nuclear division |
GO:0051177 | 0.0051 | 28.2667 | 0.1158 | 2 | 5 | meiotic sister chromatid cohesion |
GO:2000609 | 0.0051 | 28.2667 | 0.1158 | 2 | 5 | regulation of thyroid hormone generation |
GO:0032355 | 0.0069 | 3.3636 | 2.2239 | 7 | 96 | response to estradiol |
GO:0007135 | 0.0075 | 21.1986 | 0.139 | 2 | 6 | meiosis II |
GO:0021626 | 0.0075 | 21.1986 | 0.139 | 2 | 6 | central nervous system maturation |
GO:0071493 | 0.0075 | 21.1986 | 0.139 | 2 | 6 | cellular response to UV-B |
GO:2000288 | 0.0075 | 21.1986 | 0.139 | 2 | 6 | positive regulation of myoblast proliferation |
GO:0048536 | 0.0076 | 5.6755 | 0.7876 | 4 | 34 | spleen development |
GO:0050854 | 0.0076 | 5.6755 | 0.7876 | 4 | 34 | regulation of antigen receptor-mediated signaling pathway |
GO:0070206 | 0.0076 | 5.6755 | 0.7876 | 4 | 34 | protein trimerization |
GO:0007026 | 0.0078 | 8.4974 | 0.417 | 3 | 18 | negative regulation of microtubule depolymerization |
GO:0045577 | 0.0078 | 8.4974 | 0.417 | 3 | 18 | regulation of B cell differentiation |
GO:1901021 | 0.0078 | 8.4974 | 0.417 | 3 | 18 | positive regulation of calcium ion transmembrane transporter activity |
GO:0016266 | 0.0081 | 4.3504 | 1.2509 | 5 | 54 | O-glycan processing |
GO:0098661 | 0.0086 | 3.218 | 2.3166 | 7 | 100 | inorganic anion transmembrane transport |
GO:0033238 | 0.01 | 3.5086 | 1.8301 | 6 | 79 | regulation of cellular amine metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0022008 | 0 | 2.8026 | 37.0349 | 88 | 1053 | neurogenesis |
GO:0007275 | 0 | 2.0881 | 99.4194 | 165 | 3015 | multicellular organismal development |
GO:0032501 | 0 | 1.8235 | 221.0011 | 299 | 6173 | multicellular organismal process |
GO:0051960 | 0 | 2.8885 | 19.5475 | 50 | 546 | regulation of nervous system development |
GO:0048667 | 0 | 2.6635 | 20.5499 | 49 | 574 | cell morphogenesis involved in neuron differentiation |
GO:0061564 | 0 | 2.7329 | 18.7957 | 46 | 525 | axon development |
GO:0051252 | 0 | 1.717 | 115.101 | 169 | 3215 | regulation of RNA metabolic process |
GO:0048812 | 0 | 2.6119 | 20.9079 | 49 | 584 | neuron projection morphogenesis |
GO:0007268 | 0 | 2.8939 | 15.4404 | 40 | 443 | synaptic transmission |
GO:0006355 | 0 | 1.7085 | 110.8765 | 163 | 3097 | regulation of transcription, DNA-templated |
GO:0045666 | 0 | 6.5658 | 2.7925 | 15 | 78 | positive regulation of neuron differentiation |
GO:0031326 | 0 | 1.6464 | 130.0301 | 183 | 3632 | regulation of cellular biosynthetic process |
GO:0060284 | 0 | 2.874 | 13.9166 | 36 | 395 | regulation of cell development |
GO:0040011 | 0 | 1.9355 | 50.0859 | 87 | 1399 | locomotion |
GO:0043010 | 0 | 3.2974 | 9.8453 | 29 | 275 | camera-type eye development |
GO:0032502 | 0 | 1.7922 | 80.6051 | 123 | 2535 | developmental process |
GO:0045944 | 0 | 2.199 | 29.6076 | 59 | 827 | positive regulation of transcription from RNA polymerase II promoter |
GO:0007155 | 0 | 2.0673 | 36.3383 | 68 | 1015 | cell adhesion |
GO:0051093 | 0 | 2.3591 | 22.877 | 49 | 639 | negative regulation of developmental process |
GO:0010556 | 0 | 1.6081 | 124.9106 | 174 | 3489 | regulation of macromolecule biosynthetic process |
GO:0007399 | 0 | 2.6435 | 15.4787 | 37 | 499 | nervous system development |
GO:0006935 | 0 | 2.3361 | 22.0894 | 47 | 617 | chemotaxis |
GO:0051171 | 0 | 1.5681 | 144.7803 | 195 | 4044 | regulation of nitrogen compound metabolic process |
GO:0007218 | 0 | 4.9027 | 3.7949 | 16 | 106 | neuropeptide signaling pathway |
GO:0007156 | 0 | 4.2146 | 4.869 | 18 | 136 | homophilic cell adhesion |
GO:0051239 | 0 | 1.7775 | 58.7131 | 94 | 1677 | regulation of multicellular organismal process |
GO:0044700 | 0 | 1.5068 | 192.6107 | 244 | 5380 | single organism signaling |
GO:0045665 | 0 | 7.0111 | 1.9333 | 11 | 54 | negative regulation of neuron differentiation |
GO:0035108 | 0 | 4.0419 | 5.048 | 18 | 141 | limb morphogenesis |
GO:0018130 | 0 | 1.5443 | 131.9992 | 178 | 3687 | heterocycle biosynthetic process |
GO:0001764 | 0 | 4.1875 | 4.6184 | 17 | 129 | neuron migration |
GO:0007154 | 0 | 1.495 | 194.5934 | 245 | 5454 | cell communication |
GO:0019438 | 0 | 1.5381 | 130.0127 | 175 | 3657 | aromatic compound biosynthetic process |
GO:0048736 | 0 | 3.6978 | 5.764 | 19 | 161 | appendage development |
GO:0044271 | 0 | 1.5267 | 133.9325 | 179 | 3741 | cellular nitrogen compound biosynthetic process |
GO:0032990 | 0 | 2.0691 | 27.3522 | 52 | 764 | cell part morphogenesis |
GO:0006928 | 0 | 1.7476 | 55.3129 | 88 | 1545 | cellular component movement |
GO:0048562 | 0 | 3.4742 | 6.4113 | 20 | 182 | embryonic organ morphogenesis |
GO:0007517 | 0 | 2.7122 | 11.707 | 29 | 327 | muscle organ development |
GO:0035113 | 0 | 4.1581 | 4.3678 | 16 | 122 | embryonic appendage morphogenesis |
GO:0010628 | 0 | 1.8317 | 43.5343 | 73 | 1216 | positive regulation of gene expression |
GO:1901362 | 0 | 1.5158 | 133.9234 | 178 | 3767 | organic cyclic compound biosynthetic process |
GO:0003002 | 0 | 3.1275 | 7.7587 | 22 | 220 | regionalization |
GO:0021983 | 0 | 7.4518 | 1.5037 | 9 | 42 | pituitary gland development |
GO:0051674 | 0 | 1.8524 | 38.1283 | 65 | 1065 | localization of cell |
GO:0007423 | 0 | 2.8668 | 9.1614 | 24 | 267 | sensory organ development |
GO:0009790 | 0 | 2.5707 | 12.2905 | 29 | 354 | embryo development |
GO:0050794 | 0 | 1.5324 | 180.0382 | 220 | 5459 | regulation of cellular process |
GO:0007411 | 0 | 2.5659 | 11.8641 | 28 | 334 | axon guidance |
GO:0065007 | 0 | 1.4823 | 334.7914 | 378 | 9562 | biological regulation |
GO:0048663 | 0 | 7.8994 | 1.2727 | 8 | 36 | neuron fate commitment |
GO:0021517 | 0 | 6.6444 | 1.6469 | 9 | 46 | ventral spinal cord development |
GO:0030182 | 0 | 2.1584 | 19.5466 | 39 | 586 | neuron differentiation |
GO:0048729 | 0 | 2.1685 | 18.4018 | 37 | 514 | tissue morphogenesis |
GO:0080090 | 0 | 1.4253 | 184.448 | 228 | 5152 | regulation of primary metabolic process |
GO:0021530 | 0 | Inf | 0.1074 | 3 | 3 | spinal cord oligodendrocyte cell fate specification |
GO:0042472 | 1e-04 | 4.1463 | 3.5443 | 13 | 99 | inner ear morphogenesis |
GO:0060429 | 1e-04 | 1.8914 | 29.6401 | 52 | 838 | epithelium development |
GO:0003156 | 1e-04 | 17.0864 | 0.4626 | 5 | 13 | regulation of organ formation |
GO:0001709 | 1e-04 | 7.0644 | 1.3915 | 8 | 39 | cell fate determination |
GO:0030199 | 1e-04 | 7.039 | 1.3962 | 8 | 39 | collagen fibril organization |
GO:0048864 | 1e-04 | 2.7646 | 8.6639 | 22 | 242 | stem cell development |
GO:0034765 | 1e-04 | 2.5657 | 10.5614 | 25 | 295 | regulation of ion transmembrane transport |
GO:0048538 | 1e-04 | 6.8186 | 1.4321 | 8 | 40 | thymus development |
GO:0030900 | 1e-04 | 3.3696 | 5.2421 | 16 | 150 | forebrain development |
GO:0035115 | 1e-04 | 7.9445 | 1.1098 | 7 | 31 | embryonic forelimb morphogenesis |
GO:0001756 | 1e-04 | 4.9697 | 2.3271 | 10 | 65 | somitogenesis |
GO:2000679 | 1e-04 | 27.1241 | 0.2864 | 4 | 8 | positive regulation of transcription regulatory region DNA binding |
GO:0009187 | 1e-04 | 3.077 | 6.0504 | 17 | 169 | cyclic nucleotide metabolic process |
GO:0043583 | 1e-04 | 9.3353 | 0.8357 | 6 | 24 | ear development |
GO:0021537 | 1e-04 | 2.915 | 6.7306 | 18 | 188 | telencephalon development |
GO:1902680 | 2e-04 | 1.6899 | 41.3146 | 65 | 1154 | positive regulation of RNA biosynthetic process |
GO:0072358 | 2e-04 | 1.8147 | 29.5002 | 50 | 824 | cardiovascular system development |
GO:0010662 | 2e-04 | 12.3461 | 0.5728 | 5 | 16 | regulation of striated muscle cell apoptotic process |
GO:0072089 | 2e-04 | 8.7286 | 0.8814 | 6 | 25 | stem cell proliferation |
GO:0035295 | 2e-04 | 2.4114 | 10.7088 | 24 | 307 | tube development |
GO:0060042 | 2e-04 | 5.7396 | 1.6469 | 8 | 46 | retina morphogenesis in camera-type eye |
GO:0030030 | 2e-04 | 1.8773 | 25.0886 | 44 | 715 | cell projection organization |
GO:0001708 | 2e-04 | 5.6782 | 1.6584 | 8 | 47 | cell fate specification |
GO:0060021 | 2e-04 | 4.0654 | 3.0431 | 11 | 85 | palate development |
GO:0048518 | 2e-04 | 1.3959 | 144.5296 | 181 | 4037 | positive regulation of biological process |
GO:0035019 | 3e-04 | 5.4519 | 1.7185 | 8 | 48 | somatic stem cell maintenance |
GO:0060537 | 3e-04 | 2.3043 | 11.6354 | 25 | 325 | muscle tissue development |
GO:0007187 | 3e-04 | 3.0489 | 5.3702 | 15 | 150 | G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
GO:0021511 | 3e-04 | 7.7695 | 0.9666 | 6 | 27 | spinal cord patterning |
GO:2000826 | 3e-04 | 7.7695 | 0.9666 | 6 | 27 | regulation of heart morphogenesis |
GO:0007422 | 3e-04 | 4.2022 | 2.6851 | 10 | 75 | peripheral nervous system development |
GO:0030574 | 3e-04 | 4.2022 | 2.6851 | 10 | 75 | collagen catabolic process |
GO:0048665 | 3e-04 | 10.4966 | 0.6414 | 5 | 18 | neuron fate specification |
GO:0060231 | 3e-04 | 10.4453 | 0.6444 | 5 | 18 | mesenchymal to epithelial transition |
GO:0001501 | 3e-04 | 2.101 | 15.2513 | 30 | 426 | skeletal system development |
GO:0030902 | 3e-04 | 3.172 | 4.8332 | 14 | 135 | hindbrain development |
GO:0048468 | 4e-04 | 2.0923 | 15.3449 | 30 | 483 | cell development |
GO:0045935 | 4e-04 | 1.5995 | 47.5441 | 71 | 1328 | positive regulation of nucleobase-containing compound metabolic process |
GO:0072001 | 4e-04 | 2.442 | 9.2367 | 21 | 258 | renal system development |
GO:0021953 | 4e-04 | 4.4664 | 2.2867 | 9 | 65 | central nervous system neuron differentiation |
GO:0021779 | 4e-04 | 40.6165 | 0.179 | 3 | 5 | oligodendrocyte cell fate commitment |
GO:0021780 | 4e-04 | 40.6165 | 0.179 | 3 | 5 | glial cell fate specification |
GO:0035881 | 4e-04 | 40.6165 | 0.179 | 3 | 5 | amacrine cell differentiation |
GO:0060379 | 4e-04 | 15.4963 | 0.3938 | 4 | 11 | cardiac muscle cell myoblast differentiation |
GO:0072109 | 4e-04 | 15.4963 | 0.3938 | 4 | 11 | glomerular mesangium development |
GO:0032774 | 5e-04 | 1.5564 | 55.6638 | 80 | 1637 | RNA biosynthetic process |
GO:0060078 | 5e-04 | 5.8035 | 1.4252 | 7 | 40 | regulation of postsynaptic membrane potential |
GO:0021766 | 5e-04 | 4.9549 | 1.8617 | 8 | 52 | hippocampus development |
GO:0035116 | 5e-04 | 7.0929 | 1.0382 | 6 | 29 | embryonic hindlimb morphogenesis |
GO:0048675 | 5e-04 | 4.3843 | 2.3271 | 9 | 65 | axon extension |
GO:0009887 | 5e-04 | 2.0504 | 15.598 | 30 | 460 | organ morphogenesis |
GO:0021549 | 5e-04 | 3.9576 | 2.8283 | 10 | 79 | cerebellum development |
GO:0048592 | 5e-04 | 3.0451 | 5.0122 | 14 | 140 | eye morphogenesis |
GO:0071805 | 5e-04 | 3.0451 | 5.0122 | 14 | 140 | potassium ion transmembrane transport |
GO:0010001 | 5e-04 | 2.8972 | 5.6208 | 15 | 157 | glial cell differentiation |
GO:0036342 | 6e-04 | 9.0513 | 0.716 | 5 | 20 | post-anal tail morphogenesis |
GO:0043586 | 6e-04 | 9.0513 | 0.716 | 5 | 20 | tongue development |
GO:0048485 | 6e-04 | 9.0513 | 0.716 | 5 | 20 | sympathetic nervous system development |
GO:0072009 | 6e-04 | 4.2326 | 2.3987 | 9 | 67 | nephron epithelium development |
GO:0060560 | 6e-04 | 2.9736 | 5.1196 | 14 | 143 | developmental growth involved in morphogenesis |
GO:0010470 | 7e-04 | 6.5246 | 1.1098 | 6 | 31 | regulation of gastrulation |
GO:0002064 | 7e-04 | 2.6934 | 6.4084 | 16 | 179 | epithelial cell development |
GO:0009792 | 7e-04 | 1.8535 | 21.1943 | 37 | 592 | embryo development ending in birth or egg hatching |
GO:0031290 | 7e-04 | 8.485 | 0.7518 | 5 | 21 | retinal ganglion cell axon guidance |
GO:0007420 | 8e-04 | 2.7565 | 5.8682 | 15 | 173 | brain development |
GO:0000904 | 8e-04 | 3.4024 | 3.5455 | 11 | 105 | cell morphogenesis involved in differentiation |
GO:0060017 | 8e-04 | 27.0758 | 0.2148 | 3 | 6 | parathyroid gland development |
GO:0009605 | 9e-04 | 1.4718 | 67.0199 | 92 | 1872 | response to external stimulus |
GO:0008344 | 9e-04 | 3.6395 | 3.0431 | 10 | 85 | adult locomotory behavior |
GO:0035148 | 9e-04 | 2.9897 | 4.7258 | 13 | 132 | tube formation |
GO:0044259 | 9e-04 | 3.1551 | 4.1529 | 12 | 116 | multicellular organismal macromolecule metabolic process |
GO:0023019 | 9e-04 | 7.9854 | 0.7876 | 5 | 22 | signal transduction involved in regulation of gene expression |
GO:0048762 | 9e-04 | 2.8403 | 5.3344 | 14 | 149 | mesenchymal cell differentiation |
GO:0001570 | 9e-04 | 3.9584 | 2.5419 | 9 | 71 | vasculogenesis |
GO:0030879 | 0.001 | 2.9646 | 4.7616 | 13 | 133 | mammary gland development |
GO:0009891 | 0.001 | 1.5308 | 50.8378 | 73 | 1420 | positive regulation of biosynthetic process |
GO:0009712 | 0.001 | 5.0128 | 1.6111 | 7 | 45 | catechol-containing compound metabolic process |
GO:0050807 | 0.001 | 4.3585 | 2.0765 | 8 | 58 | regulation of synapse organization |
GO:0001656 | 0.0011 | 3.5444 | 3.1147 | 10 | 87 | metanephros development |
GO:0032989 | 0.0011 | 2.0785 | 12.785 | 25 | 375 | cellular component morphogenesis |
GO:0010656 | 0.0011 | 7.5412 | 0.8234 | 5 | 23 | negative regulation of muscle cell apoptotic process |
GO:0009059 | 0.0011 | 5.8175 | 1.2077 | 6 | 37 | macromolecule biosynthetic process |
GO:0007613 | 0.0012 | 3.4988 | 3.1505 | 10 | 88 | memory |
GO:0021987 | 0.0013 | 3.4542 | 3.1863 | 10 | 89 | cerebral cortex development |
GO:0003326 | 0.0013 | Inf | 0.0716 | 2 | 2 | pancreatic A cell fate commitment |
GO:0003329 | 0.0013 | Inf | 0.0716 | 2 | 2 | pancreatic PP cell fate commitment |
GO:0048343 | 0.0013 | Inf | 0.0716 | 2 | 2 | paraxial mesodermal cell fate commitment |
GO:0061032 | 0.0013 | Inf | 0.0716 | 2 | 2 | visceral serous pericardium development |
GO:0071657 | 0.0013 | Inf | 0.0716 | 2 | 2 | positive regulation of granulocyte colony-stimulating factor production |
GO:1901256 | 0.0013 | Inf | 0.0716 | 2 | 2 | regulation of macrophage colony-stimulating factor production |
GO:0045168 | 0.0014 | 5.6231 | 1.253 | 6 | 35 | cell-cell signaling involved in cell fate commitment |
GO:0007610 | 0.0014 | 2.3608 | 8.1364 | 18 | 234 | behavior |
GO:0016477 | 0.0015 | 1.6575 | 30.0123 | 47 | 858 | cell migration |
GO:0048646 | 0.0016 | 1.6944 | 26.8458 | 43 | 769 | anatomical structure formation involved in morphogenesis |
GO:0022603 | 0.0016 | 1.7392 | 23.6998 | 39 | 668 | regulation of anatomical structure morphogenesis |
GO:0021527 | 0.0016 | 9.8586 | 0.537 | 4 | 15 | spinal cord association neuron differentiation |
GO:0060579 | 0.0016 | 9.8586 | 0.537 | 4 | 15 | ventral spinal cord interneuron fate commitment |
GO:2000463 | 0.0016 | 9.8586 | 0.537 | 4 | 15 | positive regulation of excitatory postsynaptic membrane potential |
GO:0048565 | 0.0016 | 2.9281 | 4.4394 | 12 | 124 | digestive tract development |
GO:0044708 | 0.0017 | 2.0797 | 11.7251 | 23 | 330 | single-organism behavior |
GO:0009953 | 0.0017 | 3.0965 | 3.8665 | 11 | 108 | dorsal/ventral pattern formation |
GO:0001662 | 0.0017 | 6.7862 | 0.895 | 5 | 25 | behavioral fear response |
GO:0001568 | 0.0017 | 1.8373 | 18.4018 | 32 | 514 | blood vessel development |
GO:0098655 | 0.0018 | 1.7973 | 19.9771 | 34 | 558 | cation transmembrane transport |
GO:0007519 | 0.0018 | 2.6243 | 5.7282 | 14 | 160 | skeletal muscle tissue development |
GO:0048545 | 0.0018 | 2.0281 | 12.5304 | 24 | 350 | response to steroid hormone |
GO:0008406 | 0.0019 | 2.4362 | 7.017 | 16 | 196 | gonad development |
GO:0006813 | 0.0019 | 2.5203 | 6.3726 | 15 | 178 | potassium ion transport |
GO:0044057 | 0.0019 | 1.9915 | 13.2823 | 25 | 371 | regulation of system process |
GO:0060561 | 0.002 | 6.4626 | 0.9308 | 5 | 26 | apoptotic process involved in morphogenesis |
GO:0050793 | 0.0021 | 1.768 | 20.9405 | 35 | 621 | regulation of developmental process |
GO:0003407 | 0.0021 | 5.1228 | 1.3534 | 6 | 38 | neural retina development |
GO:0042136 | 0.0021 | 9.0364 | 0.5728 | 4 | 16 | neurotransmitter biosynthetic process |
GO:0090036 | 0.0021 | 9.0364 | 0.5728 | 4 | 16 | regulation of protein kinase C signaling |
GO:0007405 | 0.0021 | 4.3275 | 1.8259 | 7 | 51 | neuroblast proliferation |
GO:0014032 | 0.0021 | 4.3275 | 1.8259 | 7 | 51 | neural crest cell development |
GO:0003263 | 0.0022 | 16.2433 | 0.2864 | 3 | 8 | cardioblast proliferation |
GO:0010667 | 0.0022 | 16.2433 | 0.2864 | 3 | 8 | negative regulation of cardiac muscle cell apoptotic process |
GO:0048754 | 0.0023 | 2.5536 | 5.8714 | 14 | 164 | branching morphogenesis of an epithelial tube |
GO:0021515 | 0.0024 | 4.9734 | 1.3874 | 6 | 39 | cell differentiation in spinal cord |
GO:0090287 | 0.0025 | 2.5365 | 5.9072 | 14 | 165 | regulation of cellular response to growth factor stimulus |
GO:0097285 | 0.0025 | 1.9454 | 13.5687 | 25 | 379 | cell-type specific apoptotic process |
GO:0003006 | 0.0025 | 1.7556 | 20.4067 | 34 | 570 | developmental process involved in reproduction |
GO:0010629 | 0.0027 | 1.5603 | 35.8371 | 53 | 1001 | negative regulation of gene expression |
GO:0072091 | 0.0031 | 3.2694 | 3.0073 | 9 | 84 | regulation of stem cell proliferation |
GO:0009719 | 0.0032 | 1.482 | 46.3268 | 65 | 1294 | response to endogenous stimulus |
GO:0003266 | 0.0033 | 13.5351 | 0.3222 | 3 | 9 | regulation of secondary heart field cardioblast proliferation |
GO:0046549 | 0.0033 | 13.5351 | 0.3222 | 3 | 9 | retinal cone cell development |
GO:0051890 | 0.0033 | 13.5351 | 0.3222 | 3 | 9 | regulation of cardioblast differentiation |
GO:1901722 | 0.0033 | 13.5351 | 0.3222 | 3 | 9 | regulation of cell proliferation involved in kidney development |
GO:0042423 | 0.0033 | 7.7444 | 0.6444 | 4 | 18 | catecholamine biosynthetic process |
GO:2000311 | 0.0033 | 7.7444 | 0.6444 | 4 | 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity |
GO:0030198 | 0.0034 | 2.0259 | 10.9436 | 21 | 311 | extracellular matrix organization |
GO:0045446 | 0.0034 | 3.512 | 2.5061 | 8 | 70 | endothelial cell differentiation |
GO:0031344 | 0.0035 | 1.9521 | 12.423 | 23 | 347 | regulation of cell projection organization |
GO:0048701 | 0.0036 | 4.5276 | 1.5037 | 6 | 42 | embryonic cranial skeleton morphogenesis |
GO:1902679 | 0.0036 | 1.5693 | 32.1853 | 48 | 899 | negative regulation of RNA biosynthetic process |
GO:0001838 | 0.0036 | 2.779 | 4.2603 | 11 | 119 | embryonic epithelial tube formation |
GO:0000122 | 0.0036 | 1.7124 | 20.8721 | 34 | 583 | negative regulation of transcription from RNA polymerase II promoter |
GO:0001766 | 0.0037 | 54.059 | 0.1074 | 2 | 3 | membrane raft polarization |
GO:0002572 | 0.0037 | 54.059 | 0.1074 | 2 | 3 | pro-T cell differentiation |
GO:0003253 | 0.0037 | 54.059 | 0.1074 | 2 | 3 | cardiac neural crest cell migration involved in outflow tract morphogenesis |
GO:0021902 | 0.0037 | 54.059 | 0.1074 | 2 | 3 | commitment of neuronal cell to specific neuron type in forebrain |
GO:0032100 | 0.0037 | 54.059 | 0.1074 | 2 | 3 | positive regulation of appetite |
GO:0045163 | 0.0037 | 54.059 | 0.1074 | 2 | 3 | clustering of voltage-gated potassium channels |
GO:0072011 | 0.0037 | 54.059 | 0.1074 | 2 | 3 | glomerular endothelium development |
GO:0072125 | 0.0037 | 54.059 | 0.1074 | 2 | 3 | negative regulation of glomerular mesangial cell proliferation |
GO:0090074 | 0.0037 | 54.059 | 0.1074 | 2 | 3 | negative regulation of protein homodimerization activity |
GO:2000035 | 0.0037 | 54.059 | 0.1074 | 2 | 3 | regulation of stem cell division |
GO:0046661 | 0.0038 | 2.6212 | 4.9048 | 12 | 137 | male sex differentiation |
GO:0046579 | 0.0039 | 5.4271 | 1.074 | 5 | 30 | positive regulation of Ras protein signal transduction |
GO:0001508 | 0.004 | 2.4838 | 5.585 | 13 | 156 | action potential |
GO:0070588 | 0.004 | 2.4838 | 5.585 | 13 | 156 | calcium ion transmembrane transport |
GO:0048010 | 0.004 | 4.4049 | 1.5395 | 6 | 43 | vascular endothelial growth factor receptor signaling pathway |
GO:0007193 | 0.0041 | 3.8066 | 2.0407 | 7 | 57 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway |
GO:0050890 | 0.0041 | 2.2348 | 7.5899 | 16 | 212 | cognition |
GO:2000178 | 0.0041 | 7.2277 | 0.6802 | 4 | 19 | negative regulation of neural precursor cell proliferation |
GO:0006171 | 0.0044 | 2.8693 | 3.7591 | 10 | 105 | cAMP biosynthetic process |
GO:0035265 | 0.0044 | 3.0751 | 3.1754 | 9 | 89 | organ growth |
GO:0060872 | 0.0045 | 11.6007 | 0.358 | 3 | 10 | semicircular canal development |
GO:0048523 | 0.0046 | 1.3096 | 115.638 | 141 | 3230 | negative regulation of cellular process |
GO:0048839 | 0.0047 | 3.3097 | 2.6383 | 8 | 75 | inner ear development |
GO:0032879 | 0.0048 | 1.3913 | 64.6571 | 85 | 1806 | regulation of localization |
GO:0010976 | 0.0049 | 3.2983 | 2.6493 | 8 | 74 | positive regulation of neuron projection development |
GO:0051099 | 0.0049 | 3.026 | 3.2221 | 9 | 90 | positive regulation of binding |
GO:0045761 | 0.0049 | 3.6597 | 2.1123 | 7 | 59 | regulation of adenylate cyclase activity |
GO:0071300 | 0.0049 | 3.6597 | 2.1123 | 7 | 59 | cellular response to retinoic acid |
GO:0038084 | 0.005 | 6.7755 | 0.716 | 4 | 20 | vascular endothelial growth factor signaling pathway |
GO:0097503 | 0.005 | 6.7755 | 0.716 | 4 | 20 | sialylation |
GO:0007269 | 0.005 | 2.8098 | 3.8307 | 10 | 107 | neurotransmitter secretion |
GO:0042391 | 0.005 | 2.6461 | 4.4482 | 11 | 128 | regulation of membrane potential |
GO:0009890 | 0.0052 | 1.488 | 39.5604 | 56 | 1105 | negative regulation of biosynthetic process |
GO:0010769 | 0.0052 | 2.116 | 8.4849 | 17 | 237 | regulation of cell morphogenesis involved in differentiation |
GO:0060795 | 0.0052 | 5.0244 | 1.1456 | 5 | 32 | cell fate commitment involved in formation of primary germ layer |
GO:0009755 | 0.0052 | 2.9889 | 3.2579 | 9 | 91 | hormone-mediated signaling pathway |
GO:0042733 | 0.0054 | 3.5904 | 2.1481 | 7 | 60 | embryonic digit morphogenesis |
GO:0061448 | 0.0058 | 2.2089 | 7.1839 | 15 | 202 | connective tissue development |
GO:0060562 | 0.0059 | 2.4652 | 5.1833 | 12 | 147 | epithelial tube morphogenesis |
GO:0016055 | 0.0059 | 1.9208 | 11.4922 | 21 | 321 | Wnt signaling pathway |
GO:0007623 | 0.0059 | 2.4622 | 5.1912 | 12 | 145 | circadian rhythm |
GO:0003208 | 0.0059 | 3.5237 | 2.1839 | 7 | 61 | cardiac ventricle morphogenesis |
GO:0001759 | 0.006 | 6.3765 | 0.7518 | 4 | 21 | organ induction |
GO:0001945 | 0.006 | 6.3765 | 0.7518 | 4 | 21 | lymph vessel development |
GO:0051965 | 0.006 | 6.3765 | 0.7518 | 4 | 21 | positive regulation of synapse assembly |
GO:0060911 | 0.006 | 10.1862 | 0.3925 | 3 | 11 | cardiac cell fate commitment |
GO:0055074 | 0.006 | 1.9519 | 10.7762 | 20 | 301 | calcium ion homeostasis |
GO:0007171 | 0.0061 | 10.15 | 0.3938 | 3 | 11 | activation of transmembrane receptor protein tyrosine kinase activity |
GO:0060080 | 0.0061 | 10.15 | 0.3938 | 3 | 11 | regulation of inhibitory postsynaptic membrane potential |
GO:0071711 | 0.0061 | 10.15 | 0.3938 | 3 | 11 | basement membrane organization |
GO:0097154 | 0.0061 | 10.15 | 0.3938 | 3 | 11 | GABAergic neuron differentiation |
GO:0045597 | 0.0061 | 1.7233 | 17.6368 | 29 | 504 | positive regulation of cell differentiation |
GO:0007167 | 0.0062 | 1.5125 | 33.9754 | 49 | 949 | enzyme linked receptor protein signaling pathway |
GO:0060828 | 0.0063 | 2.4437 | 5.227 | 12 | 146 | regulation of canonical Wnt signaling pathway |
GO:0045934 | 0.0066 | 1.489 | 36.6247 | 52 | 1023 | negative regulation of nucleobase-containing compound metabolic process |
GO:0035850 | 0.0068 | 4.6772 | 1.2172 | 5 | 34 | epithelial cell differentiation involved in kidney development |
GO:0046189 | 0.0068 | 4.6772 | 1.2172 | 5 | 34 | phenol-containing compound biosynthetic process |
GO:2000177 | 0.0068 | 3.9042 | 1.708 | 6 | 48 | regulation of neural precursor cell proliferation |
GO:0021761 | 0.0068 | 6.094 | 0.7787 | 4 | 22 | limbic system development |
GO:0048863 | 0.0068 | 3.8961 | 1.7083 | 6 | 49 | stem cell differentiation |
GO:0022898 | 0.007 | 2.5203 | 4.6542 | 11 | 130 | regulation of transmembrane transporter activity |
GO:0033762 | 0.007 | 3.8792 | 1.7185 | 6 | 48 | response to glucagon |
GO:0001502 | 0.0071 | 6.0218 | 0.7876 | 4 | 22 | cartilage condensation |
GO:0030802 | 0.0073 | 2.645 | 4.0455 | 10 | 113 | regulation of cyclic nucleotide biosynthetic process |
GO:0007412 | 0.0073 | 27.0277 | 0.1432 | 2 | 4 | axon target recognition |
GO:0042662 | 0.0073 | 27.0277 | 0.1432 | 2 | 4 | negative regulation of mesodermal cell fate specification |
GO:0051665 | 0.0073 | 27.0277 | 0.1432 | 2 | 4 | membrane raft localization |
GO:0060437 | 0.0073 | 27.0277 | 0.1432 | 2 | 4 | lung growth |
GO:0060913 | 0.0073 | 27.0277 | 0.1432 | 2 | 4 | cardiac cell fate determination |
GO:0061056 | 0.0073 | 27.0277 | 0.1432 | 2 | 4 | sclerotome development |
GO:0061183 | 0.0073 | 27.0277 | 0.1432 | 2 | 4 | regulation of dermatome development |
GO:0072107 | 0.0073 | 27.0277 | 0.1432 | 2 | 4 | positive regulation of ureteric bud formation |
GO:0097476 | 0.0073 | 27.0277 | 0.1432 | 2 | 4 | spinal cord motor neuron migration |
GO:2000043 | 0.0073 | 27.0277 | 0.1432 | 2 | 4 | regulation of cardiac cell fate specification |
GO:0001763 | 0.0073 | 2.1467 | 7.3751 | 15 | 206 | morphogenesis of a branching structure |
GO:0048588 | 0.0074 | 2.8161 | 3.4369 | 9 | 96 | developmental cell growth |
GO:0007601 | 0.0075 | 2.2106 | 6.6948 | 14 | 187 | visual perception |
GO:0050804 | 0.0077 | 2.6249 | 4.072 | 10 | 115 | regulation of synaptic transmission |
GO:0072028 | 0.0077 | 4.521 | 1.253 | 5 | 35 | nephron morphogenesis |
GO:0048167 | 0.0078 | 2.6194 | 4.0813 | 10 | 114 | regulation of synaptic plasticity |
GO:1901342 | 0.0078 | 2.1978 | 6.7306 | 14 | 188 | regulation of vasculature development |
GO:0007605 | 0.0078 | 2.4783 | 4.7258 | 11 | 132 | sensory perception of sound |
GO:0001946 | 0.0079 | 9.0216 | 0.4296 | 3 | 12 | lymphangiogenesis |
GO:0003161 | 0.0079 | 9.0216 | 0.4296 | 3 | 12 | cardiac conduction system development |
GO:0048714 | 0.0079 | 9.0216 | 0.4296 | 3 | 12 | positive regulation of oligodendrocyte differentiation |
GO:0050768 | 0.0079 | 2.7839 | 3.4727 | 9 | 97 | negative regulation of neurogenesis |
GO:0050905 | 0.0079 | 2.7839 | 3.4727 | 9 | 97 | neuromuscular process |
GO:0042474 | 0.0084 | 5.7045 | 0.8234 | 4 | 23 | middle ear morphogenesis |
GO:0007215 | 0.0084 | 3.2797 | 2.3271 | 7 | 65 | glutamate receptor signaling pathway |
GO:0008593 | 0.0086 | 3.7023 | 1.7901 | 6 | 50 | regulation of Notch signaling pathway |
GO:0045668 | 0.0087 | 4.3749 | 1.2888 | 5 | 36 | negative regulation of osteoblast differentiation |
GO:1900371 | 0.0087 | 2.5696 | 4.1529 | 10 | 116 | regulation of purine nucleotide biosynthetic process |
GO:0034645 | 0.0089 | 1.289 | 111.5013 | 134 | 3206 | cellular macromolecule biosynthetic process |
GO:2000113 | 0.0089 | 1.473 | 35.5148 | 50 | 992 | negative regulation of cellular macromolecule biosynthetic process |
GO:0001823 | 0.009 | 2.7217 | 3.5443 | 9 | 99 | mesonephros development |
GO:0045766 | 0.009 | 2.7217 | 3.5443 | 9 | 99 | positive regulation of angiogenesis |
GO:0048704 | 0.0091 | 3.6516 | 1.8107 | 6 | 51 | embryonic skeletal system morphogenesis |
GO:0007189 | 0.0094 | 3.6198 | 1.8259 | 6 | 51 | adenylate cyclase-activating G-protein coupled receptor signaling pathway |
GO:0021879 | 0.0094 | 3.6198 | 1.8259 | 6 | 51 | forebrain neuron differentiation |
GO:0032835 | 0.0094 | 3.6198 | 1.8259 | 6 | 51 | glomerulus development |
GO:0021915 | 0.0094 | 2.3047 | 5.5134 | 12 | 154 | neural tube development |
GO:0051480 | 0.0094 | 2.0805 | 7.5899 | 15 | 212 | cytosolic calcium ion homeostasis |
GO:0098660 | 0.0095 | 1.6324 | 19.8339 | 31 | 554 | inorganic ion transmembrane transport |
GO:0001843 | 0.0096 | 2.9007 | 2.9715 | 8 | 83 | neural tube closure |
GO:0061458 | 0.0096 | 1.7523 | 14.3205 | 24 | 400 | reproductive system development |
GO:0050769 | 0.0097 | 2.3983 | 4.869 | 11 | 136 | positive regulation of neurogenesis |
GO:0050927 | 0.0098 | 5.4189 | 0.8592 | 4 | 24 | positive regulation of positive chemotaxis |
GO:0070848 | 0.0098 | 1.5801 | 23.1276 | 35 | 646 | response to growth factor |
GO:0021954 | 0.0099 | 3.17 | 2.3987 | 7 | 67 | central nervous system neuron development |
GO:0045664 | 0.0099 | 1.9655 | 9.074 | 17 | 262 | regulation of neuron differentiation |
GO:0010454 | 0.01 | 8.1189 | 0.4654 | 3 | 13 | negative regulation of cell fate commitment |
GO:0021520 | 0.01 | 8.1189 | 0.4654 | 3 | 13 | spinal cord motor neuron cell fate specification |
GO:0021794 | 0.01 | 8.1189 | 0.4654 | 3 | 13 | thalamus development |
GO:0048935 | 0.01 | 8.1189 | 0.4654 | 3 | 13 | peripheral nervous system neuron development |
GO:0090162 | 0.01 | 8.1189 | 0.4654 | 3 | 13 | establishment of epithelial cell polarity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032729 | 1e-04 | 11.5836 | 0.5005 | 5 | 39 | positive regulation of interferon-gamma production |
GO:0045210 | 2e-04 | Inf | 0.0257 | 2 | 2 | FasL biosynthetic process |
GO:0050906 | 2e-04 | 3.0071 | 5.7621 | 16 | 449 | detection of stimulus involved in sensory perception |
GO:0002827 | 2e-04 | 33.4665 | 0.1283 | 3 | 10 | positive regulation of T-helper 1 type immune response |
GO:0007606 | 3e-04 | 2.9648 | 5.8391 | 16 | 455 | sensory perception of chemical stimulus |
GO:0050911 | 3e-04 | 3.2094 | 4.7098 | 14 | 367 | detection of chemical stimulus involved in sensory perception of smell |
GO:0019221 | 4e-04 | 3.1366 | 4.8124 | 14 | 375 | cytokine-mediated signaling pathway |
GO:0010984 | 5e-04 | 23.4219 | 0.1668 | 3 | 13 | regulation of lipoprotein particle clearance |
GO:0009593 | 6e-04 | 2.8509 | 5.6594 | 15 | 441 | detection of chemical stimulus |
GO:0045087 | 6e-04 | 2.3247 | 10.2665 | 22 | 800 | innate immune response |
GO:0001817 | 9e-04 | 2.7131 | 5.9289 | 15 | 462 | regulation of cytokine production |
GO:0010916 | 0.001 | 77.7098 | 0.0513 | 2 | 4 | negative regulation of very-low-density lipoprotein particle clearance |
GO:0051607 | 0.0011 | 3.7516 | 2.5666 | 9 | 200 | defense response to virus |
GO:0060696 | 0.0016 | 51.8031 | 0.0642 | 2 | 5 | regulation of phospholipid catabolic process |
GO:0071073 | 0.0016 | 51.8031 | 0.0642 | 2 | 5 | positive regulation of phospholipid biosynthetic process |
GO:0045071 | 0.0017 | 8.7051 | 0.5133 | 4 | 40 | negative regulation of viral genome replication |
GO:0002822 | 0.0017 | 5.0886 | 1.2705 | 6 | 99 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
GO:0051707 | 0.002 | 2.2893 | 8.4186 | 18 | 656 | response to other organism |
GO:0050877 | 0.0021 | 1.9466 | 15.0276 | 27 | 1171 | neurological system process |
GO:0006641 | 0.0023 | 4.7783 | 1.3475 | 6 | 105 | triglyceride metabolic process |
GO:2000318 | 0.0024 | 38.8497 | 0.077 | 2 | 6 | positive regulation of T-helper 17 type immune response |
GO:0051241 | 0.0026 | 2.7367 | 4.6584 | 12 | 363 | negative regulation of multicellular organismal process |
GO:0046890 | 0.0028 | 4.5915 | 1.3988 | 6 | 109 | regulation of lipid biosynthetic process |
GO:0033198 | 0.0031 | 11.7031 | 0.2952 | 3 | 23 | response to ATP |
GO:0006638 | 0.0031 | 4.5034 | 1.4245 | 6 | 111 | neutral lipid metabolic process |
GO:0042102 | 0.0033 | 5.381 | 1.001 | 5 | 78 | positive regulation of T cell proliferation |
GO:0010529 | 0.0033 | 31.0777 | 0.0898 | 2 | 7 | negative regulation of transposition |
GO:0019441 | 0.0033 | 31.0777 | 0.0898 | 2 | 7 | tryptophan catabolic process to kynurenine |
GO:0034382 | 0.0033 | 31.0777 | 0.0898 | 2 | 7 | chylomicron remnant clearance |
GO:0044539 | 0.0033 | 31.0777 | 0.0898 | 2 | 7 | long-chain fatty acid import |
GO:0060586 | 0.0033 | 31.0777 | 0.0898 | 2 | 7 | multicellular organismal iron ion homeostasis |
GO:0009607 | 0.0033 | 2.1751 | 8.8292 | 18 | 688 | response to biotic stimulus |
GO:0050792 | 0.0039 | 3.7365 | 1.9891 | 7 | 155 | regulation of viral process |
GO:0006952 | 0.0043 | 2.2948 | 6.9705 | 15 | 580 | defense response |
GO:0045989 | 0.0044 | 25.8964 | 0.1027 | 2 | 8 | positive regulation of striated muscle contraction |
GO:0009581 | 0.0048 | 3.5895 | 2.0661 | 7 | 161 | detection of external stimulus |
GO:0009582 | 0.0053 | 3.5202 | 2.1046 | 7 | 164 | detection of abiotic stimulus |
GO:0006776 | 0.0056 | 22.1954 | 0.1155 | 2 | 9 | vitamin A metabolic process |
GO:0009972 | 0.0056 | 22.1954 | 0.1155 | 2 | 9 | cytidine deamination |
GO:0046087 | 0.0056 | 22.1954 | 0.1155 | 2 | 9 | cytidine metabolic process |
GO:0045321 | 0.0057 | 2.1565 | 7.8667 | 16 | 613 | leukocyte activation |
GO:0002821 | 0.0057 | 6.0201 | 0.7187 | 4 | 56 | positive regulation of adaptive immune response |
GO:0002682 | 0.0058 | 1.8571 | 13.8342 | 24 | 1078 | regulation of immune system process |
GO:0034097 | 0.0062 | 2.1919 | 7.2451 | 15 | 570 | response to cytokine |
GO:0046634 | 0.0065 | 5.7964 | 0.7443 | 4 | 58 | regulation of alpha-beta T cell activation |
GO:0006335 | 0.0069 | 19.4197 | 0.1283 | 2 | 10 | DNA replication-dependent nucleosome assembly |
GO:0046133 | 0.0069 | 19.4197 | 0.1283 | 2 | 10 | pyrimidine ribonucleoside catabolic process |
GO:0050965 | 0.0069 | 19.4197 | 0.1283 | 2 | 10 | detection of temperature stimulus involved in sensory perception of pain |
GO:2000515 | 0.0069 | 19.4197 | 0.1283 | 2 | 10 | negative regulation of CD4-positive, alpha-beta T cell activation |
GO:0046651 | 0.0074 | 2.9985 | 2.8105 | 8 | 219 | lymphocyte proliferation |
GO:0009605 | 0.0074 | 1.6707 | 21.396 | 33 | 1711 | response to external stimulus |
GO:0006883 | 0.0084 | 17.2608 | 0.1412 | 2 | 11 | cellular sodium ion homeostasis |
GO:0033700 | 0.0084 | 17.2608 | 0.1412 | 2 | 11 | phospholipid efflux |
GO:0046218 | 0.0084 | 17.2608 | 0.1412 | 2 | 11 | indolalkylamine catabolic process |
GO:0070672 | 0.0084 | 17.2608 | 0.1412 | 2 | 11 | response to interleukin-15 |
GO:0002456 | 0.0087 | 5.3034 | 0.8085 | 4 | 63 | T cell mediated immunity |
GO:0007186 | 0.0088 | 1.7875 | 14.3218 | 24 | 1116 | G-protein coupled receptor signaling pathway |
GO:0002443 | 0.0095 | 2.8609 | 2.9388 | 8 | 229 | leukocyte mediated immunity |
GO:0007602 | 0.0097 | 4.0855 | 1.2962 | 5 | 101 | phototransduction |
GO:0002719 | 0.0099 | 15.5337 | 0.154 | 2 | 12 | negative regulation of cytokine production involved in immune response |
GO:0006568 | 0.0099 | 15.5337 | 0.154 | 2 | 12 | tryptophan metabolic process |
GO:0032375 | 0.0099 | 15.5337 | 0.154 | 2 | 12 | negative regulation of cholesterol transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070588 | 5e-04 | 4.2015 | 2.31 | 9 | 156 | calcium ion transmembrane transport |
GO:0055014 | 6e-04 | 134.2511 | 0.0444 | 2 | 3 | atrial cardiac muscle cell development |
GO:0006941 | 8e-04 | 4.9751 | 1.5252 | 7 | 103 | striated muscle contraction |
GO:0016048 | 0.001 | 18.3771 | 0.2073 | 3 | 14 | detection of temperature stimulus |
GO:0010735 | 0.0013 | 67.1211 | 0.0592 | 2 | 4 | positive regulation of transcription via serum response element binding |
GO:0031427 | 0.0013 | 67.1211 | 0.0592 | 2 | 4 | response to methotrexate |
GO:0050951 | 0.0016 | 15.5478 | 0.2369 | 3 | 16 | sensory perception of temperature stimulus |
GO:0003283 | 0.0019 | 14.4363 | 0.2517 | 3 | 17 | atrial septum development |
GO:0042446 | 0.0021 | 6.0528 | 0.9033 | 5 | 61 | hormone biosynthetic process |
GO:0016115 | 0.0021 | 44.7444 | 0.074 | 2 | 5 | terpenoid catabolic process |
GO:0055117 | 0.0024 | 5.8433 | 0.9329 | 5 | 63 | regulation of cardiac muscle contraction |
GO:0006766 | 0.003 | 3.9405 | 1.8954 | 7 | 128 | vitamin metabolic process |
GO:0086036 | 0.0031 | 33.5561 | 0.0888 | 2 | 6 | regulation of cardiac muscle cell membrane potential |
GO:0006811 | 0.0035 | 1.7718 | 19.4423 | 32 | 1313 | ion transport |
GO:0006937 | 0.0037 | 3.7829 | 1.9694 | 7 | 133 | regulation of muscle contraction |
GO:0030539 | 0.004 | 10.6337 | 0.3258 | 3 | 22 | male genitalia development |
GO:0030510 | 0.004 | 5.1322 | 1.0513 | 5 | 71 | regulation of BMP signaling pathway |
GO:0007389 | 0.0042 | 2.3681 | 6.2488 | 14 | 422 | pattern specification process |
GO:0072511 | 0.0042 | 2.5629 | 4.9457 | 12 | 334 | divalent inorganic cation transport |
GO:0010566 | 0.0044 | 26.843 | 0.1037 | 2 | 7 | regulation of ketone biosynthetic process |
GO:0036376 | 0.0044 | 26.843 | 0.1037 | 2 | 7 | sodium ion export from cell |
GO:0050966 | 0.0044 | 26.843 | 0.1037 | 2 | 7 | detection of mechanical stimulus involved in sensory perception of pain |
GO:0034765 | 0.0046 | 2.6581 | 4.3682 | 11 | 295 | regulation of ion transmembrane transport |
GO:0032526 | 0.0052 | 4.0334 | 1.5844 | 6 | 107 | response to retinoic acid |
GO:0055001 | 0.0054 | 3.5024 | 2.1175 | 7 | 143 | muscle cell development |
GO:0035872 | 0.0055 | 6.1399 | 0.7108 | 4 | 48 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
GO:0006857 | 0.0058 | 22.3677 | 0.1185 | 2 | 8 | oligopeptide transport |
GO:0071360 | 0.0058 | 22.3677 | 0.1185 | 2 | 8 | cellular response to exogenous dsRNA |
GO:0086014 | 0.0058 | 22.3677 | 0.1185 | 2 | 8 | atrial cardiac muscle cell action potential |
GO:0086066 | 0.0058 | 22.3677 | 0.1185 | 2 | 8 | atrial cardiac muscle cell to AV node cell communication |
GO:0050691 | 0.0065 | 8.782 | 0.385 | 3 | 26 | regulation of defense response to virus by host |
GO:0055085 | 0.0067 | 1.7458 | 17.1027 | 28 | 1155 | transmembrane transport |
GO:0043242 | 0.0068 | 5.7468 | 0.7552 | 4 | 51 | negative regulation of protein complex disassembly |
GO:0003012 | 0.0071 | 2.4966 | 4.6347 | 11 | 313 | muscle system process |
GO:0008207 | 0.0072 | 8.4155 | 0.3998 | 3 | 27 | C21-steroid hormone metabolic process |
GO:0032351 | 0.0073 | 19.171 | 0.1333 | 2 | 9 | negative regulation of hormone metabolic process |
GO:0048263 | 0.0073 | 19.171 | 0.1333 | 2 | 9 | determination of dorsal identity |
GO:0044259 | 0.0076 | 3.7011 | 1.7177 | 6 | 116 | multicellular organismal macromolecule metabolic process |
GO:0051899 | 0.0086 | 3.6021 | 1.7621 | 6 | 119 | membrane depolarization |
GO:1901661 | 0.0088 | 7.7672 | 0.4294 | 3 | 29 | quinone metabolic process |
GO:0030157 | 0.0091 | 16.7735 | 0.1481 | 2 | 10 | pancreatic juice secretion |
GO:0050965 | 0.0091 | 16.7735 | 0.1481 | 2 | 10 | detection of temperature stimulus involved in sensory perception of pain |
GO:0051967 | 0.0091 | 16.7735 | 0.1481 | 2 | 10 | negative regulation of synaptic transmission, glutamatergic |
GO:0098657 | 0.0091 | 16.7735 | 0.1481 | 2 | 10 | import into cell |
GO:0060047 | 0.0092 | 3.1513 | 2.3396 | 7 | 158 | heart contraction |
GO:0010712 | 0.0097 | 7.479 | 0.4442 | 3 | 30 | regulation of collagen metabolic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 5.4606 | 4.4441 | 21 | 367 | detection of chemical stimulus involved in sensory perception of smell |
GO:0051606 | 0 | 3.9731 | 7.5441 | 26 | 623 | detection of stimulus |
GO:0007186 | 0 | 3.027 | 13.5139 | 35 | 1116 | G-protein coupled receptor signaling pathway |
GO:0007600 | 0 | 3.2674 | 10.196 | 29 | 842 | sensory perception |
GO:0031424 | 0 | 12.0136 | 0.5812 | 6 | 48 | keratinization |
GO:0003008 | 1e-04 | 2.1286 | 20.8642 | 39 | 1723 | system process |
GO:0009913 | 2e-04 | 4.8039 | 2.0344 | 9 | 168 | epidermal cell differentiation |
GO:0018149 | 4e-04 | 13.3209 | 0.3512 | 4 | 29 | peptide cross-linking |
GO:0006766 | 9e-04 | 4.8667 | 1.55 | 7 | 128 | vitamin metabolic process |
GO:0009235 | 0.0017 | 14.6188 | 0.2422 | 3 | 20 | cobalamin metabolic process |
GO:0042744 | 0.0023 | 13.0782 | 0.2664 | 3 | 22 | hydrogen peroxide catabolic process |
GO:0072525 | 0.0023 | 13.0782 | 0.2664 | 3 | 22 | pyridine-containing compound biosynthetic process |
GO:0015816 | 0.0029 | 32.9802 | 0.0848 | 2 | 7 | glycine transport |
GO:0042221 | 0.005 | 1.5443 | 42.4429 | 58 | 3505 | response to chemical |
GO:0030521 | 0.0053 | 6.1551 | 0.7023 | 4 | 58 | androgen receptor signaling pathway |
GO:0001580 | 0.0061 | 8.8692 | 0.3754 | 3 | 31 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0019852 | 0.0062 | 20.6085 | 0.1211 | 2 | 10 | L-ascorbic acid metabolic process |
GO:0050907 | 0.0089 | 7.6193 | 0.4287 | 3 | 39 | detection of chemical stimulus involved in sensory perception |
GO:0006820 | 0.0092 | 2.305 | 5.4855 | 12 | 453 | anion transport |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0072359 | 0 | 2.3708 | 20.4983 | 44 | 824 | circulatory system development |
GO:0048646 | 0 | 2.1985 | 23.5371 | 47 | 951 | anatomical structure formation involved in morphogenesis |
GO:0055003 | 0 | 18.0429 | 0.398 | 5 | 16 | cardiac myofibril assembly |
GO:0048514 | 2e-04 | 2.3696 | 11.3189 | 25 | 455 | blood vessel morphogenesis |
GO:1901342 | 3e-04 | 3.2367 | 4.6768 | 14 | 188 | regulation of vasculature development |
GO:2000049 | 3e-04 | 39.504 | 0.1493 | 3 | 6 | positive regulation of cell-cell adhesion mediated by cadherin |
GO:0043009 | 3e-04 | 2.1273 | 14.5777 | 29 | 586 | chordate embryonic development |
GO:0055006 | 4e-04 | 5.9293 | 1.3433 | 7 | 54 | cardiac cell development |
GO:0042700 | 6e-04 | Inf | 0.0498 | 2 | 2 | luteinizing hormone signaling pathway |
GO:0044259 | 6e-04 | 3.7713 | 2.8857 | 10 | 116 | multicellular organismal macromolecule metabolic process |
GO:0045597 | 7e-04 | 2.0596 | 14.4782 | 28 | 582 | positive regulation of cell differentiation |
GO:0045766 | 8e-04 | 3.9911 | 2.4628 | 9 | 99 | positive regulation of angiogenesis |
GO:0051239 | 8e-04 | 1.5563 | 50.9473 | 73 | 2048 | regulation of multicellular organismal process |
GO:0048486 | 9e-04 | 11.3086 | 0.4478 | 4 | 18 | parasympathetic nervous system development |
GO:0001667 | 0.0011 | 2.6559 | 6.0201 | 15 | 242 | ameboidal cell migration |
GO:0030856 | 0.0011 | 3.7797 | 2.5872 | 9 | 104 | regulation of epithelial cell differentiation |
GO:0045603 | 0.0011 | 19.748 | 0.2239 | 3 | 9 | positive regulation of endothelial cell differentiation |
GO:0055007 | 0.0012 | 4.139 | 2.1145 | 8 | 85 | cardiac muscle cell differentiation |
GO:0022603 | 0.0014 | 1.8923 | 17.3887 | 31 | 699 | regulation of anatomical structure morphogenesis |
GO:0070206 | 0.0014 | 6.8355 | 0.8458 | 5 | 34 | protein trimerization |
GO:0048562 | 0.0015 | 2.4844 | 6.8411 | 16 | 275 | embryonic organ morphogenesis |
GO:0042403 | 0.0016 | 9.3111 | 0.5224 | 4 | 21 | thyroid hormone metabolic process |
GO:0060048 | 0.0017 | 4.4187 | 1.7414 | 7 | 70 | cardiac muscle contraction |
GO:0003350 | 0.0018 | 78.8085 | 0.0746 | 2 | 3 | pulmonary myocardium development |
GO:0021558 | 0.0018 | 78.8085 | 0.0746 | 2 | 3 | trochlear nerve development |
GO:0021570 | 0.0018 | 78.8085 | 0.0746 | 2 | 3 | rhombomere 4 development |
GO:0035993 | 0.0018 | 78.8085 | 0.0746 | 2 | 3 | deltoid tuberosity development |
GO:0048769 | 0.0018 | 78.8085 | 0.0746 | 2 | 3 | sarcomerogenesis |
GO:0072003 | 0.0018 | 78.8085 | 0.0746 | 2 | 3 | kidney rudiment formation |
GO:0007389 | 0.0021 | 2.1147 | 10.4979 | 21 | 422 | pattern specification process |
GO:0070252 | 0.0026 | 4.7635 | 1.3931 | 6 | 56 | actin-mediated cell contraction |
GO:0030574 | 0.0026 | 4.0924 | 1.8657 | 7 | 75 | collagen catabolic process |
GO:0061053 | 0.003 | 3.9749 | 1.9155 | 7 | 77 | somite development |
GO:0043542 | 0.0032 | 3.2023 | 3.0101 | 9 | 121 | endothelial cell migration |
GO:0022617 | 0.0034 | 3.1738 | 3.0349 | 9 | 122 | extracellular matrix disassembly |
GO:0042060 | 0.0035 | 1.8257 | 16.1698 | 28 | 650 | wound healing |
GO:0048870 | 0.0035 | 1.6388 | 26.4936 | 41 | 1065 | cell motility |
GO:0010735 | 0.0036 | 39.4016 | 0.0995 | 2 | 4 | positive regulation of transcription via serum response element binding |
GO:0021557 | 0.0036 | 39.4016 | 0.0995 | 2 | 4 | oculomotor nerve development |
GO:0072278 | 0.0036 | 39.4016 | 0.0995 | 2 | 4 | metanephric comma-shaped body morphogenesis |
GO:0090132 | 0.0037 | 2.7457 | 4.2539 | 11 | 171 | epithelium migration |
GO:0060324 | 0.0041 | 5.2134 | 1.0697 | 5 | 43 | face development |
GO:0009952 | 0.0044 | 2.5513 | 4.9753 | 12 | 200 | anterior/posterior pattern specification |
GO:0008272 | 0.0045 | 10.768 | 0.3483 | 3 | 14 | sulfate transport |
GO:0071542 | 0.0045 | 10.768 | 0.3483 | 3 | 14 | dopaminergic neuron differentiation |
GO:0048705 | 0.0051 | 2.4974 | 5.0748 | 12 | 204 | skeletal system morphogenesis |
GO:0051093 | 0.0052 | 1.7854 | 15.8962 | 27 | 639 | negative regulation of developmental process |
GO:2000482 | 0.0056 | 9.87 | 0.3731 | 3 | 15 | regulation of interleukin-8 secretion |
GO:0006072 | 0.0059 | 26.266 | 0.1244 | 2 | 5 | glycerol-3-phosphate metabolic process |
GO:0006642 | 0.0059 | 26.266 | 0.1244 | 2 | 5 | triglyceride mobilization |
GO:0030240 | 0.0059 | 26.266 | 0.1244 | 2 | 5 | skeletal muscle thin filament assembly |
GO:2000609 | 0.0059 | 26.266 | 0.1244 | 2 | 5 | regulation of thyroid hormone generation |
GO:0055002 | 0.006 | 2.89 | 3.3086 | 9 | 133 | striated muscle cell development |
GO:0090183 | 0.006 | 4.7156 | 1.1692 | 5 | 47 | regulation of kidney development |
GO:0001944 | 0.0061 | 2.0734 | 8.6106 | 17 | 355 | vasculature development |
GO:0045197 | 0.0067 | 9.1102 | 0.398 | 3 | 16 | establishment or maintenance of epithelial cell apical/basal polarity |
GO:0060065 | 0.0067 | 9.1102 | 0.398 | 3 | 16 | uterus development |
GO:0061448 | 0.0072 | 2.3841 | 5.2987 | 12 | 213 | connective tissue development |
GO:0003254 | 0.0078 | 5.649 | 0.7961 | 4 | 32 | regulation of membrane depolarization |
GO:0010771 | 0.0078 | 5.649 | 0.7961 | 4 | 32 | negative regulation of cell morphogenesis involved in differentiation |
GO:0035924 | 0.0078 | 5.649 | 0.7961 | 4 | 32 | cellular response to vascular endothelial growth factor stimulus |
GO:0051785 | 0.0079 | 4.4004 | 1.2438 | 5 | 50 | positive regulation of nuclear division |
GO:2000736 | 0.008 | 3.2701 | 2.2886 | 7 | 92 | regulation of stem cell differentiation |
GO:0030509 | 0.008 | 2.9725 | 2.8608 | 8 | 115 | BMP signaling pathway |
GO:0003283 | 0.008 | 8.4589 | 0.4229 | 3 | 17 | atrial septum development |
GO:0060485 | 0.0084 | 2.4373 | 4.7514 | 11 | 191 | mesenchyme development |
GO:0021523 | 0.0087 | 19.6981 | 0.1493 | 2 | 6 | somatic motor neuron differentiation |
GO:0032808 | 0.0087 | 19.6981 | 0.1493 | 2 | 6 | lacrimal gland development |
GO:0060029 | 0.0087 | 19.6981 | 0.1493 | 2 | 6 | convergent extension involved in organogenesis |
GO:0070245 | 0.0087 | 19.6981 | 0.1493 | 2 | 6 | positive regulation of thymocyte apoptotic process |
GO:0071493 | 0.0087 | 19.6981 | 0.1493 | 2 | 6 | cellular response to UV-B |
GO:0072038 | 0.0087 | 19.6981 | 0.1493 | 2 | 6 | mesenchymal stem cell maintenance involved in nephron morphogenesis |
GO:0072284 | 0.0087 | 19.6981 | 0.1493 | 2 | 6 | metanephric S-shaped body morphogenesis |
GO:2001240 | 0.0087 | 5.4538 | 0.8209 | 4 | 33 | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand |
GO:0071229 | 0.0091 | 2.6928 | 3.5325 | 9 | 142 | cellular response to acid chemical |
GO:0009950 | 0.0094 | 7.8944 | 0.4478 | 3 | 18 | dorsal/ventral axis specification |
GO:0045076 | 0.0094 | 7.8944 | 0.4478 | 3 | 18 | regulation of interleukin-2 biosynthetic process |
GO:0002066 | 0.0097 | 5.2717 | 0.8458 | 4 | 34 | columnar/cuboidal epithelial cell development |
GO:0048536 | 0.0097 | 5.2717 | 0.8458 | 4 | 34 | spleen development |
GO:0048729 | 0.0097 | 1.7993 | 12.7866 | 22 | 514 | tissue morphogenesis |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 19.541 | 2.7036 | 34 | 367 | olfactory receptor activity |
GO:0004930 | 0 | 10.1595 | 5.6946 | 38 | 773 | G-protein coupled receptor activity |
GO:0038023 | 0 | 6.6418 | 8.9802 | 40 | 1219 | signaling receptor activity |
GO:0060089 | 0 | 5.2281 | 11.0945 | 40 | 1506 | molecular transducer activity |
GO:0042974 | 0 | 21.3491 | 0.2799 | 5 | 38 | retinoic acid receptor binding |
GO:0016805 | 0.0046 | 22.8583 | 0.1031 | 2 | 14 | dipeptidase activity |
GO:0051427 | 0.0048 | 4.8897 | 1.0903 | 5 | 148 | hormone receptor binding |
GO:0031370 | 0.0074 | Inf | 0.0074 | 1 | 1 | eukaryotic initiation factor 4G binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005125 | 7e-04 | 3.6709 | 2.9238 | 10 | 206 | cytokine activity |
GO:0005126 | 0.0012 | 3.4395 | 3.1083 | 10 | 219 | cytokine receptor binding |
GO:0030246 | 0.0041 | 2.8672 | 3.6902 | 10 | 260 | carbohydrate binding |
GO:0070851 | 0.0062 | 3.8706 | 1.6464 | 6 | 116 | growth factor receptor binding |
GO:0001221 | 0.0084 | 17.5216 | 0.1419 | 2 | 10 | transcription cofactor binding |
GO:0008194 | 0.0088 | 3.5756 | 1.7741 | 6 | 125 | UDP-glycosyltransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050997 | 0.0016 | 14.644 | 0.2336 | 3 | 27 | quaternary ammonium group binding |
GO:0005125 | 0.0021 | 4.2063 | 1.7821 | 7 | 206 | cytokine activity |
GO:0004930 | 0.0028 | 2.436 | 6.6872 | 15 | 773 | G-protein coupled receptor activity |
GO:0016614 | 0.0044 | 4.9699 | 1.0727 | 5 | 124 | oxidoreductase activity, acting on CH-OH group of donors |
GO:0004984 | 0.0046 | 3.0231 | 3.1749 | 9 | 367 | olfactory receptor activity |
GO:0016805 | 0.0063 | 19.3862 | 0.1211 | 2 | 14 | dipeptidase activity |
GO:0005132 | 0.0082 | 16.6145 | 0.1384 | 2 | 16 | type I interferon receptor binding |
GO:0038023 | 0.0086 | 1.9564 | 10.5456 | 19 | 1219 | signaling receptor activity |
GO:0000334 | 0.0087 | Inf | 0.0087 | 1 | 1 | 3-hydroxyanthranilate 3,4-dioxygenase activity |
GO:0001605 | 0.0087 | Inf | 0.0087 | 1 | 1 | adrenomedullin receptor activity |
GO:0005124 | 0.0087 | Inf | 0.0087 | 1 | 1 | scavenger receptor binding |
GO:0005142 | 0.0087 | Inf | 0.0087 | 1 | 1 | interleukin-11 receptor binding |
GO:0005456 | 0.0087 | Inf | 0.0087 | 1 | 1 | CMP-N-acetylneuraminate transmembrane transporter activity |
GO:0015327 | 0.0087 | Inf | 0.0087 | 1 | 1 | cystine:glutamate antiporter activity |
GO:0018455 | 0.0087 | Inf | 0.0087 | 1 | 1 | alcohol dehydrogenase [NAD(P)+] activity |
GO:0047127 | 0.0087 | Inf | 0.0087 | 1 | 1 | thiomorpholine-carboxylate dehydrogenase activity |
GO:1901680 | 0.0087 | Inf | 0.0087 | 1 | 1 | sulfur-containing amino acid secondary active transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 0 | 3.1673 | 15.88 | 41 | 1424 | receptor activity |
GO:0004930 | 0 | 3.3143 | 8.6202 | 25 | 773 | G-protein coupled receptor activity |
GO:0004871 | 0 | 2.59 | 16.7944 | 37 | 1506 | signal transducer activity |
GO:0004984 | 1e-04 | 3.7501 | 4.0927 | 14 | 367 | olfactory receptor activity |
GO:0031685 | 7e-04 | 89.7485 | 0.0446 | 2 | 4 | adenosine receptor binding |
GO:0005044 | 0.0016 | 8.8411 | 0.5018 | 4 | 45 | scavenger receptor activity |
GO:0004888 | 0.0027 | 3.064 | 3.4943 | 10 | 350 | transmembrane signaling receptor activity |
GO:0046332 | 0.0056 | 6.0335 | 0.7137 | 4 | 64 | SMAD binding |
GO:0097110 | 0.0063 | 8.7216 | 0.3792 | 3 | 34 | scaffold protein binding |
GO:0044548 | 0.0064 | 19.9346 | 0.1227 | 2 | 11 | S100 protein binding |
GO:0016493 | 0.0076 | 17.9399 | 0.1338 | 2 | 12 | C-C chemokine receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004872 | 2e-04 | 1.7745 | 35.0322 | 57 | 1424 | receptor activity |
GO:0004871 | 2e-04 | 1.7359 | 37.0495 | 59 | 1506 | signal transducer activity |
GO:0030020 | 3e-04 | 39.9695 | 0.1476 | 3 | 6 | extracellular matrix structural constituent conferring tensile strength |
GO:0004888 | 8e-04 | 1.7475 | 27.6272 | 45 | 1123 | transmembrane signaling receptor activity |
GO:0004948 | 0.0018 | 79.7293 | 0.0738 | 2 | 3 | calcitonin receptor activity |
GO:0048407 | 0.0021 | 14.9834 | 0.2706 | 3 | 11 | platelet-derived growth factor binding |
GO:0005201 | 0.0024 | 4.8605 | 1.3669 | 6 | 56 | extracellular matrix structural constituent |
GO:0008188 | 0.0025 | 5.8979 | 0.9594 | 5 | 39 | neuropeptide receptor activity |
GO:0001968 | 0.0035 | 7.2778 | 0.6396 | 4 | 26 | fibronectin binding |
GO:0015026 | 0.0035 | 7.2778 | 0.6396 | 4 | 26 | coreceptor activity |
GO:0005518 | 0.0041 | 4.3025 | 1.5253 | 6 | 62 | collagen binding |
GO:0004435 | 0.0046 | 6.6704 | 0.6888 | 4 | 28 | phosphatidylinositol phospholipase C activity |
GO:0005125 | 0.0051 | 2.502 | 5.0679 | 12 | 206 | cytokine activity |
GO:0043236 | 0.0053 | 6.4031 | 0.7134 | 4 | 29 | laminin binding |
GO:0005539 | 0.0057 | 2.5835 | 4.502 | 11 | 183 | glycosaminoglycan binding |
GO:0042277 | 0.0057 | 2.7264 | 3.887 | 10 | 158 | peptide binding |
GO:0022836 | 0.0073 | 2.1411 | 7.3558 | 15 | 299 | gated channel activity |
GO:0022803 | 0.0085 | 1.9555 | 9.6437 | 18 | 392 | passive transmembrane transporter activity |
GO:0008528 | 0.0086 | 3.6356 | 1.7759 | 6 | 73 | G-protein coupled peptide receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 8.3434 | 3.5718 | 24 | 367 | olfactory receptor activity |
GO:0004930 | 0 | 4.5059 | 7.5231 | 28 | 773 | G-protein coupled receptor activity |
GO:0038023 | 0 | 3.2733 | 11.7725 | 32 | 1218 | signaling receptor activity |
GO:0060089 | 0 | 2.7675 | 14.6569 | 34 | 1506 | molecular transducer activity |
GO:0047760 | 0.0025 | 34.3803 | 0.0779 | 2 | 8 | butyrate-CoA ligase activity |
GO:0005179 | 0.0051 | 4.7994 | 1.1095 | 5 | 114 | hormone activity |
GO:0043178 | 0.008 | 5.4082 | 0.7883 | 4 | 81 | alcohol binding |
GO:0004733 | 0.0097 | Inf | 0.0097 | 1 | 1 | pyridoxamine-phosphate oxidase activity |
GO:0004963 | 0.0097 | Inf | 0.0097 | 1 | 1 | follicle-stimulating hormone receptor activity |
GO:0005124 | 0.0097 | Inf | 0.0097 | 1 | 1 | scavenger receptor binding |
GO:0005519 | 0.0097 | Inf | 0.0097 | 1 | 1 | cytoskeletal regulatory protein binding |
GO:0030377 | 0.0097 | Inf | 0.0097 | 1 | 1 | urokinase plasminogen activator receptor activity |
GO:0046539 | 0.0097 | Inf | 0.0097 | 1 | 1 | histamine N-methyltransferase activity |
GO:0050113 | 0.0097 | Inf | 0.0097 | 1 | 1 | inositol oxygenase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004111 | 0.0031 | 42.2515 | 0.093 | 2 | 4 | creatine kinase activity |
GO:0015277 | 0.0051 | 28.1657 | 0.1162 | 2 | 5 | kainate selective glutamate receptor activity |
GO:0008378 | 0.0069 | 5.8511 | 0.7672 | 4 | 33 | galactosyltransferase activity |
GO:0008376 | 0.0077 | 5.6557 | 0.7905 | 4 | 34 | acetylgalactosaminyltransferase activity |
GO:0004871 | 0.0097 | 1.4815 | 35.0138 | 49 | 1506 | signal transducer activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0043565 | 0 | 3.1998 | 25.3117 | 69 | 712 | sequence-specific DNA binding |
GO:0001077 | 0 | 3.9148 | 5.1903 | 18 | 146 | RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription |
GO:0000981 | 0 | 2.8264 | 10.4881 | 27 | 298 | sequence-specific DNA binding RNA polymerase II transcription factor activity |
GO:0015267 | 0 | 2.5029 | 13.9357 | 32 | 392 | channel activity |
GO:0071837 | 0 | 16.4538 | 0.5688 | 6 | 16 | HMG box domain binding |
GO:0005216 | 0 | 2.5314 | 12.9047 | 30 | 363 | ion channel activity |
GO:0022832 | 0 | 3.3687 | 6.2568 | 19 | 176 | voltage-gated channel activity |
GO:0030594 | 0 | 5.2337 | 2.453 | 11 | 69 | neurotransmitter receptor activity |
GO:0046982 | 0 | 2.4268 | 13.4024 | 30 | 377 | protein heterodimerization activity |
GO:0003700 | 0 | 2.097 | 21.145 | 41 | 621 | sequence-specific DNA binding transcription factor activity |
GO:0022843 | 1e-04 | 3.2951 | 5.0126 | 15 | 141 | voltage-gated cation channel activity |
GO:0005267 | 2e-04 | 3.6274 | 3.9816 | 13 | 112 | potassium channel activity |
GO:0004983 | 2e-04 | 21.8621 | 0.32 | 4 | 9 | neuropeptide Y receptor activity |
GO:0005509 | 3e-04 | 1.8834 | 23.2498 | 41 | 654 | calcium ion binding |
GO:0046873 | 4e-04 | 2.1775 | 13.2602 | 27 | 373 | metal ion transmembrane transporter activity |
GO:0030546 | 5e-04 | 7.1473 | 1.031 | 6 | 29 | receptor activator activity |
GO:0070888 | 0.001 | 6.0868 | 1.1732 | 6 | 33 | E-box binding |
GO:0004383 | 0.0014 | 20.4579 | 0.2489 | 3 | 7 | guanylate cyclase activity |
GO:0005021 | 0.0014 | 20.4579 | 0.2489 | 3 | 7 | vascular endothelial growth factor-activated receptor activity |
GO:0000975 | 0.0015 | 1.8801 | 17.4551 | 31 | 491 | regulatory region DNA binding |
GO:0001158 | 0.0021 | 3.851 | 2.3108 | 8 | 65 | enhancer sequence-specific DNA binding |
GO:0008528 | 0.0021 | 2.9964 | 3.9816 | 11 | 112 | G-protein coupled peptide receptor activity |
GO:0046872 | 0.0023 | 1.3562 | 108.3379 | 135 | 3159 | metal ion binding |
GO:0008083 | 0.0032 | 2.5576 | 5.4392 | 13 | 153 | growth factor activity |
GO:0008324 | 0.0033 | 1.7387 | 19.9792 | 33 | 562 | cation transmembrane transporter activity |
GO:0001665 | 0.0037 | 54.4618 | 0.1067 | 2 | 3 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity |
GO:0004965 | 0.0037 | 54.4618 | 0.1067 | 2 | 3 | G-protein coupled GABA receptor activity |
GO:0004999 | 0.0037 | 54.4618 | 0.1067 | 2 | 3 | vasoactive intestinal polypeptide receptor activity |
GO:0005250 | 0.0037 | 54.4618 | 0.1067 | 2 | 3 | A-type (transient outward) potassium channel activity |
GO:0005251 | 0.0051 | 5.0626 | 1.1376 | 5 | 32 | delayed rectifier potassium channel activity |
GO:0004871 | 0.0055 | 1.4196 | 53.5385 | 72 | 1506 | signal transducer activity |
GO:0003677 | 0.0058 | 1.4522 | 45.91 | 63 | 1407 | DNA binding |
GO:0005539 | 0.0058 | 2.2815 | 6.5057 | 14 | 183 | glycosaminoglycan binding |
GO:0005104 | 0.0058 | 6.4246 | 0.7466 | 4 | 21 | fibroblast growth factor receptor binding |
GO:0005201 | 0.0063 | 3.4859 | 2.2041 | 7 | 62 | extracellular matrix structural constituent |
GO:0016782 | 0.0063 | 3.4859 | 2.2041 | 7 | 62 | transferase activity, transferring sulfur-containing groups |
GO:0003705 | 0.0064 | 3.1329 | 2.7729 | 8 | 78 | RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity |
GO:0048495 | 0.0072 | 27.229 | 0.1422 | 2 | 4 | Roundabout binding |
GO:0030551 | 0.0075 | 4.5553 | 1.2443 | 5 | 35 | cyclic nucleotide binding |
GO:0005184 | 0.0082 | 5.7475 | 0.8177 | 4 | 23 | neuropeptide hormone activity |
GO:0043167 | 0.0082 | 1.2463 | 200.1118 | 227 | 5629 | ion binding |
GO:0000977 | 0.0083 | 1.9631 | 9.6341 | 18 | 271 | RNA polymerase II regulatory region sequence-specific DNA binding |
GO:0004888 | 0.0094 | 1.4435 | 39.9228 | 55 | 1123 | transmembrane signaling receptor activity |
GO:0005262 | 0.0098 | 2.6827 | 3.5906 | 9 | 101 | calcium channel activity |
GO:0034483 | 0.0098 | 8.1797 | 0.4622 | 3 | 13 | heparan sulfate sulfotransferase activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 2e-04 | 3.2682 | 4.6383 | 14 | 367 | olfactory receptor activity |
GO:0038023 | 7e-04 | 2.0697 | 15.4064 | 29 | 1219 | signaling receptor activity |
GO:0004930 | 8e-04 | 2.3311 | 9.7696 | 21 | 773 | G-protein coupled receptor activity |
GO:0030955 | 0.0042 | 26.3117 | 0.1011 | 2 | 8 | potassium ion binding |
GO:0060089 | 0.0044 | 1.7695 | 19.0337 | 31 | 1506 | molecular transducer activity |
GO:0042605 | 0.0046 | 9.9083 | 0.3412 | 3 | 27 | peptide antigen binding |
GO:0016814 | 0.0089 | 7.6673 | 0.4297 | 3 | 34 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005245 | 3e-04 | 9.3591 | 0.6103 | 5 | 42 | voltage-gated calcium channel activity |
GO:0005109 | 0.0016 | 8.8977 | 0.5086 | 4 | 35 | frizzled binding |
GO:0015277 | 0.002 | 45.6275 | 0.0727 | 2 | 5 | kainate selective glutamate receptor activity |
GO:0015291 | 0.0044 | 3.2958 | 2.572 | 8 | 177 | secondary active transmembrane transporter activity |
GO:0004866 | 0.0066 | 3.374 | 2.1942 | 7 | 151 | endopeptidase inhibitor activity |
GO:0016655 | 0.0068 | 5.7397 | 0.7556 | 4 | 52 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor |
GO:0015085 | 0.0075 | 3.7087 | 1.7147 | 6 | 118 | calcium ion transmembrane transporter activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | 5.6632 | 4.3159 | 21 | 367 | olfactory receptor activity |
GO:0004930 | 0 | 3.5723 | 9.0904 | 28 | 773 | G-protein coupled receptor activity |
GO:0038023 | 0 | 2.6514 | 14.3354 | 33 | 1219 | signaling receptor activity |
GO:0030492 | 0 | 128.2456 | 0.0588 | 3 | 5 | hemoglobin binding |
GO:0060089 | 3e-04 | 2.0892 | 17.7105 | 33 | 1506 | molecular transducer activity |
GO:0015038 | 0.0013 | 56.6628 | 0.0588 | 2 | 5 | glutathione disulfide oxidoreductase activity |
GO:0015187 | 0.0013 | 56.6628 | 0.0588 | 2 | 5 | glycine transmembrane transporter activity |
GO:0016209 | 0.0072 | 5.6166 | 0.7644 | 4 | 65 | antioxidant activity |
GO:0005416 | 0.0084 | 16.9907 | 0.1411 | 2 | 12 | cation:amino acid symporter activity |
GO:0050681 | 0.01 | 7.3118 | 0.4469 | 3 | 38 | androgen receptor binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0050911 | 0 | 81.9116 | 0.2179 | 6 | 368 | detection of chemical stimulus involved in sensory perception of smell |
GO:0009593 | 0 | 67.6697 | 0.2618 | 6 | 442 | detection of chemical stimulus |
GO:0050906 | 0 | 66.4144 | 0.2665 | 6 | 450 | detection of stimulus involved in sensory perception |
GO:0007606 | 0 | 65.5022 | 0.2701 | 6 | 456 | sensory perception of chemical stimulus |
GO:0007186 | 0 | 25.3411 | 0.6615 | 6 | 1117 | G-protein coupled receptor signaling pathway |
GO:0050877 | 0 | 24.0515 | 0.6941 | 6 | 1172 | neurological system process |
GO:0031424 | 3e-04 | 94.0497 | 0.0284 | 2 | 48 | keratinization |
GO:0044707 | 0.0014 | Inf | 2.736 | 7 | 5921 | single-multicellular organism process |
GO:0009913 | 0.0042 | 25.8554 | 0.0995 | 2 | 168 | epidermal cell differentiation |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0003167 | 3e-04 | Inf | 3e-04 | 1 | 1 | atrioventricular bundle cell differentiation |
GO:0019358 | 3e-04 | Inf | 3e-04 | 1 | 1 | nicotinate nucleotide salvage |
GO:0046497 | 3e-04 | Inf | 3e-04 | 1 | 1 | nicotinate nucleotide metabolic process |
GO:0006769 | 5e-04 | 5064 | 5e-04 | 1 | 2 | nicotinamide metabolic process |
GO:0010159 | 5e-04 | 5064 | 5e-04 | 1 | 2 | specification of organ position |
GO:0060931 | 8e-04 | 2531.8333 | 8e-04 | 1 | 3 | sinoatrial node cell development |
GO:0003164 | 0.0011 | 1687.7778 | 0.0011 | 1 | 4 | His-Purkinje system development |
GO:0021913 | 0.0011 | 1687.7778 | 0.0011 | 1 | 4 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification |
GO:0060596 | 0.0011 | 1687.7778 | 0.0011 | 1 | 4 | mammary placode formation |
GO:0003163 | 0.0013 | 1265.75 | 0.0013 | 1 | 5 | sinoatrial node development |
GO:0045165 | 0.0015 | 62.569 | 0.0634 | 2 | 241 | cell fate commitment |
GO:0060920 | 0.0016 | 1012.5333 | 0.0016 | 1 | 6 | cardiac pacemaker cell differentiation |
GO:0046884 | 0.0018 | 843.7222 | 0.0018 | 1 | 7 | follicle-stimulating hormone secretion |
GO:0032275 | 0.0021 | 723.1429 | 0.0021 | 1 | 8 | luteinizing hormone secretion |
GO:0060923 | 0.0021 | 723.1429 | 0.0021 | 1 | 8 | cardiac muscle cell fate commitment |
GO:0060573 | 0.0029 | 506.1 | 0.0029 | 1 | 11 | cell fate specification involved in pattern specification |
GO:0043173 | 0.0032 | 460.0606 | 0.0032 | 1 | 12 | nucleotide salvage |
GO:0045662 | 0.0034 | 421.6944 | 0.0034 | 1 | 13 | negative regulation of myoblast differentiation |
GO:0071697 | 0.0034 | 421.6944 | 0.0034 | 1 | 13 | ectodermal placode morphogenesis |
GO:0007350 | 0.0037 | 389.2308 | 0.0037 | 1 | 14 | blastoderm segmentation |
GO:0008595 | 0.0037 | 389.2308 | 0.0037 | 1 | 14 | anterior/posterior axis specification, embryo |
GO:0009435 | 0.0039 | 361.4048 | 0.0039 | 1 | 15 | NAD biosynthetic process |
GO:0060579 | 0.0039 | 361.4048 | 0.0039 | 1 | 15 | ventral spinal cord interneuron fate commitment |
GO:0030540 | 0.0042 | 337.2889 | 0.0042 | 1 | 16 | female genitalia development |
GO:0007389 | 0.0044 | 35.1738 | 0.1111 | 2 | 422 | pattern specification process |
GO:0019363 | 0.0047 | 297.5686 | 0.0047 | 1 | 18 | pyridine nucleotide biosynthetic process |
GO:0030539 | 0.0058 | 240.8254 | 0.0058 | 1 | 22 | male genitalia development |
GO:0060444 | 0.0068 | 202.24 | 0.0068 | 1 | 26 | branching involved in mammary gland duct morphogenesis |
GO:0021511 | 0.0071 | 194.4487 | 0.0071 | 1 | 27 | spinal cord patterning |
GO:0060412 | 0.0074 | 187.2346 | 0.0074 | 1 | 28 | ventricular septum morphogenesis |
GO:0030857 | 0.0076 | 180.5357 | 0.0076 | 1 | 29 | negative regulation of epithelial cell differentiation |
GO:0001580 | 0.0081 | 168.4778 | 0.0082 | 1 | 31 | detection of chemical stimulus involved in sensory perception of bitter taste |
GO:0035115 | 0.0081 | 168.4778 | 0.0082 | 1 | 31 | embryonic forelimb morphogenesis |
GO:0048665 | 0.0081 | 168.4778 | 0.0082 | 1 | 31 | neuron fate specification |
GO:0009792 | 0.0086 | 24.7508 | 0.1558 | 2 | 592 | embryo development ending in birth or egg hatching |
GO:0048742 | 0.0087 | 157.9271 | 0.0087 | 1 | 33 | regulation of skeletal muscle fiber development |
GO:0060986 | 0.0094 | 144.3619 | 0.0095 | 1 | 36 | endocrine hormone secretion |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0019358 | 2e-04 | Inf | 2e-04 | 1 | 1 | nicotinate nucleotide salvage |
GO:0046497 | 2e-04 | Inf | 2e-04 | 1 | 1 | nicotinate nucleotide metabolic process |
GO:0006769 | 4e-04 | 7596.5 | 4e-04 | 1 | 2 | nicotinamide metabolic process |
GO:2000381 | 4e-04 | 7596.5 | 4e-04 | 1 | 2 | negative regulation of mesoderm development |
GO:0035582 | 6e-04 | 3798 | 6e-04 | 1 | 3 | sequestering of BMP in extracellular matrix |
GO:0003419 | 8e-04 | 2531.8333 | 8e-04 | 1 | 4 | growth plate cartilage chondrocyte proliferation |
GO:0071692 | 0.001 | 1898.75 | 0.001 | 1 | 5 | protein localization to extracellular region |
GO:0048263 | 0.0018 | 949.125 | 0.0018 | 1 | 9 | determination of dorsal identity |
GO:0032926 | 0.002 | 843.6111 | 0.002 | 1 | 10 | negative regulation of activin receptor signaling pathway |
GO:0043173 | 0.0024 | 690.1364 | 0.0024 | 1 | 12 | nucleotide salvage |
GO:0042074 | 0.0026 | 632.5833 | 0.0026 | 1 | 13 | cell migration involved in gastrulation |
GO:1900116 | 0.0026 | 632.5833 | 0.0026 | 1 | 13 | extracellular negative regulation of signal transduction |
GO:0009435 | 0.003 | 542.1429 | 0.003 | 1 | 15 | NAD biosynthetic process |
GO:0019363 | 0.0035 | 446.3824 | 0.0036 | 1 | 18 | pyridine nucleotide biosynthetic process |
GO:0003416 | 0.0037 | 421.5556 | 0.0038 | 1 | 19 | endochondral bone growth |
GO:0071773 | 0.0041 | 379.35 | 0.0041 | 1 | 21 | cellular response to BMP stimulus |
GO:0023019 | 0.0043 | 361.2619 | 0.0043 | 1 | 22 | signal transduction involved in regulation of gene expression |
GO:0060351 | 0.0043 | 361.2619 | 0.0043 | 1 | 22 | cartilage development involved in endochondral bone morphogenesis |
GO:0009948 | 0.0089 | 172.1591 | 0.0089 | 1 | 45 | anterior/posterior axis specification |
GO:0031424 | 0.0094 | 161.1383 | 0.0095 | 1 | 48 | keratinization |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004984 | 0 | Inf | 0.1492 | 6 | 368 | olfactory receptor activity |
GO:0004930 | 0 | Inf | 0.3138 | 6 | 774 | G-protein coupled receptor activity |
GO:0038023 | 0 | Inf | 0.4947 | 6 | 1220 | signaling receptor activity |
GO:0060089 | 0 | Inf | 0.611 | 6 | 1507 | molecular transducer activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0032090 | 8e-04 | 2958.2 | 8e-04 | 1 | 2 | Pyrin domain binding |
GO:0008656 | 0.0065 | 197.0267 | 0.0065 | 1 | 16 | cysteine-type endopeptidase activator activity involved in apoptotic process |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0036122 | 0.0011 | 1643.4444 | 0.0011 | 1 | 4 | BMP binding |
GO:0016015 | 0.0016 | 985.9333 | 0.0016 | 1 | 6 | morphogen activity |
GO:0004984 | 0.0036 | 39.4208 | 0.0995 | 2 | 368 | olfactory receptor activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005057 | 0.0011 | 16.9711 | 0.2025 | 3 | 111 | receptor signaling protein activity |
GO:0035755 | 0.0018 | Inf | 0.0018 | 1 | 1 | cardiolipin hydrolase activity |
GO:0031386 | 0.0036 | 568.0769 | 0.0036 | 1 | 2 | protein tag |
GO:0060089 | 0.0043 | 3.728 | 2.7496 | 8 | 1507 | molecular transducer activity |
GO:0001591 | 0.0055 | 284.0192 | 0.0055 | 1 | 3 | dopamine neurotransmitter receptor activity, coupled via Gi/Go |
GO:0016167 | 0.0055 | 284.0192 | 0.0055 | 1 | 3 | glial cell-derived neurotrophic factor receptor activity |
GO:0004704 | 0.0073 | 189.3333 | 0.0073 | 1 | 4 | NF-kappaB-inducing kinase activity |
GO:0043565 | 0.0085 | 4.521 | 1.2991 | 5 | 712 | sequence-specific DNA binding |
GO:0038036 | 0.0091 | 141.9904 | 0.0091 | 1 | 5 | sphingosine-1-phosphate receptor activity |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004516 | 3e-04 | Inf | 3e-04 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
GO:0004514 | 8e-04 | 2465.3333 | 8e-04 | 1 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
GO:0033038 | 0.0049 | 289.7451 | 0.0049 | 1 | 18 | bitter taste receptor activity |
GO:0001102 | 0.0094 | 144.7059 | 0.0095 | 1 | 35 | RNA polymerase II activating transcription factor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004516 | 1e-04 | Inf | 1e-04 | 1 | 1 | nicotinate phosphoribosyltransferase activity |
GO:0004514 | 4e-04 | 7397 | 4e-04 | 1 | 3 | nicotinate-nucleotide diphosphorylase (carboxylating) activity |
GO:0036122 | 5e-04 | 4931 | 5e-04 | 1 | 4 | BMP binding |
GO:0016015 | 8e-04 | 2958.2 | 8e-04 | 1 | 6 | morphogen activity |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0052731 | 7e-04 | Inf | 7e-04 | 1 | 1 | phosphocholine phosphatase activity |
GO:0052732 | 7e-04 | Inf | 7e-04 | 1 | 1 | phosphoethanolamine phosphatase activity |
GO:0032090 | 0.0015 | 1478.6 | 0.0015 | 1 | 2 | Pyrin domain binding |
GO:0008190 | 0.0052 | 246.35 | 0.0052 | 1 | 7 | eukaryotic initiation factor 4E binding |
GO:0002161 | 0.0067 | 184.7375 | 0.0067 | 1 | 9 | aminoacyl-tRNA editing activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0033141 | 0.0011 | Inf | 0.0011 | 1 | 17 | positive regulation of peptidyl-serine phosphorylation of STAT protein |
GO:0045343 | 0.0014 | Inf | 0.0014 | 1 | 21 | regulation of MHC class I biosynthetic process |
GO:0002323 | 0.0017 | Inf | 0.0017 | 1 | 26 | natural killer cell activation involved in immune response |
GO:0043330 | 0.0026 | Inf | 0.0026 | 1 | 40 | response to exogenous dsRNA |
GO:0002286 | 0.0046 | Inf | 0.0046 | 1 | 70 | T cell activation involved in immune response |
GO:0042100 | 0.005 | Inf | 0.005 | 1 | 76 | B cell proliferation |
GO:0033135 | 0.0061 | Inf | 0.0061 | 1 | 92 | regulation of peptidyl-serine phosphorylation |
GO:0046425 | 0.0063 | Inf | 0.0063 | 1 | 95 | regulation of JAK-STAT cascade |
GO:0030183 | 0.0064 | Inf | 0.0064 | 1 | 98 | B cell differentiation |
GO:0006959 | 0.0091 | Inf | 0.0091 | 1 | 138 | humoral immune response |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0042699 | 8e-04 | 2531.5 | 8e-04 | 1 | 4 | follicle-stimulating hormone signaling pathway |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002313 | 0.0011 | 2169.4286 | 0.0011 | 1 | 8 | mature B cell differentiation involved in immune response |
GO:0030890 | 0.0043 | 473.7812 | 0.0043 | 1 | 33 | positive regulation of B cell proliferation |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0070886 | 7e-04 | 3797.25 | 7e-04 | 1 | 5 | positive regulation of calcineurin-NFAT signaling cascade |
GO:0010922 | 0.0026 | 798.6316 | 0.0026 | 1 | 20 | positive regulation of phosphatase activity |
GO:0048016 | 0.0032 | 659.5652 | 0.0032 | 1 | 24 | inositol phosphate-mediated signaling |
GO:0030318 | 0.0033 | 632.0417 | 0.0033 | 1 | 25 | melanocyte differentiation |
GO:0050848 | 0.0046 | 445.8529 | 0.0046 | 1 | 35 | regulation of calcium-mediated signaling |
GO:0071277 | 0.0047 | 433.0857 | 0.0047 | 1 | 36 | cellular response to calcium ion |
GO:0048066 | 0.0059 | 344.2955 | 0.0059 | 1 | 45 | developmental pigmentation |
GO:0042307 | 0.0093 | 216.0429 | 0.0093 | 1 | 71 | positive regulation of protein import into nucleus |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0002590 | 1e-04 | Inf | 1e-04 | 1 | 1 | negative regulation of antigen processing and presentation of peptide antigen via MHC class I |
GO:0002578 | 7e-04 | 3797.25 | 7e-04 | 1 | 5 | negative regulation of antigen processing and presentation |
GO:0002583 | 9e-04 | 2531.1667 | 9e-04 | 1 | 7 | regulation of antigen processing and presentation of peptide antigen |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0005132 | 0.0011 | Inf | 0.0011 | 1 | 16 | type I interferon receptor binding |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0004963 | 2e-04 | Inf | 2e-04 | 1 | 1 | follicle-stimulating hormone receptor activity |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0008142 | 7e-04 | 3697.5 | 7e-04 | 1 | 5 | oxysterol binding |
GO:0005496 | 0.0098 | 204.4722 | 0.0099 | 1 | 73 | steroid binding |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
GOMFID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
GO:0036122 | 5e-04 | 4930.3333 | 5e-04 | 1 | 4 | BMP binding |
GO:0016015 | 8e-04 | 2957.8 | 8e-04 | 1 | 6 | morphogen activity |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |
NA. |
n/a |